cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,2.0948808782314385
MDST8,654092,-1.4293910300938224,-0.16073553819296912
RKO,52947716,-6.611161073849914,-1.9383213794272738
RKO,56963564,0.5825206420774123,0.27633676091245113
Granta-519,107970,1.5911312599666134,1.689641555477539
HEL,12003241,-0.3954740832299299,-1.8545687148534251
SK-HEP-1,445091,4.514173662724111,4.37364788348085
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,3.2210542491826146
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,0.3250752058669516
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,1.8094389536997832
HCC15,24775005,4.257174534281358,3.8759145949805647
HuP-T3,6450551,3.7588607556856006,2.8230063059385433
SaOS-2,72376,-1.862865015628177,-1.7660415564201402
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.6391634298500533
Panc 02.03,3062316,2.5231792980774,0.6958206468124252
MOLP-8,6918837,-6.2821371699611515,-4.32522493234622
SW48,1242560,3.5610164041067645,3.342105037574175
RCC10RGB,3062316,3.7206614033239833,0.7001518382336642
IA-LM,25262965,-3.1838216959830796,-1.712297650818236
BICR 22,3038522,1.9324211832044784,2.8604693350277732
SW1573,4096211,3.236722527011662,2.0298905889255217
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-0.6380199514031931
NCI-H2452,2733526,3.4563089712221,3.8760320190654856
WM115,44197249,3.814304480361476,3.4667140804160708
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.72669892063366
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,-0.32829799713632063
SW948,216345,3.8478701746280506,3.955776166737635
RKN,2858523,3.2318364946727653,2.97198636958819
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.7799576513412096
LCLC-97TM1,17759555,4.8791087487812606,3.2828721844861826
ALL-SIL,24771867,-3.516684419884963,-0.7895482105000248
WM115,11455910,0.9860510612095932,0.9667581226647939
MOLP-8,11485656,1.8270206697288176,1.6938905302071896
MOLM-13,9866186,-0.4750218873797177,0.16098742673982
Daudi,445091,3.707432883595851,3.7908197353785966
RERF-LC-MS,9907093,3.840365222907794,4.380763715659066
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,3.3705567235994924
IA-LM,49836020,4.225846480888235,2.4737350512531746
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.3517963488713805
HuP-T3,445643,4.0158423100173986,3.9228800467530895
RKO,5351362,1.5688417029382893,1.2978375933176707
SU-DHL-1,25262965,-0.1887460090186497,-1.6774396238688754
MOLP-8,3552672,2.5417747800161483,2.055130764325258
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,2.3932593570017158
HCC15,24771867,-1.1106317715549263,2.73424757564351
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-3.986009989916906
COR-L95,25161177,5.647598761093448,3.8430858047020435
BFTC-909,16219061,3.736019824418232,3.5137267319569263
LCLC-97TM1,3503,2.904492448420953,2.282860671443808
RKN,5287620,-2.679516494579474,-2.1439110370565366
IA-LM,5281321,-0.2514769440259956,-1.3628748853981738
SK-HEP-1,24964624,3.121305411780932,2.7175513052633318
SaOS-2,9884685,-0.6485333929619777,0.5365076894024058
MOLP-8,44566777,0.3680572795114795,0.41677215968790593
K-562,3081361,1.217245739162405,2.428930062818116
HuP-T3,53392493,2.0684681956337654,2.51481731622213
SW48,11404337,-1.6842588085779022,-0.5801523150414205
RKO,24771867,6.323343540042099,1.1194218667653708
MDST8,11497983,4.366208744407351,3.952414598487887
Daudi,6918638,-1.8107043721369585,-0.42070760059897117
RERF-LC-MS,107970,3.001301355490032,2.2623891733066652
NCI-H2452,56963564,2.315469414243469,0.4886767518551619
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,-0.03399565951091675
MOLM-13,4259181,-1.5110532495146267,-0.6247219820670719
RERF-LC-MS,5566,3.05978093065268,3.070030555744486
HEL,44607531,1.529117499700861,1.0393340747080884
BFTC-909,25262965,-1.7887871070762158,-1.4898750200187467
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-0.6402375424893801
BICR 31,46191454,1.7584497327325264,1.8051777594228207
UACC-812,426756,4.999419351863596,4.447569279765409
SW1271,9911463,3.695583497273472,3.8819880842763554
COR-L105,219104,4.205860409291191,3.8625700268409555
MOLP-8,46943432,-0.8980695552897974,1.0681756772172626
MOLM-13,11626560,-0.3289224093786886,0.5183593861873154
SU-DHL-1,73707398,0.2992121771474305,0.7806689813702689
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-0.766624026715296
HCC1500,9907093,4.182225492860836,4.2663074620885775
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,1.1597796085079795
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,2.008218736152607
NCI-H1568,5746,-0.0019321539800122,1.146353481069469
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.3560166964455744
HEL,10385095,1.0320529067741009,0.8936142286075532
P31/FUJ,374536,-2.654779926412406,0.9335160462370442
KU-19-19,119607,4.136898976237774,5.406517263679327
HCC1500,11656518,1.3375266797474916,1.3758915945349737
NCI-H1568,44819697,-2.651253194329211,-0.1498299101757154
COR-L105,6918328,0.8369476830507139,0.5289148529190226
PaTu 8988t,1750826,2.46453979570572,-1.5310209718509262
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.1213903997839871
HCC1500,6438330,2.8683818740810088,1.8602458261605497
HEL,11214940,0.9295508638766669,1.129479556240594
HCC15,104842,-2.640027553911029,-3.129298952817348
BICR 22,53495165,-1.022289455565369,0.7623384904275526
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,1.3153295907930092
SW948,11167602,-0.1815305116238505,2.316666884527647
SaOS-2,119607,5.401113896800015,5.170525949485942
SW1271,444795,4.935671262335122,4.583298953558436
LS411N,107970,2.4864618038552724,2.247907966456018
RERF-LC-MS,3025944,4.157794890121567,4.328716043582199
IGROV-1,5282054,3.614574021382022,3.8015553390617565
MOLP-8,5284373,1.9803114216772224,2.0898434528037817
SW1271,46907787,1.639327018501732,1.9446824010938635
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,3.82309000789796
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.273235893231574
ALL-SIL,5351362,0.9273092220520184,0.9145341913885018
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-2.448898839064787
LCLC-97TM1,54618164,4.1848187977728,3.9109170756852474
SK-HEP-1,123631,3.617013696107864,2.4737048006170554
LS180,1641662,3.031869457755623,3.351436877968104
LCLC-97TM1,46199207,3.402623883365983,3.2932305165643845
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.36865396002768164
ALL-SIL,168312962,1.491579787235829,0.26202067351874264
IGROV-1,135398516,1.9751898057484376,2.1970834181079133
SK-OV-3,4261,3.2658157069367615,1.9680496614520937
Panc 02.03,11707110,-0.717341284128793,-0.3422173616442008
P31/FUJ,4261,-0.12536828191131,0.5473879971392184
Daudi,53481919,2.490259403593742,2.3549504881026873
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,1.7563573605338432
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,1.97409480440257
SW1573,12003241,-0.6702221198842615,-1.0059380649479794
COR-L95,11238147,1.8523673489534709,2.6719609990891873
SW48,452548,-3.152923699933953,0.07818620512869176
ALL-SIL,46224516,1.508509192124363,1.6050125240738853
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.1915979893222644
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.3112642426715273
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-3.748520258297829
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,0.8498123332744598
Daudi,6918837,-6.333799665630375,-4.373654391084231
K-562,57330099,5.557476297558147,4.2248474497918584
MOLM-13,3038522,-2.559283473550591,1.7213990831559585
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.2064505000022321
SU-DHL-6,9903786,1.8029536633965553,1.8607787815776176
Daudi,151289,0.3893937359913983,0.7962414336202558
MOLP-8,51037431,3.96461280344528,3.107426268950112
BICR 31,11152667,-0.7818812516610519,-0.5021400370501552
LS180,46907787,-0.2837252988913812,1.664760626813729
PaTu 8902,16725315,5.393152185048805,4.301611902901723
Panc 02.03,6914657,-4.005158687469553,-3.4587309503345733
HuP-T3,54613361,5.307179038572215,0.13707587368881546
PaTu 8902,107970,2.826401466277882,2.396651085812456
RKO,25183872,-1.1635703485572924,-0.973231077669163
RCC10RGB,135659046,5.776465120313546,3.853059563079937
BICR 31,16725315,5.360398456728244,4.4330399485597365
IA-LM,216239,1.6797579071033788,2.2732358163229502
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.8550104511594057
COR-L105,6610216,4.21117605455994,4.332618180759189
COR-L105,10427712,4.508625829006449,4.421681973121727
NCI-H2452,6610355,4.992583267176856,4.5868417656709655
PaTu 8988t,11364421,0.0778741703331701,-1.9794056871920618
RKN,3552672,1.948192158503618,2.7336554518187763
Granta-519,46174525,4.2506809125564615,3.1291674295742746
SW1271,44819697,-0.8585090240358869,-0.8140941818776477
WM115,44486219,4.206639028474801,4.3134933657457015
MOLP-8,6918736,-3.613498069188207,-2.046770526038868
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-0.45207510269388707
LS411N,49836020,4.501659667614969,2.8221154657650174
WM115,9927531,5.125567810288171,4.895047420273791
SW1271,24797083,1.5469513987685792,1.2886007807191546
HCC1500,1566236,1.5057997400762737,2.22476142930087
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.091178664143426
LCLC-97TM1,5566,3.3253657103683976,2.985582257346415
NCI-H1568,1242560,2.6554382745340046,3.6545533296598904
RKO,11717001,3.92417498432234,3.8573021820050717
SW1271,11612883,2.3755529899406604,2.8373473506519415
Daudi,11396600,1.6595042173405945,2.587781533881271
P31/FUJ,60700,-1.8341903870446763,-2.096057070239917
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,-0.26885678477128694
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.6781154377975912
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.105485149533469
IGROV-1,3552672,2.134472496867482,2.6071931960984664
Granta-519,637858,1.0013506713179747,0.9905462025301418
RERF-LC-MS,24753719,5.208830602571573,4.379671946609435
BICR 22,10385095,0.7738978245677988,1.6385851690249709
IA-LM,216468,5.467489395679956,3.1093375747641936
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.539601907934082
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,0.9752965642522576
SK-HEP-1,5738263,4.7811273930471065,3.6629915002002695
SU-DHL-1,44632017,-0.1440136540504316,0.7618392340703586
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,0.6283837825291346
PaTu 8902,11152667,1.2355675895718252,-0.5395222082000968
RCC10RGB,53245473,3.741106102916085,2.8337537450628956
RERF-LC-MS,637858,3.156110522031532,2.3857205023769392
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.8515188556088085
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,2.3156175858490577
MOLP-8,23635314,-4.658988245687028,-2.402470497771732
HCC1500,241158,4.347158152842418,3.726983630453169
NCI-H1568,16065773,2.3280951044534923,2.605799939300921
COR-L105,24771867,3.297975412837562,3.0840437000062333
COR-L105,11625818,4.2515796910784385,4.511302777489471
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,1.628264005068038
IGROV-1,2841722,3.834853118277962,4.217414364571604
SaOS-2,51039095,1.985897726070115,2.7113569049129542
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.4376746650873216
COR-L105,44589607,3.154557065472522,3.11565755015441
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.606038287013751
LS411N,9911463,4.267700407985282,3.505823461946402
IGROV-1,4378219,2.016502068118561,2.6481158316655073
Daudi,135659046,3.1156448500687923,3.122134964481629
KU-19-19,16722836,2.3762239171314894,1.6503212302817563
IGROV-1,10410894,3.2660402181528263,3.3968964084837587
Panc 02.03,49793307,-1.288996397670963,-2.922110729934159
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-0.926896573228676
MOLM-13,3136844,3.815118683612459,3.760317532427639
MOLP-8,6914657,-3.275680842626438,-4.352531298020618
K-562,9887053,4.062685534067952,2.7178834658664743
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,1.1932310281188518
NCI-H1568,52947716,-4.502411459776945,-0.18565722805269888
BFTC-909,11178236,-2.4757289909406683,-3.129944440879443
Daudi,6610355,3.6984054922795906,3.803858470551782
HuP-T3,10184653,2.026243337908569,1.4504979880104603
IA-LM,36462,3.5803800151684384,1.630169147963353
SU-DHL-6,46907787,-0.6700724490980451,-0.24269381290345904
HCC15,10231331,4.227224330005602,2.1307325942453654
LS180,135398516,1.9815935031047112,1.8940236592736546
MDST8,53495165,-1.6914230136545845,0.9747453213240914
SW48,135411,0.1882785626851766,0.3108563687845893
COR-L105,11485656,1.8131666015075352,2.350310743774927
HCC15,1239801,5.074899811919598,4.080616656978775
SK-CO-1,11497983,-2.036472499029009,3.700739620476296
Granta-519,2742550,3.255820788990773,3.2180246704053523
ALL-SIL,16720766,-0.6951675656481376,-0.8538010403864004
COR-L105,11175137,3.2551565890936165,2.814984061247218
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.7729755305249555
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.763697769619712
IGROV-1,409805,5.990596261907717,4.905079220661316
Panc 02.03,11485656,5.602754460209725,2.409463328458757
Granta-519,54619267,3.910643053444693,3.2418839410491684
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-1.5666044528074914
BICR 22,6252,-0.1324642168432157,1.275435774389961
MDST8,11404337,0.5498361952050128,-0.21913918452840236
SaOS-2,60750,-3.1697993298632183,-2.3802313184590513
SW948,11717001,4.275182691709766,3.8881352445757806
MDST8,11175137,2.5746086097463974,2.6775501962625845
IGROV-1,322968,4.140599241163106,3.8211871453548945
HCC1500,1242560,3.704354238917139,3.5989106981765993
MOLM-13,9911830,-0.5537570191991712,1.4187134124645084
COR-L105,16038120,1.5247864010803889,1.2472104467938825
COR-L105,45279963,3.905008730311125,3.948089641396739
WM115,148198,-2.543343591950365,-2.907744054096745
IGROV-1,2749,2.0319044408234954,1.8022973740283967
K-562,4477,-0.1635303329058878,0.4527570272807543
SK-HEP-1,25227462,1.4628952719758763,0.5663257496150935
Panc 02.03,23582824,1.3457270338170706,1.0695318645496712
SK-HEP-1,241158,4.116654148222159,4.075129948022433
SK-CO-1,168313047,0.9150038640573646,2.524256168475104
Granta-519,9823820,3.571742016367909,2.406082026130306
SK-CO-1,159324,2.1120355222347738,2.7726218294987293
SK-CO-1,10385095,1.4661007046294967,1.4874873306180403
NCI-H2452,71304818,2.7948147605911218,2.6064027449316645
MOLP-8,4578,4.125075782233611,4.211067524322716
NCI-H2452,11455910,0.7111396076654327,1.0061575412500379
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-4.991707319945644
LS180,10074640,3.3464344717087333,2.9366166869021533
MDST8,71466578,3.80352554053155,4.39645463115037
LS411N,6184667,3.0967158778150465,2.9929489595902794
SW948,11317348,1.1175502037929408,2.477092386992842
MDST8,119607,4.705186592802013,5.393850672216899
SW48,11507802,0.6466338181730511,1.1929669754286778
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.5914617615652468
WM115,5702613,3.6693021536028367,3.1198352930241118
SK-CO-1,23725625,2.337747507524157,5.1024361386561985
K-562,2749,1.8349792189296796,1.227244638488666
IA-LM,3825829,4.571991496451351,3.9529892488836693
KU-19-19,104842,-1.861779032385676,-2.561011612738112
SK-HEP-1,12001922,2.448252559355595,1.9327457522605784
HEL,135440466,1.1488755358131115,1.312583922527725
Panc 02.03,6918328,1.3018368822202735,0.22861277986153283
SaOS-2,72734382,4.901362762899978,4.492563308811418
HuP-T3,135421197,1.625440100707307,1.997988894545341
HCC1500,3384730,2.626558190955656,2.6403091227002324
IGROV-1,51037431,5.669320749085174,3.275422474806777
BFTC-909,4917,2.929839520827846,3.16983714742863
WM115,637858,1.77843641117838,1.9103251474254015
MDST8,44589607,2.007770745404649,2.6264778850991646
LCLC-97TM1,5282054,3.1900504557345664,3.8501772148594218
HuP-T3,46199207,3.4499209547515433,3.1762595453454634
BICR 31,25262965,-3.4333038857773093,-0.8443818055619363
LCLC-97TM1,6914657,-1.7973267784986633,-3.463778467575474
MOLM-13,9823820,-0.5140029045699521,2.1825160005181155
RCC10RGB,327653,3.228661308812885,3.361661955893033
NCI-H1568,4705,2.022283964907955,3.2928193095550085
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,1.7577241933532561
RKO,6914657,-2.9196237708628505,-3.8420124594493115
WM115,72734382,5.455243998512052,4.757700334323801
SW48,46398810,2.2376864399879,2.2661933317142666
LS411N,2945648,3.381909997555915,2.758760075857974
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.0146607901529188
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.3350709661653686
ALL-SIL,421610,2.937759224643201,2.1441025656708774
COR-L95,11404337,0.1032061359669597,-0.7801370573060373
WM115,11427553,3.734660617826416,2.6248456901130686
HCC15,122327,4.313110702061898,4.536210744318667
Daudi,9444,3.424690286905087,3.7703314474645255
Granta-519,4521392,4.382822475618979,3.9857070630182085
SW48,31703,-4.626106549902408,-1.060789451242148
RKN,10127622,5.371150210721622,4.216347746171001
ALL-SIL,71466445,2.2002248480614925,2.182421534105685
MDST8,656346,0.9697505348816438,1.6351447223363182
Daudi,71680916,3.7291665773697,3.6969981947754893
HEL,135398516,1.4688857829361923,1.0589854841955337
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,2.3120164144418593
P31/FUJ,9936388,-7.166815071220185,-5.330507890321176
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.2763012121190367
HCC15,11625818,4.624206979967606,4.5693536550510085
LCLC-97TM1,42611257,3.4642891468760957,3.01095442087626
LCLC-97TM1,5311,1.9621633752287055,1.4033504502042258
RERF-LC-MS,52912189,3.970931922009392,2.604980933052037
BICR 22,9915743,0.3047863731286212,-0.07250455152214354
Granta-519,11612883,3.2575401906490895,1.8733310697645
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,2.7458939782855962
NCI-H2452,3543504,4.306818718463235,4.606178183940837
SK-CO-1,676352,2.6575015884388704,2.205036787955344
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-2.5458292798051687
RKN,71304818,2.008207131108322,2.6107974088906802
IGROV-1,67156097,0.1763939852409119,-0.8830504008465531
IGROV-1,51039095,1.7163430299301403,2.9656937542964728
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,-0.09895944250067049
IGROV-1,72193861,2.0623829231433293,1.340412507497983
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,1.5182296421512944
NCI-H1568,11167602,1.5259281753697294,2.661698132368725
NCI-H1568,52912189,3.4016367932827563,2.1089864058041017
SU-DHL-1,107985,-3.306496987383706,-3.9820886183756095
P31/FUJ,73707386,2.311695228129917,2.5138367703847924
WM115,9884685,-1.925323313513864,0.7767010258701447
SaOS-2,16722836,0.8662367041162377,1.7601338984521482
PaTu 8902,46843906,4.340257675131653,3.3696824857017975
BFTC-909,656346,-0.1018552101429806,1.1555778684130582
COR-L95,54618305,4.5292428127427575,4.068830285023538
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.1878815777495193
Daudi,24772860,-3.9771177154169304,-2.882734124907797
BFTC-909,9911463,4.114346930944119,3.805911283535486
LCLC-97TM1,44197249,3.7483906325702545,3.614451517852883
BFTC-909,6918837,-1.9878509916437357,-2.5014027788154207
RERF-LC-MS,24797083,0.2985814331764478,1.4365562445483464
P31/FUJ,135928012,4.893710575363991,3.327089575985714
P31/FUJ,53232,3.343897726239282,2.543985586247054
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.8639267349995937
MOLP-8,25062766,1.6722099464266416,1.8609455471364287
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,1.1285586578627136
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.6727773921786887
SK-CO-1,262093,3.1807391377127376,2.8352112117244634
LS180,72376,-2.8322202153843703,-2.5453670278978917
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,3.0238950660916726
KU-19-19,6918328,0.0154884073180988,0.32811717592070166
SK-HEP-1,107985,-2.2891993358893856,-3.202113044384705
PaTu 8988t,216239,1.832862266271042,2.422863521778238
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,1.2764581110108886
PaTu 8902,156414,2.7243668654536206,1.1162845470674292
Daudi,16659841,2.946181230411034,3.1213835899886697
LS180,123631,2.1427319304120624,2.034905392813518
BFTC-909,10385095,0.9839595624316404,1.2099029468453049
NCI-H1568,241158,1.943489424131273,4.024343877826007
UACC-812,44589607,1.3537953197929582,2.7089400492606774
Granta-519,11960529,3.2261057296158593,3.4859530156752294
LCLC-97TM1,25062766,2.2139494005881293,2.2010680443145674
LCLC-97TM1,5291,3.6350350305332424,3.7451744889774408
MOLM-13,44491742,3.7695621371445975,3.5510002676316264
P31/FUJ,3025986,-2.3655111331800067,-1.4293184252876736
PaTu 8988t,2749,1.558615062570056,2.02508145572457
IGROV-1,2113511,5.982902824257526,5.6532613747635985
Daudi,54639126,5.221444108043,2.8003870279109186
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.6392097768926743
HCC15,9868037,2.5640614102548556,3.288155249843612
PaTu 8902,6918837,-2.118913626513807,-2.505279949181493
ALL-SIL,23725625,2.2136327630148736,3.61811223925312
COR-L105,11455910,0.425998653780944,1.2000301911511417
K-562,16013152,3.768503882504226,3.498456183525484
Daudi,67156097,-2.7448600083467163,-2.2564460544926472
SW48,6610216,4.461301788418361,4.215771098966789
BICR 22,11977753,-1.1105881150796446,-0.9487537114748565
Daudi,753704,2.787779434331829,4.078043919796971
COR-L105,46943432,2.471907312248233,2.431315189686929
IA-LM,16736978,1.926640001137528,1.389672310439263
IGROV-1,176870,1.8349827429681411,3.173230980409394
SK-CO-1,148198,-1.1611262776602205,-2.9494811273295256
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,3.9770160871908273
IGROV-1,46943432,4.105714883822214,2.1033314736434736
LS411N,168312962,3.224541058203402,1.3687309360258877
LS411N,1641662,3.6634193785306337,3.175680120994365
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,0.37063316916926536
LCLC-97TM1,26596,-2.266692800551727,-0.8895030045950952
HEL,151289,0.2321343459174182,0.26260863327289885
Daudi,1285940,3.7558538743643792,2.702610236480754
MOLP-8,2749,1.3302247490678565,1.2366124780062346
RERF-LC-MS,10427712,4.250983789220692,4.343332226123577
WM115,16725315,4.630500047502962,4.280145546167032
Granta-519,9840324,5.864872193260208,5.442172392870812
HuP-T3,25262965,3.989652761156405,-0.6975426877643741
NCI-H2452,11719255,2.41462187851326,3.5434629059411957
COR-L105,1641662,3.72017777917812,3.5088961087597528
SaOS-2,89928392,1.2892186505806515,1.3863023080739445
LS411N,969516,3.2917111714105647,2.6058406766579325
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,3.2888999245877613
NCI-H2452,327653,3.049758242791241,3.2157217881826847
LS180,4521392,3.9983682640735094,4.262354620196015
IA-LM,2113511,5.955012720035456,5.598786456481957
HCC15,11167602,2.587200682435675,2.726885172795479
RCC10RGB,9911830,4.5526597563763795,2.7442913027740166
P31/FUJ,168312962,2.530788243280419,0.5590779161165307
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,4.188523303657646
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,3.092079882581159
Granta-519,9933475,1.54115480203428,0.9554757466540772
HuP-T3,73707398,1.153693297692098,1.4798659121780031
SaOS-2,409805,5.764413924489168,4.5872004590642215
KU-19-19,984333,-0.867877464903324,0.6115059108925479
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.66466078527671
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.194061440430133
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-1.9966439094420352
SW48,6918837,-4.354568378072889,-2.6861104078670106
LCLC-97TM1,16741245,5.12826814210941,4.0311317683937995
NCI-H2452,11507802,3.578778888517491,1.8314691987649083
HEL,11175137,3.15338888234114,1.5262350729541205
BICR 22,60750,-4.532323865382038,-1.0337161452347159
Granta-519,44491742,4.018752292224149,3.6131264158882974
SK-HEP-1,12003241,-1.7510835313415607,-1.3009854549398638
SU-DHL-6,36314,1.1358641594844867,-1.5855627814648026
HuP-T3,11152667,0.3145958176635,0.037796040757526045
Granta-519,15547703,2.599412791530534,2.515780617861201
IA-LM,25126798,4.097105087874825,3.916420401828029
MOLP-8,119182,-1.11255726511749,-1.8732812558114056
BICR 31,65064,5.259646525120305,5.091632186182689
COR-L105,6917907,-5.504495586582428,-4.7209325862616645
LCLC-97TM1,11238147,1.840896458617422,2.6874908715920327
HEL,51039095,2.698396554100347,1.9450463356810455
PaTu 8902,44185566,2.9137350944736653,2.4918706926249725
Daudi,53495165,-3.885820769064659,-1.6604117921431447
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,4.620154991781382
MOLP-8,439501,-2.9296652389863267,-2.3126447095172513
Panc 02.03,4259181,2.0313571914007604,0.6367678720240095
PaTu 8902,126941,-2.2828817630557228,-2.68998458811008
RKN,5328940,2.201806852003849,1.6746291863703875
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-0.8478831917027203
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.9725372604451195
COR-L95,246676,4.317733637680926,4.20693898313884
K-562,135928012,4.4390204871751004,3.7145021543841907
MOLP-8,56946209,-6.528820954061854,-4.795082802773088
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,2.719935039877837
COR-L105,135421197,1.9442341701951136,2.0442232487749266
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,2.420437998247107
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,2.209967765680295
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,3.54960441846739
RCC10RGB,5280436,4.525748645562069,3.446566246353308
NCI-H1568,31703,-1.6950574450364193,-0.903844752961028
SW1271,148198,-2.630785543453804,-3.08196357903619
Granta-519,11964036,1.5223427206827596,0.676434344153858
MOLM-13,16725315,3.788691115651132,3.43121991793443
Panc 02.03,1716436,3.766168811644757,3.002635851354753
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.5817777830803987
K-562,1566236,1.8179642124055264,1.7024209235414538
RCC10RGB,409805,6.020159348453613,5.44302191302206
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,0.9763733550945006
HCC1500,11175137,2.755904594476177,2.664459089648081
HCC1500,11494412,1.8019649514762912,1.9080209849864809
HCC15,10127622,3.735977541508184,4.209672188166324
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,2.237009877731316
SK-HEP-1,168312962,-1.3309808369359073,2.0346603318735617
COR-L105,24180719,3.693037976394381,3.7963426393798834
Daudi,46943432,0.8866201698678313,1.3513352740137912
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.816610899717864
Granta-519,24180125,1.2477770260094014,2.356768147836279
RKN,9967941,2.6996754619948065,3.755857930932698
RKN,135398516,1.9656218312143572,2.321297339729767
KU-19-19,16115403,-3.194116920729502,-3.690670944822171
SW948,56949517,5.5880132005349505,4.195182345623084
NCI-H1568,44632017,0.9967277604489184,1.3157794511117225
COR-L95,11175137,2.52315362607855,2.2891049907340713
NCI-H1568,676352,1.7505105304855018,2.156977728039615
NCI-H2452,126941,-2.0674603287446964,-2.8522363722409763
NCI-H2452,4477,0.2060981637085811,0.767074442002407
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,0.8664706622011538
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,2.8020131822196475
BICR 31,11647372,2.8607835505972035,1.433640428778783
WM115,52912189,2.2242444616857417,1.886983860864256
COR-L105,2729026,3.0417945234466863,2.820448528889354
COR-L95,65064,3.24172080303354,4.284034655967203
IGROV-1,54613361,1.0826132998561049,0.3233384412649651
NCI-H1568,53232,2.5527200815554587,3.1493637717191008
IGROV-1,9884685,-0.088911709267569,0.28496798068071444
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-3.0797589806840215
SW948,16720766,3.3510678765666517,0.5288614172636391
ALL-SIL,135928012,2.5698772014589992,3.4412037988317015
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7097095266235555
COR-L95,56946209,-6.902335125637694,-4.778466955808501
IA-LM,49867926,4.185996432673056,4.1562000209904735
SW948,11625818,3.962309646097391,4.130189553597886
IA-LM,4259181,2.3536383664390734,0.36293321354213354
NCI-H1568,4259181,0.5766231269303183,0.07928698417347597
SW948,6438330,3.286047925562068,2.0872814398658828
P31/FUJ,15547703,2.950164329068843,2.570186187751945
COR-L95,1750826,-0.7485912803642704,-1.449239899317725
HEL,51037431,1.91843497941606,2.9026952468021032
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,1.170482547047614
Granta-519,462382,0.1364457210972633,0.02087225786582301
LCLC-97TM1,11719255,2.8064116850649774,3.4162058295908526
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.1573435434800563
MOLP-8,1242560,2.9421278446513393,2.8956104846744046
WM115,9911463,2.5241618652619007,3.786212622680515
RKO,3025986,-0.6013959236761957,-0.6837275238795186
PaTu 8902,5335621,4.440333682211631,4.814413074085931
NCI-H2452,19582717,3.9299005055458793,4.4727293512848885
NCI-H2452,171352865,2.832902682703541,3.5690926486019765
COR-L105,5566,3.258554573596101,3.095240419022637
BFTC-909,11647372,1.2423847125416496,1.2316059593390116
Daudi,3503,0.8148417795144576,1.7726113181646697
COR-L105,25183872,-0.7403581245059931,-0.2907781269872237
ALL-SIL,375860,-1.552794194023853,-0.7531959371379799
HuP-T3,72193861,3.3106720937076233,1.6535394567350779
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.8324347693451873
SW1271,6438330,2.1351654373433764,2.2806644853151123
SU-DHL-6,25262965,-2.983432395440536,-2.907725444932335
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,1.4229764714521027
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.5760246036029704
SU-DHL-1,44489367,4.533806271256096,4.290763058116514
MDST8,31703,-1.4422735490012837,-0.6326839810993206
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.6059127610809245
IA-LM,10302451,4.177351274859187,3.4109171088760757
SW48,11214940,3.1705360221414134,2.041391128151077
RCC10RGB,10074640,3.4095283906874956,3.095000169965347
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.4097603556839067
COR-L105,25227462,0.5095099099095757,0.5023567542822263
COR-L95,66577038,3.0490878420221934,2.677367321909836
LS180,46191454,1.5509574675684803,1.4710834667105426
RCC10RGB,65064,5.251967206688168,5.202441331046727
IGROV-1,72376,-2.111352545322758,-1.8398078290707869
MOLM-13,89183176,2.661461024404157,2.8163094668988213
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-1.0490744324183003
RKO,3384730,1.0492755436091918,2.458226971523659
SW948,11656518,-0.9054812480406104,1.782579341266237
ALL-SIL,2949965,1.286096946783907,2.065564799879307
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,3.4966468162339015
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,4.336328403386891
K-562,5287620,-0.244838249137823,-2.1272816265550647
Granta-519,3825829,3.4773445434270243,3.3559875003219686
MOLP-8,10385095,0.909191851453096,1.0008663295488043
COR-L95,135928012,3.4969711227856397,3.9815637427379817
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.436736408722394
UACC-812,25161177,3.457735095549926,3.8794000404163014
SK-HEP-1,11178236,-5.847785565222589,-3.355487069204207
SW1573,16741245,2.047879460545898,3.9754464688825184
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,0.7046331263191032
K-562,89183176,3.981701702250952,3.6226642912945994
P31/FUJ,9915743,-0.8907797257006451,0.09016029220685481
WM115,3503,1.3325075362119865,2.41598897000639
PaTu 8988t,44202524,3.9754310935930968,2.5517559554025415
SW948,9952709,2.6604018004594514,2.94476009749657
Granta-519,56946209,-6.359988120178517,-4.956360808010191
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.9629541235018784
Daudi,613000,1.9882519691431488,1.8774654064738923
RERF-LC-MS,374536,3.716253113618047,2.594137638701412
LS180,72734382,4.032476699930466,4.38992129038614
Daudi,1566236,1.0534301581716357,1.567841039547983
BFTC-909,9868037,3.24226767674478,3.4526062881465323
HuP-T3,107985,-4.90392348596967,-3.4567685791277643
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,2.0393181635309365
IGROV-1,168312962,3.022863957843741,1.8466543300469178
IGROV-1,3081361,0.99973562532788,2.3729824120567757
BFTC-909,5311,1.6846521587280363,1.539045574146517
NCI-H2452,2841722,4.2339337769073175,4.291448535619825
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-0.951604333432769
RERF-LC-MS,5278396,3.382202757419261,3.5668579358521835
COR-L95,44607531,1.1147625805359247,1.1912648759725237
SaOS-2,135440466,1.1747227113697256,2.0653903283343436
RCC10RGB,285033,2.114091727684993,-1.3195644443108652
SW1573,448949,2.6434946381292703,1.943746402873835
SK-CO-1,11964036,1.41955554287601,1.2547501332656568
SK-HEP-1,24901704,5.545234809796251,3.4425702418645305
RERF-LC-MS,71751553,4.213964581210796,4.518060520515143
SW1573,11178236,-2.507507612037206,-3.4176103524568386
HCC15,6450551,1.6627728253820353,2.704030422970868
SU-DHL-1,54619267,3.144461009217004,3.5852470539668513
P31/FUJ,11626560,0.2148563033664798,0.5636951361850795
COR-L105,119607,5.370152891195211,5.38579441022581
NCI-H2452,11427553,2.818972077820031,2.9313444611040933
HuP-T3,2871966,0.5817483683031975,0.4566591547565727
Granta-519,439501,-6.00499370561019,-2.716471776108477
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,2.03945650023074
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,0.9696406473216855
BICR 22,2945648,3.5832925483527625,2.7446525315043755
NCI-H1568,11228183,4.140816994678141,2.12179372155133
COR-L95,89928392,1.3878824566143364,0.903420136885146
BICR 22,2871966,0.0284401826322965,0.8820031186028217
HEL,46199207,2.3973871372245372,2.7525014205422895
HCC1500,52912189,2.5783780690097857,1.7745319787340261
KU-19-19,52947716,-4.518413756843173,0.62013552330027
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.6696209298661575
NCI-H1568,7326481,2.864470016727109,3.0103971403312357
RKN,53232,2.2291100881655037,2.6814901952879318
KU-19-19,4477,-0.0533500132034658,0.8168809152685629
SK-OV-3,107970,2.5604111984812152,2.3565279021277106
BICR 22,1242560,3.7933374150058015,3.6503999645265734
ALL-SIL,5738263,2.854339564213428,2.45079063473442
HEL,5329102,1.6539669706420914,1.318123395566871
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,3.472526888790553
SaOS-2,3854666,0.6354016080385003,1.6048002252305187
P31/FUJ,107985,-4.114404549725097,-4.16001027889185
SK-HEP-1,54619267,4.307302877095537,4.114019153707271
MOLP-8,11213558,1.2108381509164672,1.3065791919375016
LS180,6914657,-4.58065814502937,-3.9119309777552695
HEL,71466380,3.121887792191312,3.7229596299577628
COR-L105,25154868,4.769445801979145,4.482040434040486
LCLC-97TM1,25105715,3.527934306265534,3.3850318638963306
SW1271,16013152,5.485365595141675,4.17320963622758
ALL-SIL,1750826,-2.8707446972397483,-3.2415772479183436
SW48,44632017,-0.021210675828241,1.1746736685392571
NCI-H1568,4578,4.166510450069308,4.612896535598956
SW948,24180125,1.460789729891403,2.910088215780531
COR-L105,25161177,3.712985248467103,4.0558609304423126
P31/FUJ,57519531,1.451496749892495,1.7111904837061598
ALL-SIL,6918837,-4.772645295536399,-4.715434426585205
RKO,16720766,-1.2722083569090707,0.42867648163137134
Daudi,11707110,2.6257952816009498,-0.4873724032908603
PaTu 8988t,24785538,3.127280515757933,1.7095926301787383
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,2.407778122237326
HEL,46174525,3.393297616528365,3.17739327882819
MDST8,17759555,5.018522859633252,3.5823661516318968
SW1271,53392493,2.79081275696651,2.676149225438894
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.1221619199740998
SU-DHL-1,9927531,2.969590320438058,4.1900451072955756
Daudi,445455,3.7530002864178416,3.976611711983649
SW948,24951314,0.7675285489701543,0.956204233543811
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,1.9103227559756073
SK-CO-1,9866186,-0.7388742913087788,1.168988938470478
RERF-LC-MS,60700,0.497286081450591,-0.1603864667294398
BFTC-909,11364421,-5.034674750215906,-2.3860633700566454
SW1573,49766530,-2.79322841384178,-0.7696262894320768
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,3.3953676918442137
MDST8,25126798,3.890491738661291,3.8400284072959505
HCC1500,3543504,4.272332537756205,4.349134089770249
COR-L95,25062766,3.209944577871265,2.041856820831061
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.7446955308168322
SK-CO-1,44632017,0.9847861620501556,1.3873964894987052
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,1.8461933755115156
NCI-H2452,445455,4.8000860101003235,4.844881597249276
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,3.0275296462525865
HuP-T3,439501,-2.469428626730465,-1.8590550205792227
RERF-LC-MS,9884685,0.4531053665233772,0.5189564279706032
RKO,5281321,1.9988379902215376,-1.3272132707536322
NCI-H2452,10410894,4.350169635958685,3.461659473650841
HuP-T3,24951314,1.4235135044150102,1.5706902209105056
SaOS-2,71466445,4.363709574185696,3.6314565843322852
BICR 31,44185566,3.0664042381745946,2.656433626117838
NCI-H1568,11625818,3.359978935972883,4.47981348606157
BICR 31,3552672,2.13577451695998,2.758866086857739
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,0.8053306400531972
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.5346850559290766
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.911086762324527
LCLC-97TM1,119182,-0.294501899208461,-1.222819211878196
ALL-SIL,52947716,-0.7216046839402591,-3.0067732925989548
RKO,11640390,5.295981617059328,3.220438399776881
RKO,25150857,2.5785304193211247,2.178890720697621
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,2.7958699364825548
ALL-SIL,1716436,3.0252724323132374,2.432976788403691
RCC10RGB,262093,2.8343922904091134,3.197971592285729
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.6662521588022754
SK-HEP-1,439501,-2.4482777943885856,-1.671537618655926
RKN,71466380,6.199959456698308,4.575986431059748
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,4.287104105878019
RERF-LC-MS,1242560,3.610791422912421,3.708850404160692
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.6582135900409354
Panc 02.03,66577038,3.3089612685646985,3.1034728852013576
LCLC-97TM1,52947716,-3.0616129604635565,-0.26825448728951096
SU-DHL-1,20959075,-3.3128713931491087,-3.1140589144196578
BICR 22,2113511,7.552062733189383,5.714226665380685
SW948,25126798,3.357341035223679,3.856339376634517
HEL,3854666,0.8085723321900852,0.702863834853762
HCC15,168313047,3.1265794948701338,2.3809097847174967
WM115,107985,-2.5041726579949857,-3.484185067347994
WM115,42611257,-0.3600732192588895,3.122187344092521
HCC15,60700,-1.3823438115431317,-0.4681197260066683
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,-0.1552765914962836
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,1.036223329916836
SW48,60750,-4.2221568193195225,-1.9324345050160496
NCI-H1568,262093,2.8880881470868585,2.955638572733844
PaTu 8902,53392493,3.316041661234319,2.7521965284750824
Granta-519,11647372,1.7523915142224398,-0.15024521321048862
SK-HEP-1,8515,5.0523689066797495,4.141545805033515
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,1.881049936754177
LS180,702558,5.586038369213652,5.109780809906944
IGROV-1,15983966,1.7101486625531308,-1.6566795340985425
SK-CO-1,6505803,-2.970063061644963,-0.652048023532041
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.4417204198812272
PaTu 8988t,11485656,1.82057121616084,2.1303120562360087
KU-19-19,2874250,6.302627434426347,4.626466773762526
MOLM-13,11175137,0.3158641445144168,1.4856016487267272
WM115,644241,2.021542714802758,2.3698290823148556
SW48,52947716,1.8444935422046616,-1.222109168463645
NCI-H1568,10302451,3.040030486332468,3.1030271435753964
COR-L95,44185566,2.2555949878605484,2.117318113959767
LS411N,16725315,5.1123164266785714,4.314752762467085
BICR 22,25195348,4.085059979970886,3.184666985631535
SaOS-2,5311281,0.944453452900516,2.1086463712179953
SW1271,613753,3.197731710568041,3.2993208111591428
IA-LM,9840324,5.344700856558617,5.807600261393057
LCLC-97TM1,439501,-2.367039612081251,-1.8983343469870329
LS180,9825149,2.508714096118433,1.9583963973760479
COR-L105,9911830,1.908645944756667,2.6046114699112075
Granta-519,25126798,3.857539921377872,3.2355419613590697
K-562,11238147,1.4367734907149323,2.410211703261726
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-1.150235886319523
IGROV-1,4705,3.3098412390054603,3.3313741830095394
RERF-LC-MS,1716436,4.437154842045929,2.989309991475758
COR-L95,6918638,0.5429028056483723,-0.07649448527608392
BICR 22,11507802,1.0844954054416946,2.067334485358093
Daudi,54626689,2.8292455243221264,3.884637184084276
COR-L105,148124,3.589067174421039,-1.3044349243746596
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,-0.6154414197490813
IGROV-1,9825149,2.5588021380929553,2.2349602448665253
LS180,2113511,7.0742493322433955,5.619164062552191
MOLP-8,16038120,-1.6086793301450355,0.10206043918636168
KU-19-19,67291369,2.2261044123877656,2.6448591320002874
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,3.403633255055864
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.5698696495965757
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.2199021576543885
Granta-519,44462760,4.300929542453815,2.7091823578198135
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.686027171868554
KU-19-19,17755052,6.06318579738538,2.057348078461089
MDST8,11214940,-0.3312007430689519,1.9567189886106129
SaOS-2,57519531,1.7793183342968584,2.4886959742657124
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,3.0600733820044512
LCLC-97TM1,44493528,4.18527882332477,4.25311787118815
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,1.5800592508456694
SW48,10231331,-2.95597966611556,1.7121041732852726
SW948,24797083,1.9027092264791332,1.5458846510083228
IGROV-1,11238147,2.1723642292765084,2.730042107366019
COR-L95,17755052,2.817022282186957,1.5638192198428746
LS180,25126798,3.79328534931886,3.7361236619709035
IGROV-1,71304818,2.4878074097553378,2.5364627682681107
SK-HEP-1,10302451,4.165168773877425,3.096207570164363
HCC15,25102847,1.68346873279249,2.4304172254625867
SK-OV-3,15983966,-3.6834707194333927,-1.2686186367987984
HCC1500,54143018,1.195335139641603,0.4424322308744336
COR-L105,11364421,-0.5536252833264237,-0.6420294442255464
RKN,148198,-1.0178445286580065,-3.055065176321773
KU-19-19,400769,-0.482585358097733,-0.6144217095478145
COR-L105,7326481,3.3886978035876547,3.213571887554393
COR-L105,44819697,1.466179589978979,-0.2930042291678631
SW1271,5281672,5.179464513143849,4.615642995266984
PaTu 8988t,3634881,3.651211463421112,3.3548180081146235
IA-LM,11404337,0.4340662777154989,-0.38653204328691904
NCI-H1568,5287969,-2.4053225408736405,-1.5752688588102641
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-1.5588300380576576
COR-L105,54619267,4.07987987500145,4.185092313804978
SK-OV-3,9907093,4.994966956142975,4.271200029655335
ALL-SIL,11167602,0.1759872916057691,1.8739193608478024
MOLM-13,49836020,-0.1965532240483963,1.7049490865421744
HCC15,52947716,3.127529556956005,-0.6699193658938205
SW1573,4261,3.544037815747042,1.9871468701333972
MOLM-13,6184667,1.666374934082413,1.953349772569191
SK-HEP-1,3854666,3.0622551399292264,2.139958029284666
Granta-519,241158,3.1692083740262373,2.1844228246369872
MOLP-8,5978,-7.284134927472065,-3.030470217929186
LS180,10302451,1.4669812473297774,2.5889778433465933
RKO,16065773,3.3120716405166615,2.1583414508621304
MOLM-13,24964624,0.892926396159225,0.7247637950224989
KU-19-19,11427553,3.4053411651543035,3.2090470054410276
SK-CO-1,44137675,3.0714779264964074,3.4840749199909498
P31/FUJ,6852167,1.016015239887951,1.7048774516205212
HCC1500,5351362,1.2955308259083285,1.519238522849934
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.590760629787359
MOLM-13,252682,7.80657372951634,6.088836793239585
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,4.253138846474198
HCC1500,44607530,1.2894809747133489,2.044047088932114
SW1271,3025944,4.184087558749553,4.387444211918453
HCC15,44493528,4.34604946513687,4.308807710183303
P31/FUJ,6918736,-1.9353169891324984,-2.487877215831087
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,4.967174070110154
K-562,24856436,0.0017034666231649,-0.7379290536289198
LS180,216468,-0.2416288368660945,2.720782107659244
SU-DHL-6,11507802,0.7208159532280615,0.5691105995224494
SW948,5291,4.046310039203204,3.5544770044431804
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.6722721002039616
HCC15,11152667,0.1037945221143532,-0.6276102157064747
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,0.8601294991598989
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.258267360270524
SaOS-2,49766530,0.3706728408995327,-0.6614819940270222
SU-DHL-1,168313016,5.361416197440646,3.883979179562802
HCC15,168312962,2.4994502868710677,2.039568256588391
IGROV-1,24797083,1.5319862293819655,1.3679882591269616
WM115,71751553,4.133313051647094,4.75801107727037
SW1271,24951314,2.0404240106098723,1.4920281181854234
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-2.7964047161675016
SaOS-2,676352,2.2074841133021432,1.9215180200671753
P31/FUJ,322968,1.4419696378870497,2.516063861149205
SU-DHL-1,10127622,2.7675483211751466,3.2327355842648524
COR-L105,44137675,1.808161252080405,3.849253959237443
PaTu 8988t,11625818,4.482422780967983,4.580974060527365
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.2501784068471549
Panc 02.03,16038120,1.606654693103348,1.3155857601158432
BICR 22,3854666,0.9977305103930704,1.9806045056474395
Daudi,46398810,1.6020476162665716,2.0270672445173292
COR-L95,984333,1.162546188419483,0.36131493311591784
WM115,1317464,3.7806694387813753,3.743813264160323
K-562,71680916,4.727537128358906,4.062012176760783
BICR 31,25183872,-0.4870171412848909,-0.5933893726187107
COR-L105,11626560,2.2911739511823503,1.9645701749080917
SW1271,9936388,2.2656701786136315,-2.228833471722765
MOLM-13,135421197,0.945680487717708,1.235791729112265
SK-HEP-1,136227924,3.6301481247272287,3.1605210935003765
K-562,375860,-0.3542925626582329,-0.6315365191422823
SK-OV-3,9887053,4.42879128381072,4.11178915475054
LS180,9936388,-5.017955750811216,-2.6953863787611643
SW48,9935249,1.3330175828473068,3.160502211517326
SW1271,11214940,1.5931636594582963,1.9675326732252771
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.261825892085683
RKO,67156097,-1.3338800856316015,-1.2622068681102567
LCLC-97TM1,51039095,2.799665973949055,2.6938000588693893
MOLM-13,54143018,-1.3895840664016086,-0.651435419673223
Granta-519,5738263,2.4520737989935246,2.7206836311874993
SW1271,2828334,6.430891789984985,6.274652393002061
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,5.194242810227223
HCC15,3136844,4.306118753112888,4.51077338244943
IGROV-1,54454,2.453541831966438,2.7260297504660542
BICR 22,9935249,5.2884064452137585,3.039698781613873
BICR 22,72376,-2.4643814155147634,-1.3463614974434
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.630703021003734
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.4311269885792233
SK-OV-3,25022340,0.9085118587340768,3.1140068638709635
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.7183848879528885
P31/FUJ,11238147,2.0504580426090286,1.9692249564441413
NCI-H2452,44607531,1.7526351480007742,1.6985784444861816
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.611058340341242
WM115,119607,3.834781850796951,5.483768362370287
IGROV-1,71466445,2.3758001916617797,4.038007224415717
SaOS-2,54618164,4.337585482929099,3.965119777393264
SaOS-2,46843906,2.56299568717197,2.82790972711546
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,1.6031652744340497
LCLC-97TM1,2841722,4.284298549740087,4.112023530022331
LS411N,36462,3.380504085081747,1.6272565870296853
COR-L95,637858,1.3348673917451612,1.7157280748809662
HuP-T3,10113978,4.191114511390656,3.4059108916202736
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,1.451108483088739
MOLM-13,24772860,-4.1681928866236415,-3.05565879943256
WM115,9823820,4.472944540337913,3.723424642436422
MOLM-13,3676137,4.483658238026924,3.505102549791585
MOLP-8,49766530,-0.668776240648524,-1.0292055952966743
SW1271,107970,2.3235168881670285,2.2681489736544003
PaTu 8988t,16065773,3.154821962511545,2.6585219541995837
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,3.64101361161661
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,1.8263501233148758
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,3.1594382520021607
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.8209009968105545
NCI-H2452,11364421,-0.8742390414707,-1.224506030433497
NCI-H2452,4788,5.30317679490816,5.758616513817656
P31/FUJ,11396600,3.188193103342261,2.8071754509780806
SW48,2130404,2.4705566813277215,3.312184586757261
SU-DHL-6,322968,0.8712022459195665,2.3880406986185236
BICR 22,107985,-3.867593954539223,-3.1092249335628135
COR-L105,46215462,2.588599789838095,2.006407024353426
PaTu 8988t,5287969,-2.0890298278516513,-1.727167562100793
SaOS-2,9866186,1.0217998308229927,0.6577578353425096
SW948,16065773,2.2305150921307653,2.3518417719748297
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,4.894571882198543
WM115,10127622,-0.9383410403940764,3.383085860088664
WM115,2733526,4.043531113233861,3.768734940655641
PaTu 8902,49850262,5.593248228762752,3.6289529679549117
HCC1500,54613361,2.498230028210423,0.4036286686656222
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.41990843949826007
Daudi,5746,-2.3170879531966273,-0.01663272101874741
MDST8,6610355,3.7892287954147457,4.679733251908107
SK-OV-3,219104,6.736269406359778,3.760778616821414
MOLP-8,49793307,-5.094504062696007,-3.8231916152887817
NCI-H1568,54626689,4.298451601405369,4.695906130248863
IGROV-1,156414,1.4212019235656712,1.1535031814450174
Daudi,4477,-0.8111056564008632,0.5792329194191492
K-562,135398738,1.706304792848783,2.6002138953593765
MOLM-13,57330099,4.105312173478173,3.707733702477684
SW1271,42642645,0.8738549597199083,0.9804008869796539
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.6173906652017545
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,4.105497829935144
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.7693852059811217
Granta-519,16725315,3.130545070245978,3.448141373323683
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,3.1666903280533525
RKO,3854666,1.2691133577357363,1.5169725253492234
SaOS-2,119182,-1.602754826097209,-0.848479686386955
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-2.258268383972832
Granta-519,9843750,4.294258272153345,2.0945799656096624
MDST8,5329102,2.639161266907228,2.4315772009618355
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,0.2568775115378925
SW48,36314,-6.6979677874770065,-2.016370380766737
RKO,9825149,2.459088339864112,1.8603982513481463
MOLM-13,9911463,2.5287579203643986,2.999724442230366
RERF-LC-MS,44566777,0.4059341966526995,0.6198013082498991
SK-OV-3,10184653,1.9718742380811307,1.2444072904164627
HCC1500,16219061,2.7461663809715375,3.106092250100284
SK-HEP-1,9926054,1.934364320328667,2.0729665797821375
IGROV-1,24901704,3.0789156375765936,3.3206369378704554
BICR 31,9933475,1.7480026685414405,2.180108230412033
COR-L95,3552672,1.407232830890507,2.4449402215274203
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.6327442557147598
COR-L105,66577038,3.4359280481345755,3.1287643441160604
COR-L105,24753719,4.356648297258706,4.502788240143148
ALL-SIL,24978538,-2.389127379896269,-1.3676482255818516
SU-DHL-1,3025986,-2.176216514163443,-1.1978405304554751
IA-LM,3062316,1.9598487648076035,0.8502258098638109
MOLP-8,448949,2.0087568721459146,1.662215831702689
HCC15,89928392,2.045660123087396,1.736251175408008
SK-CO-1,16720766,-0.9325558438762483,0.7546142957720403
IGROV-1,11485656,1.900409616013456,2.1509280772549495
HCC15,44137675,4.493981948720765,3.650414997952667
SaOS-2,5284373,3.659507244236858,3.1231278015707256
COR-L95,44589607,1.7004659608333377,2.2126017663034436
PaTu 8988t,16659841,4.413190590676007,4.072168327418153
MDST8,5311,1.1196330054843209,1.5782657151213189
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,4.066526981655745
K-562,168313200,4.769830643466651,2.912040005032687
SU-DHL-1,36314,4.070517798024083,-1.4163105550423427
COR-L95,219104,2.3748233222255144,3.1747788940063257
Granta-519,44566777,1.2837383493022634,-0.12181610818042955
WM115,45279963,3.6868070952026506,3.6881139145854873
HuP-T3,10127622,4.169685865232827,4.214071942182311
SaOS-2,54454,3.299905279612609,2.166352877579675
COR-L105,71466445,5.452991683251573,4.322226214728257
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,2.1724156985876353
COR-L105,19582717,3.403236730524823,4.375650815615865
K-562,11625818,4.129982389727392,3.7250162235138156
LCLC-97TM1,3384730,2.793888789676347,2.779609198627279
BICR 31,4917,3.733916426719056,3.028000172939879
PaTu 8902,54619267,4.2510877724746585,4.152074155929738
ALL-SIL,25102847,-0.1309610459144975,1.6856534658966384
MOLM-13,23939,5.7894293981406,3.82677819142258
COR-L95,2828334,5.963676169995917,5.939819002338778
PaTu 8988t,44137675,4.243997881661858,3.835768825968673
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.636402860252502
SW948,5978,-3.22198817122066,-1.4562246263259278
RKN,375860,0.0559819210079563,-0.07853633627166565
NCI-H1568,49836020,3.1231470101883336,3.010720977912684
NCI-H1568,12001922,1.1909466973303815,1.8642476111507122
HuP-T3,135411,0.8125735513868637,0.48221273791119507
NCI-H1568,119607,3.825066299684422,5.312040083398495
WM115,9825149,1.8328544820090609,2.120220303712308
WM115,104842,-0.2362637011987665,-2.818845150531806
P31/FUJ,327653,2.543614095842417,2.7012603532008193
RKO,11396600,3.504834935214814,3.1876944416287785
SK-CO-1,135440466,-1.3303352220830715,2.163100186797856
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.714519265426112
P31/FUJ,23635314,-1.6494447832357666,-2.641041898041714
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,3.504027517751703
SW1271,46215462,2.0233113088179406,1.829527099627994
MOLP-8,969516,1.8716619229833695,2.4367386790806242
K-562,135999136,3.657737204061429,2.974121354684324
SW1271,9866186,1.0057234740027048,0.761038865808131
BICR 31,5278396,4.450921628721945,3.6039183287347503
HuP-T3,462382,0.4397112913332706,0.9853867001232937
SW48,44202524,0.7134579720144102,2.13564950468818
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.2201500569649495
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.2389526793507075
LCLC-97TM1,3025944,4.079230434060959,4.158602839379597
SW48,46174525,4.111785915347283,4.1606105266693065
HCC15,11396600,3.725702968544969,3.7656639491216506
SaOS-2,2949965,2.5764816921436067,2.868591824873211
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,1.68130813218414
NCI-H1568,10296883,3.9462373745058863,3.924399488055173
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-0.6184545749260512
Panc 02.03,216345,4.682043945218969,4.183551463327538
Daudi,26596,-3.612902475241139,-2.3079796662565544
NCI-H2452,262093,3.2163720661137942,3.249594754978728
PaTu 8902,9936388,2.1491039356268966,-1.051612092144552
SaOS-2,4477,0.5134457679146515,0.7185684822696018
RERF-LC-MS,4096211,1.8582313750529689,2.097205332183393
SK-HEP-1,53232,2.505434368946379,2.609305715847343
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,1.698149998133656
KU-19-19,439501,-2.2192304341921205,-2.207506503978509
SW48,11222830,1.1015320686905217,1.5747261098926648
P31/FUJ,71680916,4.420716560192731,3.9663213151834635
IGROV-1,73707398,0.8848064516600974,1.2572712297714388
BICR 31,176870,3.2718013899021607,3.0079319878931674
PaTu 8902,72193861,3.6637635590803384,1.8189278829947608
SW48,10427712,4.323791553226545,3.876109748980281
HuP-T3,5470400,-0.4965810223867313,-0.16708399322466552
BFTC-909,3385,6.578023483143935,4.143175000996498
LS411N,5278396,4.113687735714835,3.3571414868290206
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.675353452009712
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.7272472166537112
P31/FUJ,36462,-0.6599401629031103,-0.1259070754469623
IA-LM,24964624,2.660053298461781,2.3737545793555475
Granta-519,4477,0.7960263088071861,0.6200248303175308
WM115,675434,4.127717546006753,4.648585127092571
SW48,2708,3.1864056833879726,5.014838535173345
P31/FUJ,11964036,1.0580497047985076,0.32531805601096664
SK-CO-1,4096211,1.2314360568652074,1.9379626664768301
Granta-519,24748573,3.0643863299071668,1.2393532601670416
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,5.0205378772434335
MDST8,6918736,-3.3936356144084066,-0.9983326752149787
IGROV-1,3062316,-2.2361832227909075,1.123401232530914
Daudi,136227331,3.813653547789358,3.5508458324996184
MDST8,3385,6.506797592159471,4.203009210372886
MOLP-8,3101542,4.39402228569031,2.725938907283232
PaTu 8988t,19582717,5.440280671607156,4.347930371368179
ALL-SIL,54618771,-0.3818526805852408,-0.16785014681964186
SW948,9911463,3.099005262739027,3.620409543774612
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.7726171396278741
HEL,4259181,-1.3539346499127438,-0.595687967455105
Panc 02.03,702558,5.477624163348055,5.278673608599491
RCC10RGB,9911463,4.415558893727306,3.9541927541581594
P31/FUJ,2828334,6.241721397046506,5.787839606218175
BFTC-909,53232,2.9810373365160316,2.7143871094827676
KU-19-19,1750826,-1.6748688873644846,-0.9237338115156455
WM115,54454,3.1744679186495963,2.773588494174335
LS180,5329102,2.7428602070947266,1.9042816278136012
K-562,25102847,1.0686863962440132,1.976339903163845
NCI-H2452,51039095,3.311280338748592,3.009672384033776
SaOS-2,107985,-4.209612864808627,-3.1830983400846447
RERF-LC-MS,24180719,3.6010609924552455,3.621768090923016
P31/FUJ,9967941,3.859476565836545,2.962970817491546
ALL-SIL,19582717,3.9660864037028793,2.9759469570009656
BICR 31,448949,3.395825088667814,2.22796918040691
IGROV-1,9926054,1.8111808945519428,1.8435459493634383
MOLM-13,44632017,0.3571286974750209,0.5905771367853216
RKO,984333,1.1849980625737155,0.26184063758970916
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,4.7348123781113625
LS180,5311281,2.3621140012684014,2.222402069747387
IGROV-1,5328940,0.347812751869877,1.687007816023055
SU-DHL-1,126941,-4.504729002827146,-3.2353923122693033
LS180,49850262,4.041689005821524,3.5034264688096943
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,1.1177910370121367
SW48,10113978,2.97157913395206,2.6784122204534797
COR-L95,227681,2.232633220711044,3.1044764916780987
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,0.8986046032726659
SW1271,65064,3.2018268639765908,4.825354928453487
Daudi,2733487,3.89488184101632,5.934825528977063
MDST8,4096211,1.945430248625456,2.315114113207891
MOLM-13,56963564,-0.6687647359934185,-0.23349904096216106
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,-0.14455935034649223
Daudi,216468,0.1519487612341026,1.9964530933779023
COR-L105,11494412,3.277457630260471,2.2506899223877204
BICR 31,31703,-0.4867862372580436,-0.837801575735812
P31/FUJ,49793307,-4.015617000908982,-4.159712713597162
ALL-SIL,6450551,-1.4599471288533186,0.9805408256827056
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,1.1952948303194144
SW1271,36462,1.4389686814792042,1.9630262857374914
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.436736408722394
SW1271,17755052,4.188603356762487,1.913647808209677
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.1405720323273405
Granta-519,9967941,4.009641048767512,2.9440137318851436
HCC1500,25105715,3.368057340132644,3.3609263735473514
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,0.07966319228439486
HEL,2858523,2.985624119180162,2.790655707106247
SaOS-2,3543504,4.845259948636094,4.299165525120521
HEL,71466578,3.2881122758034413,2.722383140030344
MOLM-13,44185566,-0.1979234147827578,1.761534330633728
RKO,46215462,1.869666408515056,1.7593649882290552
PaTu 8988t,16720766,0.7633491404380248,0.7340808305841493
MDST8,17755052,0.7758841708349149,2.30563476685691
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-0.6097596150729302
Granta-519,16741245,4.459375532286075,3.1559887598686465
LCLC-97TM1,36462,0.8347023875377979,2.0550338033315305
HEL,24785538,4.025400084811953,0.43131133594022436
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.4551801083056655
SK-CO-1,54613361,-1.1953747905350511,0.4098231021834098
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,1.5700523017428856
Daudi,25105715,2.455657378323054,3.1229092271155663
SK-CO-1,3038522,3.74499401693701,3.0673431277525003
LS411N,11625818,4.428513603720294,4.100927966755337
SW948,445643,4.022773961540602,3.9785785716532853
COR-L105,135984461,4.336047626093702,3.9545390046731006
NCI-H1568,71466578,4.264938806787537,4.858818780331138
HuP-T3,11364421,1.6783982807514195,-1.290801752692688
Daudi,49867926,3.659415180241599,3.766425792835578
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-0.7337275752733463
SW948,11404337,1.0073661261070797,-0.5559774999444195
SU-DHL-6,5278396,3.0928075812605123,3.05314099198252
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,0.8643230056100218
PaTu 8988t,24964624,3.238300662516523,2.683163473341966
Granta-519,135411,0.2246473977843227,-0.863308495692984
LS411N,3025986,-2.0648766502168843,-0.5287058843545032
HEL,BRD-K58730230,4.651487565209977,2.3644630591949705
K-562,148124,-7.41486725283878,-2.803020911900767
K-562,10302451,0.1323934402367818,2.8472982647384497
K-562,1641662,2.591871767435193,3.038405350338349
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.226518311139095
Daudi,156422,2.1936092532092295,3.445553673045238
BFTC-909,44491742,4.0640318167931255,4.158612416971692
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-0.8400360616799608
MOLP-8,135398744,7.476327693514706,5.7074052000174325
IGROV-1,54618164,4.2184521751950115,4.065347164511936
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,2.417836332129321
PaTu 8988t,4259181,-1.3402011211504403,0.18883251337131832
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,2.527160579194107
KU-19-19,31703,-0.69897788572983,-0.8794404727792176
SK-HEP-1,5460769,6.10306620405049,2.897986256238437
K-562,11404337,1.5978316825317844,-0.8940208251408224
NCI-H2452,9840324,6.282829349463256,5.946718948895956
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,0.3754437017634549
KU-19-19,11214940,3.3843502872937106,1.8680559890947463
MOLM-13,3815108,3.4784839929418343,1.7334283098860492
IGROV-1,16065773,3.3717508464278585,2.3267038517978325
Daudi,6252,0.2227136884944618,-1.2578647923871982
SK-OV-3,1641662,4.382504296977698,3.5604020197335937
MOLP-8,11238147,1.6731293567937424,2.180749106072654
K-562,44462760,3.6560426907742896,3.380183822253474
RKO,9911463,3.963116579454927,3.490295565214791
KU-19-19,387447,-3.0100561484626738,-4.206425439567262
LS180,219104,3.901138037988577,3.5342597178871857
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,3.371099254726159
LS180,11609586,3.254650235567635,2.569555445850519
RKO,3025944,4.391654014934833,3.9317272916342922
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.7370116622072367
SW1573,11640390,3.5338327701281176,3.6424435716229504
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-4.0434735991436055
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.6328040148299576
LCLC-97TM1,2708,5.63991197078878,5.052832147080198
HuP-T3,262093,3.018266583248783,2.878607441449655
PaTu 8902,3503,3.0706473844938422,2.3686575574920257
HCC15,6918328,-0.0257689511183662,0.32841742041571437
COR-L105,24797083,1.0360227961267732,1.6085945238990476
P31/FUJ,9887053,2.876589254443052,2.4574595508833808
WM115,446155,1.535185995815247,2.72632935890782
COR-L105,613753,3.1601590793812,3.3608702940467414
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.7031286962030526
IGROV-1,10385095,1.0670946713416192,1.1222186471463151
NCI-H2452,6252,4.582294901932163,0.7702799774413728
MOLP-8,72193861,1.011292170776,0.524256968230831
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,0.8337852657453504
IGROV-1,26596,2.910298792762654,-1.0534713817801566
RERF-LC-MS,11640390,2.8932892314821927,3.8058150602323493
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,3.428587374982074
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,4.329831058213979
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,1.1272432869959217
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,2.828039496687797
SK-OV-3,168313047,2.892407732266751,2.486286834441083
Daudi,9926054,1.7776420054693636,1.5573526793746162
COR-L105,2749,1.1758378373045044,2.2464073416281165
SK-CO-1,6918837,-2.3986996753086305,-2.953409019306626
IGROV-1,12003241,-2.0122972114546904,-1.1809399157809688
HCC15,9866186,0.9811967871114916,0.5315987370866528
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,1.2533066082801922
WM115,9887053,3.7520086754622657,4.161735685393968
COR-L105,9933475,1.7212192557919994,1.972668747853762
MDST8,9967941,4.864965348465847,3.9460899779439296
KU-19-19,5566,3.5813761109507154,3.033857814089815
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-1.0199151963693263
ALL-SIL,168313016,2.945013463521221,3.8620203252617995
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,1.27583678735161
LCLC-97TM1,216239,3.3274661005628636,2.124728714608895
UACC-812,9935249,3.1921366544842,3.1962970223111564
KU-19-19,46398810,3.059016393641159,2.652590599807179
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.3943105420574136
Daudi,24901704,1.6931015271472445,2.626798852695182
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.7077454660498066
SU-DHL-1,135440466,0.4118800450630493,1.7841347293532914
IGROV-1,5311,1.0068816368200209,1.4637901996748877
RERF-LC-MS,5329102,2.8374518121885637,2.125181499602691
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.4073743024855965
Granta-519,10302451,3.667767303482806,2.261117702607122
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,0.27799318666874806
NCI-H1568,4096211,1.8643847121139272,2.1153882781844864
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,2.837387825114987
LS180,44487872,4.564049669792266,3.6233178373231514
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,-0.5787286882282511
SW948,135411,1.551236240082995,0.6166638552777371
PaTu 8988t,216345,4.148994433618168,4.073691889323122
LS180,9935249,3.57280690269837,3.0107446204704615
UACC-812,46926350,-4.425607795744521,-4.0914348995627385
K-562,46224516,3.0237589268452396,1.7382326550076999
SW948,16013152,4.211275799279611,3.787266536888227
BICR 22,10074640,3.373223414806136,3.0280344574761022
Granta-519,54618164,3.794628352719798,3.456426268567437
K-562,49793307,-5.346924391172112,-3.856872954423451
IGROV-1,54678924,1.4704159748793169,1.8817998324752545
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,3.2848282564039386
IA-LM,24785538,2.950939703376364,1.2297746806622092
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.614190350903802
ALL-SIL,262093,0.6753795238054565,1.42461218081895
SK-HEP-1,49793307,-1.6219654789172164,-2.552596461456968
UACC-812,9915743,-6.921665690083625,1.0776802768081526
MOLP-8,24964624,0.5129160642166024,1.005580871930338
SW48,16725315,4.089936042929296,3.998912271841573
P31/FUJ,25102847,1.6695774391929423,1.9218658929010852
MOLM-13,216468,0.0785275755512733,0.9029043714759746
HCC1500,135421197,1.2704457907642457,1.9894142788998448
COR-L95,445643,4.015431140089913,3.8987150639944264
Granta-519,9826308,-1.279512827450026,-0.5709172957596848
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.569366913998396
HCC15,44589607,3.4730057914725005,3.0400745410366143
SK-CO-1,73707398,0.894037962240185,1.2671660847248638
RERF-LC-MS,46191454,1.934559197398404,1.8832672197095133
PaTu 8902,44491742,4.263402068757711,4.1954596880284205
PaTu 8902,53481919,4.066569856261274,3.5483180701128676
HCC1500,4521392,5.662319691471263,4.405843589858392
BICR 22,11364421,-5.708558910936986,-1.0017168373941265
LCLC-97TM1,6610216,4.478615539127516,4.244057513009116
BICR 22,52912189,1.443997008169696,2.0673414451386964
SW1271,11404337,-3.6050810245472382,-0.5008777757593011
IGROV-1,969516,2.460805405371151,2.82163648875191
LS411N,25062766,1.7796504921777256,1.977730959584614
IGROV-1,11977753,-2.2284230058029433,-1.0437608059316792
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.309494466000233
IA-LM,54618164,4.43488746250501,3.8742766213334376
SU-DHL-1,135398738,3.5570959576905983,3.076886007606593
HCC1500,23725625,5.012282150953445,5.043760654080034
SW948,56973724,2.5267361451247647,2.7218707145187926
COR-L105,2742550,3.8597521863519257,4.075519132298594
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,1.8166218847287245
SW948,11485656,1.7814283284456571,2.164450224730032
LS180,56963564,-0.4927248320174067,0.4612388797808971
RKO,9866186,0.3829002704071885,0.7625979664634593
Daudi,44202524,1.1056351253600936,1.322440988047004
NCI-H1568,11964036,0.8982081488420575,1.264689824083131
MOLM-13,9915743,0.7456385275428815,-0.06746568133350098
Panc 02.03,4788,6.040807258084593,5.758395928183427
SU-DHL-1,10410894,1.885737679840171,2.765067508679656
WM115,3062316,1.2654694678882143,1.4919056672431321
HuP-T3,148198,-3.5090934063696153,-2.9723621059442324
HCC1500,24748573,2.217224851211772,2.153620986575743
RKN,44185566,3.394049733904779,2.6108389552250544
WM115,73707371,4.316198918387243,4.855573723401332
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,2.132390077741414
COR-L95,119607,5.444677320305195,4.885610572903678
SW1271,3543504,5.279434126076659,4.406785247463206
RKN,613753,3.037549827357118,3.3431158940948444
MOLP-8,9933475,1.6461417731910544,1.5758495619895732
SU-DHL-1,374536,2.32669265560356,1.2223868291571542
NCI-H2452,11222830,1.0864314168284432,1.6740663249882488
BICR 31,16736978,1.5520316002325725,1.5012984923022947
BFTC-909,11656518,3.71751997684089,2.1800658340578263
SW48,49793307,-4.357023521296349,-3.015035276912718
HCC15,676352,2.734399334153108,2.304316790051551
K-562,9933475,1.5582186007451084,1.5427575326550969
COR-L105,1716436,2.5827881779858797,3.0397019877394404
MOLP-8,71751553,4.257415338539138,4.159872139963493
MOLP-8,11427553,-1.470461076327197,1.775614694805389
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,2.126014071114937
HCC1500,65064,3.4319990575629484,4.704519232314112
BICR 22,54678924,2.835542995017498,2.4900416047573746
SaOS-2,52947716,3.1327874038156636,-1.1496927586033332
RERF-LC-MS,327653,4.17889189356682,3.2012738464213495
RERF-LC-MS,216468,3.2358353560937267,3.5351368964554486
LS180,637858,2.1359320280537704,1.864310729829241
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,-0.2456545897746863
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.9052995009691527
HCC15,25154868,4.699010678354358,4.506881458929691
BFTC-909,1716436,3.115342072857748,3.13634361226997
WM115,208908,3.0871953707393662,2.1255243982667364
COR-L95,5287969,-1.974656124599848,-1.716291245316906
MOLP-8,9907093,3.7363465424365567,3.6778903585059792
RCC10RGB,5738263,4.593697299478501,3.71614379464897
SU-DHL-1,446155,1.7989638936827528,2.491517138882318
Granta-519,51037431,4.032962229357369,3.010342540690512
BFTC-909,24771867,4.730369684143592,2.8388864338113455
SW1271,9926054,1.9992649208496855,2.023289026801438
IA-LM,46843906,4.034671652936036,3.025272066828092
PaTu 8902,3634881,3.736044150449037,3.3312000797318033
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.477018028943762
COR-L105,89928392,1.7234999745886912,1.6729165979804812
Panc 02.03,6917907,-5.450554920776264,-4.784114619759136
ALL-SIL,216345,2.7239648031314108,3.006526864058653
Granta-519,5311281,1.2060114833285496,1.6603181689500306
RKN,25150857,2.829513348324473,2.603220020485809
RERF-LC-MS,702558,6.005509402748126,5.323323306747118
Granta-519,44202524,0.8355806814666445,1.2140442425401448
IGROV-1,65064,4.920352624378345,4.75645367397454
HCC15,82146,4.430619158397189,3.956008463480394
IGROV-1,135984461,4.285945029851472,3.5967598847391566
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,3.0388164442643824
RKN,25183872,-1.1518449365963386,-0.8287654053587624
SW1271,6450551,2.703162256598128,2.7047592279954307
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.4512021940786268
RKN,656346,1.677354805367284,1.134061985780356
MOLP-8,3503,1.781914224283778,1.9185425869290882
COR-L105,2828334,6.248355208389406,6.208232306623886
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-3.6516206279574974
MOLP-8,135875424,3.0291075959050233,3.2834398909255587
HCC15,24748573,2.004363812639911,2.4640393768285653
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.5515451917953857
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.6258894396452184
IGROV-1,56649450,0.515518984822669,3.556981349337528
KU-19-19,9444,4.28834999434395,4.30460254186136
Granta-519,3552672,2.198733357723822,2.2378719595865024
SW948,66577038,2.9537896679300655,2.7668337338204116
NCI-H2452,119607,5.591396796149955,5.531437840918462
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,3.6671584998597613
HuP-T3,2729026,2.9922624267509317,2.5963398870066148
SK-HEP-1,71466578,6.341226391578653,4.945055706403135
Daudi,24785538,-0.3082535888445589,0.6069216755004675
IGROV-1,5280436,3.2616766817665086,3.4120329828631633
RERF-LC-MS,7251185,3.4578262740878976,2.8257818218586412
HCC15,156414,2.365134958139565,1.532405478326307
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.955985113969223
BICR 31,10127622,3.719060323270891,4.198515234869003
SaOS-2,15547703,3.066966974063678,3.1042414284038506
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,1.0833111651055674
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,0.8336214969733602
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,4.227347114626615
SU-DHL-1,3689413,-2.511818154735677,-0.8289884839402443
COR-L105,56946209,-4.798718381888378,-3.788310670053586
IGROV-1,5978,-1.5618214380165825,-1.8536393558125368
BFTC-909,11222830,1.7098036316197358,1.4951260399457391
IGROV-1,216239,2.21703825410177,2.1823616333312903
MDST8,135440466,3.3221976295713342,2.495301929961253
P31/FUJ,44632017,0.6534437162154956,0.4045387120706574
IGROV-1,219104,3.803083685328391,3.7532836470820308
SaOS-2,637858,1.716758511666406,1.9201775488922863
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.3074872264185482
COR-L95,24753719,4.203119149122614,3.9644406369204535
HCC1500,3025944,3.928139296588046,4.246399287958017
Panc 02.03,56946209,-4.513446270471167,-4.10459632935479
HuP-T3,25126798,3.926602492728053,3.91192165886079
PaTu 8988t,3011155,4.341218756124128,4.014284647002826
SW48,20959075,-3.67297247887529,-2.7971157980745303
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.7344643587859048
BICR 22,44486219,3.936553836391045,4.352522680531198
RERF-LC-MS,6918736,-1.8242544668906209,-1.1469464265887703
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,3.868595797896043
RKO,44137675,4.282234128328841,3.089565792042742
IA-LM,11626560,2.8197095065502515,1.5414563668876917
SW948,2746,1.2183078272507333,2.6237360105507146
NCI-H1568,168313200,3.516432771095034,3.2704106701787476
IA-LM,262093,2.9896562434219627,2.7490471131312284
MOLP-8,4261,-0.435327551985223,0.5795085048583773
HEL,2708,3.2519957529556716,3.796099980794407
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,3.057457482279534
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,2.9144068966968733
MOLM-13,51039095,-0.7255439577713276,1.6647711495985638
IGROV-1,426756,6.142776526139055,4.528644308375763
NCI-H2452,25154868,4.866167054223791,4.5151281646661445
PaTu 8902,4705,3.6244040622068256,3.05200119937207
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.532745339021702
Daudi,135421197,0.2989842149032058,1.4213850435285484
IGROV-1,10427712,3.944243047938238,4.1936635120178885
COR-L95,24978538,-1.547703636473998,0.15543377319962384
SaOS-2,52912189,2.036463757447864,1.9771578620366819
PaTu 8902,452548,0.9739796251952438,-0.12126539768621523
IGROV-1,52912189,2.3966568144845666,1.9951983966956808
SU-DHL-1,387447,-5.562438756444553,-4.83878799358781
HCC15,135398516,2.1695814103654696,2.311590716707316
SK-CO-1,6610216,4.838209270425191,4.0910857674928245
MOLM-13,5351362,0.6925875902125201,1.0089437855363834
HCC15,46191454,1.8626809755345697,1.8539688517662452
SW948,9825149,1.8114941973110277,2.159239698272834
Daudi,54639665,4.383406013207389,2.525691436954821
HEL,2828334,6.1216048061751795,5.794147522860177
BICR 22,71466445,3.433479198461154,3.487009244629965
ALL-SIL,9826308,-0.8056632694679019,-0.42039607923664835
NCI-H2452,57519531,1.3990882913061125,2.4508781258860273
BICR 22,54613361,0.4978505675466737,0.3842174384622698
SK-OV-3,135440466,2.5162908691834405,2.3741789850735646
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.612214384009496
SW48,6852167,2.2630322871527913,2.781287701183319
RKO,11404337,-0.3534280477619294,-0.7424285313535914
ALL-SIL,5291,-1.9713425457655045,2.7277662426579443
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.863385543204595
IGROV-1,24771867,1.9944882740161016,2.317720973193553
MOLM-13,46224516,1.6904951862054391,1.7958155929814827
SW48,119607,5.387394946551996,5.074930977847348
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.7597762716467845
BICR 22,49836020,2.6142262300183305,2.570934048912912
BICR 22,16720766,0.4876582946813295,0.6606321509980236
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,2.936427744694729
SK-CO-1,123631,1.846760097113305,2.1410299202132603
BFTC-909,36462,4.374665451212183,2.1354092956532633
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,2.795088042285148
RKO,5328940,1.7974237645790871,1.5179982960715757
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.8300071008300602
ALL-SIL,5281321,-2.461016259028612,-2.4564088515820193
P31/FUJ,568763,-0.9310646254211032,-0.3404731928939031
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,3.155823473962347
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,1.926134820930078
WM115,3081361,1.7542351340434374,2.7542705551167703
Panc 02.03,676352,3.0262590525496895,2.100795564408338
Panc 02.03,44462760,5.147948611944762,4.101010954407815
COR-L95,11228183,-1.8408108773608771,1.3854963471951474
WM115,56973724,4.208743527700851,3.172417972150801
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,3.2318238871708416
HEL,65628,4.10911337005638,3.359603290954457
Daudi,11612883,1.1925703345745973,1.9421787472541048
RCC10RGB,24856436,4.070420512574028,0.8995622729952869
COR-L105,46199207,3.6604959991625825,3.3997001928448842
Granta-519,25195348,3.9328442274761217,2.127416672180422
NCI-H1568,1750826,-3.116085482779225,-0.7764269727253738
IA-LM,12001922,1.9531449792239188,1.943472413048849
IGROV-1,19582717,6.764352444432722,4.1810522197326945
HCC15,10113978,2.260363506948615,3.250509804065909
SK-HEP-1,10074640,3.7857764861964935,3.2297678452584595
PaTu 8988t,6918328,1.905296387062238,0.3645265565039895
HuP-T3,24785538,1.540895569713237,1.4065782118319523
BICR 31,5281321,1.1837918014475457,-1.0720126477729242
MOLM-13,216345,0.0865178974102724,2.806442409560404
HCC15,448949,2.8674184346568414,1.9612462974677616
K-562,44566777,1.311822236929868,0.38658347370346485
HEL,452548,-1.769607447996444,-1.9610835955869592
SU-DHL-1,11507802,0.9378608618407872,0.9941869571289801
SU-DHL-6,2113511,5.89050983447184,4.928711166480954
SaOS-2,54613361,0.0035364978270003,0.1699929833731068
SaOS-2,24748573,1.7294478830476196,2.0305918211990845
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,3.275469503486928
HuP-T3,49766530,1.2218451996302029,-0.1797892336369137
HEL,262093,2.3252232523203995,1.9409335076361987
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,3.1493272963395396
MOLP-8,675434,3.835070621627746,3.9263662355297995
RKN,16725315,3.256745916563384,4.314604037842496
RERF-LC-MS,5746,1.1068525081764873,1.3087142584849596
SaOS-2,11964036,0.5086023979470407,1.5777790976475523
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,2.3147160772626765
LCLC-97TM1,126941,-2.218385477362075,-2.65064018097396
HCC15,54618771,1.6567762934530044,0.8646443883381374
RKO,2113511,4.623772297498578,5.230287750267561
RKN,9929138,7.419607622812729,5.676772920352668
HCC1500,5460769,5.1304942195737935,2.453628463871345
COR-L95,31703,-3.0462560513884203,-1.3962500413773988
HCC1500,46224516,1.0534131743048871,2.3984572726723874
Panc 02.03,5328940,2.397017671249583,1.6775849424940044
LCLC-97TM1,11404337,-1.4043223473519348,-0.4170698737567764
HCC1500,42642645,1.451455976812008,0.6776647224603812
IGROV-1,51037431,5.669320749085174,3.275422474806777
SW1573,107970,2.0608182724975266,2.2419941222609294
SW948,46191454,4.338482378206047,1.4049805736590102
Granta-519,11455910,0.302072347623865,0.4144019249396902
COR-L105,2113511,6.080993735084838,5.726301888079198
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.6496623355137099
IGROV-1,448949,2.098499309472767,1.775308239208118
NCI-H1568,107970,1.680617581032042,2.3442481957251924
SK-OV-3,24797083,1.6169926593639932,1.5811717048382636
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.3474496019348903
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,3.569925803271172
IGROV-1,4259181,0.1937358171291443,0.2344295659738771
LS180,135875424,4.384751932486372,3.628519531057683
UACC-812,54765302,2.961863639252158,3.963763264279964
SW1271,49867926,6.0238397416149345,4.309148035612709
SU-DHL-1,3025944,3.851371371046294,4.012102771273161
SW48,9967941,4.423983829284398,3.6096054052582076
SW1573,11609586,3.686627979451031,2.9730216016632385
Panc 02.03,16065773,3.1661848504472023,2.644701371499555
RCC10RGB,135421197,4.393109316582631,2.4512697808702066
IGROV-1,24785538,1.106246320450551,1.3954443160685017
HuP-T3,5278396,4.193223405360703,3.694874024280513
IA-LM,24901704,3.940918836251392,3.3694534203998376
SK-HEP-1,11214940,1.8009666315936252,2.390306847119732
K-562,11364421,-5.792707438494169,-4.034992014008572
LS411N,3384730,4.573317632228089,2.5366998484536105
LCLC-97TM1,568763,-0.0784771886342085,0.44264487440075095
HCC1500,9936388,-2.5304598124234365,-2.4351782311266663
HCC15,5311,0.7792586953300233,1.5866902840314483
SU-DHL-1,54686904,3.5039759810509676,3.0161363535073513
PaTu 8988t,11626560,2.010870886496287,2.004445429626402
HuP-T3,2749,2.009482044490881,2.1480352616093144
RKO,60750,-2.2331483998906654,-2.526818178351205
HCC15,5287620,-1.6098111318920385,-1.6944029862015315
HEL,654092,-1.523294365181231,-1.1768158022803115
SK-HEP-1,71304818,1.6350171624170464,2.686269565461757
SU-DHL-1,448949,1.2808073887625644,1.7403575091288672
K-562,5281321,0.5422415972342122,-1.9533769876370435
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,1.6242241760113918
LCLC-97TM1,5351362,1.316382729979947,1.7656317313991243
MOLP-8,5460769,1.8843864880791628,1.899876886411998
SaOS-2,56963564,-0.1924881408966614,0.2974924240352568
RKN,446155,3.7628691651204234,2.51847689462395
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-2.4021546461667254
NCI-H1568,16038120,0.8714631615296456,1.2822004275129237
Daudi,25102847,1.3031740879242997,1.935995921675922
LS411N,25154868,4.929077040033465,4.256413446508276
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,1.8973307480672241
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,3.958654950834645
LS411N,9915743,2.8294092926119028,0.7399186176008155
Panc 02.03,BRD-K55473186,4.513191364064351,4.21076505377613
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,1.0554923488044587
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,2.1353245571153527
SU-DHL-6,4917,2.9501994456287792,2.742884143803286
Daudi,16741245,3.410771008602035,3.3248181502917022
MOLP-8,3062316,1.3489297980566397,0.7447366030838275
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,3.3839227769939795
RERF-LC-MS,25183872,-0.4545636564638026,-0.43636316881162907
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,-0.1833230450620219
MOLP-8,60700,-2.8082015295780858,-1.2794618024769133
NCI-H2452,637858,1.8545349692582156,2.1340549862390086
LCLC-97TM1,11626560,0.938916298027116,1.6328692222632002
HuP-T3,136227924,2.888640375816574,3.0715167588303545
IA-LM,5284329,5.1954673618886655,3.3952929677857537
RKO,104842,-2.5196749638548,-2.8192880979781068
SaOS-2,11494412,0.4895123820960489,1.419477392943379
IA-LM,9926054,3.212619063516659,1.8901174342530667
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-2.370448804525682
MDST8,23635314,-2.200660522590374,-0.7917467530057261
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,0.4617254897839455
RKN,4261,1.529955054772996,1.9340293142270955
SW48,11396600,3.829401994456863,3.6040719094219207
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.2658956595413493
HCC1500,16659841,5.303826701580757,3.5889257609981398
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.4988176823389843
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,1.1912483083327259
MOLP-8,10231331,1.2198029486879254,1.031742466685567
COR-L95,16725315,5.004914745056217,3.9380998908749314
HEL,16115403,-4.756245139541522,-4.743149876376944
WM115,11717001,-1.1241138002933555,4.073946159140709
SaOS-2,11626560,1.1465195781021866,1.7836184042463332
BFTC-909,9907093,4.635414583134371,4.418087745080839
HCC1500,66577038,2.9555971550997935,2.9742121722423853
IA-LM,285033,0.5092837727748464,-1.8700162863275134
IA-LM,4917,4.737499942891754,3.107353960186397
BICR 22,44632017,0.9263322393180023,1.4372679874690528
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-1.0092999616765035
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-3.5082548132409386
SW1573,89928392,2.032641459256584,1.7682886942426286
MOLP-8,119607,5.472499710124238,4.730093134579768
COR-L105,46398810,3.2483226376094194,2.5965218795410987
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,2.1668964447502095
HCC1500,135999136,4.086589117257826,3.559479261312474
WM115,11497983,4.51521868458229,3.528949346507166
SK-HEP-1,46926350,-4.110479335135347,-3.578009587694821
RKO,322968,3.8471310775605216,3.1601981482514776
LS180,25262965,-0.0916364033105869,-1.536828637399565
HCC1500,246676,4.424448695399937,4.141431839317489
COR-L105,104842,-0.9230389281504464,-2.185846820990825
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,2.1729851267171214
SK-CO-1,6610355,4.767157937449789,4.174319159033395
IGROV-1,676352,2.310492141650647,2.059411781255289
SW48,262093,2.726859331273406,2.846593111195702
HCC15,55508,3.481008151195261,3.582989325846829
HCC1500,2126,3.801078614960916,4.476239594968294
PaTu 8988t,24951314,3.0808050806085188,1.541220683065257
RKN,11455910,3.815213247766997,1.0393223644633403
SW1573,3062316,2.075650426956439,0.995013685712409
SK-HEP-1,5287620,-1.0463187584720948,-2.1680921554068346
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.564169992627338
MOLP-8,24779724,4.381900106399647,4.030199795643129
Panc 02.03,107985,-4.238430695688479,-3.5015279734922338
IA-LM,322968,2.7570489193637018,3.4337093199733575
K-562,448949,1.070656561881704,1.4115309888326562
LS180,54649381,3.823257143411622,3.7059532135747055
IGROV-1,5281321,-1.4962463697398798,-1.4636750081451422
NCI-H1568,42642645,1.4281976900349445,0.8645359825239276
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.783599618293447
K-562,44185566,1.8580861510177096,1.7852489643957832
SW48,637858,1.3097623359774897,1.8883324293017412
SK-HEP-1,613753,3.3794099216210203,3.276603427997647
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,3.586885101087981
COR-L105,11234052,4.539846823478364,4.5337915911144275
IGROV-1,72193861,2.0623829231433293,1.340412507497983
SW1271,3503,3.0280256153278606,2.4244283504521196
NCI-H1568,57330099,4.373464200171548,4.446814939317895
MOLM-13,1750826,-3.2515027143289728,-3.454148644723556
SW1271,11222830,1.3106603955640226,1.6216403497283374
RERF-LC-MS,445091,4.218142840499499,4.454996366021468
BICR 31,3062316,-1.406162609577698,0.84532257952922
HEL,25126798,0.3968700607761156,3.2059742674671257
COR-L95,5738263,2.419040765220329,3.0166856791876353
SK-CO-1,36462,0.7476665664464673,2.2370631961963907
WM115,49766530,-0.6421157759153451,-0.0950316834568089
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.7689928736596081
BFTC-909,46901937,4.445112058189045,3.7861799848459934
SW1271,136227331,4.376300443457216,4.130817782485238
COR-L95,25262965,1.4716002732306153,-1.2728693218374598
COR-L105,5281672,4.46136628199001,4.877375757939313
WM115,73707398,1.178086440828875,1.26725123111671
Granta-519,6852167,2.2648312753409887,1.3895256539970102
RERF-LC-MS,46174525,5.020740506928848,4.418958156755899
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,2.0086345163759685
RCC10RGB,44202524,4.922768729279552,2.989346289744544
BFTC-909,BRD-K27188169,5.152610673434624,2.8516104669680584
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,1.9072061707035097
IA-LM,439501,-4.16745845294267,-2.073561612617614
RKN,25262965,-0.5506090189051945,-1.0790293478450668
SW48,3385,1.919145280274203,3.812708036095092
RERF-LC-MS,12001922,2.43602915295576,2.0410190534875903
IGROV-1,568763,0.665047061839467,0.4927026960877601
P31/FUJ,10385095,1.5135865779060806,0.8682800026616344
HuP-T3,12001922,2.3367896101102907,1.9678800940053245
HCC1500,1641662,3.3816027924522487,3.3134101470803814
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.359690169753102
P31/FUJ,1242560,3.8275456086274127,3.0897414166112545
NCI-H1568,57519531,1.3161148530355309,2.583693985391516
SW1271,42611257,4.308869978455437,3.2354567369948506
Daudi,10184653,1.026270071695755,0.49052807952655086
K-562,2858523,2.745068324935018,2.793027227295125
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.6939819980833055
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.134287106409618
BICR 22,12001922,2.2523981699696165,1.9312204932625798
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.2670893751527257
UACC-812,5978,-2.554443854158195,-1.1215506645165068
MOLP-8,753704,3.0200894206550877,4.336770232718383
ALL-SIL,5394,4.4345454375843625,3.422271741514523
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,2.083949306796478
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,1.5192373653184372
NCI-H2452,44137675,2.6709050374584846,3.949139845368975
BICR 31,52912189,2.5113420173615464,2.5332784011576517
WM115,72199292,4.562209520612744,1.4177021926151319
BICR 22,25154868,5.114547534217177,4.379079675928999
SW48,25262965,-0.5589271325062998,-1.0911322935239465
IGROV-1,4705,3.3098412390054603,3.3313741830095394
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.6195498830987276
COR-L95,11955716,-2.3894028875885778,-1.6094285448075352
BICR 31,241158,4.31214680273537,4.1125485740465555
RCC10RGB,25062766,2.0619451400109265,2.212599506091811
HCC1500,25262965,-5.244904140838402,-1.3717111127721455
PaTu 8988t,285033,-2.1993510069972215,-1.5041515540438926
PaTu 8988t,44566777,-0.8532538772982161,0.6908865926027822
SW948,71466445,3.954398511848749,3.760800357688989
IGROV-1,6610216,4.310938387105607,4.322452817271722
PaTu 8902,11497983,4.394920409770125,4.125357010536749
SW48,11612883,0.3553002535249436,2.5672996073012886
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.13427229330262253
HEL,9868037,2.50949616555346,2.020664594029155
HEL,11178236,-0.8324730036537664,-3.6306301556736646
RERF-LC-MS,60750,-4.1612389836176,-1.738539725986208
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,0.5633962528979233
SaOS-2,24901704,3.518814077302041,3.413650404807356
COR-L95,6914657,-4.192308975603822,-4.356384026568314
COR-L105,262093,2.940873643596252,2.921773338750935
LS180,44486219,4.325065743764261,4.185709407082234
RKN,10074640,3.313081701902331,3.2181588890390094
BFTC-909,5746,0.5111824642409613,1.1468203127506746
K-562,8515,4.039482215632923,3.6449203492360946
PaTu 8988t,31703,0.1373281877500042,-0.8563441534807449
MDST8,135984461,4.124255066625015,4.079235842158777
WM115,107970,1.780812210779262,2.3231711252583
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.9940194549460046
IGROV-1,327653,3.667792542405671,3.059262676719692
P31/FUJ,89183176,3.539325961528454,3.1176486265995624
RCC10RGB,6438330,2.9900078425794385,2.427007190043638
RKN,5280436,4.161667428331563,3.0943885624435286
COR-L105,445455,4.3186388426275535,4.996090061081681
LS411N,24785538,0.7817075732213645,1.208243767615059
Daudi,11152667,-2.9472151872913104,-1.5929843152828564
P31/FUJ,448949,2.0159916590055067,0.9676228762657569
Daudi,11609586,-0.3532025604686024,1.8540370142419698
SW948,46926350,-4.641976408237662,-4.158278418240816
SW1271,72193861,2.914678902909763,1.5596223755664627
PaTu 8902,25126798,4.210533326596683,3.8282340201154694
COR-L105,11955716,-2.257823880116287,-1.4120765044921653
HCC15,46224516,2.679221759698836,2.6866126421642758
HCC15,135423438,2.37991378319322,2.32076348825658
Daudi,421610,1.7509728437935097,2.5757620366475256
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,1.866001785641413
SaOS-2,11238147,2.85636627636287,2.8199918485324518
IGROV-1,374536,0.7022324251593053,1.9738422093677273
SU-DHL-1,51039095,1.7422871999086744,2.2368141164642164
IA-LM,72193861,3.820444995189443,1.3907410960845872
HEL,5738263,3.378820716395454,2.603324391276502
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,1.6435335815591654
SW948,6852167,2.188206161672083,2.5859369034688386
K-562,71751553,5.367911183247371,4.098383688496358
BFTC-909,71304818,3.116417285157316,2.559286665887141
SW948,25227462,-0.2382390684396511,-0.1470991659415602
SK-OV-3,637858,3.830307013284548,2.1329489740969505
RKN,49766530,-3.8574490235665584,-1.1220891943837068
NCI-H1568,9933475,1.8521331470520848,2.0715376095079177
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,1.9476129755082134
KU-19-19,17759555,3.7275461226555566,3.5986422292321016
LS411N,44589607,3.372730635507476,2.3331127345374623
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.7781584705608156
SW1271,5278396,3.101008990901291,3.6633104093604247
LCLC-97TM1,46398810,1.8633773855233131,2.561778783124711
SK-CO-1,6852167,2.111498553552754,2.7867792740095143
SW1573,5479543,3.675213844165782,3.661649720847127
COR-L95,12003241,2.921570030601445,-0.7779584469247789
Panc 02.03,9911463,4.953148943637795,4.000176357326648
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,1.0965607037529208
RERF-LC-MS,3384730,3.247206310046507,3.0169388479039783
IGROV-1,51039095,1.7163430299301403,2.9656937542964728
KU-19-19,89928392,2.8864230284497747,1.5811463947176683
SK-CO-1,216468,0.6363757446548435,2.8800573817380575
LCLC-97TM1,3038522,2.979698040139259,3.0246010222380253
BICR 22,6914657,-3.057028291966878,-3.1922189115658592
MDST8,3815108,3.655140825789689,2.9309857267771395
HEL,11364421,-3.0976744543470067,-4.540615305141697
SW1573,10074640,3.956421484938757,3.1866946423600395
LS180,6610355,3.640469161520063,4.270655335478811
Daudi,2858523,2.224035136584194,2.7725746421607225
BICR 22,135875424,4.925705128316808,3.9822006668061998
SK-OV-3,23582824,0.9299959314677436,0.8495258430557004
K-562,5282054,3.5952240521498062,2.9446226643725915
NCI-H2452,44589607,3.0010828964799208,3.1629538780137345
LS180,638278,3.5544678930796656,3.249974246118258
MOLP-8,426756,3.5390437920539117,3.9409591538026465
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.3880414503505576
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.7010228151082423
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,3.5768424443461493
BICR 31,71466380,5.422644788319504,4.664560376686549
PaTu 8988t,53392493,3.5279637137541524,2.7059220599338714
UACC-812,6610216,4.947422623598504,4.251568490570225
SW1271,16038120,0.5203426502283315,1.1763595690300945
IGROV-1,67156097,0.1763939852409119,-0.8830504008465531
UACC-812,216239,2.3945159107119767,2.068073527686978
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.1080100543208244
ALL-SIL,36462,-1.376242093473402,-0.3823378417335676
BICR 31,1750826,0.6511109819152475,-1.0070944039234762
IGROV-1,56649450,0.515518984822669,3.556981349337528
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,3.1199145246750377
PaTu 8988t,6918837,-0.8891471976747255,-2.623841332902012
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-0.2626660812719069
NCI-H1568,2828334,5.9155051642717,6.2170318839998195
MOLP-8,56973724,1.5171827826362807,2.0057078987002184
MOLP-8,2729026,2.779201693602774,2.389499936229632
P31/FUJ,753704,3.2802738483106766,4.255747383746561
SaOS-2,25183872,-0.102413301755783,-0.8549050718920925
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,2.325847073452709
LCLC-97TM1,9825149,1.404394440199107,2.3466960834815387
WM115,9929138,6.7694003006369226,5.730980486150591
RERF-LC-MS,2746,3.2731211053052647,3.305279333398279
COR-L95,5351362,0.837381680047442,1.3003892299467321
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.9041478769200283
RCC10RGB,3101542,4.48788654191394,3.7740581523715004
BICR 31,44566777,1.4466588952743178,0.765037496756693
WM115,5746,-0.962904812763719,1.1815765514308982
HEL,9903786,1.206049982415758,1.740710386373727
NCI-H1568,44486219,3.435494584556288,4.366865390706589
SK-CO-1,124202324,2.795373404058925,2.565496127372329
MOLM-13,5329102,-5.212236525427112,1.1000015879388614
SaOS-2,10427712,4.893681366378875,4.1867240292407715
SW48,409805,3.4729287041870127,4.815662267483959
HCC15,216345,4.3772403070959705,3.969300293054591
NCI-H2452,46215462,2.291566037713401,2.0030487947085494
SU-DHL-1,55283,1.0511806970329092,2.1190454019525267
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,1.2128043690042352
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-3.92246136898101
MDST8,24821094,3.627663013095859,3.0137232848188735
HCC15,9911463,3.642862209488471,3.9181249360323367
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-0.9346635341305022
SW948,11178236,-0.7120713487548671,-2.7588416784851426
HCC1500,5329102,1.6369795361395487,2.070942698511272
SU-DHL-1,11364421,-4.160715855029451,-3.0071408209378223
SU-DHL-1,176870,3.225718242496366,2.990278664856113
WM115,2742550,3.774256401917875,3.8434937072798165
SW48,12003241,-0.9746028071684796,-0.5476917589335897
NCI-H1568,11494412,0.631822071405162,1.9913884049687045
WM115,25102847,1.9091464851380515,2.3942841574199907
COR-L105,23725625,5.8274909459435165,5.315459567523715
Granta-519,9956119,4.186560294974692,2.3704019676708072
COR-L95,72193861,1.6807669427950571,0.9884042326173699
IA-LM,6917907,0.442667441503668,-4.307368904016838
SW1573,53232,-0.4627324496874346,2.874155970352717
Panc 02.03,19582717,5.117031119305748,4.4346241622299605
RCC10RGB,227681,3.758665689171896,3.4380437543133184
WM115,24901704,3.629786211252992,3.14532417995705
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.690992167543945
K-562,637858,1.3097643671251342,1.4514524276712018
SW948,613753,3.0653891790249617,3.0968166679293057
Granta-519,9926054,1.8135939424605243,1.4648474895302528
SK-CO-1,55508,3.57241133457179,3.3957231916337633
HCC1500,5426,4.174536858194301,3.5999839231154906
IGROV-1,4521392,5.131794979216607,4.362022143503702
UACC-812,6918878,3.827620339158657,2.604387058373281
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.45679100597714334
KU-19-19,72193861,2.401782330602402,1.825130526009193
WM115,5281321,0.1495893125543727,-0.8858528706109772
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,3.2491292342285276
P31/FUJ,31703,-2.5575864334968976,-2.822211370266797
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,-1.0451231009369926
ALL-SIL,44589607,0.5481515481681011,1.7660777847031206
PaTu 8988t,11955716,-2.6731660557009267,-1.572500954395003
IGROV-1,5738263,4.037832478240785,3.404896724443838
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.723662769806412
BFTC-909,650361,3.8112149600795706,3.7886263458542153
SW948,16725315,5.2631267850751335,4.1771065058060035
Panc 02.03,25102847,3.3458680072040603,2.710544921074773
BICR 31,216239,4.655547148927136,2.2260274970856853
SK-HEP-1,51039095,3.60670356936783,2.8246666550601147
IGROV-1,9907093,2.687959785702283,3.9778999569330433
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-2.5333743955568107
LCLC-97TM1,49766530,0.6419783818490065,-0.466596678681192
Granta-519,2113511,5.634502761977105,4.521976589304644
COR-L95,322968,2.331837213900703,3.4227272910471114
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.17802133643261475
SW48,60700,-1.9747801062936423,-0.16827214799583953
SaOS-2,46907787,1.5905885991562354,2.1978478661776335
LS411N,5311,1.0830647686053458,1.293169343232676
NCI-H1568,5278396,3.684546625455108,3.572515101792425
P31/FUJ,2858523,2.921593087757198,2.7160809783360507
MOLP-8,25102847,1.798391543473315,1.8988653377782956
HCC15,57330099,4.175732386995395,4.3194432987322475
LCLC-97TM1,16013152,5.423690206414697,4.031445487343279
SW1271,16065773,2.6188234772001886,2.252338540502967
RERF-LC-MS,52947716,-5.597592816818683,0.6748967035517859
MOLM-13,11167602,-1.7638454235436123,1.5274493944702068
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,3.288866638066225
Granta-519,3038522,1.8764454398289976,2.3267014180955345
SW1573,54626689,3.958399976383255,4.622786350361008
K-562,445455,4.202279962055385,4.3823287682263175
SK-CO-1,25262965,-3.291258197582341,-1.1050108154869636
Granta-519,54618771,-0.1786557603441652,0.21453123424603956
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,4.041167566517513
HuP-T3,42642645,1.566786855324099,1.0152998808016502
MOLM-13,44589607,2.917529465117915,1.744884303957623
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.4034544338629211
SU-DHL-6,753704,4.418086475877281,4.225455164633136
SU-DHL-6,6918837,-4.716152603392634,-4.570025133346266
P31/FUJ,46199207,2.4446101047156215,2.695646430753757
SaOS-2,156422,4.313289259132858,3.9494445913653142
BFTC-909,5282054,4.21714099973987,3.82598910536876
RCC10RGB,9803433,4.221770064596342,4.481065566607811
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,-0.5404322504762211
RKN,89183176,6.327700475537756,4.49250724541723
BFTC-909,16038120,1.74161234898449,1.21663133496193
HCC1500,71466445,3.970736335461394,3.585496823177299
Granta-519,25062766,1.8322611726564384,1.3794698584953207
SK-OV-3,216345,4.761928129554225,4.064595838545581
Granta-519,11609586,-2.485330170292811,1.5406496008243908
SK-HEP-1,6918878,4.4325993547595655,3.046669996612957
P31/FUJ,676352,1.6175160353980318,1.7284169895879657
UACC-812,25227462,-0.2916299121927669,0.06789175701701618
RERF-LC-MS,54596558,4.400747096440468,4.542091102241965
Daudi,9911830,-0.0057102646081846,2.1283262422253473
COR-L95,72376,-2.5853838467146493,-2.257120087738055
LCLC-97TM1,135875424,3.9585615026829823,3.8243890844777444
P31/FUJ,49850262,2.7073676452568427,2.7831695573584985
HEL,10410894,1.686960620182283,2.8162217388501056
LS180,10127622,1.4423864514133429,3.1626474110369402
LS411N,16038120,1.458068935835204,0.7213929962098059
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,2.941185695860369
IGROV-1,11214940,1.360660548899077,1.8783909318610017
Panc 02.03,969516,3.806573436208542,2.975714549667888
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,0.6880612700513136
SW48,656346,-0.2718986936332406,1.1717857693060352
SW948,285033,-0.875487938395224,-1.9748282916086897
Panc 02.03,4261,3.516583077320981,1.8201159752886216
SW48,49766530,3.606492941369466,0.08513540582104503
SW48,16038120,-1.7922421690180796,0.5099459729921921
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,0.8144893424413455
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.256311539932097
WM115,2945648,2.5851994154769025,2.7194210220719977
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,2.993950466633046
BICR 22,25227462,-3.180570489875023,0.47707007883563807
IGROV-1,5460769,1.6083174601829917,2.3052607097740268
K-562,753704,4.7227938780788525,4.308450866801954
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.13994693531119626
HuP-T3,4788,5.894927949545096,5.69185886917539
SK-OV-3,42642645,1.640931292575566,0.9875467282813618
PaTu 8988t,11222830,1.761666424308375,1.6695949657271365
BFTC-909,448949,2.818327130228084,2.0340673324836875
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,1.0685645654933484
WM115,5281672,6.287836255113029,4.682458713661243
Daudi,3384730,1.441294292217556,1.6035644248115808
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-1.036655991825202
LS180,6252,-0.5438897009285958,0.3829669294117576
SaOS-2,3025944,4.435896212894107,4.250603447241081
SaOS-2,25161177,4.43427627730954,3.9351179970484087
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,0.6251194212373741
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,0.03353708219899562
BFTC-909,11228183,3.298719229946038,2.531239624351006
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,1.6837908657228187
Granta-519,135659046,3.900512348834848,3.159431084848013
LS180,126941,-2.6871715133008385,-2.6936865427766925
MOLM-13,3081361,0.9632978577503784,1.8101093642995236
WM115,9936388,-1.175666523167262,-1.653559032445634
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-0.7658702998645742
IGROV-1,15953870,2.712793598656007,3.570040224568836
RKN,10410894,1.511663597063748,3.3333263192182137
IA-LM,6918638,0.61198230609435,0.6397791575125502
SW1271,56946209,-4.174123648346971,-3.9819450170955655
BICR 22,67156097,-1.5899611273150889,-0.13784007543229493
SW1271,2749,2.846909316544141,1.8556705634152189
KU-19-19,65628,4.405271017285275,4.277412636246081
MOLM-13,5566,2.591289759721003,2.645102527885736
HCC1500,89928392,1.0051530188155344,1.3387624443377482
SW948,25102847,1.6816963863778185,2.3617666464133458
ALL-SIL,10427712,3.5706749567785625,3.528315212941062
IGROV-1,2749,2.0319044408234954,1.8022973740283967
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,2.6124498129934053
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-1.0410737724965453
SaOS-2,1242560,3.6046854082724034,3.516354525962866
RCC10RGB,123631,3.672101761387351,2.6032623605066423
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.8836724392392206
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,2.686978668351937
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.586236792714746
MOLM-13,23725625,2.3173082013566204,3.818965565931683
SK-CO-1,15547703,3.920131639479481,2.9466755312389643
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-0.7404635732443379
SaOS-2,71729975,2.29546286795302,2.117204768369852
KU-19-19,12003241,-0.0608702413973226,-0.8669396212382889
SK-CO-1,568763,0.0338205510733868,0.5132036872420183
SU-DHL-1,984333,1.5848171755072842,-0.04841411385080896
RERF-LC-MS,49766530,0.7744144603938863,-0.5411384084798011
SU-DHL-6,11152667,-4.5064226702829,-1.532409535213809
HCC15,2130404,2.6093174666871293,3.6531286228856152
RKN,11626560,2.593417875894138,2.0034062700836723
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,0.9746164222202891
Daudi,44137675,1.0044684727898117,2.6445185952987713
SW948,54619267,3.654776559833868,3.7901452160324225
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.1827085239922885
RCC10RGB,4259181,1.719089746142662,0.6888846396846618
SU-DHL-1,9887053,2.0473441666614156,2.721437768916081
SK-OV-3,9911463,4.2249846626647125,3.95651087973851
HCC15,49766530,0.5190445493569186,-0.21924845834128656
Granta-519,3385,2.090684083959823,2.351138619987483
RKO,54613361,0.2998145946125954,0.12833088516359145
HEL,3384730,1.593743887858678,1.325072558631208
NCI-H1568,11977753,-3.4091025242198696,-0.7220572132816891
SK-OV-3,285033,-0.1977879636486448,-2.089700391573507
Daudi,3385,1.70419989930712,2.773146598024052
NCI-H1568,9825149,1.6639399446813206,2.4130644242331587
IGROV-1,654092,-1.340387623873854,-0.0810077324444633
SW1271,126941,-2.215477966101826,-2.663702574348392
IGROV-1,6852167,1.5305143027352028,2.724939136727143
HEL,11626560,1.0872099702081388,0.4804574157223233
SW948,126941,-3.436390914894009,-2.577626401981409
RKN,107985,-3.0900461086436404,-3.392723166282063
P31/FUJ,12001922,1.6134382673725098,1.5374840715722222
Daudi,11404337,-3.064654238522792,-1.0113834015848167
SaOS-2,6438330,2.0981522234577064,2.254362413749375
LS411N,126941,-2.790198017582557,-2.657391455578534
HCC1500,10302451,3.7658874637842135,3.1323623581987197
BICR 31,4259181,2.3774772051226685,0.45817321830901464
MOLM-13,11656518,1.5202718128538335,0.49389298424859635
COR-L95,148124,-0.3758104123213183,-2.349600638452771
MOLP-8,53232,1.5052202963885184,2.3862698751194737
NCI-H2452,3038522,3.3601174997652725,3.3629503754633934
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,2.976444885198903
SW948,16722836,1.2939108289094092,1.4412042639387392
HEL,439501,-2.350875236844296,-2.6679500947497727
NCI-H2452,445091,5.08182727911324,4.382843806314454
RKO,9840324,5.302067215897717,5.7035508827276695
SaOS-2,44489675,3.960447273667139,3.7790101869546358
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,1.9225435549055456
BICR 22,46901937,4.667354689676901,3.8528370448575826
LCLC-97TM1,2746,2.92478275020961,3.1327591573282714
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,-0.18905181483493894
Daudi,44491742,3.5549145676591314,3.6077701367192
BICR 31,374536,2.383890315264743,2.7787070880509135
NCI-H2452,17759555,4.398260875691204,3.8003876098359224
LS411N,25183872,0.0970121311419586,-0.7999837730738456
Panc 02.03,23725625,6.172373492037936,5.408393376393742
Granta-519,65064,2.9178387202883735,3.644801906338094
COR-L105,11222830,1.704570553497338,1.83117240695699
NCI-H1568,5394,4.198509108960074,4.126382462695742
P31/FUJ,135984461,4.1454221372139894,2.8030155066139173
K-562,49836020,4.414855158615189,2.6492235390824646
HEL,4788,5.03605552733545,4.835977119027073
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,0.30030456281613616
LS411N,6610216,4.962940577428159,4.16744658125592
NCI-H1568,23635314,-3.8228905075414055,-1.3078214698958803
HCC1500,5328940,1.924598719414512,1.5743246545748195
BFTC-909,44589607,3.3115887945185496,2.9726037164385373
MOLM-13,5281321,-2.338854439084819,-2.414415881783222
MOLP-8,71466380,3.4619880715079603,3.6721779985892606
K-562,439501,-2.3563528898814905,-2.5384136656025778
LCLC-97TM1,44819697,0.4394946813834864,-0.12200812558615341
HCC1500,9956119,4.194319271525248,3.4967039026761633
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.5502552460309025
HCC1500,6505803,-1.3038553273576796,-0.8532607904144226
SK-CO-1,16038120,-1.5377645940979283,0.928392341095106
MOLP-8,46398810,1.7248083632166018,2.003205316674449
RKN,73707386,3.296207724675486,2.9026749884665226
HuP-T3,6918638,1.0959798369911515,0.7482512178330657
SK-CO-1,72734382,5.327408257337546,4.5029949069037185
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,-1.4207004319742953
SU-DHL-1,23725625,3.354193732931358,4.467319094195316
SW948,4378219,2.7444419460246716,2.617615909272522
Granta-519,6610216,4.381057854502396,3.9255415577094896
SaOS-2,25126798,4.16568157244383,3.754068848180225
MOLP-8,11719255,2.3085103352777057,2.6573226753400236
SU-DHL-1,969516,2.44648475018104,2.3848269960642363
HuP-T3,9884685,1.9355517940144655,0.7867759507397442
SU-DHL-1,54618164,3.660876980117255,3.889622851182026
P31/FUJ,4788,5.1911977113578285,4.851082532939621
IGROV-1,10074640,3.2681490579824426,3.139481013052144
LS180,46224516,3.8200366067107714,2.236778673696159
K-562,24753719,4.107201496626299,3.611220534533956
HCC1500,46926350,-3.99988450675712,-3.5655797824644835
LS411N,11175137,2.6624545374598,2.4272612359668604
IGROV-1,71466578,4.017291197092763,4.758420313978169
Granta-519,10184653,0.998312657126817,0.4954664364691997
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.167658400848441
MOLP-8,6918328,-3.583816044173495,-1.3129709255626836
SW948,56649450,1.940604714075546,2.881180888948194
BFTC-909,374536,2.594742723017773,2.5911542954821876
KU-19-19,44185566,3.361767971446376,2.6248918326282586
NCI-H2452,1750826,0.2631697114156899,-1.313105239782809
LCLC-97TM1,24180719,3.1823264447338837,3.5160230509059143
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-3.062266194441976
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,2.1778084715670785
RKO,675434,4.252493680505022,4.251753186565767
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.3327074250453266
HCC15,25105715,3.3758270019314147,3.484140921782664
HuP-T3,6610216,4.722811341582641,4.430140094054147
MOLP-8,156422,3.6985484587412394,3.456175739749964
SK-HEP-1,6917907,-0.2672796642005143,-4.447463481425498
SW948,984333,0.954004982504914,0.754982660511252
PaTu 8988t,51039095,3.672985699080835,2.9387753178548826
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.10817623946948
MOLM-13,10385095,0.2048351805935088,0.6952107756416416
WM115,2842253,4.366205978966029,5.199121542887169
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.3199781498041638
IGROV-1,135423438,0.764137689665023,2.191668657879789
RKO,16725315,5.119694523443236,3.6307291185828046
MDST8,11609586,4.829072296940778,2.7831683777003264
COR-L95,7251185,1.1216187825494426,2.133463705067757
RERF-LC-MS,51039095,3.2453184174795324,2.758530256502062
P31/FUJ,17759555,3.626728737883383,3.229689027738142
HCC1500,5113032,4.590685122922873,4.8361022911580855
P31/FUJ,16741245,4.043144814115882,3.2662096686876714
HCC15,5746,0.6503914795852271,1.300861624397797
RKO,10074640,2.8357111382750646,2.9157987308087665
WM115,10322450,3.651827454662003,3.9236276404134105
LS180,11404337,-0.0678179476465551,-0.3775006083798432
Daudi,46191454,-0.8094751773550651,0.0013350384483014678
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,0.927863926895434
P31/FUJ,44202524,1.0280075167408849,1.2836503808530262
ALL-SIL,44185566,1.0410692737439569,1.346188266100189
PaTu 8902,54618164,4.284638344065584,4.176462352431711
COR-L95,46224516,1.2687748324677306,2.114359319238288
COR-L105,56949517,4.666554440626914,4.475243863187159
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,2.14447502316449
BICR 22,45279963,3.757910341256097,3.6114845747947477
HEL,9911463,3.4775133545177774,3.1429026895089036
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,1.3347680219884848
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.5460220997640621
Granta-519,5287969,-2.420005986832857,-2.3412966709624947
IGROV-1,71466578,4.017291197092763,4.758420313978169
Daudi,1323703,3.9745876209629354,2.8456120911926712
COR-L95,9956119,3.960527548011759,3.584107306904682
SW48,15953870,2.1672009909649415,3.514835144120486
SW48,5278396,2.530949009900888,3.198855495950422
WM115,10296883,3.9273376390568138,3.8646205089155568
NCI-H2452,10302451,4.286596307748033,3.3046569816452314
SW948,9915743,1.1952390119197474,0.9654926330110888
SW1271,9903786,4.005340236032604,2.960218152428047
LS411N,49793307,-3.1894754739686455,-3.4284456208672087
Daudi,126941,-4.413815937813151,-3.426131520872577
SU-DHL-1,89183176,5.662525063156772,3.2949544496271232
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-1.0512791337669294
SK-CO-1,216239,2.5779715954988656,2.1785230906026367
SaOS-2,24889392,3.914866726590468,3.6801252357818455
LS180,3025944,4.8838055311701805,4.083511090177864
SW48,11626560,-0.4765255311776857,1.52420211419518
RKN,168313047,2.366456695786382,2.435339953646174
NCI-H1568,4788,5.820003751306211,5.699245245954115
RKN,65628,4.337575078598336,4.215123229900536
LS411N,5311281,3.759327828108219,2.026293622061315
RKN,23725625,4.172652901782409,5.05184570205344
BFTC-909,168312962,2.436518653578315,2.23147996195773
K-562,56946209,-4.819463057676977,-4.812783277352968
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,0.731295112117342
Daudi,11647372,-0.1839602824658907,-0.04195568247509812
SW948,5479543,0.3482839273666757,3.127359614655855
SU-DHL-1,11626560,-1.697644171575415,0.9051400484047153
BICR 22,71466380,4.042212978424107,4.528553749689134
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,3.045573545982449
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,1.9808524153179767
MOLP-8,9967941,2.6295638429027206,3.2176827712680307
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.8231626546456028
NCI-H2452,25183872,0.970145395005522,-0.6062721231711528
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,1.105631638971145
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,0.9518658037596688
HCC15,8515,2.8931769079597767,4.171898646244587
SK-HEP-1,7251185,3.0945137710223687,2.7736752657996004
HuP-T3,3689413,-1.422602865458103,-0.2211606253034168
HCC1500,2113511,4.626117550925971,5.422835365495518
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.434951701562705
SW1573,5351362,2.395315345585997,1.579667506684027
SaOS-2,16725315,3.258166087647875,3.670920033161199
SK-HEP-1,44566777,0.1035402456781041,0.8576314101138075
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,4.298001025176034
NCI-H2452,54618771,2.226699645078912,1.134187690464277
RKN,5329102,3.127163305072316,2.1902975012170263
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,1.1370525128013609
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,1.866001785641413
NCI-H1568,5287620,-3.0605655272876104,-1.8588899847846816
IGROV-1,5329102,1.2794664511054334,1.9709742844099276
SU-DHL-1,71680916,6.473574001994787,3.8863507055513895
COR-L105,25262965,-4.3344847799771,-0.8506403316820991
SW48,3503,2.2068347221848605,2.251457764938713
BICR 31,36462,3.088359748996336,2.3754250556132606
SK-HEP-1,24753719,4.401042857593667,4.294598528150045
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-1.0599027570233472
IA-LM,16659841,3.92216274325252,3.616083003583428
WM115,24771867,3.628628048718056,2.705537460369684
SK-CO-1,67156097,0.6545128366700663,-0.6864511732447588
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.2493676030127867
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.5598278140603685
IGROV-1,71466380,4.863636874274779,4.299147394761865
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,2.6878457769014035
Daudi,5281321,-4.970506938945455,-2.517366135995572
BFTC-909,12003241,-0.8371396827795129,-1.1929167383513972
SaOS-2,44185566,3.018169617675811,2.296485843768676
SW48,54619238,4.554849733994691,4.651637678760519
Granta-519,25227462,-6.0432717278136066,-2.429136523522002
HCC1500,72376,-0.7270592073375387,-1.6342270634986624
SK-OV-3,3689413,0.6002437290843657,-0.41879738205223516
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.711993726943377
COR-L105,71466380,4.962997689396809,4.619870807926959
K-562,56649450,4.352548214039191,3.008288261245149
ALL-SIL,2828334,5.780519190951295,5.761278830510194
MOLP-8,5746,-0.9490954024297016,-0.16943049468238414
LS411N,9935249,3.5378716054356927,2.9038802640308012
KU-19-19,148198,-3.572091199224797,-2.9689801496562582
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,-0.2350561397940087
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,-0.09073183323008711
RERF-LC-MS,54619267,3.9836959677109354,4.157070254718347
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.4484114904490832
SK-CO-1,445455,4.388752059403359,4.649646271413344
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.4055745043423995
BFTC-909,6914657,-4.61933610547547,-3.476481258912269
IGROV-1,54619267,3.9701367924453455,3.8922518594649107
NCI-H2452,6918289,-3.5458030779688277,2.8140062231774516
SW48,654092,0.3720639788768654,-0.210090326689814
LS180,10184653,1.1411409682713576,0.7213685603290745
SW1573,4259181,2.0061423198913766,0.3499428723154328
BICR 22,5978,-3.054007840707858,-1.434469244237794
SK-CO-1,446155,2.509492168961503,2.989579073599165
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,2.0172681135979627
MOLP-8,6917907,-6.199761218038622,-5.020785563367198
WM115,6610216,3.675624927368402,4.142394217155198
BICR 22,11964036,1.4111698106068242,1.3309001386898016
IGROV-1,135440466,0.9791523710816318,2.1411341907688235
SU-DHL-1,46224516,1.9664047258697153,2.0763046204905065
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,1.264375432195766
NCI-H2452,156422,4.888821376667332,4.175695783205501
BICR 22,446155,3.7361559304721106,2.556763527008646
BFTC-909,3038522,3.685618431455981,3.0646422054422966
RKO,46907787,4.104881837237831,0.8151222002858308
IGROV-1,123631,1.7694522866439453,2.4069838469422877
LS411N,5280436,4.183720769167266,3.199054067157603
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-0.7869420412037207
HEL,5311,0.0816485968486221,0.5022270813688821
SU-DHL-1,327653,2.51842673185387,2.7790102473111453
MOLM-13,8515,0.8268618162227004,3.0152368134066676
MOLP-8,25183872,-1.6811002192977054,-1.8875347477340338
Granta-519,11228183,-2.3490545548585335,0.4890767097881242
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.3463527501405759
SaOS-2,5470400,4.204063595869918,-0.11804537803757789
BFTC-909,5738263,3.1091802601858185,3.3905778811549134
SK-CO-1,20959075,-3.269929661945314,-2.464644551812938
SK-OV-3,9956119,5.08600620496794,3.7256074558124834
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,2.7373351761124862
BICR 31,5978,2.6862960741960693,-1.2772482103700842
RERF-LC-MS,375860,-0.2896823379882159,-0.20492845453277322
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,3.0289104454353213
COR-L105,44202524,4.8543272504702895,2.711821514721489
MOLP-8,44137675,1.775364766844489,2.9077549192212175
IGROV-1,9907093,2.687959785702283,3.9778999569330433
LCLC-97TM1,10385095,1.2595894653665305,1.2849883255467538
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,2.00406818696122
P31/FUJ,3038522,3.230912995410489,2.528406589892215
PaTu 8988t,5281321,0.6032906637165831,-1.3692417149113318
HEL,9866186,-1.054303819018661,0.13660627308551446
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,3.14109901616332
SW948,2708,5.7755473109613265,4.712441915810496
PaTu 8988t,3025944,4.261130932115319,4.172246923045352
SK-HEP-1,3689413,-2.4602386660304143,-0.19808425334047908
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,3.356839620781859
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,2.815250205323971
RKO,6252,0.5352436981906653,0.4077970021106531
SU-DHL-1,4521392,5.192178694848648,4.079482877549835
Daudi,72376,-4.854665282210012,-3.5127818410507747
RKN,4259181,0.9508926940780028,-0.06400188286115963
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,2.2392339042276634
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,-0.4041892307775104
SW1271,36314,-4.053350989931705,-1.8504405777429016
COR-L105,1750826,-1.9007119452090728,-1.0568325146276414
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,5.06336140363267
Granta-519,46215462,0.9491023197189584,1.3874582617082314
SW1271,3676137,4.713113076263269,4.4972814427766785
IA-LM,5278396,3.9030690758091904,3.4366800923967724
NCI-H2452,24775005,5.579264227156813,4.061816729571538
K-562,23635314,-4.3400265171433725,-2.5697637925492605
COR-L105,6852167,2.71981320036177,3.034265703490974
Panc 02.03,16741245,4.354855972582246,4.290011196839745
SU-DHL-1,2733487,6.186604270067288,5.836899009371779
Granta-519,26596,-3.6955660538224784,-2.4705578198824796
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.680430961519429
ALL-SIL,176870,2.444675771693443,2.295391021648565
LCLC-97TM1,19582717,4.783105330370089,4.09261381814634
HuP-T3,119607,5.841541098284191,5.433107608540334
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,3.3596554109646464
P31/FUJ,637858,0.7903103947120294,1.003653913972457
COR-L95,5329102,1.6379635813529434,2.082203228315489
BICR 31,5291,3.978522058600436,3.8197811485163173
LS180,6852167,2.255231171645259,2.7959908320737235
IA-LM,89928392,1.436934436501384,1.42192508557135
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-4.349219246436034
BICR 22,9903786,3.2901982519836213,2.678238517889814
SK-CO-1,3384730,3.2619898650330272,2.8240376345937572
SW48,17755052,-0.4852421045975616,1.6517329488190655
COR-L105,568763,0.9810834095142736,0.5463085422339731
HCC1500,9866186,3.137309558941867,1.1355353923665306
HCC15,124202324,2.163317754038658,2.484526180863488
HCC1500,6917907,-5.345696307345718,-4.093637753415153
HCC1500,23635314,-1.1425681705854864,-1.219935719843451
Granta-519,126941,-4.311277898608593,-3.3284334049703173
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,3.5777636837294606
SW948,24771867,-2.1331828785420166,1.3573430418233263
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.4556602090169166
LCLC-97TM1,10410894,3.7243046596553344,3.3358759631074952
COR-L95,11609586,-0.6075050167057128,2.3840382205977293
MOLM-13,9952709,2.652499766566874,1.8236408704070775
HCC15,24951314,1.20775234306688,1.4507076530924818
BFTC-909,11175137,1.859642091823866,2.757910605632105
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.37244411792726184
SaOS-2,9444,4.299296809659387,4.014292839280552
Daudi,71576739,4.751042411789338,2.4419745958953305
SU-DHL-1,6505803,-0.92520479323989,-0.5208055344381699
SU-DHL-1,11214940,-0.4959690036226346,1.7654874632187019
IA-LM,71466578,5.490140561499378,4.171775503258029
RERF-LC-MS,262093,3.104487938727744,3.05651040380056
SW1271,71466380,4.990835020791986,4.5265400255197905
Panc 02.03,135411,0.8368106867561712,0.807853060720808
RERF-LC-MS,8515,3.770178660744851,4.120763142609796
HCC15,45100309,5.717971650422449,3.199161871082881
COR-L95,54618771,1.9587299059916856,0.6877420420975483
LCLC-97TM1,16736978,1.4629436365964008,1.248708842956292
IGROV-1,9825149,2.5588021380929553,2.2349602448665253
IGROV-1,227681,3.5439813498262347,3.0832793243518326
RERF-LC-MS,44489675,3.7548789887197183,3.90315087530257
MOLP-8,3136844,3.797428854524256,3.924150187358704
COR-L95,5746,-1.1189080553056585,0.5232290232858253
BICR 22,135398516,2.7677082767193117,2.5348706215357635
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-0.5960781016826452
ALL-SIL,57330099,4.126515702027515,3.9273671918496422
SW48,135398738,2.3509294796071454,4.125389901490472
WM115,2113511,5.303490143807845,5.672901548245752
Daudi,2729026,1.2833432455886875,2.127563806247239
P31/FUJ,100016,5.4217002529902185,5.145045924087781
IGROV-1,71466445,2.3758001916617797,4.038007224415717
ALL-SIL,6918878,-0.682122479171039,0.11001607803500518
Daudi,73707371,3.866210661620395,3.8222599797579107
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,-0.20210102861458723
SW48,11364421,-4.967269122022574,-1.6172546752855033
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.7321326520968188
LS411N,135411,0.7383506227122603,0.3649328472933528
K-562,3634881,3.4419902111623473,2.965880987592476
KU-19-19,969516,2.8919422545546043,2.847681978440404
Daudi,135999136,4.063293138043838,3.2168800280118215
SU-DHL-1,12001922,1.0574025128990867,1.743013075765613
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.561581462328683
MDST8,11427553,3.108888701151444,2.8464549451231385
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-0.9105665239183703
HuP-T3,9840324,6.187364891887578,5.809673101952371
RERF-LC-MS,5281321,-2.2570738048063257,-1.4393031407637662
UACC-812,16725315,4.601797708491857,4.171494869331921
WM115,53481919,3.625694730030069,3.46079190230189
WM115,3136844,4.4781621433894925,4.4496939671
SK-HEP-1,135999136,5.290710201924687,4.003576060920582
SK-OV-3,72734382,4.397767647147488,4.788217803093822
SU-DHL-1,4096211,0.0680701310214702,1.5315834236109884
SK-CO-1,2749,0.8616454488616467,2.0050115204572267
COR-L105,4477,0.3499366832640422,0.8193226285657558
SW948,24785538,-1.2786696026485709,1.2394495295026557
BICR 22,25161177,4.685384367036766,3.9892008669921206
Granta-519,11955716,-3.0537796337487064,-1.741237388915007
ALL-SIL,10127622,5.469150259822909,3.5044582265372024
SK-CO-1,11238147,1.2924304468719774,2.7518629770875687
IGROV-1,11427553,2.926316692603687,2.744396092492394
BICR 22,54618164,4.171441086739322,3.945488400684162
BFTC-909,57519531,3.2286550647211025,2.492831261668689
SaOS-2,1750826,-1.0374385524430834,-1.9909936140822877
SU-DHL-1,71466445,3.7763473385017994,2.427185445871263
SW1271,6852167,3.737297660761554,2.7783646170244407
SW948,9549297,1.722924191719054,1.9843445872845527
BICR 31,72376,-0.802396523967939,-1.5180238485351356
SK-HEP-1,56946209,-4.57873882670014,-3.8084954858541327
RKO,24964624,3.0430796891613903,2.0671710218243797
NCI-H2452,54143018,0.9899128272921088,0.4596895733071152
SU-DHL-6,60750,-4.821248170588626,-3.3645985878147684
HEL,44259,1.31343744649104,0.5839078724895103
MDST8,3038522,4.546677862508445,3.03628614351132
Daudi,72193861,0.2314245956601211,0.3538602998840466
NCI-H2452,4096211,2.487981551988898,2.132518445273534
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,2.8460038039405937
Daudi,208908,1.616008502166041,1.8980414507665861
LS411N,46191454,1.665967132338862,1.2981191004267187
Panc 02.03,262093,3.467425891303458,3.229274610705754
COR-L95,462382,0.8255977399878551,0.3904886946997658
IGROV-1,16736978,0.1982875499977011,1.4555474105294524
MDST8,107985,-3.301997074358414,-3.094728120856948
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-0.35424854507243736
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,5.103847222243654
RKO,54618164,4.0326978900214705,3.7287213712043963
MOLP-8,5311,0.4432260076750803,0.5263501491484489
SK-HEP-1,5291,4.1108608913621545,3.7221708220756295
SaOS-2,107970,2.235066344736828,2.1576749946046254
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.4355625910731944
Granta-519,6252,-5.172240666242431,-1.12956122144153
IGROV-1,285033,-1.3538783590767758,-1.8515845115183862
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,1.6532065250117625
NCI-H1568,46191454,1.7726304550427152,1.807169582271263
PaTu 8902,24856436,4.585148807200659,0.6629349802821988
WM115,5351362,0.9981168658111552,1.6979963224987318
IA-LM,387447,-4.406032561698067,-4.065750568889893
MOLM-13,656346,-0.3431029585418202,0.5382456350018764
COR-L105,637858,2.3247583240908405,2.2345269204579337
Daudi,448949,1.1283153338590814,1.2530427471498407
SW948,42642645,-0.386998084672917,0.6532472705771808
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,2.0459753671899135
HCC1500,52947716,-7.376885049387286,-1.119459666989064
MDST8,439501,-2.351670240427255,-2.121732416622743
RERF-LC-MS,25161177,4.303824118845859,4.15050946826081
SU-DHL-1,3634881,1.9377929493272257,3.040573561039505
RKO,46398810,2.934390735401444,1.9522093632324342
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,3.1183881419595423
HCC15,159324,2.6315252421023536,2.908749307038338
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,2.2655959802142944
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,2.901208237127109
Daudi,2949965,1.2926680931891954,2.1070089367061873
RKO,23725625,3.9986828157613616,4.1635603089869315
HEL,16722836,0.561669465799647,0.6207846409596167
Panc 02.03,11175137,3.7353172411310696,2.917449205112019
KU-19-19,6918878,0.8609723302141853,2.9708943174751012
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-5.295775604952846
SW48,3854666,0.5343434371102147,2.1880220514345416
SK-HEP-1,11626560,2.7034566874481745,2.0822379021631723
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,2.006934556251398
NCI-H2452,3825829,3.8827569930751937,4.154378968742453
BFTC-909,126941,-2.0975077483758415,-2.3262292733366294
NCI-H2452,24951314,1.9717681393720747,1.5400076409756938
HCC15,54454,0.5186235809490349,2.8174176099336234
BICR 31,4096211,1.2121831781068038,2.2953894244276096
SK-CO-1,6914657,-1.8836208914019363,-3.271930613902053
SW48,44493528,3.8128145383765992,4.054638095217141
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,1.7424373273873497
SW1271,168312962,3.6054980890180746,1.9747550483546712
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,3.184085841205373
Panc 02.03,135440466,3.0724615257354153,2.365276840620879
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.879306347640766
BFTC-909,11427553,2.7610941057010754,2.977513497455482
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.5056276123463264
SW1271,44493528,4.286060334293371,4.290643971930695
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,-0.3424083800699056
LS180,49836020,0.6204023867713871,2.4503893138140533
HEL,148198,-3.399100076616297,-4.198684034118162
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,4.500700488306049
Granta-519,3543504,5.0961511485487705,3.7858591742482077
HCC1500,3038522,2.0060085934463108,2.9464034335225335
RKO,4917,3.097539294413192,2.914085858439021
RCC10RGB,168312962,4.335962117924443,2.681461781432325
SaOS-2,104842,-4.966916923279438,-3.234474999291876
Panc 02.03,753704,5.09544361232119,5.155093005011473
PaTu 8988t,439501,-3.4446792284706347,-2.019350918904803
LS180,5282054,4.115839158247494,3.5764092931111016
IA-LM,5287620,-0.8479822353163541,-1.9753981423012248
RCC10RGB,6610216,4.531223922644925,4.388677102330041
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,3.2658198867235995
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,3.3894790088170303
SW1271,9911830,2.7072275961126997,2.527810031535758
WM115,11719255,3.1992621528929166,3.361938693537225
RCC10RGB,42642645,2.104174802814935,0.9990772299879923
K-562,72376,-2.627875463605781,-3.089301844939259
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.300915931466714
HCC1500,9549297,1.8848953505663728,2.288931961292534
HCC1500,44241473,4.374636754710865,4.766568048655973
HuP-T3,2708,5.229598766149438,5.201194770248684
P31/FUJ,9866186,-0.5408158091236333,0.09584429467879665
RERF-LC-MS,11657048,4.330866638894723,4.523160504196409
HEL,119182,-2.1951032337756935,-2.6154465129882887
RCC10RGB,10296883,4.350673741830848,3.982347722505378
MDST8,10385095,1.2575537617816142,1.2796440646220335
SK-CO-1,23635314,-1.3218098525260824,-1.661449039236123
BICR 22,72199289,4.441607504718354,2.593705410831422
MOLP-8,9911830,1.992368688928045,1.8556803373848763
SW48,24772860,-4.097111396936187,-1.6729891910494803
COR-L105,8515,4.561371818511258,4.1846006408216345
IGROV-1,15547703,3.339928221860449,3.390111105257537
SU-DHL-1,656346,-0.4085927723055031,0.6441815210094863
COR-L105,168313200,3.683873258385797,3.1629867472199336
Daudi,46224516,0.8162026590632436,1.8633320148546944
Granta-519,5287620,-2.8216901996678985,-2.069012185413063
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,-0.4904916187274705
UACC-812,11640390,4.086462739167014,3.3901191602243723
K-562,17755052,3.8994339695870326,1.5427197460865196
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.500953977318954
LS180,656346,-0.0089884994203474,1.0136046900189084
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,2.8006195974422075
SU-DHL-1,5311281,2.996662642824561,1.753011062516859
RCC10RGB,25161177,5.612412997721579,4.071900796252091
K-562,3854666,0.2872946014041473,1.0374866400373022
P31/FUJ,9825149,2.400010374644864,1.3784294698775474
SW1271,11964036,1.1602803966527862,1.5417824124440533
LCLC-97TM1,176870,1.9757247403033509,3.1056661276595
K-562,168313016,4.482960220744853,4.098722690264121
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,3.3016275791629988
SW1573,285033,-0.3175288260868649,-1.8393778760859676
BICR 31,4788,6.181654669045445,5.704385728017313
LS411N,11404337,-0.9351547419605356,-0.5564923958439639
RERF-LC-MS,9967941,1.5454786965180345,3.8110908869238664
Granta-519,56973724,1.8473061894805545,1.7874806730748423
K-562,11507802,0.4095176942133114,0.886855575731729
SW1271,1750826,-3.093550008900348,-1.9185062431657383
P31/FUJ,135398738,-0.0291234665218711,2.4124732591102003
WM115,5329102,1.7959886386080517,2.0999966087901067
MOLM-13,5470400,-0.3466627309634489,-0.022864354592495407
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,1.655739650561137
Granta-519,44607531,0.7355881041308102,0.9800788411014135
RCC10RGB,5566,3.997570642857795,3.1650777956584646
KU-19-19,24964624,3.8522438290321768,2.546251919331128
WM115,1641662,3.4019570651475557,3.4407215196959533
BICR 22,5282054,4.223594396310054,3.7730550247808763
BICR 31,10231331,3.776464743887352,2.273909358591615
RKO,3825829,4.017808531984142,3.591177872441954
Daudi,10322450,2.3131627402631905,3.266796759979813
BICR 22,285033,-4.068757657270757,-1.358877385622454
SU-DHL-1,5281321,-1.7372628502658949,-1.9656075217952995
RKO,5287620,-1.9975210326345276,-1.9579099987169875
Panc 02.03,53232,6.367991743549877,2.836069272213925
SaOS-2,9826308,0.4955218987390744,0.7532022080098393
HuP-T3,10074640,3.8159838645365807,3.2921998496484566
SW948,4259181,0.2292867461834122,0.1084660108033503
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.5557616339098477
IGROV-1,568763,0.665047061839467,0.4927026960877601
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,0.1389914335258725
MOLM-13,322968,2.556875190594409,2.3569166801651007
ALL-SIL,9903786,1.532435199339551,1.7062563594648605
SW1573,409805,6.568626512075582,4.84651540731968
LS180,1750826,1.061711606063746,-0.9840328177392369
HuP-T3,46191454,1.9484889201022677,1.7540458985873835
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.304905837156074
HEL,216345,3.87635579429504,3.0825259988423097
BICR 31,2749,2.2358137088107033,2.257459644131076
SaOS-2,3385,7.1536746080698395,3.957622114287949
WM115,11626560,1.643291568999912,1.7075416943653494
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.5010191897869085
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,2.4437028376745835
Granta-519,24964624,2.975569692960617,0.8624554788173758
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,1.156035011877386
COR-L105,6918638,0.8528151020185122,0.8875732622973159
RCC10RGB,9825149,2.634802111166888,2.6613170609133006
HCC1500,44493528,4.240662848371031,4.191036793186443
COR-L105,44489675,3.747818158649104,3.99899031579961
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,2.8821894647043407
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,2.0662327697574265
BICR 31,2746,4.041774334142006,3.315330242870216
MDST8,51037431,3.453193232905579,3.2905796879450175
K-562,676352,1.515837042857868,1.864045542937711
LCLC-97TM1,73707386,3.587652793939767,2.9783434833588744
SK-CO-1,54618164,4.180915062416914,3.9981171617245725
SaOS-2,5329102,1.942826181308244,1.8991102038093148
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-1.830392596526904
LCLC-97TM1,151289,0.9235530786043882,1.1478066859533704
BICR 22,400769,0.1100780529561809,-0.5504187002465388
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-3.3370122605722794
SK-CO-1,400769,-0.6897300489229926,-0.5121558556398277
SW1271,56973724,2.58013716529859,2.9067628659617126
LCLC-97TM1,2945648,2.6479910997037934,2.765561885786838
SU-DHL-1,439501,-2.3864560258185916,-2.5940615267500764
NCI-H1568,148198,-4.9953315451672005,-3.1531430538252154
RKO,11507802,1.7455765117352984,1.207930317902454
Panc 02.03,216239,3.7763245170365183,2.3103794679777065
HCC1500,9825149,1.9829642871568696,2.151815790714522
NCI-H2452,53232,3.5381177646863837,2.7399741811571268
MOLP-8,11494412,0.4734092912657368,0.6581501773401102
Granta-519,9911463,3.5000933341892733,3.0395243506167993
SK-CO-1,10410894,3.775604170297083,3.377175082005737
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-2.0939680341960325
MDST8,5328940,2.138158341424683,1.7595741298832337
SaOS-2,1716436,3.427239396926117,2.926051606811999
HuP-T3,9887053,4.07990532641299,4.293759191595211
NCI-H1568,24772860,2.3104914540479324,-1.4462537111477252
LCLC-97TM1,135999136,4.356650968290631,4.051808486979824
IGROV-1,4378219,2.016502068118561,2.6481158316655073
BICR 22,46199207,3.899734747403315,3.0828766391898785
BICR 31,9915743,-0.3251640044425866,0.9649810846975656
NCI-H2452,613753,2.817247196569438,3.292459434508595
P31/FUJ,46174525,2.51911302821391,3.1883138347670785
P31/FUJ,5335621,3.2282922271331613,4.32310796578853
IGROV-1,5278396,3.119031774261392,3.564265341017065
HuP-T3,16038120,1.51216352382263,1.157235550883428
LCLC-97TM1,17755052,0.1986775459223547,1.6115652084597158
PaTu 8988t,66577038,3.1818565141070625,3.028443172675093
PaTu 8988t,54618771,0.599962301527202,0.8922288113694095
SK-CO-1,46191454,1.747962727561699,1.669948278737017
SW48,46907787,-1.5740012638710297,1.8282024055448178
ALL-SIL,11485656,1.390704841990788,1.6795000197550374
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,3.5318330233992636
SK-CO-1,4788,5.843658659854095,5.610554728178248
IGROV-1,16725315,4.890680859998698,4.184004477774753
SW1271,24821094,3.627509655063773,3.151769484417305
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-2.250945020634235
WM115,216468,3.848857711215856,3.2361322653680484
SaOS-2,24779724,4.377738848523283,4.323147940454763
HCC15,675434,4.852455641097197,4.598378084967863
SK-CO-1,46398810,2.9216967746168625,2.5163931694279658
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,0.7916005765054437
Panc 02.03,123631,3.5560371664842325,2.449745081717711
SK-CO-1,448949,1.9523830928265349,2.060891352368689
RKO,285033,-2.0365968290915393,-2.3852825322387607
SW48,2749,0.8385534684858028,1.8153883833580995
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-1.1254920290265564
HCC1500,54618164,3.7944844711277264,4.13051123356071
Panc 02.03,2858523,3.458791746781272,3.0815136792440985
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,2.027725047537175
COR-L95,4261,0.3666433774913241,1.201057724386917
HEL,126941,-3.7945695708983664,-3.2675680301160464
HCC1500,54596490,4.413271545106012,4.808685294879563
BFTC-909,375860,-1.1901103647211757,0.06803813008427873
COR-L95,9866186,0.0204391385842873,0.7076396078868449
BICR 22,66577038,2.5300885228037813,2.8502036079013298
SW948,9826308,0.2428169991227084,0.2446781696931242
MOLM-13,73707440,5.976327057082507,3.6171839692959287
PaTu 8902,5291,3.72219732976082,3.7690079040794124
RERF-LC-MS,5470400,2.5584942331402623,0.2829562113952
SW1573,16725315,3.253832365815957,4.050764180714831
SU-DHL-1,3552672,1.9257473882600096,2.103727196940392
HCC15,60750,0.68669542572171,-2.1917680606661105
SW48,5328940,0.1162920415883012,1.5407264455687255
PaTu 8988t,4378219,1.99751885903338,2.6351774846734735
HEL,241158,3.370113308144609,2.7163686374135154
MOLP-8,53495165,-2.6639864548579535,-1.0240621095425386
LS411N,46943432,5.879073426568822,2.011260406916487
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.5280906974713387
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,3.4481313483045772
Panc 02.03,4521392,4.25988041093388,4.320483466218813
SW1271,5951923,6.143368489838077,4.5330735549110095
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.501154279288455
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.5924934671279685
RERF-LC-MS,11717001,4.567893424272946,4.255768268027946
NCI-H1568,25102847,1.8020479238639409,2.3649696493905994
MOLM-13,44137675,1.768154079183361,2.5501191699442822
RKO,10427712,4.823698606341804,3.8318764842298823
BICR 22,6852167,2.9570859917106533,2.8840171688030143
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,-0.5883604177244098
SW1271,124202324,3.327062905972079,2.3307862659233662
WM115,400769,0.2375153529743729,-0.3132561430284524
RKN,3038522,4.332475047921768,3.0188549923901546
SW1271,4096211,3.040458805184357,1.9096382135939518
BICR 31,60700,1.4006980690412227,0.06429200384090182
Granta-519,448949,1.64880276038625,1.1682112919151948
HEL,11964036,0.787171767074348,0.29087011917704064
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,2.329657036915788
BICR 22,11485656,1.7887481250962165,2.36826813157728
HEL,44202524,1.7623585771552046,1.171232133493964
COR-L105,3503,2.4932686195421625,2.465114994472669
LS180,4788,5.917574515812926,5.565225606234966
IGROV-1,219104,3.803083685328391,3.7532836470820308
IGROV-1,11152667,-1.4116509977729443,-0.4950685120911667
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.3153878457745631
HuP-T3,11485656,3.0565489144797224,2.3207700471137933
NCI-H1568,9907093,3.7800753982052697,4.211665046009768
LCLC-97TM1,10184653,1.174063194948861,1.3446690032406878
MDST8,16038120,1.9679009346440888,1.0566433146513803
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.9130615925606933
NCI-H1568,216239,1.54277692538335,2.4474950509866993
LCLC-97TM1,5280436,3.0011603005672804,3.4640954825132786
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.1633965022983888
Granta-519,5281321,-3.900138103622144,-2.379121511530172
NCI-H2452,6917907,-3.4621989648593696,-5.528077194015476
HCC1500,135659046,2.9858139057826905,3.858970231520118
P31/FUJ,3825829,3.1586120375796516,3.3371784560328837
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,3.510315279374653
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,0.7986212504911865
SK-HEP-1,7326481,2.0213225214426505,3.1189558893587583
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,0.8702035430165728
HCC1500,3634881,3.181593200231373,3.1742622194041257
HuP-T3,5311,2.274555641774389,1.494773804335782
P31/FUJ,969516,2.490551298955204,2.080113877280071
LCLC-97TM1,25183872,-1.9138026924081315,-0.817500766024157
WM115,54619267,3.5599503094850244,4.005795005019125
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,3.140383054505881
SaOS-2,17755052,-0.5339241699834809,1.975961632330141
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,1.4786677743908816
SaOS-2,19582717,4.316823865856345,4.133442056504889
COR-L105,25105715,3.731140483220641,3.488637515810824
SK-HEP-1,5278396,4.037206436677834,3.6427103432125825
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,3.2932818050476027
COR-L105,6918837,-2.1114263163326177,-2.573782512260785
IGROV-1,25262965,-3.18785020602057,-1.4864501341399734
HuP-T3,6505803,1.3238670991795596,-0.30996021285119935
NCI-H1568,11214940,1.6761106979183067,2.0984296058331795
HCC15,44543605,4.452652862359365,4.020550155281304
SW48,46199207,2.9489751610364405,3.272582119602669
P31/FUJ,104842,-4.465734156959207,-4.054202556091672
MOLM-13,24180719,3.226510234308061,2.440185331584678
HCC15,12003241,-1.0460858766179792,-0.8333759463905116
IGROV-1,10231331,1.9104831176724932,1.9253202807340335
IGROV-1,107970,2.287061680908213,2.289511146350267
LCLC-97TM1,46907787,1.8795083111860824,1.9914251951012703
IGROV-1,5278396,3.119031774261392,3.564265341017065
SK-CO-1,5329102,2.034917542642271,2.0800972453527966
SK-HEP-1,11152667,2.375581084403437,-0.2695057899708441
WM115,2126,3.806678244062894,4.649088018861016
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,3.596496138100676
K-562,6918736,-3.666344542032524,-2.1526107790673357
Granta-519,6450551,1.162651959279597,1.2781409078013444
NCI-H2452,5479543,3.804245584293823,3.6975991596874365
Daudi,11497983,1.6119133198716458,0.5507248468300407
WM115,4521392,4.32247006400087,4.2878401242742195
MOLM-13,24901704,-2.733844077576574,1.914245516848983
Daudi,56973724,1.9677776982823123,2.1304317183152484
HCC1500,613753,3.153964202511791,3.230387992495526
Granta-519,5460769,2.1422187145203897,1.6828412656572826
RCC10RGB,53495165,3.554009618530711,1.1661155451356822
PaTu 8902,3854666,4.137852419807088,2.153198053859634
Granta-519,151289,0.2062194994497177,0.46946956285885905
MOLP-8,5479543,3.0970965636903327,2.6036594382545264
LCLC-97TM1,4096211,1.6170661636178802,1.9503877207929798
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.331764138570079
SW48,9907093,2.826389946725867,3.919066208149182
MOLP-8,5281672,3.2641398124752063,4.145155649556952
SW948,6610355,3.913576061403015,4.245655662550979
SU-DHL-1,5746,-2.2023974745237815,0.4009719449138059
MOLM-13,10410894,3.311191932806664,2.3348561992696504
SW1573,3384730,1.5192292760027193,2.8609042455224114
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.6468084105097283
NCI-H2452,54649381,5.966732082850981,3.8506456788108223
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,0.8822153870194929
BFTC-909,9444,3.603329432205708,4.247605910507548
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-0.8506605570898251
SW1271,9952709,3.6093754742197706,2.9282249148814503
IGROV-1,4788,5.801051990484709,5.566180622447097
K-562,3825829,2.9396673791475587,3.4466691029843814
COR-L105,53232,1.738169806280081,2.718452272956446
Daudi,25195348,1.3194617548918357,2.7187503791970418
NCI-H1568,46199207,1.8853593558521984,3.1835429509196547
RCC10RGB,135440466,4.497503570362309,2.616128390537257
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,0.5039750709480322
NCI-H1568,3062316,1.133797551734723,1.0076418216781688
Panc 02.03,56649450,3.905458120664549,3.5438583196521556
RKN,44589607,3.09715941328701,2.9830435801904502
MOLM-13,568763,-0.9067431163570788,-0.3025170921389693
MOLP-8,444795,3.9342801961368417,3.300773371922725
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.2581522430508576
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,2.570141155711958
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,1.3687463812058147
IGROV-1,6918878,1.6706182189896102,2.758796416739406
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,2.044735731813926
BICR 22,5280436,0.2666608642372045,3.0321787597948036
BFTC-909,3081361,3.110656330811392,2.652674508818091
PaTu 8988t,45279963,4.21642269895433,3.8590200058164568
MDST8,613753,3.2461287764543085,3.1714796541219785
LS411N,6917907,-5.419583860239815,-4.695178919521547
HCC15,5335621,5.428336568471036,4.743501300046797
SW48,71466380,4.3724837890251935,4.536570046062996
SK-OV-3,66577038,3.416512813520814,3.1424747334260394
RCC10RGB,49766530,-1.6086406954404375,-0.7742705422675271
HuP-T3,16722836,1.72068374216493,1.8464666630178428
MOLM-13,168313016,3.5509192860421592,3.804512527195593
SU-DHL-1,675434,3.83709506639581,4.2832586321216155
P31/FUJ,9911463,3.6551866379259743,3.104523199772921
P31/FUJ,445455,5.725867195241275,3.978619121102378
MOLP-8,285033,-4.447286141218139,-3.008469828926936
RKN,107970,2.600341318615175,2.217243781793385
IA-LM,4788,5.899787929501101,5.6463992099099904
RKO,71680916,5.910552922648844,4.082515098665798
K-562,9825149,1.660902694463834,1.973951464334551
RCC10RGB,4261,3.441062261939301,2.083881296896403
IGROV-1,387447,-3.9508602289798658,-4.1699180460191005
WM115,54618164,3.776567993994872,4.092990804244601
LS180,44607531,1.744731406430345,1.191405221050439
NCI-H2452,123631,2.1406097245383062,2.6108201176799697
K-562,262093,3.1056763935044813,2.1558501383474935
MDST8,24180719,2.4870372971011374,3.595766457647346
WM115,66577038,2.911239385644133,2.7001573691296663
SU-DHL-1,6918328,-0.7249486298416586,-1.241032332847555
NCI-H2452,135999136,4.5117873079445205,3.965227771175519
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,3.9755784381317465
PaTu 8902,11609586,3.6092581559147185,2.9901531207135847
IGROV-1,11497983,4.37450324471555,3.55695816928922
RKN,387447,-2.9807645129134066,-4.1820214170683485
LS180,6184667,4.288388758455988,3.1692212879074537
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.681996216510013
NCI-H1568,5460769,1.1324377767406906,2.8890243280339147
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,2.498036580924301
HuP-T3,3025986,0.0333046209415895,-0.622790093361936
IGROV-1,11625818,2.877471533668122,4.469666775530476
SaOS-2,122327,5.211292969638739,4.672153326500659
BICR 31,46943432,4.176233154169203,2.436260818670888
HCC1500,10427712,5.196976599700856,4.102841056688698
K-562,9866186,0.7861847855254385,0.2335840174728508
RKO,10231331,2.816804700080647,1.869893234832101
NCI-H1568,126941,-1.411149621431801,-2.7505186140152835
HCC1500,9933475,1.9677534910437375,1.992488730524721
ALL-SIL,53245473,2.8781179496967666,2.1369532847693065
K-562,135423438,0.8826240773524879,1.584687948869756
BFTC-909,9956119,4.255413767268681,3.4987775262401226
HCC1500,9884685,1.9086372211674376,0.4620204023393641
P31/FUJ,71304818,2.235751993715144,1.9003944316954915
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.5548830640832477
MOLP-8,5470400,0.1664110443814662,-0.7868121968624958
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,4.0829323886344975
SW48,44819697,-2.186530212001632,-0.6069771501633562
SW48,12001922,1.4259296039497584,1.7345453250928071
NCI-H1568,24951314,0.6613293075425478,1.5425641072595548
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.2522689501913358
SW1573,51039095,4.568767182944777,2.893773569826367
BFTC-909,46224516,1.8849058086882595,2.810435111386586
SU-DHL-1,52947716,-4.8688827763192135,-2.74618628559781
IGROV-1,262093,3.169376516915595,2.8338464642733787
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,2.243712070510372
WM115,24821094,1.6911725066550027,3.008171893922152
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,4.01133327713017
SaOS-2,53325874,4.45514535643454,4.463375918673054
SaOS-2,4261,1.4562926555721387,1.461735980922928
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,3.2436129705982757
SK-CO-1,9907093,3.652313916117519,4.149713531734068
SaOS-2,613753,3.192322830330122,3.198245491148307
BFTC-909,148198,-2.03933057080943,-2.996261150532834
MOLM-13,49793307,-4.691237884437231,-3.910878286125193
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-0.9665889319612507
COR-L105,135411,0.974173137304268,0.800842843773024
RERF-LC-MS,135411,0.496828330774242,0.653799203619169
SK-OV-3,16725315,5.283554915030345,4.112025965215185
SK-CO-1,3854666,3.8596661393399927,2.1930762839906857
LS180,51039095,2.999333495393298,2.6713742918887466
RERF-LC-MS,135440466,2.007932851474071,2.357571778356494
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.1572311077996869
LS411N,446155,3.6642844723827266,2.9436071339125776
HCC15,72193861,-0.2523453521741511,1.728973820115428
BFTC-909,52947716,3.1995758728854224,0.23259136035316552
SK-HEP-1,9933475,2.440596541444364,1.8614537617172735
MOLM-13,702558,4.671896667990455,4.111496764758808
P31/FUJ,375860,-1.2092771030706315,-0.7702753026228687
Panc 02.03,57519531,5.330694472788803,2.7305174042387375
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,3.8438412679762504
HCC1500,11238147,3.2515653100317023,2.6146620150904285
RKO,11427553,3.456895276763714,2.1158962864886606
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,3.0362749228831847
HCC15,9927531,3.758901572486559,4.624941224214937
Panc 02.03,107970,3.0394503344184214,2.4057682358365104
BICR 22,6917907,-5.724798000333263,-2.0236501076324696
P31/FUJ,219104,1.0946129740431632,2.5372715561767127
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,2.874224270858851
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.3891072924151127
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-2.753256694498769
COR-L105,23582824,0.3539942370445449,0.7855759762771721
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.5893099345594597
NCI-H1568,135999136,4.3721543597322405,4.1578507831793
HuP-T3,11404337,1.0495167124251128,-0.2437323165287482
MOLM-13,2729026,2.3347481789683564,2.126958353605367
IGROV-1,9935249,3.330117761231163,3.2010142090905096
IGROV-1,16038120,0.2864038103759729,1.0711185756193322
NCI-H2452,11167602,2.565240148317103,2.6496836362682132
Granta-519,4788,5.939837006566146,4.829567640614912
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,3.3839624076338803
Daudi,2842253,3.640131040983124,4.262058785621517
PaTu 8988t,9911463,4.367264855700764,3.9232233289514102
IA-LM,613753,3.1957676281974328,3.225760703151965
HCC1500,168312962,0.9454061370050444,1.7673554340965973
Granta-519,52912189,-1.096728840522365,-0.0023787471035517315
K-562,67291369,1.5957287334193675,1.4674916158760138
HuP-T3,1750826,-1.878047057258104,-1.0543851355594733
RCC10RGB,24180125,2.398663234613943,3.153769686974131
SW1271,5566,3.0013167075914344,3.052137927710598
P31/FUJ,126941,-4.476387704672624,-3.421023561318917
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,1.571050347684787
HCC1500,44486219,3.883233561942222,4.308400588395395
SW1573,24964624,5.100144587499453,2.6329571289733753
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.9716801556460875
Daudi,42642645,-0.8700738631175318,-0.06993104837995974
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,1.9692319181345599
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,1.2678996193686358
SW1271,969516,2.705669665349302,2.8395075404285355
COR-L95,6918837,-4.56092327324237,-4.102199016136557
SK-CO-1,25154868,4.619527339846263,4.385971836661703
RKO,159324,3.5523933893017583,1.8625285273684398
HCC1500,168313200,1.6452616775244175,3.0076270703429304
IGROV-1,4788,5.801051990484709,5.566180622447097
KU-19-19,5746,1.6270456089520258,1.569333380996422
RERF-LC-MS,46398810,3.3112335021243977,2.64548781663369
IGROV-1,6438330,2.7487580937365683,2.2552543367916544
PaTu 8988t,123631,3.803217986992814,2.6453472723480354
LCLC-97TM1,5278396,4.167561166456711,3.508195935281013
WM115,71680916,4.535911767348542,4.458904168975775
NCI-H2452,322968,3.869715934392993,4.057739415696281
NCI-H1568,2708,3.449118605167301,5.111542409550729
Daudi,5470400,3.6690588756853706,-0.9100395169430965
NCI-H1568,3038522,2.281352774411324,3.2020038074507995
K-562,24951314,0.9405452740645998,0.7737177594196036
BICR 31,44137675,3.031084694210408,3.8161607262728454
SaOS-2,82146,4.466197629976123,3.6968029911636875
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,1.030866464480364
HuP-T3,5738263,4.055810266621769,3.5047903269721843
COR-L95,11494412,1.7619372096243109,1.1586983791901957
Granta-519,11507802,0.4974969144595386,0.49466827349731785
WM115,2949965,2.619280368742809,2.7861457221827117
HCC15,613753,3.363668001401703,3.160144072694505
HCC1500,107985,-3.8501888791364034,-3.194675388661009
WM115,54678924,1.8194282087981308,2.171957843903367
Daudi,135398516,-0.2737475793919353,1.131924809774259
PaTu 8902,5280436,5.000479378124589,3.5947115817659925
RKN,439501,-1.5558449248177562,-2.200307838338383
RCC10RGB,5287620,-0.3857243809023412,-1.7794420583885062
Daudi,5566,2.2518803351891616,2.787676647298779
COR-L105,31703,0.0245204691354453,-0.5123050394274171
LS180,44507138,3.917968702075208,2.322221065645238
Daudi,11964036,0.3747037141940179,0.740372575631302
K-562,16659841,3.212428083743772,3.1511170075370187
MOLM-13,54618771,-0.6841479707721928,0.13709341527320493
NCI-H1568,49793307,-3.5648882234860895,-2.3915075993225816
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.3948542421444463
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.3354378144512224
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,4.167231133066207
SW1271,107985,-2.924919788256343,-3.337314663983893
COR-L95,2746,2.78697970441755,2.7141535152952962
IGROV-1,104842,-1.6690343627553987,-2.8090247880415893
COR-L95,16038120,0.5843691628917023,0.7994114678865093
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.5163779262737693
HCC1500,123631,1.5682585338280497,2.193920043231691
PaTu 8902,322968,4.547287257097872,4.003494312436618
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.266518030166161
Daudi,11167602,1.0022899570414256,1.7174528658705994
ALL-SIL,10074640,-0.3353589360570669,2.51649538907986
COR-L95,57519531,1.325264870307383,2.0744403538142935
LCLC-97TM1,46191454,0.3820919964810073,1.5321488109636403
ALL-SIL,439501,-2.349752310116714,-2.8102411725513745
IGROV-1,25126798,3.9275606774720817,3.8981466515172385
WM115,24753719,4.6734048968266775,4.392429725958212
HCC15,36314,-6.084589216701663,-1.4551083611029823
HEL,16720766,-1.3120587580234824,-0.6597198101483671
SU-DHL-1,11222830,1.179409628644554,1.1092586371762891
HuP-T3,3634881,3.0028113890745707,3.2866298986301454
K-562,5738263,2.3545721599917027,2.72537880058061
SK-CO-1,16725315,3.5012946679092853,4.351445572296666
RKN,327653,3.2518035953304434,3.0159574018228885
RKO,24772860,-3.046302255649564,-2.674665662231244
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-0.7409842572148729
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,2.0345318316521186
SK-CO-1,15953870,2.1343083972614725,3.697977441631002
BICR 22,71751553,4.276876209585518,4.500176345295478
K-562,24964624,2.9615918690112717,1.690054988078796
RKO,11222830,1.6656419736189183,1.2418011155556388
RCC10RGB,25105715,3.76392637454814,3.495591056694689
ALL-SIL,54618164,3.625474128679928,3.550043094884682
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.7418201057303032
SU-DHL-1,49793307,-4.256389272054101,-3.604302936740371
SK-HEP-1,9915743,2.4580731883892293,1.1461639520417943
SaOS-2,10410894,2.56650375580144,3.32906131408607
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,2.117791433657711
COR-L95,44491742,4.146782751375218,3.9734566244929703
SK-OV-3,44137675,2.687297746540291,3.6489936639701117
SU-DHL-1,4477,-0.6876815909262691,0.47839682614621415
RKN,5311,1.8833679583763572,1.526883634334571
COR-L105,11640390,3.408966388045623,3.86811893566899
RCC10RGB,637858,2.3286326267725084,2.239430029925276
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.8609754779498315
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.727246549336462
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.043873829280412
SU-DHL-1,6852167,2.266746993939426,2.246886600868572
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,2.864794215401061
HuP-T3,49793307,-5.3581383477853555,-2.589176099932812
SK-CO-1,5282054,3.655593178279643,3.7538749980630364
RKO,2841722,4.522769482159767,4.1614186719047925
Granta-519,65628,2.6603144373939154,3.360380487535356
SU-DHL-1,637858,0.6782178889909583,1.6239581541241264
RKN,9911830,3.6623648245681744,2.5120168223358768
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,0.6579107482233475
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.6686172068183474
BICR 22,9884685,0.2149660223226223,0.67869200393688
COR-L105,46907787,0.7742744471044445,2.0106444432468082
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.844869760711802
RKO,54618771,2.3159310195777985,0.3949794656864916
HCC1500,6450551,2.2317386689521816,2.682380179044444
BICR 22,10296883,3.888864516393213,3.9069054894511464
Daudi,10302451,1.2926011902861492,2.419816087233568
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-3.040299095165888
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,1.878338512346356
Granta-519,216239,2.502983600228736,1.6770272508355548
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.831469964247151
NCI-H2452,4521392,4.554150979099382,4.388146345565555
IGROV-1,123631,1.7694522866439453,2.4069838469422877
IGROV-1,5566,3.174346862827938,3.0610436860351147
MDST8,72193861,1.790495642839322,2.2453337441500953
COR-L95,400769,-0.6446482680437077,-1.010304837915598
SaOS-2,5287620,-1.8033063725700844,-1.9255760652484428
COR-L95,6917907,-5.619348954097505,-5.116976969608317
WM115,9840324,5.544544164897635,5.87862993227591
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,2.974654178446497
SW948,10322450,3.138867511839475,3.7219922225994653
K-562,25126798,3.746183025237492,3.3962560866043283
LS180,5335621,4.412574333730147,4.570104215957482
SK-CO-1,9911830,2.5560928673864676,2.54798551379191
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.420843103820872
SK-CO-1,9825149,2.4273154495027147,2.1885574523338067
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,2.977113544787625
KU-19-19,10074640,3.725362653690234,3.259031388970765
NCI-H1568,24901704,3.012455129702266,3.167351728533524
PaTu 8902,216345,4.855612410794221,4.033215122135677
LCLC-97TM1,44202524,1.0559659544617075,2.1506964914469107
MOLP-8,9884685,-1.6145757941110517,-0.1414509331124991
SaOS-2,11656518,3.53164758658959,1.9742159633786789
ALL-SIL,5280436,2.610850174870569,2.5564565791202423
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,2.5139596509722155
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,1.2182795427871023
COR-L105,16659841,4.469572921203622,4.0850237544933234
SW48,11625818,2.5740084903132914,3.7317902068467976
COR-L95,135875424,3.0866900102445816,3.636215238132395
NCI-H2452,10074640,3.4255764700713685,3.184052176259809
SK-CO-1,60750,-4.4937571478067495,-1.766917826015322
BICR 22,374536,2.9550889228261386,2.1990470237651336
MOLP-8,2126,5.134995770793403,3.9464247641809918
NCI-H2452,5566,2.960608772215372,3.157332302642592
Daudi,54618771,-0.114332288085178,0.29594519125069085
NCI-H1568,44137675,2.485428235347338,3.5884194807240983
BICR 31,24771867,6.325583215176513,2.9659923104138644
HCC1500,135875424,3.5744445956281483,3.8070462498574242
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,2.5292793828859845
IGROV-1,753704,6.461140333581179,4.8567923714659385
SW48,11497983,-4.007853458767396,3.2862568256530498
MOLM-13,25195348,1.114215790958376,2.0335992312974103
Daudi,441298,1.3514709590925575,1.9135837851207653
SK-OV-3,124202324,3.0713957973247186,2.418393071314524
BFTC-909,23635314,-1.3241610546701814,-1.722671580604628
COR-L95,71304818,2.943301589855332,2.0897124977529824
SW1271,44607530,2.17277245139498,1.8982851799934195
RERF-LC-MS,219104,4.628133490361187,3.799199616530051
NCI-H2452,31703,-0.2834256058580119,-0.7171539482495003
Daudi,462382,-0.0525304302162242,0.44520197073130313
SU-DHL-1,25183872,-2.297532702486321,-1.592262263216608
K-562,54618164,3.946994253297547,3.8101537867119806
SK-HEP-1,568763,1.0235069184223942,0.5731268273462838
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-3.5004654643959414
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,1.861895951861667
Panc 02.03,2828334,6.385741192046609,6.2517010285406265
HCC15,5702613,2.8473188935914835,3.154620672562736
PaTu 8902,11625818,4.430115392870615,4.44921728521552
COR-L105,53392493,2.0389615313780256,2.8629021013866445
RKN,3062316,2.6330403907451863,0.9090005346326601
UACC-812,6505803,-4.59801553223132,-0.7335672862317649
UACC-812,16736978,0.0217391388778129,1.7497563832680187
BFTC-909,5278396,3.473037688340168,3.586360184171261
SW948,73707398,1.7510146080607218,1.1889440805985578
BICR 22,107970,2.71438120007047,2.460642194838905
SW1271,984333,0.5174855517327741,0.6517033515932585
IGROV-1,9967941,2.9735049794712545,3.6468630012599887
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.2466600109794447
SW948,135984461,4.375312800732864,3.599232883407873
LS180,5280436,4.14000298943632,3.454036468430777
MOLP-8,219104,2.0853040324344536,2.9052483927585535
MOLP-8,1716436,2.7387406442001287,2.5754735392129744
MOLM-13,171352865,4.594115651620468,2.568844022467593
KU-19-19,10127622,1.068304480617998,4.016016924950269
KU-19-19,5460769,4.3332822587900255,2.645461766467611
LS180,675434,4.417044491450032,4.384890451313821
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,3.4065512139849248
SK-HEP-1,66577038,3.45712203265648,3.1128061113555687
SW1271,3689413,-1.2412691685690602,-0.7273741487782115
COR-L95,10296883,4.074268886544182,3.700758564737912
HCC1500,5287620,-3.8084705838741306,-1.8622500521581793
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,0.9232748858754378
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,1.7590409828270261
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,1.1871963881556906
SW1271,46843906,3.0036733058278298,2.960731289607064
SW1271,10184653,2.439662406391272,1.4745607902059965
SK-CO-1,31703,-2.259601900898513,-0.6921666417106589
COR-L105,10074640,3.626128603914542,3.2753333400111884
MOLP-8,11152667,-1.9226575172330305,-1.0304352870502331
SW948,56646779,5.261847054930003,3.5507376736948095
MOLP-8,9825149,0.6088991704164435,1.5638589776685081
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.0779900101993096
RKN,1641662,3.781184529562369,3.345370551618832
Daudi,1750826,-5.008838903624334,-3.3046395201333825
RERF-LC-MS,24856436,0.2419222597799965,0.6209423677135277
COR-L105,6184667,3.4155069342084916,3.115300260081927
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,1.2120049422261956
MOLP-8,568763,-0.8505432933185847,0.006747905390571448
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.204596891770955
SK-OV-3,54618771,2.5849230632376923,1.2339104752441188
SW1271,135398516,2.256973153183445,2.2637759921131053
MOLM-13,44819697,-1.7672663076184636,-1.8526295981656695
LCLC-97TM1,24748573,2.1629406196043894,2.16820951346618
NCI-H1568,10113978,1.8126489257310032,3.2868463336155527
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-3.106313919209959
COR-L95,1566236,1.7351682171374878,1.998950275081293
PaTu 8988t,54619267,4.243668204976347,4.1105172262970795
BICR 31,73707398,2.635299985295534,1.3673362500596178
P31/FUJ,24978538,-1.1674360999825653,-0.8127762891560621
HuP-T3,25227462,0.1487181406442073,0.5435366536256045
Daudi,439501,-2.973914496380735,-2.635112712951906
NCI-H1568,67156097,-1.7914617240991686,-0.7474068615722067
WM115,36314,3.85550299796777,-1.1821218851018636
MOLP-8,409805,3.552664043240888,4.083316554506481
SW48,24753719,4.052743892866938,4.126642119400652
SW48,3825829,3.1303188593692854,3.836444818221025
PaTu 8988t,54613361,0.5051194448617704,0.19261542493313066
SK-CO-1,44493528,4.973545843770428,4.178384347566117
MOLP-8,44202524,1.1617664844294235,1.7622583345505427
P31/FUJ,11656518,-0.8295634521320199,0.586505268559594
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.498229221074612
LS180,36314,2.4476112429633403,-1.818303821408334
SK-CO-1,119182,-2.3548964470523974,-1.030815444300637
LS411N,72376,-2.6969507034435236,-2.172068260245406
BICR 31,51037431,4.633533363663127,3.526544990227482
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-1.2531755260375235
HCC1500,46907787,2.786329845885891,1.6332100990401672
MOLP-8,2708,2.5820066460748015,4.0358008706931034
HEL,10113978,2.6394190696879662,2.153161327016262
HEL,1641662,3.192273244328466,2.925606664632902
LS411N,12001922,2.0246848718715604,1.8004922259284797
ALL-SIL,56963564,-1.2928564241979046,-0.48069005912941953
ALL-SIL,168313047,1.973173862571291,1.876005182647047
COR-L95,3038522,2.051786867518871,2.6927287229836288
LS411N,25102847,2.9606059837222767,2.3202608449933
SW48,5566,2.216391660090734,2.8731584509504997
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,2.2039803662366713
SW48,6917907,-5.957551707769467,-4.52986686995527
RKN,246676,4.414592383854902,4.462797986955464
IGROV-1,285033,-1.3538783590767758,-1.8515845115183862
PaTu 8988t,11609586,2.9135578891851233,3.040203126983962
P31/FUJ,19582717,2.23583270668625,3.118421924165201
SK-OV-3,71304818,3.289226671933847,2.648706935479653
SW48,9903786,0.6824641791663469,2.758393540148459
SW48,107985,-4.220376672084107,-3.3677041851280736
ALL-SIL,49836020,-3.56746653346715,1.948938311180022
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-1.3623083227134247
MOLM-13,7326481,3.309466894819375,2.1314602120746478
PaTu 8988t,387447,-4.215036300164339,-3.6614754826481173
IGROV-1,10231331,1.9104831176724932,1.9253202807340335
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,5.050493264711111
WM115,6852167,1.3860811523021286,2.961059704405275
SW48,11175137,0.8049020199472112,2.5085717995225854
NCI-H1568,6918837,-3.937828464321892,-2.4624590605780754
ALL-SIL,409805,3.511042482554543,3.8675496876771
BFTC-909,11485656,2.882750602975944,2.3967629384893043
HCC1500,6610216,3.984830656845064,4.1913174333179875
MDST8,46191454,-0.3052251724831438,2.0264917349635327
NCI-H2452,52947716,2.3907771066336543,0.40789313149393913
COR-L95,135411,0.6709946332822974,0.3918616367670933
RERF-LC-MS,11497983,4.204546577264711,4.241289105560359
MDST8,3025986,-2.3601391308628368,-0.394278953580812
K-562,10113978,1.9599198523990544,2.195224026724332
MDST8,66577038,3.4472401917824387,3.157563052741878
RCC10RGB,6917907,3.54732574828972,-3.3441633434778435
SU-DHL-1,54618305,4.34503505735179,3.0726478877089947
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,2.3371130771078863
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,2.0984920236673563
WM115,448949,1.6539360415615445,2.0836373622680098
ALL-SIL,216239,1.0502640873271551,1.8649922666764684
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-3.3893407569243226
IA-LM,53325874,6.131967715828746,4.427603252853492
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.7014788617549645
P31/FUJ,119182,-2.8125390579467244,-2.45643145022911
SU-DHL-1,11717001,3.585470860794662,3.8279242593528067
MOLP-8,168313016,3.7646553629166304,4.07839264632558
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.4375988378312856
SW1271,9823820,4.369434873409536,3.9576061522351984
SK-CO-1,51037431,2.025162533854422,3.423818751774089
SW48,11964036,-0.90016316876993,1.266696226752779
Granta-519,702558,4.9740995052838874,3.831057487109315
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,-0.6256456056835921
NCI-H1568,6918328,-2.169641972219076,0.2111434565459337
Daudi,637858,0.7785119720749748,1.1785417136824925
SW948,53495165,0.2015090818079991,-0.0015075135138428997
SW1573,46398810,3.5765453048302933,2.5417409402219793
MOLP-8,637858,0.6022882265593398,1.1605672700834675
NCI-H1568,3825829,3.749474944576795,3.9891619548637203
MOLM-13,4788,4.00969340257961,4.9382765233112424
SU-DHL-1,135398516,1.716785738144405,1.4188891365335983
HCC1500,2945648,3.001490751925554,2.8492871673789595
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.145341851816622
HEL,46943432,0.8947528664895825,1.1606122195732558
RKN,3689413,-4.085525957083088,-0.7447126613396652
COR-L95,45279963,4.007720953160328,3.4129837429550065
LS180,11364421,-2.9792456594346945,-1.568908836073814
SW948,51039095,-2.1737453378627567,2.500291874631319
HEL,135421197,2.810551353794614,1.4562597747413717
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-1.126101633023028
HuP-T3,5351362,1.4959503226370765,1.485569608123781
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,0.5729014920840424
SU-DHL-1,6623618,1.9512254956144048,2.155858054459704
BICR 22,31703,-2.104947288409208,-1.047928407380044
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,0.9460748556866659
IA-LM,17755052,4.247702528352723,1.8866707975840697
IGROV-1,17755052,-1.0246415273055465,1.5039672617535274
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.486791645053077
IGROV-1,3503,2.453392942972796,2.250229495848225
BICR 31,10302451,2.0763164615496232,3.0739391277927717
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.5365876105535322
MOLM-13,2841722,4.084965304911922,3.6537208424439656
COR-L105,9549297,5.541569761250669,2.611379827002682
COR-L95,4705,3.007858501345706,2.977065984793405
SK-HEP-1,54626689,5.252317432323977,4.6160899655726215
BICR 22,24964624,2.8366894332481127,2.159663654392206
K-562,3384730,2.2830550335302555,1.7637876769977063
RKN,46224516,3.695788234754723,2.6226126981443225
Panc 02.03,44607531,1.9299895981807216,1.620644785809336
MOLM-13,11317348,-4.1893096196029465,0.9397427286416087
LS411N,60700,1.793788628592944,-0.04817216117104312
ALL-SIL,9967941,3.4348481015027628,2.809343315516976
SK-HEP-1,46907787,5.1061569205326505,2.3783295954042507
RKN,5351362,2.529766574998156,1.5415462448840502
HuP-T3,31703,0.4675615226322689,-0.7560727177127561
SaOS-2,6610355,4.596244040557677,4.553911368713954
BICR 31,25195348,4.130650271984148,3.2617476588724044
MOLP-8,73707438,3.908454567487333,3.741997702692298
MDST8,3503,3.3556251865549065,2.2660217437247545
COR-L95,439501,-1.1523844892623298,-2.4114845204928117
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,3.4562299858288843
P31/FUJ,5281321,-2.503740446113486,-2.2018843838769784
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,3.379774971344574
BICR 22,2729026,3.062923067871907,2.530475094333355
SW1573,51037431,1.8928004764191728,3.4324746378586326
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-1.489459091436842
RERF-LC-MS,16741245,3.282184197465347,4.07639558813275
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.658584182009048
SK-HEP-1,11427553,3.604603983851784,2.9757839716567367
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,0.17965953702500329
SaOS-2,36462,1.0480120523183942,1.744059892793584
IGROV-1,124202324,2.2563058955522157,2.5582644839726085
P31/FUJ,54618771,-0.1557090961755644,0.22605763385329103
HCC15,6918837,-3.491973763742546,-2.6111867118423557
RERF-LC-MS,10302451,4.085913110869725,3.4695147224443215
WM115,9866186,1.4274901944164853,1.2325375874719586
RCC10RGB,3634881,4.1231622503065495,3.3502341008903738
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,3.1849402814444674
SK-OV-3,56946209,-2.3996417591607235,-3.7613395365873328
Daudi,9907093,2.3595872536278977,3.5306319049056976
UACC-812,135421197,0.8848266315498433,1.9950918492665464
COR-L105,11707110,-2.3960237918310967,-0.10907305439965248
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,2.0120712179185154
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.760080798239704
BICR 22,5287620,-2.2777736835755076,-1.9383134024225877
HEL,135398738,1.3240045179008624,2.3044230094379485
SK-CO-1,3825829,3.015639513793665,3.9177005221079084
BFTC-909,135398516,3.047749913114312,2.4191117396331805
Granta-519,252682,6.242071482699392,5.929209874186386
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,1.9804551560719772
SU-DHL-1,241158,1.6235055790866513,3.256268655577827
PaTu 8988t,8515,4.36808886077581,4.014250307152141
NCI-H1568,44489675,3.7863062268563064,3.9923340804790564
MDST8,135875424,6.383148165610491,4.09647935854352
IA-LM,24771867,1.1290385026114922,2.3924441411789616
PaTu 8902,12001922,1.8953174279693872,1.7826599500847278
HCC1500,8515,5.3989297102528715,3.988733840551766
MDST8,4259181,0.8851574645315519,0.5144419257083794
SK-OV-3,16038120,1.745962946040546,1.1553899663505565
SK-CO-1,25126798,3.6561952188996503,3.6787207114989484
HCC1500,4261,0.9221319619811188,1.4353693969585775
WM115,613753,3.1291419252746877,3.1431308938128693
IGROV-1,6505803,-0.2382223795960626,-0.3234428518340662
KU-19-19,49766530,0.1366302187334878,-0.22206839590319002
BICR 22,11494412,0.8036857209518554,2.0529239248337854
HCC1500,11955716,2.281516197797272,-0.8454230141302291
MOLP-8,71680916,4.479993680298279,4.146333295159812
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.44313715003108
BICR 22,15983966,-4.391384426150851,-0.3856138669564971
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,3.3731698268953427
RERF-LC-MS,9866186,0.0636323256725951,1.1084461979480522
IGROV-1,54613361,1.0826132998561049,0.3233384412649651
K-562,4259181,-0.7813149193344907,-0.07287427288900394
SW48,6438330,1.214777505056659,2.243652561894704
LS180,54618305,4.3130332958468385,4.231492598045208
K-562,5746,1.9738407973257048,0.4368004842591466
COR-L95,3081361,3.577896308939448,2.496200864958253
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.5062610889512024
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,0.20484060383625624
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.790819439662186
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,0.7367221116655474
K-562,53495165,-1.204911447319433,-0.8720034095796947
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,0.8955756701468155
HCC15,3676137,4.952150033317278,4.464601799511757
PaTu 8988t,46398810,3.220252132938068,2.6345650961229574
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.4311698844671766
BFTC-909,9927531,5.31835549136936,4.757938023045068
Panc 02.03,16722836,2.9028860212849565,1.738701393158351
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-0.8942611925411194
Granta-519,3011155,5.044202810550695,2.6475349247729607
IGROV-1,3825829,4.144093606877803,4.029102566058425
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,-0.3625473933856356
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,-1.231142497774234
WM115,11238147,1.7518250261640556,2.77760979840528
HEL,6610355,4.700351008256091,4.051078840066106
COR-L105,10410894,5.46795970795096,3.5217358776051215
K-562,135421197,2.032823128578147,1.4427166275303713
HuP-T3,25105715,3.756943800954468,3.3800698651203493
BICR 22,11717001,4.533318725499836,4.0379925293679495
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.5317103704589536
BICR 22,176870,3.0604023761484154,2.8574502750082957
COR-L105,9823820,3.977631180290917,4.146931581198063
P31/FUJ,66577038,3.0536576112540916,2.6389297649823886
HuP-T3,11612883,3.639610964764467,2.8246801561466324
PaTu 8988t,12001922,2.536714978511883,1.9668768480265209
P31/FUJ,24771867,-2.604308550432203,-0.6519935006891663
P31/FUJ,3634881,2.159990781463395,2.7034524380995673
SW1271,11640390,3.706316930576478,3.5921632984785243
Granta-519,984333,0.7513060576966085,-0.22964642720425954
COR-L95,46398810,2.3153378536205036,2.3139346008214003
NCI-H2452,4259181,1.4154165902225178,0.3190504866006137
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-2.8654097182834226
RERF-LC-MS,3503,1.2198018250646854,2.383411318553787
BFTC-909,168313047,1.967772312792883,2.409571931777737
NCI-H1568,49766530,-3.205306991379519,-0.4794223323685155
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,1.1475231926726979
IGROV-1,44491742,4.406671418311328,4.167595100528765
SaOS-2,54596490,5.687426160237218,4.385153905742823
Granta-519,46843906,0.846372381562089,1.4817777557714709
SK-OV-3,46398810,2.6339706660379205,2.6201406016587483
WM115,25154868,2.4497388117539773,4.7520400645335314
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-2.2605005401392884
BICR 31,123631,1.818021308876907,2.386431187023747
HuP-T3,60750,3.212181181151216,-1.8492795241522015
WM115,71304818,2.065667497969779,2.4880591487604744
SU-DHL-1,11964036,1.0253922980362349,0.9659169805846274
SW1271,9444,4.046685913234064,4.1643326956449975
IA-LM,1716436,3.827820678542469,2.9628842502010104
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,2.2679699547916936
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,0.4650884049496679
SW48,44137675,1.8984167228990951,3.4055114090819814
IGROV-1,11364421,-2.1205062036040982,-1.8559211257803125
PaTu 8902,3465537,3.540732953494624,2.545775617610885
HCC1500,54618771,1.4039271563223086,0.9608892574454849
NCI-H1568,23725625,5.336887169251221,4.824430068183274
BICR 31,9936388,2.7244047649519074,-0.7042430399642696
IGROV-1,49850262,4.068828647042517,3.4509962685761293
HCC15,5280436,4.320878094694944,3.49548831129662
COR-L95,46215462,1.6156782364555438,1.559157640116863
SW948,25022340,4.946878477600784,2.7063160027478284
P31/FUJ,3025944,3.8644283212627895,3.8980306179764534
SK-CO-1,5978,-3.732613512446313,-1.3685866776454816
LS411N,19582717,5.192972758226466,3.9859621722079033
SaOS-2,26596,-1.8442798913702467,-1.051739350500633
MOLM-13,6610216,4.131122051839403,3.7511141151958665
KU-19-19,3025944,4.41555498235696,4.345261595741637
HCC15,11497983,1.686538707374479,3.6714904417427134
HCC1500,216468,3.3608861469702735,3.0824750147838773
NCI-H2452,56649450,2.972344092085675,3.6128613756429946
SK-OV-3,25262965,0.4953902890441227,-0.9585387687074568
HCC15,10184653,1.3258142209068642,1.4898737566458726
SU-DHL-1,3825829,2.249840075454991,3.620402236427256
WM115,49867926,3.8689880289876446,4.343701869635599
K-562,285033,-3.792012978388577,-2.761612993244968
Granta-519,53495165,-2.785106410212646,-1.9630672451139974
SU-DHL-1,5335621,3.5965276677583846,4.418050403128745
NCI-H1568,1566236,1.6523344134899465,2.653894616150713
HCC15,25195348,3.62058364960133,3.501775551539437
LCLC-97TM1,7326481,3.961997196958484,2.9795233815956954
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,0.49623680614625854
LS411N,9887053,4.348393626170801,3.1634360702886823
LS180,208908,2.3350670945107783,1.7806125023529071
IA-LM,54454,3.681506421747591,2.8293359802463875
RKN,4378219,1.9905206425028277,2.7961175868275085
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.459663756073461
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,3.0053776910599352
IGROV-1,216345,3.498629789107092,3.7633839611102013
SW948,5282054,2.5738720751419746,3.2723076668674445
PaTu 8902,66577038,3.2739824602509304,3.0469252338221393
COR-L105,1566236,2.352597865521479,2.5974823211914053
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,3.5875256755000167
MOLM-13,46191454,-2.5774836063329905,-0.3084713334427502
HCC15,72734382,4.010055800269774,4.822275650738877
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.5244892036450782
SaOS-2,53232,1.3253237607162072,2.719900638195165
KU-19-19,9936388,2.972521935644637,-0.8400829885728142
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.5531722083300883
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.6102277311457307
SU-DHL-6,445643,2.4790626422724107,3.422855824978922
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,4.705719129154025
HCC1500,208908,1.6399748300125228,1.8574443500569366
P31/FUJ,4917,2.744589019426067,2.687342263767176
HuP-T3,241158,3.8412641522091144,3.7693881566599443
SaOS-2,46224516,2.521923040225463,2.3499297205420886
LS180,54618771,0.643112685351952,0.818640909196694
Daudi,23725625,2.2816125857144978,3.8285265788301537
Panc 02.03,25227462,-1.0518848939229315,0.3054504661541065
WM115,462382,0.0353255606914336,0.929466094433112
SaOS-2,135875424,3.0421388786055727,3.7271712441983804
Granta-519,10113978,3.360346958971763,2.1912829927482496
SU-DHL-1,51037431,2.2415500634191763,2.57433820924287
SW1271,135440466,1.7072517695379112,2.4464472755138256
BICR 31,208908,2.9880095911503983,2.5054004945991872
NCI-H1568,11719255,3.5544275615483087,3.5066530515076892
SU-DHL-1,4259181,-1.4222017445817885,-0.11149588700047003
NCI-H1568,135984461,4.216726883570129,3.8787099062699384
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,0.5897731100668615
K-562,25195348,2.6278567451650394,2.524862956706304
SW948,6918638,-0.8188756331889222,0.524060161055674
UACC-812,216345,3.8515167014354152,3.6127104031294612
PaTu 8988t,446155,5.325372031764619,2.5550523160880454
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,3.6629075482215567
NCI-H1568,54618771,0.8004506686595156,1.5007709531023945
HCC15,9823820,3.975711917882334,3.96531142295174
RCC10RGB,9935249,3.9754060705766943,3.4089267089264843
SK-OV-3,3854666,3.321518045263264,1.972705648078096
Daudi,135928012,2.6114481479622516,3.4367587360744154
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,3.45320265451271
HCC1500,44491742,3.6723474636183537,4.269999061564335
K-562,54626689,4.3954029102592145,4.228482674200818
SW948,11152667,-0.307089718187717,-0.4277242052678853
NCI-H1568,984333,0.7198134332239758,0.8586819997573748
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,1.2986184947670145
IGROV-1,44507138,2.359177395411688,2.6474908072100125
COR-L105,44566777,0.9614143121394376,1.0492936832026574
HCC1500,25126798,3.9309577641895137,3.7789815107836318
LS411N,5470400,-0.4509258648896809,-0.9203934937273407
PaTu 8902,11427553,3.388107623793881,2.9426672900972846
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,2.1095575208557342
LS411N,11364421,-0.88941081068058,-2.836424379751064
Panc 02.03,6918638,1.5939476449475074,0.9875301467940792
IA-LM,73707398,1.4255919606814562,1.3313602938604812
Granta-519,54613361,-0.5306815642640709,-0.7633894078920601
IGROV-1,176870,1.8349827429681411,3.173230980409394
SK-OV-3,24821094,3.4952627197751744,2.930103366307205
SaOS-2,5566,3.2892304449964125,2.959035655260917
BFTC-909,44486219,4.380685277356905,4.42756074988567
SW1271,52947716,2.875834451056303,-0.5982622116203362
LS180,20959075,-3.038194424999374,-3.066555996372685
BICR 22,2708,5.160276397343071,5.046804467141868
LS411N,24856436,0.7977520405714393,0.21364229430865453
RKO,3062316,2.656751778030552,0.9731326186257576
IGROV-1,2841722,3.834853118277962,4.217414364571604
SW948,9967941,3.223093544556301,3.593328125334094
WM115,5291,3.6779708977342263,3.70034443175919
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,3.1329704224302155
NCI-H2452,11152667,-1.2581393219211725,-0.25684279126928433
SK-HEP-1,54454,2.662573207119838,2.4930552299936175
PaTu 8902,46398810,2.87785673961289,2.7267588681698185
MOLM-13,4096211,0.3628379797080729,0.9985214207136492
SaOS-2,31703,-1.4545352226195103,-1.2137050625578565
NCI-H2452,89928392,1.3829077368930702,1.6284405296781588
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,0.8742674736559095
SU-DHL-1,216468,2.865615091111303,1.9145088411047777
BFTC-909,5335621,5.263558209813896,4.696742851284612
IGROV-1,984333,0.6618578113050116,0.4003837724533901
SaOS-2,53393127,5.00574224434263,3.9966451555646954
LS180,26596,-1.3053249122689552,-1.178047553526482
PaTu 8902,216239,3.2515461693373946,2.219195667108827
RERF-LC-MS,216239,1.5111459083459036,2.3103373329702785
IGROV-1,327653,3.667792542405671,3.059262676719692
MDST8,25062766,1.7641764997703038,2.1742119374591344
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.2451315820520562
SW948,9911830,2.1163810502856344,2.367674988103407
SW948,25262965,-4.786935998048743,-1.7176653610537573
Granta-519,17755052,3.698735089058188,0.6155442396644647
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,2.99963893864409
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,1.059794047944392
BICR 31,65628,4.368112552275168,4.397646240041105
LS411N,1716436,3.6051806229528394,2.8472969201335694
HEL,31703,-1.5815868160580933,-2.8736482558450502
ALL-SIL,46191454,0.8221974593607395,-0.518859271926157
IGROV-1,46843906,3.392503571349757,3.1060620877666723
MDST8,52912189,0.1558018738717314,2.2799057797613944
SK-HEP-1,73707398,1.730256970360003,1.5111340490607126
NCI-H2452,969516,2.821538204226011,2.9757541985392346
Daudi,9825149,1.5190393381512124,1.8103593476762816
HEL,49766530,-2.395534265113236,-1.5228327586148884
SU-DHL-1,445643,3.1136870030048116,3.749297369311531
Granta-519,25102847,2.235988678650905,1.7982219779256239
SU-DHL-1,8515,3.677486404661737,3.7204332480305005
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,3.8232569153096527
NCI-H1568,73707398,1.0000031751048108,1.4513124205781236
RKN,44607531,3.612700906890815,1.6636500524768427
RKO,448949,2.722052887717566,1.5875300026905044
SaOS-2,123631,3.143555798261004,2.3423050180470315
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-3.365549653149121
HCC15,445455,6.40486213649735,4.798312343589653
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,3.9860693604646684
MOLM-13,16720766,-3.0154852550238473,-0.8052390866121985
SU-DHL-1,52912189,2.819399061651446,1.0571302555769773
IGROV-1,6918328,-0.5330006254346346,0.329236118728103
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-1.1148701068266442
Granta-519,168312962,2.8455100129937447,0.4149665167858905
RCC10RGB,24748573,3.544482176439233,2.7663711619650053
NCI-H1568,71576739,4.4464222538448075,3.2383026091927674
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7097095266235555
MOLP-8,3025944,3.977744021049233,3.8848540586615705
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.7094208952514918
SW48,3025944,3.8378875325919513,4.101919878958139
P31/FUJ,5460769,2.718083541162644,1.7967689411112306
PaTu 8902,56946209,-3.5225671286307585,-4.149406029086932
IGROV-1,11964036,-0.1609353030421705,1.137510508297581
HCC1500,327653,2.623652361439541,2.980509339690027
BICR 22,11640390,3.3009766271386014,3.471540136877996
IGROV-1,400769,-0.5589612210030486,-0.6897832473664086
HuP-T3,24821094,3.9398095537443023,3.261041064658577
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.9964640665420013
RKN,54618771,1.93479648501244,1.0384116574481594
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,3.854943671805342
PaTu 8988t,73707398,1.170719580837983,1.64056955764718
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.292016056408646
Panc 02.03,10231331,3.962628244123872,2.498789396680907
HCC1500,387447,-5.435802195710178,-3.638338186289607
K-562,25150857,2.2256112733235978,1.8456331026851558
COR-L95,135398516,3.161482452438301,1.807180119814709
MOLP-8,46191454,-2.2442719810217984,0.30417264958238754
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,1.2440847319054735
BICR 22,4259181,0.3497439952553443,0.34711199100987905
SU-DHL-1,49836020,5.336381428124731,1.8515655513189477
P31/FUJ,246676,3.344572915959865,3.5758453144859503
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,0.15588580500595473
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.7215881345213813
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.2183203787857946
SK-CO-1,135875424,3.678629656731489,3.7679540751135714
SW948,3552672,1.903682389315955,2.2601482136789546
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,4.4321135504537335
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,0.6586406107464857
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,3.349445580119113
P31/FUJ,6610355,3.438139996915945,3.999865710075129
NCI-H1568,446155,2.3736727750277455,2.97075055906551
HCC15,107985,-2.9906891972859415,-3.2646507175819552
Daudi,6918328,-3.006382851838594,-1.1301188467088699
Daudi,25161177,4.237474374185298,3.615208933771699
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.3089958360459732
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,3.433389067423676
HCC1500,374536,2.8802619944250765,1.8104367975246278
SU-DHL-1,400769,-1.357151076144479,-1.1636193322928634
MOLP-8,16725315,4.20287759788283,3.5929247790317618
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-2.359448422305759
MDST8,24753719,4.799692184779076,4.341406737408133
Panc 02.03,25195348,3.9334722209588735,3.2757409125196135
IA-LM,5328940,2.67230513268953,1.7510054311516767
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-4.151501869572462
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.4355625910731944
Granta-519,676352,1.633141874861156,1.6797456001585593
HCC15,49793307,-2.657858659953827,-2.8345432948633187
K-562,16065773,1.923835638804153,2.2188211413662744
RERF-LC-MS,23582824,0.1470987082457378,0.9433755454278351
SW948,9907093,4.923675844906718,3.9776482249318694
HuP-T3,374536,4.193584653265312,2.704487360796193
WM115,11396600,2.8854117577089378,3.3800980441224793
IGROV-1,16722836,0.856484234547582,1.3854263834907874
LS411N,89183176,4.7846004508379085,3.7932438502679076
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,1.8468426412231183
HCC15,6917907,-3.7751611818797897,-4.225640713981899
NCI-H1568,637858,1.7833024505225796,2.2139603903457177
PaTu 8902,5329102,2.5341846500240246,2.0792948486109477
Daudi,54765302,2.540510911033338,3.326126178992179
RERF-LC-MS,100016,6.56071523320666,6.508489523617686
NCI-H1568,387447,-3.95080818095812,-4.010531752330475
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,2.5418794949866266
SaOS-2,11612883,2.0316436721768087,2.587444906021753
SK-OV-3,135411,1.6318689765112546,0.5095275023941003
IGROV-1,208908,2.822483792004996,2.1050416699331125
RKN,51037431,2.467401650082352,3.1099085260276706
MOLM-13,3025944,3.8428716966726992,3.8030629857984444
PaTu 8902,135421197,2.3024316473658004,1.8843325272663711
MDST8,969516,2.598297465814476,2.7997243035844246
MOLM-13,60750,-4.5529472050787545,-3.218331575176579
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,0.7296333781082069
IGROV-1,9915743,-0.4757488934941289,0.8657374090463829
BICR 31,56946209,-4.213875977630207,-3.7206608123065843
MDST8,124202324,2.333625526818204,2.5188855475796577
BFTC-909,46907787,2.3649992203474515,2.389527500653797
Daudi,12003241,-4.903510386182724,-2.1555381737871855
PaTu 8902,969516,4.108056616445131,2.9291489292899837
RKO,24951314,1.467797052763695,0.8686928435182223
SW48,439501,-2.266376314928653,-1.9942148033246283
IGROV-1,5311281,3.3250623444804206,2.407616153397923
BFTC-909,9825149,2.463033939289578,2.248129389782145
LS180,2858523,3.002923184305197,3.088425322426224
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,0.5218183734332791
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,0.6102864401236615
PaTu 8902,10074640,3.6154267469790304,3.2555195498380374
LS180,135421197,1.2375553911833763,1.6137922440793704
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.6803198576694944
HuP-T3,4259181,1.3598984416642497,0.3200494777785792
MOLM-13,9840324,5.573129737038137,5.47439230946002
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-3.404884987290515
RCC10RGB,7251185,2.312506998895348,2.7988215479045078
LCLC-97TM1,23725625,2.954034200595367,4.942927680956944
RKO,24797083,0.8657042008278414,1.2372575857902028
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,3.6754205641972493
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,2.864797589503299
ALL-SIL,24951314,0.1921049921473096,0.29987850379254033
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,2.8829375546620106
K-562,16725315,4.409558206085648,3.7010629390251517
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.489028391969093
SU-DHL-1,9915743,1.482861419138649,0.6792051290723177
SW1271,4917,2.7806051488376293,3.0460023735964756
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,1.8103188532816687
COR-L95,3062316,3.2830028596837217,1.3898471491519706
MDST8,10074640,3.541716125988611,3.0292852200792235
IGROV-1,44185566,2.2104732991243248,2.549310576875425
SU-DHL-6,57519531,1.2127003418717253,1.745852662822571
SK-CO-1,241158,4.831010946536929,3.908192612521522
SW948,46843906,2.6248020109336023,2.8346431235810616
RERF-LC-MS,6610216,4.063402980130349,4.284783605567088
RERF-LC-MS,46843906,4.323049782377064,3.3616106897080984
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,3.4728057127709673
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.9774996042118127
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.7446397754617538
HCC15,24180719,4.303391195547382,3.9315882687458306
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.582050940547111
MOLP-8,6505803,0.6382990348001342,-0.6752619679049339
Daudi,5278396,2.816567405543214,3.1111457125802797
RKO,66577038,3.1469091340303637,2.609798798299427
MOLP-8,54143018,0.5860183196437395,0.08395729182627604
SaOS-2,24856436,0.4386880001360848,0.6818440947925771
BICR 31,9866186,1.254760755448308,0.663057936244727
RCC10RGB,11257553,3.6405008146732434,1.44317739199713
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.47070236566531376
RKO,57330099,4.8516025997257275,4.011248101191274
P31/FUJ,54649500,4.423311343715707,2.3615794376164696
SW948,10302451,4.082058519290096,3.0156543410627195
WM115,2746,3.2273654457979957,3.1620450833601517
KU-19-19,654092,0.6096416345891582,-0.23150464089894998
PaTu 8988t,10296883,3.999790485906541,4.010588115081143
BICR 22,54143018,1.1733542553992964,1.0043739645669745
MDST8,71466445,2.0942740576673593,3.939533556453737
PaTu 8902,36462,3.471634301287976,1.5620255523321003
LS411N,44632017,5.0127460000138,1.2413083265344467
COR-L95,9911830,2.1813921058815553,2.2848636091575947
ALL-SIL,9911830,-2.857836139869332,1.681532815233137
WM115,3465537,1.2344570371137795,2.3445629035643636
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.4852832040659747
SU-DHL-1,54454,0.0220955119836291,2.4950981221067874
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.818557139627727
MOLP-8,24821094,3.654707766369703,2.557485231334312
MOLP-8,6852167,0.8455390099609336,1.941411613999443
Panc 02.03,11222830,1.865607722872823,1.5175434412023021
MDST8,2746,2.514425635914287,3.1587932532611696
Granta-519,1716436,2.7310795448836904,2.3810675386166777
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,1.9004022312295155
RERF-LC-MS,11625818,4.251014876931036,4.638830939742234
P31/FUJ,4378219,1.2412027933720209,2.325639859465647
HCC15,3062316,2.729530034687651,0.9897435169939284
LS180,9903786,2.2166672873522857,2.749497286239681
PaTu 8902,16065773,3.37985868216597,2.426144461350516
LS411N,9911830,3.118029057589745,2.5304494213442483
LCLC-97TM1,6438330,3.0238187505324885,2.3737962569374065
KU-19-19,25062766,2.9321374053838807,2.2405973982499283
HCC1500,10074640,2.968051262406446,2.8930576380235347
P31/FUJ,6505803,0.2535639265329721,-0.778499924180785
NCI-H2452,387447,-3.2957708741809975,-4.15241638829431
MOLM-13,11228183,-2.7074565632423546,0.2404659899146676
SU-DHL-6,5566,0.7122829809928822,2.741939502374436
COR-L95,24785538,1.0654849938174582,0.9033969197864897
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.6928707738527663
WM115,4578,4.221194502857287,4.437161266033423
COR-L105,4578,4.590840204947243,4.577348026134789
K-562,374536,0.780579010414565,0.9761548427361653
COR-L105,60700,0.1425021915553204,0.1044092491686364
K-562,46926350,-4.162486097405079,-4.342628998603249
SW1573,4705,3.887877577681455,3.3841412671299973
LCLC-97TM1,637858,1.4157632634757724,2.1176402393600293
WM115,46926350,-4.284670953339827,-3.574508449436868
RERF-LC-MS,15547703,2.8085711207925015,3.214691037407701
NCI-H1568,11497983,3.872384435522252,3.685947018822175
MDST8,4788,5.889593740712007,5.732240625044853
IGROV-1,8515,2.1861539315976053,3.9872983018790573
RKN,24772860,-0.333409077824626,-1.7277057852369437
PaTu 8988t,322968,4.849886698333752,3.9397842938502494
RERF-LC-MS,16720766,0.5604118097796991,0.5384102060524136
SW948,6505803,-1.4287073835677784,-0.7095902188304345
BICR 22,462382,1.3729135623232431,1.164630785892029
LS180,322968,4.435040308321651,3.7233062073215577
SaOS-2,11152667,-0.1732170298835725,-0.41469705556195124
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,2.191372745459276
HCC1500,227681,1.895909952215359,3.2504956797030116
SU-DHL-1,57330099,3.736750567984075,4.004696677938005
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,1.9092392110951328
COR-L95,11977753,-0.4790698517891548,-1.211169182129381
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.988415312979305
SW1573,11427553,4.057369297610019,2.9279487079425337
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,2.7629420063933336
LS180,12001922,1.7594619366424422,1.7144453481594337
SaOS-2,12001922,2.1147367002170494,1.8398757828779997
SU-DHL-1,3543504,3.7817510655567625,4.056201335212042
BICR 31,24901704,3.914024172074534,3.476798832533922
MOLM-13,5287620,-2.884996470216499,-2.312012868430214
BICR 31,25102847,2.842271629600241,2.6556294742503797
COR-L95,10113978,3.7452762075447104,2.9503270076825054
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,0.8418510330638571
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,0.40786294416838514
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-0.6664273350431366
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,1.6367065023501954
COR-L105,168312962,3.0410731046381065,2.5754617673742914
LCLC-97TM1,10322450,3.85878970197106,3.6491440027807247
HCC1500,25161177,4.357780519617112,4.192667703855321
SK-CO-1,9967941,1.837567054996146,3.5881121003753105
COR-L95,5311,1.4789786210040632,1.1721656494957056
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,3.95703489015306
LCLC-97TM1,72193861,0.688846554638978,1.4036766392353022
SW48,4096211,0.1208358665406906,1.7881298461508495
LS411N,135875424,4.300305751936665,3.5375424231441372
SK-CO-1,42642645,0.466262192383588,0.9170449843806154
IGROV-1,1566236,2.765820903157784,2.291225156494775
HCC15,10410894,4.508285516741203,3.5299788597129127
IGROV-1,6450551,2.579641476451469,2.7488953215962
IGROV-1,452548,0.0422661560146271,-0.043882482067293595
COR-L95,216345,3.729430833860697,3.4559398559460295
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-3.005260183529889
LS180,2945648,3.723684880750219,2.9400632400085476
RKO,9936388,0.8183869926163714,-2.40484995973331
HuP-T3,10231331,2.6811135289001236,2.4302812430559957
PaTu 8902,44493528,4.360494725244959,4.40735205572985
Panc 02.03,45279963,4.323488067826322,4.022948739820916
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.970664320834822
BFTC-909,44507138,2.8704731321552734,2.4649363806908466
ALL-SIL,49766530,-2.347000417785464,-1.9909465186803643
SU-DHL-1,6918289,4.3249644726818275,2.025334911684183
NCI-H2452,54626689,4.879011133008654,4.62408016630186
HCC1500,4917,1.9149154714535184,2.9603647446312245
LCLC-97TM1,15547703,3.011827246330581,3.109136794901401
MOLM-13,71304818,2.1544936448447873,1.9575204840689244
SU-DHL-1,4917,2.4666047815714154,2.7594475124091873
NCI-H2452,56946209,-3.558178980562316,-3.9123019354024393
RKN,1750826,-6.055252220387113,-1.5542022993740139
RKO,25105715,3.388469834531371,3.404897710878808
RCC10RGB,46191454,4.887818963424851,2.1259797585830107
LS411N,3815108,3.549037613932863,2.670860274318951
HEL,56946209,-4.040477533762366,-4.634924564354767
BICR 22,122327,5.571410232221064,4.938297446492132
BFTC-909,969516,2.723005004244225,2.9860926959741767
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.6780330323039925
RKO,24856436,0.2423564692967549,-0.1976978649092923
SU-DHL-6,5746,-1.2123840023346684,-0.7403297577251905
SU-DHL-1,135411,-2.10627226052293,0.18794735178712554
SK-OV-3,1716436,3.636442167288748,3.1021436635375865
IGROV-1,44543605,3.88270235241076,4.19700624618148
K-562,6914657,-3.91828110768511,-4.291105844946027
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.865134175059953
NCI-H2452,25262965,-3.6663688304344695,-1.4264104346429698
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,1.0849461330396755
MOLM-13,11404337,-1.791363376051536,-1.2443046369879043
RKO,36462,3.4370564574699185,1.108899122045785
IGROV-1,446155,3.750396425244744,2.4815042072132996
COR-L95,72734382,4.117898969233179,4.058551901232633
K-562,11396600,3.7562155275673415,3.0849325231471574
LCLC-97TM1,4705,3.0319662392534057,3.142728426707269
Daudi,2130404,3.4806417402967993,2.6792439658795666
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,1.0813130948016585
MDST8,327653,3.1544218347658375,3.0575876653077905
SK-CO-1,11656518,0.968890652064466,1.8436341674919523
K-562,5311281,3.9022564066083967,1.841228415165166
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,0.8684567458357653
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,2.7778358768375195
RKO,445091,4.342692134156949,3.9072806698795857
MOLM-13,9935249,2.7939558009041283,1.6927313208828059
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.507058492571823
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.8623612997014587
SU-DHL-1,124202324,2.3695119203399906,1.7605490618622033
COR-L105,9884685,2.6443959528770167,0.7562281875195349
BICR 31,10113978,4.990782635230478,3.458580733843915
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,0.8053031522930376
MOLP-8,6610355,3.5622833697709178,3.799061101423924
LCLC-97TM1,2749,2.4194398786749067,2.0084378370543927
Daudi,5311,0.1794409230409946,0.6043316752729821
HuP-T3,2113511,6.036487802507154,5.682383812276287
P31/FUJ,452548,-2.598049093653093,-2.4334211150291623
SaOS-2,16065773,3.691866894593861,2.2360762177697215
RERF-LC-MS,65064,5.274588293813746,5.148062441386843
HuP-T3,89928392,1.747135585577409,1.576407315266909
P31/FUJ,56963564,-0.6738396792941169,-0.0985360572230634
LS180,5746,0.8609008276830991,0.6501948048794539
BICR 22,11707110,-2.2145574606059912,-0.23465743028133304
Daudi,9952709,2.2307089742515713,2.1467271258027183
SW48,3543504,4.30466926238752,4.318944509747402
SW48,11427553,0.5193301330840923,2.6409650518758143
WM115,56649450,1.7070260970326938,3.5960853090184854
IGROV-1,89928392,1.4824233552493276,1.2226530040788344
SW1271,72376,-1.909620961604672,-1.5671817135630004
SaOS-2,5278396,3.8495121754699686,3.4557940562896863
K-562,42642645,-0.9952706094252596,0.23706484507572795
Panc 02.03,446155,2.721578883226381,2.940182217817948
RERF-LC-MS,44462760,4.251912039026111,4.009938089718309
BFTC-909,3503,3.411270469206907,2.3366827184668115
MOLM-13,104842,-5.846939346357726,-3.927666828490241
K-562,11656518,1.1460195934444493,1.0198398498259
HCC15,76446078,6.244123044550032,4.069796935988774
COR-L95,6438330,1.555078701387849,1.9448873982993846
COR-L95,9926054,2.0133423062539726,1.9690523477644095
BICR 31,462382,1.217928478873545,1.1819541861199327
UACC-812,46199207,3.606176782545976,3.2077277880200628
SW1271,16725315,3.214819296898604,4.046691114856432
BICR 22,3385,1.594485383262216,3.806962394314595
HEL,11234052,1.6482548628813194,3.150710356975942
SW1271,49793307,-1.6735159246770874,-2.545632283165664
HEL,3025944,4.107185950107739,3.9401881504124874
SK-CO-1,1641662,2.678789461404506,3.2946181017990623
RKN,71680916,6.446363106372924,4.76614756403047
IA-LM,25183872,-0.4633226224219731,-0.6728331136391208
IGROV-1,6918837,-2.9804518885508635,-2.5907816122069596
HEL,252682,5.808471376099282,5.984731311471995
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,-0.10688416635536115
MOLM-13,374536,0.9670025892080272,0.557230273444008
NCI-H2452,168313047,2.588327036215806,2.5157051508647696
Granta-519,4917,3.021022166883331,2.761562296688089
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,2.0761970072281692
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,0.20000401876499577
BICR 31,262093,3.397835562493394,3.0059541059715973
LS411N,12003241,-0.0946051023392001,-0.44632925322836536
HCC1500,5282054,2.2651950194203323,3.5418203701539364
HCC15,322968,4.854333863324092,4.120936621023307
RCC10RGB,9936388,2.3235560801623465,-0.32783085266275336
NCI-H2452,46199207,3.026577128215497,3.4190810174311763
Granta-519,9444,3.3091580955395146,3.7207113212993717
IGROV-1,53392493,2.352084848618059,2.5506020443416753
COR-L95,151289,3.0372683791028705,0.9190057318005213
NCI-H1568,216468,4.700562763036761,3.4390206713378713
WM115,25195348,4.859937697346287,3.434039063708984
SaOS-2,2858523,3.094677154220442,3.0644395007208853
SW1271,421610,4.471416490511734,3.299101615925719
BICR 31,637858,2.611871003184785,2.0626550107145194
SW948,11175137,1.686043515242534,2.332097580950072
MDST8,11625818,2.7981930885976705,4.609436810157914
Panc 02.03,11609586,3.3931905350155915,3.030265416828377
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.0581592224104965
PaTu 8902,9825149,2.767587999144615,2.2725426350975235
HCC1500,6918837,-4.362896894201754,-3.3626982015285383
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,2.3145201583357697
SaOS-2,5282054,3.07206551989859,3.54860276996302
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.9888157571020195
SK-CO-1,72376,-3.2194985981528808,-1.7437662540273708
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.685062951068259
WM115,10302451,3.6553280898048905,3.114625398681794
Granta-519,613000,2.2510291651452143,1.758178892715528
SaOS-2,11222830,1.0878926350484104,1.5047537436192076
IA-LM,54678924,1.6007306497128662,2.0872818140625458
HEL,119607,4.922739390517752,4.5467735579462945
HCC1500,6918328,-0.2689126411143879,0.025420469706720704
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,2.120756371538999
LS180,3062316,2.327440880417239,1.1988437590610304
LCLC-97TM1,11317348,1.7152030009838672,2.7306177384105483
SaOS-2,6918736,-1.8799034133096575,-1.921191896873241
SaOS-2,12003241,-0.699813042979073,-0.8224424201001007
LS180,10113978,3.7861477365363383,3.0819888477769597
SW48,54618359,4.4319552735559,2.575377293476234
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.5262039274546599
HEL,387447,-4.961191552031455,-4.992355250442515
RKN,6610216,4.220445612403551,4.334152246038695
P31/FUJ,656346,-0.3707458386499477,0.5322982415394152
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,-0.18157240346177678
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-0.9895567468472868
MOLP-8,9952709,2.638563783306324,2.6526256491964535
SaOS-2,11455910,0.8777485884783317,0.7946563534776465
K-562,10184653,1.719293175029272,1.1437741349453443
Granta-519,4259181,-0.7648884727300508,-0.628221894381186
BICR 22,4521392,3.4098909359208625,4.51366388313174
HCC15,2874250,4.519421691404506,4.687119650196225
SaOS-2,6918638,1.2055090485954645,0.42071807602481237
MOLM-13,9868037,0.9756233042827712,1.847776587989356
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,1.9571153379346777
MOLP-8,16659841,2.203571056365997,3.0156379932751025
LS411N,656346,4.206497662771029,0.8092301553070571
RKO,5460769,5.660789679983863,2.350168735772279
BICR 31,6610355,4.797647038745592,4.722381603986018
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,1.8839059056274952
RKO,11964036,1.8153618806471208,0.9337674816130098
NCI-H2452,7326481,3.286880233884326,3.08874146983597
RCC10RGB,44491742,5.1484686760969645,4.384781677669148
IGROV-1,50905018,6.092412272559071,4.361051054609062
BICR 31,9884685,0.303781088019613,0.8338992343317619
Panc 02.03,3081361,3.1546648300373357,2.6436702764201425
BFTC-909,25126798,3.8219929141120166,3.9137250568322663
MOLM-13,66890843,1.9738756301734208,1.8070345936346621
HCC1500,24180125,3.164669305988548,2.8514930680224593
SK-HEP-1,53392493,3.66906541895257,2.9596212934760042
RERF-LC-MS,2945648,2.437954541344266,2.937004703007615
HEL,25150857,2.447529551071105,1.568489311394456
BICR 22,65064,5.333446499438452,4.9354369509599305
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.377610835217209
P31/FUJ,123631,2.0303759233077017,1.9963183703523755
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-0.9885386869975613
IGROV-1,11175137,1.8411496230681277,2.5028088951004492
KU-19-19,44241473,5.030815161961597,4.992312602487964
SW48,72193861,-0.4534629909928462,1.2466701680146068
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.6224094289922717
MOLM-13,5311281,1.6146001182421037,1.6635348578002955
HCC1500,9915743,1.9340540182592263,0.6149223592760782
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.33770906572971626
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.8405749032534888
LS180,4096211,2.1975503712063604,1.668405652959877
NCI-H2452,66577038,3.355972963473848,3.1203269554501922
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.6893579584619862
HCC15,11175137,3.485795641541794,2.821198230066209
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-1.3134464466206388
HuP-T3,2945648,2.5475895191101197,3.0361970612852414
Panc 02.03,6450551,4.166761052507323,3.1743363275170475
K-562,2708,5.362475494708341,4.102200656123689
RKN,219104,3.4277527780329096,3.9879323095652435
RKO,16722836,2.0172870973895085,1.2812178293848704
UACC-812,439501,-1.4243957864326813,-1.8332709448703153
MOLP-8,11222830,0.9410853080031706,1.2563677694239415
WM115,1239801,4.563824386797348,3.9273346252009707
Daudi,11717001,4.763561920962392,3.679227348224676
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.6095730693516057
COR-L95,16736978,-0.5228132160938015,1.3051837063337717
IGROV-1,11213558,0.52356811652227,1.6434736931597151
MDST8,44202524,1.4033794041893788,2.8108678388157857
SU-DHL-6,10113978,2.1190356124222194,2.341756429222259
SK-HEP-1,4917,3.764636353681369,3.211900989958416
HCC15,452548,-2.1001752731425727,-0.06060643352001611
SW48,46191454,-0.9829938197758128,1.6195981360025067
MOLM-13,4521392,4.5803067712490115,3.8292984540097796
HuP-T3,25062766,2.4453672011464023,2.232326918481207
COR-L105,107985,-4.244896937866387,-3.041766561311147
SU-DHL-1,89928392,0.4021872915525221,0.9550300986178241
BICR 22,55508,4.44611517999926,3.1256181049040133
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.9509253511225815
MOLM-13,675434,3.665195693175508,3.843960262976274
SK-HEP-1,6610216,4.694225049802747,4.31905786443939
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.6468084105097283
SU-DHL-1,49766530,-4.824875359994143,-1.066779374590299
HEL,12001922,1.658840092002429,1.3728346170641503
HCC15,46398810,2.6134237903958093,2.674946482933257
NCI-H1568,3136844,4.658915015928919,4.559577670769183
NCI-H2452,24821094,3.1123469452418537,3.2526181740134903
LS180,3543504,4.376890558116308,4.284632578374729
ALL-SIL,9927531,4.600523700119875,3.754122543502906
BICR 31,11167602,4.451308398956488,2.5689245062532673
SW1271,16219061,4.25548468975063,3.4903706928363407
PaTu 8988t,448949,1.751499890417066,2.0042521651332033
WM115,2858523,2.9957579985597467,2.89380552390627
RCC10RGB,11364421,1.2845393833467151,-0.7429045580765952
SK-CO-1,984333,1.8899562330111348,0.7886279876039723
COR-L105,72376,-1.002534224494363,-1.3757237641092386
NCI-H1568,168312962,2.190321562510239,2.0148846039381683
SaOS-2,2746,3.4161371679978436,2.8930105542786326
Panc 02.03,51039095,3.661030142872421,2.8726861586370087
SK-CO-1,65628,3.554197618459022,4.190919528153907
COR-L105,16725315,5.297524124299076,4.410019562632353
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.67556230185605
RCC10RGB,46224516,2.231293839634299,2.8044272565520667
RKN,9956119,4.4432647969313,3.594550688199389
RKN,16065773,2.958619348149216,2.517151271223319
WM115,17755052,0.4002517605741686,1.8561164972971755
WM115,168313200,2.1363369230808593,3.061707842417247
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.6435359816861294
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,1.0012656587349584
LCLC-97TM1,9903786,1.8016114643921617,2.8240398190412193
SaOS-2,49867926,4.146129188416838,4.437698342999225
RKO,25126798,4.002843113400742,3.57825009750398
ALL-SIL,219104,1.1543769867483644,2.349516041294051
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,0.9744861707680316
SK-OV-3,3062316,0.5292744016150154,1.2048427947360885
SK-OV-3,11178236,-2.424602318267421,-3.1839688178446495
LS180,9887053,3.1718141126704618,3.613982179935013
BFTC-909,25183872,0.7872065650622051,-0.588289174951136
NCI-H1568,2945648,2.136721092573253,2.93541444082131
RKO,1716436,3.795795915163565,2.7287817360973143
SW948,65064,5.291153994733523,4.745953655835849
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,4.8459586764137885
SK-CO-1,16115403,-4.417233339728943,-3.771715785114601
SaOS-2,400769,-0.6660591873157414,-0.7189776243003151
SW1271,2733526,3.2893803459487594,3.91974741627676
BICR 31,4521392,4.267019749412992,4.510796099478527
P31/FUJ,25154868,4.728907139536709,3.8742136357396904
HEL,676352,2.4086189638079643,1.6234398835555097
PaTu 8902,BRD-K27188169,4.434214541500356,2.951743365964509
KU-19-19,44607531,3.044914521934579,1.4936637805594821
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.4285029877338546
SK-CO-1,72193861,-0.1340038294528125,1.4994247934228406
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,3.228068870846294
WM115,135423438,3.926483426744841,2.5195517032075174
RERF-LC-MS,135875424,2.839581382146162,3.8553733426668084
PaTu 8988t,46926350,-4.145321949318386,-3.2748733669950854
Daudi,23582824,-0.638376916275564,0.7457821897684948
Panc 02.03,168313200,4.226618217059218,3.123324451058498
NCI-H1568,11175137,2.3278621292073067,2.6723136261683544
COR-L105,11152667,-0.3968124554752262,-0.09226279585878545
IA-LM,5281672,4.428935042775787,4.507550642216189
IGROV-1,3062316,-2.2361832227909075,1.123401232530914
SU-DHL-1,5281672,4.30860315799997,4.086692177669841
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,5.0520388079226635
BICR 31,11625818,3.9395546041344858,4.508662473604369
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.677633585521753
NCI-H1568,445643,3.6093957886383814,4.13130562807236
NCI-H1568,4477,0.3996701755478256,0.8200789164644122
RKO,36314,-4.63858923378885,-0.3954159350783531
Daudi,675434,3.694219652985114,3.907886855383861
MDST8,60750,-4.217127024403589,-1.5978577025834946
WM115,9903786,3.894434750277636,3.0479057039798296
RCC10RGB,5282054,3.6705963985990993,4.006309323839745
HCC1500,262093,2.85046563878574,2.6108992648827956
BFTC-909,4259181,-0.0277162117211437,0.3367786722944177
COR-L95,252682,6.347695054422412,6.269954168313952
LS180,9911463,3.681535048080384,3.518017408834335
SK-HEP-1,1566236,1.7725788045776691,2.4619521473353014
LCLC-97TM1,6918736,-2.1743152466595626,-1.5523501714330439
SW948,10231331,-0.4116197219649379,1.5699066123608623
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.630419605590143
KU-19-19,52912189,3.155674258646967,2.414434833117003
PaTu 8988t,44185566,3.1955818251601493,2.633552241033046
ALL-SIL,31703,-2.84181702758724,-3.351483118962189
MOLP-8,67156097,-2.505693621695456,-1.8435596221520347
P31/FUJ,12003241,-0.93015536828776,-1.6220385376067556
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.451787042595133
HuP-T3,72376,-1.771653200109272,-1.6131335477622546
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.629693111229451
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,1.430289655011806
SK-CO-1,54649381,3.727346200170898,3.773538268475937
BICR 31,4578,4.306546690441069,4.572840062358914
HEL,24856436,0.2549549224561803,-1.1831200332025762
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,1.6240980619758418
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,1.3499063244133245
NCI-H1568,568763,0.1547040002068053,0.5658882022031937
SaOS-2,10184653,1.5674189620168135,1.499949688630172
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,3.225564748649302
SK-CO-1,10127622,-1.7782095442547816,3.098890082056057
RKO,6450551,2.9764230599456782,2.0275892440114105
RCC10RGB,11222830,2.1708629162803654,1.718203685956563
MOLM-13,439501,-2.531564352317227,-2.6391520379884486
KU-19-19,5328940,2.592216165266187,1.8632452376261248
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.716362354764935
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-1.038183947071864
LS411N,46224516,2.772468105753273,2.451129544258137
COR-L95,3465537,1.5360689669151406,2.1415748275407
NCI-H2452,650361,3.725817753027947,3.69931708629024
MOLP-8,135423438,1.7176055832456645,1.2844664099298169
Daudi,15953870,2.3174310256528017,2.8437346082474746
HEL,25062766,1.0860006913119025,1.4593345566118665
LS411N,9866186,0.9541786681011424,0.735521142834486
NCI-H2452,72193861,1.1802568558602904,1.8247886407416392
SW1573,104842,-2.57352069349058,-2.3829462382061948
SW48,1750826,1.3136286655933227,-0.9887752580927459
HCC15,25262965,-1.0400697166295236,-1.2700685394874958
SW948,156414,1.6424995325300082,1.4006901439603243
HEL,49793307,-3.822273429090704,-3.9806990270384173
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.7817502522321005
KU-19-19,15983966,3.017543110767297,-0.4530694193597425
Granta-519,445643,4.101892829369416,3.565104004553995
WM115,44462760,-6.607584862322745,2.867804832681398
COR-L95,16722836,1.6737270586986386,1.4076757499241
HuP-T3,19582717,-4.617931701404403,4.471925656683884
MOLP-8,135984461,3.690365922940533,3.1776973909884396
WM115,25105715,3.143290836206988,3.556924299420672
SU-DHL-1,6610355,4.337111630655639,4.108057459026441
P31/FUJ,107970,2.0437014771117425,1.8020324335221463
BICR 31,9903786,2.10396775229317,3.0580812336664422
HCC15,119607,5.6213928119464285,5.216602741013633
K-562,53392493,1.9280012389180945,2.010091836276313
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.4462924377972017
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.7364033561057886
SaOS-2,6184667,2.75971928345779,2.9155229236407805
HCC1500,49867930,4.391361036771465,4.740749761826421
HCC1500,156422,3.756088196252004,4.0351749299045885
LS180,2729026,2.858515315971793,2.5739273824548534
UACC-812,9926054,1.7122964049751828,1.99034994364259
BFTC-909,2945648,3.347829093032643,2.8443278325860852
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,2.2615733078171387
COR-L95,10427712,3.3507411292398315,3.9355711153959776
HCC1500,73707371,6.057238887548947,4.679995804123717
SU-DHL-1,5566,2.363543718324467,2.815754057715327
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.5103477418740022
SW1271,44137675,2.993655891868926,3.6642178775546315
PaTu 8988t,10385095,1.1295524511895831,1.2775453696025298
IGROV-1,107970,2.287061680908213,2.289511146350267
LCLC-97TM1,3081361,3.200154540210029,2.2271654127299514
MDST8,24797083,1.659668465713326,1.5145109797766807
MOLM-13,100016,3.967621300341963,4.97037532400878
SW48,6914657,-5.582748420606011,-3.586393290620125
RKN,54454,2.1815674244706407,2.6160975834152884
SW1271,54686904,4.077781574312711,3.9047120485796127
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,-0.7014810978719123
LCLC-97TM1,11152667,-1.9849905525936635,-0.1297682071540586
RKO,6610355,5.147293026177706,4.108627768502152
HuP-T3,11234052,4.425621489915021,4.501855537537139
BICR 31,11485656,2.9684140094972387,2.529519053596939
HCC15,445643,3.643779771767104,4.108272503167233
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.6813332145774198
Granta-519,6918878,0.9437787040623058,0.2772729049186145
SU-DHL-1,16720766,-1.7997333167058054,0.2286580248994726
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.7027767922280161
RKO,11626560,1.596896929931414,1.291578536379098
IGROV-1,44589607,3.0909001492794377,2.796391946896969
HEL,168313047,1.7739787927154282,1.74483392196063
IGROV-1,11964036,-0.1609353030421705,1.137510508297581
SK-HEP-1,969516,2.3030983588134917,3.0130625516044827
LS411N,68056272,3.648680202626129,3.327488600202512
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.4850006673926575
HEL,2749,1.5352641298417238,0.9763530132231789
MOLM-13,135398516,0.1807695197937267,1.0418815735888178
Daudi,176870,1.9898427065198672,2.489865276277066
HEL,10427712,4.076538081897971,3.72101817429516
SW948,24772860,-2.2115718578693495,-2.250312834743692
Granta-519,2729026,1.8472912754822493,2.070428816702566
COR-L95,5394,4.313147278509764,4.008076885020157
LS411N,46907787,0.8939335106347707,1.4662626976572626
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.299092002830884
KU-19-19,11485656,2.7576201496249264,2.4340225162841493
IGROV-1,2858523,3.196384505087132,3.0447671525884927
SW948,702558,5.163408425848839,4.963772706722231
RERF-LC-MS,72734382,4.885789692793362,4.748994941605863
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,1.0058927028461198
RERF-LC-MS,11964036,1.6707185338079893,1.596078677335549
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.540362402507217
SW48,3038522,2.575519148977434,2.9081655048703077
IGROV-1,11364421,-2.1205062036040982,-1.8559211257803125
Daudi,24753719,1.7041863717102288,3.537488049452449
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,2.1508950487968566
SW1271,73707438,3.2742940196229022,4.138202362751782
MOLM-13,44487061,4.373293273870424,1.7247971904673005
SaOS-2,568763,0.7449819257203903,0.5546780243075342
SaOS-2,168313200,1.7182390433527042,2.6732014651824985
K-562,15547703,3.09098547046412,2.8133692605432
BICR 22,24785538,-0.3286106781648999,1.9953183692438687
IGROV-1,9936388,2.10108466287406,-2.718363449887523
BICR 22,4477,1.559722374810713,0.6229236187188834
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.8300753414100257
BICR 22,16038120,1.2563245393113998,1.2854296058599979
PaTu 8988t,56649450,4.324867884259214,3.531268585821967
PaTu 8988t,135411,1.3050507330755643,0.6597954329618666
NCI-H2452,12001922,2.2907278374018296,2.1042295861817797
RKO,44185566,2.4837284923488063,2.1955766164558024
K-562,9826308,0.1842141800186153,-0.04909848614745832
RCC10RGB,5311281,4.058856975975892,2.343715544289762
WM115,5460769,2.9023963298546507,2.6554397012481057
HCC15,119182,0.1055567812373319,-1.03836436367468
BICR 22,44607531,1.5270609291983028,1.6405467127285396
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-1.2441231725961923
NCI-H1568,25262965,-4.225307409424958,-0.8857176472991845
SW948,5328940,1.2304763256018572,1.4265471707881756
IA-LM,10296883,4.25848729020474,3.796988497620693
LCLC-97TM1,11964036,0.9095700511944136,1.3463294740009843
SK-OV-3,10074640,3.759507235638381,3.1611647086901145
BFTC-909,25062766,1.7422044094415416,1.9877218956914329
MOLM-13,44202524,0.8413416322030352,1.131592292454666
P31/FUJ,44137675,3.225768708166513,2.7530683515163976
PaTu 8902,42642645,2.254917267204718,0.6639564876635181
RKO,53232,4.485666667988006,2.7225643419871317
MDST8,51039095,3.753808380930837,2.755271757094555
ALL-SIL,25150857,1.7729123360103365,1.6904621852215016
KU-19-19,136227924,3.1447471190609217,2.9759510632487247
BICR 22,9911830,2.5765146499323497,2.8068160867930634
SW48,26596,-2.356334812614481,-1.0956921146068637
WM115,8515,4.149615392892544,3.789881698393246
SaOS-2,3025986,-1.3703894596366477,-0.30356149552130857
LS411N,6623618,2.410312404439064,2.043994186725621
RKO,2749,1.3580925102381314,1.5993193401991144
SW1271,9915743,1.6128868969613257,1.0686308705683905
SaOS-2,44589607,3.1014372869468736,2.550208056578943
BICR 31,9908783,4.390198834476992,5.038553539737895
RERF-LC-MS,1641662,3.403538628142178,3.5814974860503157
SW948,168313200,2.3052543991742933,2.7308694286416277
BFTC-909,16720766,-0.0189955240044846,0.6787521935304898
HCC1500,46843906,3.5664723036358703,2.687295485095309
BFTC-909,5291,3.495280995080932,3.8445565558471086
PaTu 8902,5287620,-1.817962379422155,-1.8398219438821446
Granta-519,24772860,-2.616849709254195,-3.0743906478998673
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,2.6043291502370813
MOLM-13,2858523,2.990787770243497,2.5474637041786874
MOLP-8,73707398,-1.5200522985211378,0.6134003015666025
WM115,4788,5.364989483250021,5.616968513968106
KU-19-19,11717001,1.9129980214779312,4.266790296718457
PaTu 8988t,3854666,2.839522644305469,2.14835246857062
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,-0.15278675311648882
RKN,11222830,1.5707482267531538,1.454112424091473
SK-HEP-1,5978,1.689065603838291,-0.6040629673401441
LS180,374536,-1.6764778169414856,1.9551718761778023
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,0.7301981013608398
RCC10RGB,46199207,3.760684270246491,3.4888912334754663
SW1271,49836020,-1.4027167140646708,2.940150345614475
BFTC-909,2130404,3.366307483642889,3.455254210633845
SW1271,3384730,3.1846503121443144,2.905527967798848
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.1535958421461565
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.7165222081192497
SaOS-2,285033,-3.099559966451384,-2.1805972289073874
LS180,71466578,4.68838045718991,4.506679473834826
LCLC-97TM1,2126,5.523539990092585,4.536492438953818
NCI-H1568,9936388,-8.53108348301746,-1.8207254813624556
Panc 02.03,6505803,-1.93196111296706,-0.7653410275796395
BICR 22,9926054,1.8271931211135617,2.141558082617532
SW1573,54618164,4.339091959582753,4.1328035233513125
COR-L95,9907093,4.309721999642839,4.024073932079112
LCLC-97TM1,9911830,3.2250615193472085,2.5264255277143186
K-562,151289,0.3703020531314545,0.6041536293324042
HCC1500,24821094,2.4557115965701257,2.811869513126711
ALL-SIL,11222830,0.8263932665864424,0.7013673228219929
ALL-SIL,44490293,5.541636788423512,2.0518228403140877
BFTC-909,15547703,3.647732910564925,3.2249877665001803
PaTu 8988t,11175137,3.61207596874577,2.6934596982544208
COR-L95,44566777,1.612039010223373,0.6741409958109122
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.4447179610083327
SW48,9444,3.3118033011757806,4.1026202779064285
COR-L105,52947716,1.1539739817838972,0.6672168405481048
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,2.735548409146255
SW1573,16013152,3.6979705228045354,4.193243888561951
SW1573,17759555,4.342323370433329,3.8315638766308364
SW1271,11609586,3.768986685585146,2.9219253446226774
K-562,3552672,6.190745251508109,2.3003582308261863
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,1.339570946332058
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,3.023560976555517
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,4.249680111578559
IGROV-1,57519531,2.639098862164858,2.659404066119837
IGROV-1,1716436,3.2816872421007375,3.0521746271271333
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.6555703670617097
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.5546406780185257
IGROV-1,2828334,6.070696247039626,6.073680577107041
SW1271,53495165,2.774319130141937,0.5395861277408731
SW948,67291369,3.8063591597957593,1.9091008600299648
Daudi,11507802,0.3815953316544085,0.8440915978196465
RERF-LC-MS,2708,5.106155932743474,5.068731648192521
SW1573,52912189,3.9296893768173065,2.5040819401080907
SU-DHL-1,25154868,3.5324679540942165,4.030223537491796
BICR 31,24772860,-2.497965982707089,-1.312999451895422
K-562,11719255,4.077642177046201,2.6743143010887733
WM115,5470400,-1.5377493662522326,0.5148441650017211
KU-19-19,44589607,3.6813877406069246,3.0477330074584668
LS180,11626560,1.7567799331145733,1.478982468555208
Daudi,11427553,0.4642664556868584,1.5735715150732235
HCC1500,44607531,1.3781074542184104,1.4325022905478813
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.47258195839857314
PaTu 8902,4259181,0.9791956381618654,0.14736377593143402
SaOS-2,216345,4.363902597199754,3.6903304498224294
BFTC-909,100016,5.8134150302243865,6.178370616259437
BICR 22,56963564,0.2615280103832354,0.5547186999319841
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.104061726436161
LS180,613753,3.1711720082363337,3.1604026808212073
BICR 22,3825829,4.259881935728516,3.782055060306393
P31/FUJ,25262965,-1.897985536240049,-2.50366708190888
RKO,15953870,3.3462063589818034,3.1724577788640484
ALL-SIL,26596,-3.0181503922951674,-2.3825420326864144
SW1271,4788,5.888244914590778,5.67974073307711
COR-L105,25150857,2.68968810352953,2.5371668909630705
RKO,24753719,3.882573791668401,3.798248181948779
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.5269921732123555
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,2.73551690940118
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,2.4354356482318407
PaTu 8902,613753,4.768885644214674,3.210116152258266
PaTu 8902,44589607,3.762990171329796,2.931612745393049
MOLP-8,176870,4.692998654081846,2.706520313142426
MOLP-8,216468,0.300035377459394,1.797981790744785
NCI-H1568,1641662,3.419317894706959,3.561704935552063
HCC1500,11626560,1.5792444837322512,1.8034475949586746
HCC1500,3689413,-1.6712109221216571,-0.300656611259293
RKN,984333,1.094463938199557,0.8777229179655599
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.769074221884642
COR-L105,4788,5.897633886873905,5.755696147622925
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,3.0928622794248706
PaTu 8988t,136227924,2.49705731140334,3.122742395582066
LCLC-97TM1,3634881,2.947438100526324,3.329970471552639
RCC10RGB,53392493,3.4706572822964072,2.8509198964000797
Panc 02.03,10385095,1.3097039910351371,1.4257219600703221
RERF-LC-MS,445455,4.41080153827665,4.934706248450104
PaTu 8988t,6918638,2.256433939948275,0.6374349124118125
KU-19-19,24951314,1.2793314486163916,1.5773052770166325
MDST8,25183872,-0.5549651899708961,-0.385440210952164
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.0882216335479806
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.6777035846705073
COR-L95,9908783,4.358103020890871,4.833396403507722
COR-L105,3552672,2.0991572824292435,2.633270832944512
SK-CO-1,5566,2.706069596509063,3.0905500505305277
RERF-LC-MS,969516,2.2498421794663095,2.805384601945956
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.6600422160637203
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,2.168435245614857
NCI-H2452,452548,0.0358025934468,0.11232491109268078
Daudi,409805,3.686040208403983,4.081982118507304
BFTC-909,5287620,-2.871557478653834,-2.150358069436142
UACC-812,25183872,-0.2383295665292847,-0.5832980615340932
SW48,36462,-1.5563073788110886,1.9098074682685888
SK-CO-1,327653,3.1822308576162692,3.1049072478940944
MOLP-8,11507802,0.9747707839930404,0.9061039630986352
SW48,55508,1.9258231187784565,2.895038543596219
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,2.109531997712353
COR-L105,16065773,2.993283969068687,2.434996705178989
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,0.9714055580156993
LS180,451668,4.827094473942733,2.3328859306375618
IGROV-1,36462,2.313632721410001,2.019502426955063
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,3.58526527003699
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,0.6655381850721046
MDST8,11719255,3.580824685094748,3.3966944186240533
BICR 22,135984461,4.376718251500639,3.6126861703249262
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.155010872391246
Granta-519,2871966,-2.0442685638601947,-0.7126793028649147
Panc 02.03,136227924,3.0839082623333387,3.152501876162637
IA-LM,10074640,3.892343788144062,3.2302491728921634
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.964092254611396
BICR 22,10231331,2.1949493731732095,2.1512942360191287
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.497942183868279
NCI-H2452,10127622,4.466077980380041,4.351551456123518
PaTu 8902,11178236,-2.9840755573739943,-3.301902523854147
MDST8,6918837,-2.3764765121755,-2.438406523533987
HCC15,1716436,2.8917896521916537,2.7974330542571746
Daudi,5351362,0.314899635949887,1.103937590782337
IGROV-1,1750826,-3.124548162001242,-1.0641209794509396
SW1271,24779724,6.290779023739936,4.490795473211144
SW948,216468,0.513065020542466,2.5589122990511326
HCC15,5738263,4.375256926251463,3.499776557694381
Granta-519,25183872,-2.24080905771406,-1.8350836043874434
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,0.34794271538946847
SaOS-2,46926350,-4.2820912559124995,-4.084925002994217
COR-L105,49766530,-0.5480688242609842,-0.1362656712631981
HEL,2874250,-2.245656223692803,4.305923510768925
K-562,45279963,2.402740503794971,3.3057696761659754
SW1271,441298,2.7117876410913073,2.390435108263392
Daudi,46215462,1.1016280052611975,1.257059275201766
BFTC-909,9915743,2.0959000942543025,1.1160577035573551
Granta-519,55508,1.5366901224911111,2.36728320816841
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,2.115371804812536
SU-DHL-1,445455,4.339452591135178,4.4008877146298255
Granta-519,11222830,0.944926764715042,0.8392814393493547
SK-HEP-1,135421197,3.339831791709741,2.090040307902358
COR-L105,11719255,5.177770829400177,3.4470646288544837
SaOS-2,49793307,-3.0698778362667807,-2.9174032569102177
SU-DHL-1,54618771,0.3433661921186922,0.3709502487176282
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.5382831980695928
IGROV-1,54618164,4.2184521751950115,4.065347164511936
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.8070750317207787
HCC15,4259181,-0.5021574884501439,0.33292794801829606
PaTu 8902,5311,1.4468060231693458,1.4440180604783983
SaOS-2,11609586,3.464015551213678,2.7534211309133503
BFTC-909,26596,-1.7437210940555867,-0.926577416351888
RKO,3385,4.410917651107157,3.3287216685053793
SW48,5282054,3.4229655251352984,3.351276750692776
HEL,3025986,1.4059985389197358,-1.2284516461368176
HCC15,2749,2.6993987110059456,2.067688258475289
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.264497453306755
MOLM-13,2733526,3.3430267495988693,3.3393801509155354
HCC1500,71466380,5.203984730888507,4.531806060833691
SK-HEP-1,104842,-1.0887000355540395,-2.387318323145589
SW948,5566,3.1149649258053107,3.0074972854636592
Daudi,11234052,2.508646185471885,3.358093245154032
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-0.23473937572578052
SW48,208908,0.7661322887377208,1.8853223681382432
SW48,24978538,0.0148337391131729,1.0381126538905678
P31/FUJ,9926054,1.2698752833949425,1.5769869910526204
Daudi,5287620,-2.5355659158885167,-1.94357881229463
BICR 31,53325874,4.467091056736401,4.691143474194274
LS411N,400769,-0.3072623933562745,-0.5887554856894044
HCC15,7326481,6.13295321500094,2.9949681721367107
LS180,6610216,4.524725364990245,4.166524926085984
BICR 31,11609586,2.804864928293696,2.990077013935099
NCI-H1568,5351362,0.9370615420718584,1.5757566301894568
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.808147055587249
HCC1500,26596,-0.8174609850015592,-0.9276100248971265
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,0.18422257902666062
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.332673149867062
BICR 31,5311281,1.899563489561116,2.6850782314527573
HuP-T3,11964036,1.9148977928601396,1.5038562424904125
HuP-T3,6918328,0.6989696425214073,0.22881120484631168
IA-LM,56963564,0.8197284064300991,0.6493093758609596
K-562,25227462,-1.535473545694956,-1.6333925502263387
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.8289997860366327
P31/FUJ,6438330,0.60015264799364,1.3058648281096021
NCI-H1568,54143018,1.7330311939537375,0.7168916949643028
MOLM-13,10184653,-1.0304513474260102,0.2757852822781243
COR-L105,3081361,0.7591954413754667,2.4713536193637817
SW48,3465537,3.829258919586145,2.1568336882987382
SK-CO-1,135398516,1.0451560562277196,2.5120808317535905
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,2.135163049792944
BICR 31,11222830,2.7999268343872603,1.5355706511079807
P31/FUJ,1750826,-3.787471607079622,-2.945544507668944
MOLM-13,124202324,0.9453642044256088,0.8945519513662028
LS180,445091,4.461419397707798,4.280425850014705
K-562,4578,4.401657334703153,4.172258366934047
BFTC-909,31703,-0.9928331583982526,-0.8731895676368588
Daudi,54618164,3.154466747848232,3.4020031560100676
HCC1500,375860,0.1348683063529126,-0.1962849282396469
MOLM-13,3385,-0.0516453787728095,2.3991930618619874
Daudi,123631,1.6174763425926726,1.9705080321519681
SW1573,6610355,4.129027118562099,4.570120122302879
K-562,44589607,2.662527895237601,2.009055858105574
SW948,24964624,1.7910099631647045,1.7459605327348213
LS180,387447,-4.2321913932512185,-4.511960473748524
SW1271,445091,4.3767610709371025,4.328871184927644
LS411N,5328940,2.1913370268343324,1.4327295064805878
ALL-SIL,46199207,2.4207183231317826,2.48824430166919
BFTC-909,644241,3.062866082016443,2.5457218424432755
SK-CO-1,5738263,3.1381077819263954,3.355755410713479
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,4.049483347493591
PaTu 8902,3385,6.504553614083827,4.037566733858389
SW1271,5328940,1.739297434861375,1.7650276322714669
Daudi,444795,4.05018196872557,3.1530309379884334
SaOS-2,9887053,4.468769125876902,3.8966534742071106
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.757253452543384
MOLP-8,9936388,3.4211096692910052,-4.5111205988382235
SaOS-2,5746,3.648398890023908,1.2691588943277872
PaTu 8988t,135875424,4.8815767191826325,4.016425460644181
SaOS-2,25195348,4.111342507306749,3.5814932512648023
NCI-H1568,135398738,4.732110826035958,4.500403493075482
RKO,5329102,2.192208184281935,1.8685690945955529
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.822665550329528
WM115,11612883,3.668907379861532,2.779298790654891
HCC1500,24785538,2.8337652504333817,1.5552097138217318
ALL-SIL,3854666,-1.067048731148745,0.4887450480964856
WM115,11494412,2.975341542339242,1.9002250928640025
Granta-519,9884685,-0.5481626961732873,-0.5714312480579474
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,2.0591055332403863
KU-19-19,5287620,-2.913600334543538,-2.1027284182634145
HCC1500,25227462,-1.134185511373382,0.04825235204832706
SK-OV-3,9936388,2.038842599711319,-1.8038599804611652
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,4.908593623758148
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,1.9259048230332656
COR-L95,9840324,5.902997789616562,5.651299531856278
SK-OV-3,159324,5.082712026660022,2.774984381602963
COR-L105,5426,4.419968019169297,3.562788144690326
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.544928005689374
HuP-T3,44491742,4.372770131484514,4.236968093562143
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-3.0609423158881532
MOLM-13,5978,-4.923441638627742,-3.040968492353315
KU-19-19,9911463,4.338553857034003,3.876222315638229
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.2062998526934288
MDST8,9956119,3.20428794924567,3.6090957654788673
IGROV-1,44137675,1.8406125640672395,3.6312928321466513
NCI-H1568,24771867,2.7621066837370156,2.494096534944224
SW1573,3503,1.662872296112478,2.3081357774574682
ALL-SIL,54143018,-1.6646130342073118,-0.7091844552095998
KU-19-19,9903786,4.470072542277405,3.1112931922274925
Granta-519,67291369,2.669151289874282,0.8131289396475352
HuP-T3,126941,-4.07371973001698,-2.4868851227295736
IGROV-1,11175137,1.8411496230681277,2.5028088951004492
LCLC-97TM1,3543504,4.4040963352609825,4.146613824871573
PaTu 8988t,10184653,1.9115764380070437,1.6889282953431286
BICR 31,10184653,-1.3652350776002238,1.1582148329408681
PaTu 8988t,4917,3.9515789700022728,3.115543713961092
LS411N,9967941,4.95978669187673,3.3856595166711996
SW948,6918837,-5.2716912634433815,-3.466588433213088
Granta-519,19582717,3.2223711893143796,2.836635038711752
HuP-T3,753704,5.56041062328625,5.133570114840955
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,2.478041766423755
HuP-T3,44819697,0.7007171788005963,-0.42713036912408264
Daudi,49766530,-5.535187194073846,-1.8119228317087845
RKO,168313047,1.9322709085928884,2.060251647347578
HEL,451668,-1.9900462993769088,-1.1418999417224454
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.6558493435600665
ALL-SIL,637858,0.2842777242368783,0.9015126225905901
SW48,375860,-0.9823609780883206,-0.08849170167856898
Granta-519,426756,3.1337304970475865,3.8976294595628307
LS411N,3038522,4.360410119835835,2.9247793891549816
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.359852167783848
NCI-H2452,11626560,1.8431584922948163,1.9800331383415664
SW48,135398516,1.3232406127849534,2.2161798564127686
SW48,5329102,0.4162536894409948,2.0430284742750495
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,4.116856300522221
BICR 22,11427553,3.133254296040306,2.8861190631570857
NCI-H2452,72376,-3.519434001557919,-1.3882915060615268
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,3.0374438936288533
K-562,135984461,3.2548026411837787,3.369233465393592
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.6656628278926116
Daudi,73707398,-0.7942959168982594,0.4477862257106279
NCI-H2452,46398810,2.3683678826725387,2.5441646886622307
PaTu 8902,5738263,4.741832860910815,3.703326151647974
MOLP-8,10322450,4.082153801594249,3.369347516827174
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.09940848571624
SW48,5287620,-2.9796019172473747,-1.909603863991762
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,1.3001841958003157
MOLP-8,56963564,0.2564931281605764,-0.009345795780939269
Granta-519,375860,-0.9367901929922506,-0.7126587403586295
SK-CO-1,656346,-0.6691405855346803,1.3938573235162526
RCC10RGB,44607531,1.912198544747903,1.5909824845592282
RKO,9823820,5.913042612438718,2.933277994232349
SW1271,25262965,-0.6695626057691765,-0.8563486237645749
SaOS-2,2742550,4.001711578380083,3.8012423126786556
SW948,44491742,3.910317363967626,4.018690138155966
K-562,25105715,3.3934107563871088,3.378779004470084
K-562,3689413,1.0071697658281389,-1.2982963640465015
NCI-H1568,9911830,1.3917537385715242,2.621561088752031
IGROV-1,42642645,0.3750175292659389,0.8951668088073391
MOLP-8,53392493,1.8438027475223988,2.0235857784905193
BICR 22,4788,5.9489186959823845,5.634591165843465
IGROV-1,5287620,-1.5394168430569777,-1.6522119307221979
IGROV-1,446155,3.750396425244744,2.4815042072132996
LS180,15983966,-3.417830365026362,-1.8609203618476877
MDST8,5566,3.234550965497495,3.043555409566449
K-562,644241,-4.86229706466587,1.1106681190420742
SU-DHL-1,135421197,1.1384736779813156,1.4885504638455997
KU-19-19,44507138,1.5611189443326865,2.586980025344538
Panc 02.03,5281321,1.7682996743542674,-1.1538716170848675
SW948,44607531,1.464462944366021,1.4042541373225137
KU-19-19,54649381,3.8760376098429616,3.937925050692952
Daudi,25062766,1.1734245449662122,1.533679247766908
IGROV-1,56946209,-4.416985130578084,-4.065076124998485
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.7748728472458661
NCI-H2452,11238147,5.37150149846425,2.76914549685016
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.4108499427645718
HEL,3689413,-2.191477482826257,-1.5420298624542794
WM115,285033,-0.1832916587196474,-1.6825702757812444
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.5513112549304875
SU-DHL-1,426756,3.3694285311129777,4.233289281988109
WM115,135999136,1.8466122948256136,4.156101346850078
IA-LM,45279963,4.638115534107364,3.6955524128650152
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.6039013856302018
SW948,4917,3.7157271581620166,2.9236281726064135
Granta-519,119182,-4.107570420442856,-2.851138739621136
MDST8,56946209,-2.145438357732055,-3.301343585945716
HuP-T3,9927531,4.952379772704904,4.871365443556787
RCC10RGB,72967,3.7162805539485775,4.084812552145085
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,2.022501145786046
COR-L105,25126798,3.974391104898093,3.928714281688985
IGROV-1,676352,2.310492141650647,2.059411781255289
MOLM-13,11640390,3.605079146985929,1.7620269714183217
SW1271,10302451,1.5832525718610488,3.0296859816385546
HEL,123631,2.2046071754004553,1.9829676657961657
Daudi,9887053,0.4273795924431001,2.6755647890188596
HCC15,53232,1.2438342439906054,2.7591343404092594
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,2.0251066482589173
MOLP-8,107970,1.7976582890286323,1.9168498860414092
COR-L105,12003241,-1.8759508779616432,-0.553274738764754
SW948,11222830,1.2602033369542562,1.5104018656228428
LS411N,60750,3.4958773713368725,-1.86813584341372
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,3.9063869248006786
COR-L95,11152667,-1.0192155235937173,-0.5777689108043415
RCC10RGB,136227924,3.611686331312014,3.140821101306933
Granta-519,46398810,1.929291860170987,1.905181278465531
SW1271,135999136,4.614562085611917,3.7887195318557314
IGROV-1,53232,2.4872106086763393,2.543715750483633
SW1271,5329102,1.7502689549650896,1.964104409055565
Granta-519,136227924,1.3333863896282263,2.2111641167771916
HCC15,11213558,1.313690011959325,1.9822112009257356
BICR 22,54619267,3.924840101579574,4.117889104159499
MDST8,9907093,2.778674083883115,4.574165771208604
P31/FUJ,11175137,-0.7372235608093404,1.7130706062450394
MDST8,36314,1.6029219233562175,0.08369729371430516
PaTu 8902,2746,3.932313359375791,3.1883613048151163
P31/FUJ,3543504,4.167476980253382,3.6110191900275135
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,0.6777486422766716
HCC1500,2749,1.6972528944159595,1.6809705187571966
HCC1500,2858523,2.9580940168196372,3.094107627490215
P31/FUJ,241158,2.9181679480161997,2.699057018391065
IGROV-1,44202524,1.8303703172382677,2.2073173276404976
COR-L95,24856436,0.3013384579313291,0.04791767911456013
Daudi,15983966,-4.480185591931726,-3.990498902816963
MDST8,9903786,2.958137426904596,3.0503707336750123
SU-DHL-1,57519531,0.9649766396601452,2.015811185069721
IGROV-1,25262965,-3.18785020602057,-1.4864501341399734
MOLM-13,135411,-0.7080955458923358,-0.3195965745016438
HCC15,24901704,2.315976175325417,3.501024065532065
SW1573,656346,0.5263129478884733,1.352386995039135
SW1573,11238147,3.4967804964098517,2.9453290160929884
MOLM-13,6918837,-5.322581124261525,-4.051452087372978
MOLM-13,444795,-0.8871401586886155,3.0020619413989458
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.8890400221727974
SW948,44486219,4.202726475674803,4.067379728332338
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,3.1849105718418156
SK-HEP-1,4259181,0.3926762831937545,0.2670737100233113
MOLM-13,11152667,-8.249378694414048,-1.5076067799790969
HCC15,46199207,3.454904957256138,3.164568043596582
COR-L95,BRD-K55473186,4.076833088818027,4.000824577269165
SK-HEP-1,11612883,3.763210558313423,3.051169097356229
SW48,54619267,2.8192087316830587,3.879200561681692
COR-L95,448949,2.666065821382702,1.7566856984457173
SW1271,31703,-2.541706035799043,-0.8707286374343025
SW48,374536,2.9137455711630365,2.083684513063902
HuP-T3,25183872,-1.5149537087973208,-0.6546901137457114
BICR 31,71466578,6.11729815776394,4.727214759012039
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.7380764503822668
SW48,135440466,-0.9616456131279733,2.024179262611384
Granta-519,322968,2.3569390760499234,2.108017538947971
RCC10RGB,25227462,3.0929907596871646,0.6478912157944465
P31/FUJ,6917907,-6.201167718101803,-5.468132798900135
PaTu 8988t,49793307,-2.0749757720441164,-2.573237513836139
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,0.8318003210188002
Granta-519,12001922,1.093482575381039,1.483579909055506
SaOS-2,54649381,4.670802712896813,3.755882807372223
BICR 31,11213558,1.307666782243681,1.8090558116872268
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,2.1027545512171173
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.607638102029747
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.6978187441740167
SW1573,216468,2.7570678542174294,3.499652922574421
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.5757834920375813
LCLC-97TM1,441298,2.906797889353979,2.4920338580936874
LS180,24753719,4.21554861148433,4.242292066304992
ALL-SIL,65064,2.797289094590348,3.682648863099512
BICR 22,67291369,2.228219380635809,2.3436730402122175
RERF-LC-MS,168313200,3.896073258981905,2.9994239347180627
SK-HEP-1,9444,4.343802313850578,4.190828237183699
PaTu 8988t,5328940,1.37213408852796,1.7341914709774275
BICR 22,5311,1.9321946929787237,1.8202288747582736
BICR 31,219104,4.339385963743166,4.0178248647757355
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,1.2836140782645589
ALL-SIL,4477,0.1906678465210559,0.3239295606074101
K-562,25154868,2.7747166739598264,3.9175101255095206
SK-HEP-1,16065773,3.000790971898234,2.5657089586546
PaTu 8902,11364421,1.1100050491651887,-1.4622466509149874
NCI-H1568,3081361,2.134244125445247,2.4985372116964393
HCC1500,11640390,3.4842141291887234,3.3071745143865234
BFTC-909,11626560,2.2197507332783735,1.9675945065122258
SW948,107970,1.650733689507072,2.154266318337172
RKN,15983966,-2.847635435689191,-1.3988106086891918
P31/FUJ,11455910,0.7543092217738059,0.5310991367176744
MDST8,71466380,4.4925072325945825,4.49547894621041
HuP-T3,44185566,3.047929926499308,2.555288093089171
WM115,24772860,-3.130789858430774,-1.1977031058469771
COR-L95,327653,2.664763845896721,2.7444961244719552
BICR 31,46398810,2.284799792972812,2.6324634462713585
MDST8,46199207,3.2831338438462545,3.3635569763921644
P31/FUJ,54143018,-1.089453758548118,-0.5716190018306566
RKN,119607,5.106543735080002,5.511545205568919
COR-L105,5746,2.3338049438674933,1.6824704544884694
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,-1.477024113907099
MOLM-13,5738263,2.9100103684660237,2.4919237693041687
RERF-LC-MS,216345,4.25766275770173,3.9569640906064314
P31/FUJ,10322450,3.023071845081992,3.115431059600644
BICR 22,16065773,3.2562595111068933,2.6120051777197473
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.475447630511939
RCC10RGB,2858523,3.1824977664847833,3.1325529403229693
HEL,3634881,2.3660153954756,2.6235660694736462
BICR 31,4705,2.7587837218207194,3.1104313421110614
Daudi,16736978,-0.1290294552432643,0.34563990123947874
HCC1500,409805,3.5957056987066407,4.563773595885803
COR-L95,11497983,3.7904455836505977,2.854015968379662
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,3.085308577207723
HuP-T3,123631,3.4682236131630213,2.427838466799527
MOLM-13,6918736,-1.7098661921605196,-2.6424968260279242
MOLM-13,46943432,-0.154947866345158,0.773186364380682
HCC1500,219104,2.0821347677363473,3.5276901747174194
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.7240766726548165
NCI-H1568,65064,3.2204713254113373,4.887033370826627
SW1271,16720766,0.8044088826386648,0.5505752943572143
Daudi,119607,3.8512151262400978,4.611439886972699
HCC1500,72193861,2.243893882523798,1.6788008100879734
K-562,5328940,0.7651330448756731,1.2552072184776113
SaOS-2,644241,2.5011234622868415,2.5701037841643806
HEL,60700,-1.2821695146150829,-1.4573160181959182
RERF-LC-MS,25227462,0.8140348385016122,0.5795577631852599
COR-L95,4521392,4.944619543772989,4.2177224988481825
KU-19-19,16720766,1.6427063989874335,0.7172635097842901
SK-OV-3,3025944,4.375754256809385,4.168960676060677
P31/FUJ,36314,-5.221113398603202,-1.817984759256555
Panc 02.03,568763,0.7660787595735656,0.6964277271812129
PaTu 8988t,60700,1.4149082605005396,0.09881812209940348
BFTC-909,421610,2.763760389372973,3.300017113385021
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.247048755357649
RERF-LC-MS,123631,2.7610356359897104,2.631345151011451
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.4379642645884214
RKN,10385095,1.0188882527918253,1.2649083837392814
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,1.6848463981478188
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.3975342001258
Daudi,44486219,3.679556481815833,3.710544407772371
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,2.150826719477885
P31/FUJ,159324,1.227532336429348,0.5746970846149402
SK-CO-1,6252,-1.3434891204218062,0.6501056095828194
LCLC-97TM1,656346,0.6605690440583806,0.9905079549616483
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.1401357982320561
RERF-LC-MS,675434,4.646232548137413,4.638650111259614
KU-19-19,123631,3.236221278135049,2.407341187888584
MOLM-13,15983966,-4.417403089755366,-4.045125544115723
HuP-T3,4917,3.663340719397695,3.16068524217461
LS180,44185566,1.7571027497277631,2.4620826237386852
P31/FUJ,11228183,-0.9086595542209992,0.2840558110126705
WM115,9933475,1.7795579913266513,1.914534572304863
RCC10RGB,445643,3.986839371383198,4.232628318007563
LS180,11238147,1.5426585727528574,2.7879741916623635
SK-OV-3,6918328,0.3966751205296329,0.1911592937040418
SU-DHL-1,71466578,4.395132834723917,2.770751722742145
ALL-SIL,135421197,0.8278001934093618,1.1814377708381905
BICR 31,2858523,3.440938149330432,3.1309190748457003
NCI-H1568,72734382,4.159676082420196,4.543541329092882
BICR 31,10427712,4.26091650049326,4.334813498682317
K-562,5351362,1.2059406782397044,1.2695167812097121
HEL,44589607,2.8579344181758164,1.961206573633419
RERF-LC-MS,89928392,3.2509495975064193,1.7720074651899451
K-562,4705,3.481256778033869,2.9222821521238354
SW948,400769,-0.4902020150535968,-0.6417137336616646
RKO,46199207,3.448070090368443,2.923777922887001
HuP-T3,10410894,4.484643398072658,3.4664356680794595
BICR 31,969516,3.644181632779252,2.794096696246076
WM115,54618771,0.9043395114740442,0.8984498509404502
MDST8,2749,2.5181508528519365,2.2822847118292136
SW1271,4378219,1.9495591217614856,2.9097881893143205
RERF-LC-MS,12003241,-0.3897829713203344,-0.7921646410696097
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,4.042024781244144
PaTu 8902,44620216,3.796821774118314,3.77007171984612
MOLP-8,4378219,3.751203523477959,2.3305477568383965
PaTu 8988t,11152667,-0.7220641758089987,-0.21784066705896912
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-1.7029142755529596
SK-OV-3,60700,0.4435128165358443,0.08222907360025135
LS180,168313047,2.515878081381246,2.1807851288693847
K-562,400769,-0.7978860959413716,-1.1453226587098797
Panc 02.03,126941,-0.7071805078882285,-2.678605881108586
NCI-H1568,3634881,3.2529386900783024,3.3581680362360786
LCLC-97TM1,24821094,3.5658031163211996,3.05963158899181
LS411N,11485656,1.6093796612349578,2.020032125393568
HCC15,16736978,2.153897232237977,1.6504640670844961
LCLC-97TM1,6610355,3.6494140877324273,4.459593850532057
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,1.938328746867572
IGROV-1,9911830,1.9130562323799436,2.581080133406977
LS411N,159324,3.2133975478450005,1.9887233464726308
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.6043999404933778
SaOS-2,322968,3.970591848140582,3.5429836273164543
BICR 31,216345,4.54975912567895,3.9946138597508645
HEL,3825829,3.033394475732853,3.152913345751132
COR-L105,46191454,3.4168297701439223,1.7334964450619685
K-562,5113032,4.649240406472478,4.894429610688954
BICR 22,156414,1.4774483319728589,0.644068619404504
SW1573,135875424,1.8143158468632437,3.8984490278619135
WM115,12003241,-3.303596686294694,-1.117645866388072
RKN,11640390,3.613472996393559,3.730307208889127
HEL,23725625,2.914554844202699,3.740456653918284
COR-L95,36462,-0.8944975018350346,1.6155728058999148
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,3.129953264869927
HuP-T3,11977753,3.281021154274905,-1.3663108625165312
SK-HEP-1,400769,0.2777482831309371,-0.46003707861895793
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,2.8768403830648674
SU-DHL-1,246676,5.693727803678488,3.7574096228425935
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,1.8051683640027354
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.7662034921054934
RCC10RGB,44507138,4.147954700367582,2.781733225464102
LS411N,123631,3.048490743589503,2.124234713888944
MOLM-13,11213558,-2.3442824820578347,0.7865055044868435
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,1.4497557944077277
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.7506343906665276
PaTu 8988t,444795,4.288290341819835,4.685124195604797
SK-CO-1,66577038,1.9378658470267984,2.8329323058682045
SW48,24771867,-3.897611921368264,2.0338716805303316
NCI-H2452,9907093,3.826391051371518,4.449486181539841
SW1271,171352865,2.2565348875691624,3.3929096900410074
SU-DHL-1,11152667,-1.9410189761528236,-1.185136709336116
SK-HEP-1,148124,3.734435411699081,-1.5603786269529973
RERF-LC-MS,107985,-3.0933260647006215,-3.2768544975545324
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,2.971889894658879
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-0.7873450364042892
RCC10RGB,10184653,2.2305820416370965,1.8073788187021185
LS411N,17755052,2.4732315703899226,1.6958835248294388
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,-1.130407635971479
KU-19-19,24753719,4.40371401160258,4.303296514563578
PaTu 8902,72376,-1.694582331183855,-1.5100030010149164
HEL,72376,-3.0304513894944933,-3.244845845491736
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.617331680709731
SW948,9884685,3.1398548031465525,0.7498618274870545
Daudi,24748573,1.578133478161721,1.4474378242511248
COR-L95,4917,3.3160135329409406,2.7777644717288403
SK-CO-1,2708,2.7526164010571152,5.128902273803674
Daudi,5479543,1.606221989903471,2.5529925069369783
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,1.266234389207474
MOLP-8,44632017,0.8356757219547752,0.7449694691680311
SW1271,9868037,2.9396003878324857,3.1429284339431978
COR-L95,11455910,1.0154509596480157,0.93339785765538
IGROV-1,445091,5.8777802446160825,4.381545172690848
IA-LM,107970,1.9308025720075177,2.2314290160335593
BICR 31,15953870,5.115358479555731,3.612158576455931
HEL,135984461,1.7610482730169696,2.9251788401261107
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,3.3099399029876757
PaTu 8988t,5311,3.6038975682992422,1.5406237208248788
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-1.7521753708847831
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.808801491920661
SK-CO-1,11228183,0.9546983133897222,2.2713722021318334
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.7817502522321005
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.3884522902268683
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.917657428835574
BICR 22,42642645,1.569820729256039,0.9242028939619746
RERF-LC-MS,387447,-4.351660250848144,-3.5892951994845124
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,1.852075284314656
RKO,676352,2.3070338313311547,2.0275982451898713
HEL,66577038,3.4935326109734217,2.4932624643282466
RERF-LC-MS,25062766,1.7296886540377192,2.0332343305837712
RKN,52947716,-5.912196482956353,0.46197556826720676
SW48,56973724,0.919295357428288,3.1825794885779453
LS180,66577038,2.8527700320727725,2.5350698225075288
K-562,7251185,2.894408284149289,1.8162657241178102
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,-1.6432360678383222
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.41485060628445647
MOLM-13,6918878,-0.6248914400619264,0.5793273860519961
IGROV-1,135421197,1.96820638017286,1.8202908244170097
RKN,11404337,0.6786980557761386,-0.27671026452134256
SU-DHL-1,6918878,1.5556600104975795,0.8560047959592657
MOLM-13,176870,1.4073018577806429,2.4883194139357654
SaOS-2,44566777,0.9896093397626105,0.7506275925748008
COR-L105,5470400,0.2171168006478052,0.050975453183178095
LS180,44632017,0.4358481157568056,1.131917755597261
RCC10RGB,16065773,4.176477311044804,2.519413899771713
BICR 31,156414,0.5699919561712937,1.1688962306747084
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,-0.951079799850125
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,1.0665364066418954
Daudi,54596490,4.948926549609605,4.250097363899336
NCI-H2452,11317348,1.7824301660124695,2.884147587813595
IGROV-1,60700,0.4424479122017752,-0.1811381159181215
IA-LM,135421197,2.370501142960713,1.7460750436240284
NCI-H2452,135423438,1.816833708086427,2.448831392009057
NCI-H2452,6918837,-2.3246752526945413,-2.4262364900772133
HuP-T3,409805,5.703463345532586,5.337208780112567
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,0.05622014227690841
WM115,3025944,4.015069634557516,4.276736583039796
BICR 22,10127622,2.812639951672956,3.4523792533212774
RCC10RGB,16741245,4.755009504271123,4.30680893145631
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,-0.2994553963025898
BFTC-909,1641662,3.805506520632872,3.5729685167487952
SK-HEP-1,3136844,5.506062707172487,4.462684110731656
MOLM-13,5335621,3.915836728943439,3.9228072139660264
ALL-SIL,6918736,-2.784980550106597,-2.5335571014548544
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,2.3639840404698473
SK-OV-3,5311,1.582209129738937,1.3917896609732656
NCI-H1568,4378219,1.8995328874154,2.9963769255726684
PaTu 8988t,135440466,2.5529183901912456,2.4566273142339075
P31/FUJ,208908,3.0114989034455415,1.9188143107412623
MOLM-13,55508,1.530825081139479,2.1950630134484084
ALL-SIL,15983966,-4.919474478826657,-4.191160991676959
ALL-SIL,72193861,-0.8088702984298154,-0.10724326759204604
Granta-519,135875424,2.983761714085865,3.189214742860457
Panc 02.03,25062766,3.7424097220448207,2.2507098517378386
LS411N,5282054,4.11513360382112,3.34447536597892
WM115,9956119,3.8110537513046423,3.241047752376451
Daudi,10077130,1.7104594990439606,2.3438832052285514
PaTu 8902,54618771,-1.3103145579416535,0.855632107526422
LS411N,6610355,5.174673905344729,4.345921392047336
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.8315329706556094
Daudi,11364421,-5.814557541528941,-4.058237939556496
SW48,10090485,5.377611493091081,3.6636622843138156
RERF-LC-MS,252682,6.464777279315186,6.4893874560048515
RERF-LC-MS,25195348,2.310586589861769,3.3632589023982162
LS411N,57330099,4.386912904802011,4.22477235081526
RERF-LC-MS,5351362,3.2669953777859493,1.7492296733031865
SaOS-2,5281321,-2.1045144226453134,-1.8032129701419473
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-0.839325629472568
HCC1500,15953870,3.698430879415157,3.41895891909945
BICR 31,107985,-2.559614665868775,-2.9002755703491228
SU-DHL-1,5978,-4.006589870739168,-3.0947381504698837
SK-HEP-1,387447,-3.995016034956776,-3.8527986337929048
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,2.9793147180992827
BICR 22,44491742,3.912327775797625,4.3792531500267
NCI-H2452,10113978,2.1292579793865167,3.303064072922069
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,2.1385015308014497
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,0.9105466601887828
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,1.3472416220541479
PaTu 8988t,10074640,3.912219918984309,3.094018409293929
RKO,25102847,3.0524897378806033,2.148254304782334
K-562,446155,2.553560117982406,2.509604994922515
HuP-T3,3062316,-3.5835263694309862,0.7832877625096227
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,3.610237051137561
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,2.0326214311841198
COR-L105,9915743,-1.8659407955600968,1.4845747713016941
SU-DHL-1,676352,1.6127382742380425,1.8109103959877053
SK-CO-1,15983966,-2.8914318783251733,-0.544965484859144
BFTC-909,6450551,3.0302116860685886,3.0357516618507248
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.545348811744558
LCLC-97TM1,6852167,1.822160840349085,2.902344555968171
K-562,1716436,3.607306146681396,2.7570134170457674
ALL-SIL,6917907,-6.413711962559719,-5.214346978245309
SW48,44505237,4.455085659285412,2.812599655594501
MOLP-8,4788,5.509648062033256,4.954104336024877
KU-19-19,49793307,-2.3409308252506777,-2.502973724132578
IGROV-1,46843906,3.392503571349757,3.1060620877666723
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.4637889607684662
NCI-H1568,23582824,0.2708211860244319,0.8481436806236282
P31/FUJ,156414,0.8249508749632878,0.6428321637542013
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.8795233643999554
Panc 02.03,24951314,2.3006835537528585,1.6010329505996972
RERF-LC-MS,46199207,3.61094494328213,3.3674552609089443
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-4.71393790064899
IGROV-1,25102847,1.7007012555618253,2.344395448810973
COR-L95,9884685,1.274087436172542,0.2092225891649852
RKO,5738263,3.4166283525852523,3.025851497854061
BICR 31,446155,3.004688823756655,2.7531969452280594
MOLP-8,3081361,3.002632255231731,2.1879439493357946
KU-19-19,124202324,2.2262797687523266,2.544812446436826
COR-L95,241158,4.468160037389037,3.6318350319044628
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,3.2500198008278356
SK-OV-3,9926054,2.1800400954819716,1.9816324469829814
NCI-H2452,285033,-1.1649166052412432,-1.8126163867163072
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-0.6725466321468719
SaOS-2,3136844,3.967600163436525,4.341832409765994
Granta-519,36462,-1.2340392932323463,-0.7006681005106168
Granta-519,24785538,0.1958729752370936,0.3663022829809098
WM115,5566,2.8846390038255127,2.735955018692081
IGROV-1,31703,-1.792518264692263,-0.8760985932235889
HCC1500,3025986,-0.5847488606379614,-0.4660404993940295
K-562,2828334,5.968313970587813,5.960911133417674
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-1.031893242731348
LS411N,72193861,2.8187845663214848,1.0707378567425994
SU-DHL-6,11964036,-0.1529025297927845,0.5100799604806008
LS180,6918837,-2.789669873343886,-3.019242143709219
Granta-519,445455,5.050402748491994,3.9615664050269244
LS411N,9926054,1.9376785020428349,1.9385883094330123
MOLM-13,135398738,2.371405234005272,2.3980610812112477
BICR 22,53392493,3.288173891171126,2.820066795884192
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.134493325986296
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.587149766641924
MOLP-8,9823820,3.862667538801475,3.303457967904774
SW948,219104,3.4463785749905886,3.355032151720995
Daudi,56649450,2.7731175257265757,2.7407428567594825
RKO,446155,4.170579555483674,2.6482380968430044
COR-L95,2708,4.088828930735336,4.472822004545797
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,2.9635889234833455
SW948,6610216,4.184431800680971,4.227967090087273
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,0.429216569146292
MDST8,24978538,-1.5034064763640302,0.9637023230264429
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.6956772116970126
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,-0.2383528739361468
RERF-LC-MS,44607531,1.5104561529736475,1.5656906005059568
MDST8,16065773,2.461320056751215,2.4990608594288184
Daudi,11955716,-2.451420398730992,-2.0247607334847864
Daudi,44566777,-1.3909109996970672,0.283066682474342
WM115,53495165,2.3633352174150155,0.6964160387494445
MOLM-13,10077130,2.656845569256352,2.3357357867014783
LCLC-97TM1,11364421,-5.841421445385269,-1.7994055363132828
MOLM-13,9887053,0.5396890830211841,2.335490467236485
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.0757025010074917
IGROV-1,46191454,1.3777495915525844,1.6808407930597744
Granta-519,5328940,0.7430401080732436,0.9508472368540177
SW1271,54618305,4.440463475812739,4.260121780587857
COR-L95,23725625,3.551891881441416,4.477263135026458
RCC10RGB,46843906,4.246883034106686,3.3783572147542147
Granta-519,2945648,2.528276278220214,2.208439229244031
Granta-519,11977753,-6.302388202708452,-2.604885715260297
SU-DHL-6,15953870,2.4587311871536315,2.9494607256779335
MOLM-13,10322450,2.9930800125873045,3.1499833193625175
LCLC-97TM1,6505803,0.2281876141434561,-0.5846416175927474
WM115,9967941,2.88500943866673,3.5403601834276794
K-562,44202524,1.302888790519651,1.6117452746724228
K-562,252682,6.220409267483573,6.218061126161586
HCC15,49867926,4.259454552862098,4.317575033778309
BICR 22,25183872,-0.1596442578279089,-0.7705376367701655
RKO,17755052,3.988455753476612,1.4921612473793064
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,3.315927361512573
PaTu 8988t,5566,2.9380975134161553,3.084141531669005
K-562,219104,3.3686951285077273,2.7280612215176916
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,4.357092749174937
WM115,100016,7.477930972064711,6.273415832338525
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,2.176620853651277
SU-DHL-6,46191454,-0.3846699961999978,-0.14571090610748116
LS180,124202324,2.088899784140079,2.3046065934297832
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,1.2051931345821845
K-562,4261,1.1039684536741017,0.846259315011626
NCI-H2452,5282054,2.993265650723398,3.9797636716255904
MOLP-8,168312962,1.5743557083321402,0.7212701532679034
Granta-519,969516,1.9567849087702365,2.0686448306383682
NCI-H1568,25062766,1.9660972036535989,2.0835265624906714
MOLM-13,448949,-0.3738099635599754,0.5791243093954647
SW48,11647372,-0.0986138935854908,1.0498327238198213
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,2.4484248118684464
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.387342675499146
RERF-LC-MS,11977753,-0.575574044510787,-1.380302280697596
LS180,49793307,-3.6014942577594415,-3.2334178107399305
SW948,3854666,3.050289300885683,1.9423514020973485
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.2151123743149475
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,2.2043044208617353
WM115,5278396,3.4301399168519153,3.303564389696947
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,1.6201807127762842
HCC1500,11485656,2.6610961572019103,2.170091605178668
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,-0.0898304739609771
Daudi,2945648,2.1407869976239087,2.058953977469746
MOLM-13,3689413,-2.8005667715254017,-1.8564353016215491
RKN,3543504,4.234888347098623,4.610918251015176
IGROV-1,24964624,0.5052308994941754,2.1215309591522162
PaTu 8988t,676352,1.787056590779638,2.0611263781992446
RERF-LC-MS,10385095,0.7812016081678173,1.2986613516481496
WM115,4259181,1.0090630393378868,0.6316888498780832
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-2.2163327872992564
SaOS-2,1239801,5.3522865443092575,4.177701206231046
Granta-519,44137675,2.975150065736677,2.2613628788625304
Daudi,11455910,-1.173613913103254,0.5781723007716459
UACC-812,11152667,2.562952126743398,-0.09865723467819333
SaOS-2,16219061,3.147835700454569,3.2274117938773217
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,2.5659797548384025
SaOS-2,71304818,3.198114510015862,2.3351421268118107
IGROV-1,57330099,4.391385744785918,4.314720005917076
LCLC-97TM1,2729026,2.4668071198749555,2.7685017870338324
HCC1500,5281672,4.190998095776345,4.606003964298601
NCI-H1568,9884685,-0.6579514975056241,0.8099710930263163
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.7923446128964775
LS411N,107985,-2.091782559178726,-3.552966512166478
COR-L95,42642645,0.7279572059378924,0.6862118022934802
LS180,5566,2.7460265721966897,2.9371177991380755
COR-L95,104842,-6.859012992539376,-3.635789123207125
K-562,702558,5.364922414830515,4.124326074198333
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.2523355864201964
LCLC-97TM1,9929138,5.774162864206733,5.869759293386296
LS411N,31703,0.7183186901084707,-1.0521522173338742
WM115,23725625,4.964211357698685,4.93294967070808
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.055753424744963
SaOS-2,24978538,2.44958290959275,1.1072603296435446
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.6229097099063252
PaTu 8902,2858523,3.3217981805434196,3.0840318928791692
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.2638157742663414
SW48,65628,3.988389614478155,4.265643523657868
Granta-519,9903786,1.2937892753152922,1.6269640682005981
IGROV-1,71304818,2.4878074097553378,2.5364627682681107
COR-L95,25105715,3.673741872436949,3.250735342357192
HuP-T3,6918837,-1.8626358392084263,-2.427374084080605
PaTu 8988t,72376,-1.956580109455481,-1.7052726391258144
NCI-H2452,46907787,3.091101876271566,2.3728079436516443
SW948,23725625,5.544404993552476,4.698745057395421
K-562,25062766,2.5223735702376753,1.6591981912958673
SaOS-2,753704,5.53840358060444,4.537528628277685
NCI-H2452,56973724,2.8465784993073564,3.046946880994603
Granta-519,71466578,4.383489061930637,2.5153840924477997
SW948,11609586,2.9863433458317714,2.5863412114642075
HEL,71466445,1.5745300131733593,2.0997983510814158
Daudi,5329102,1.2784768117884069,1.5453087654984787
HCC15,409805,6.461768980239098,5.0296868819699005
Daudi,2871966,-2.2343916463272873,-0.7354008302013546
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,3.4131595928693286
RERF-LC-MS,135421197,1.554065103888189,2.060560459124768
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,3.152586873672378
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,1.9974984865043095
PaTu 8988t,25150857,2.5954794764360343,2.525115443427935
P31/FUJ,11152667,-2.5755274762926095,-1.5565041447557268
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.7329446240669985
BICR 31,2828334,6.263113325647995,6.252732536337911
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.5130329560746416
IGROV-1,11507802,1.5049911819213722,1.3267942333311271
Daudi,11485656,1.7254760898020216,1.539490475423236
Granta-519,11152667,-3.975154363660797,-1.7443206205438033
SW48,11640390,-0.422464249163724,3.1416791324604687
IA-LM,2828334,6.3387056990337705,6.208821025934635
HEL,36462,0.8349109175120154,-0.017305204216675182
LS411N,4477,1.0450277541726452,0.8350585902482244
NCI-H2452,16219061,3.733701707144141,3.3319118719731597
RKO,16741245,1.399079485469943,3.896970775014062
NCI-H1568,445455,4.330931204553833,4.729719129887683
K-562,15983966,-4.450185495623787,-3.6135908065467466
HCC1500,4096211,2.7054358198440345,2.2705345279023805
SU-DHL-1,46191454,-0.3713761809994262,0.8577798507163688
IGROV-1,387447,-3.9508602289798658,-4.1699180460191005
NCI-H1568,71751553,3.6437596116554887,4.6118456673783355
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.3064975938202354
WM115,46199207,3.650123600055899,3.322172417485791
SaOS-2,71680916,4.865393442781168,4.352079523324234
COR-L95,9823820,4.611798945344124,3.3286520769616015
HuP-T3,44589607,2.433680498088492,2.9962302390688493
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.2285032381030245
IGROV-1,3634881,2.769147818550815,3.3833270354696223
COR-L105,54626689,5.0742986339862926,4.7248177845543795
HEL,176870,2.3693727744318887,2.222276040926868
LCLC-97TM1,9549297,2.332709006301325,2.5316985787671036
COR-L105,24180125,3.5925931777332676,3.178913201827677
MOLP-8,89928392,0.1045876418070581,0.5971892161678478
BICR 22,3025986,-2.8899356497226756,-0.4969810013126225
ALL-SIL,400769,-0.758162988868875,-1.5710821691584778
BFTC-909,71466380,5.267829049221599,4.563872341356429
MOLM-13,24951314,-0.2336633009541456,-0.0005767067254228952
MOLP-8,3038522,2.029025514425164,2.331668495497883
RKN,16741245,1.555254881894904,3.9330971043695206
COR-L105,71751553,4.255827287979035,4.59875635119592
MOLP-8,60750,-8.573260651984995,-2.5354222637587878
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.619410077084267
BICR 22,24772860,-1.3590035600374548,-1.174644593975882
LCLC-97TM1,5470400,0.2889153362640624,-0.2718643300445118
BICR 31,53232,3.653430995715962,2.8457638441889888
BICR 31,8515,4.104799625743522,4.082537719973827
COR-L105,10127622,2.236200578684094,4.2027137004335176
NCI-H1568,5328940,0.3466597705312412,1.837756554931687
MOLP-8,135421197,1.7506124789909805,1.4400744244995027
SW1573,54454,1.176648172779268,2.4373062259767697
NCI-H2452,11964036,2.1879069513719087,1.3899314928198079
MOLM-13,44493528,3.9608078939228175,3.8113106935419894
SK-HEP-1,11396600,5.84824704867975,3.715428153889939
WM115,46215462,1.6800224060395437,1.8458963777299917
Granta-519,23939,5.101725753715152,3.776720967724588
BICR 22,46907787,3.4905986586009843,2.123857172156954
HEL,10184653,1.0835446596032057,0.6845545621627191
LS411N,9903786,3.6806866285220017,2.361049108302709
SW48,9840324,6.311735261945371,5.633310558379395
HCC15,24753719,5.171121417544096,4.398171053876382
SW948,11507802,1.163064588903486,1.248222891303251
COR-L105,2733487,7.427108299628283,6.3561975778760935
SaOS-2,439501,-2.8243657156627724,-2.2583585418686734
UACC-812,5287969,-2.4803922230812527,-1.7529702520193282
Granta-519,66577038,2.6663435544296346,2.6911462536951847
RERF-LC-MS,6918837,-3.051376318733669,-2.506479863640468
NCI-H1568,11152667,-1.392140833696634,-0.13200223517509688
KU-19-19,49850262,4.263742487880845,3.6851543816727537
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,2.0156196071734014
SaOS-2,156414,1.509432711545826,1.5633385813469445
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-1.0330059932977322
Granta-519,216468,0.2159572219264565,1.0633550589450318
P31/FUJ,3136844,4.357504973194935,3.4487964247445095
MOLP-8,6918638,-1.572747132532541,-0.2813639521149297
LS411N,445643,4.311506480272609,3.9604040836320333
MOLM-13,25126798,1.909946064109967,3.4098209780491118
BICR 22,9927531,5.395078942533075,4.885634560464865
SU-DHL-6,3385,2.96945431954736,2.725808064279586
SW948,49766530,-0.6875988061214425,-0.2840965026763893
MOLP-8,5287620,-5.023262566828496,-2.3117177735549803
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.3491105960202843
SW1271,5746,1.8306286254207629,1.1660668397345375
SU-DHL-1,4788,5.095368657375766,5.0833455372286975
UACC-812,44607531,-0.3950460021726514,1.4624185194860484
SK-CO-1,10074640,3.0297361304753143,3.1108752608447525
IGROV-1,65064,4.920352624378345,4.75645367397454
P31/FUJ,9444,3.558733501871851,3.700378000628735
MOLP-8,16722836,0.6223558214261112,1.1727723206256537
LCLC-97TM1,11647372,-0.3650454903758569,0.9731635987365793
COR-L95,9911463,4.18924595414168,3.525740397441244
MOLM-13,3634881,2.324290549736021,2.6016138461876768
IGROV-1,1242560,3.902441161940491,3.586070697937061
LS411N,702558,5.325144902608101,4.932290721090153
MOLM-13,969516,1.839627080728713,2.1342413262375852
IGROV-1,50905018,6.092412272559071,4.361051054609062
SaOS-2,5311,1.6246857228566176,1.4054242821160028
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-2.010698238695083
BICR 31,11178236,-3.7191700347439176,-3.166582882902
IGROV-1,16736978,0.1982875499977011,1.4555474105294524
HEL,54613361,-1.063581606127445,-0.7861579145725074
LS411N,409805,5.900990799691521,4.888075956957691
RKN,44819697,0.8547407464301948,-0.5469160597301453
SaOS-2,7326481,3.920515261577408,2.6955603400104042
HCC15,135411,0.5020362424433897,0.7031676536170666
SW1271,135875424,3.8663800475620542,3.712431099847022
SW948,5281321,-2.986965028390854,-1.3937171701809703
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,0.5882927112041135
ALL-SIL,16722836,0.4684239096852854,0.6518017464824877
BICR 22,3384730,2.588423009806214,2.8485953781697604
SU-DHL-1,5282054,2.781862093779865,2.8949942979495837
COR-L105,10385095,2.1444085139831643,1.2852110825143965
Panc 02.03,409805,5.9877775932277615,5.023237862969663
RERF-LC-MS,11707110,3.327368501952155,-0.27674705489046425
Daudi,46199207,1.9328464692742409,2.5018934305984804
SK-HEP-1,9907093,4.5474965014619455,4.413700662707324
NCI-H2452,6918736,-2.096990091914002,-1.4859708863862935
SW948,25062766,2.473025838261029,2.036735579386678
SW1573,73707398,2.4757839790774123,1.4591960904162986
WM115,19582717,5.070140237856123,4.059860931517318
LCLC-97TM1,9926054,1.7367616025320842,1.8417248099767733
Granta-519,46907787,0.1510211143130647,-0.43426771192784785
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.5199128880373707
Daudi,9866186,0.2429325896096028,0.12765486245798718
HCC15,19582717,3.4575202036464665,4.264124237468492
BICR 22,3136844,4.306912771504561,4.491493819678931
PaTu 8988t,15983966,3.5024124287376477,-1.4109865624662785
WM115,24964624,1.5810045411950775,2.284792787368342
Daudi,5335621,3.7832010435602568,4.040612197767677
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.64564895811242
HCC1500,67156097,1.177976655162538,-0.7516725112826481
LS180,6918878,3.4964027843545775,2.600982244085916
MOLP-8,4096211,1.580191863417666,1.4024586542893984
P31/FUJ,6252,0.489412050489878,-1.2069089612381088
RERF-LC-MS,6505803,-0.6931241555509828,-0.3100153565220728
IGROV-1,24821094,1.720998716331183,3.224276293083715
BICR 31,5311,2.2783252682939876,1.5426555523997691
K-562,6438330,2.2742899368871123,1.4859681800995364
HCC15,71466578,3.4480874510133708,4.853115203165511
RKO,5566,3.2270609816668308,2.9084037565116074
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,0.8432825041004273
Panc 02.03,24785538,2.724480470289088,1.6831046763243789
Granta-519,3025986,-4.58955813375105,-1.416857934964569
BICR 22,6918837,-3.531862368916405,-2.4919351704676633
MDST8,25262965,-2.668035259531665,-0.8517839706141013
IA-LM,5329102,2.7310604185474654,2.1217281562400028
SK-HEP-1,3385,5.476337571299632,4.150436573929973
LS180,16722836,2.063998190370722,1.5768636447464663
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-0.3463037305364241
LS180,2749,2.025296960861402,1.9032557222489594
WM115,25262965,-0.2525217612691299,-0.7957829419171643
PaTu 8988t,5287620,-2.232870102756846,-1.7077599651922069
BICR 22,1641662,3.554805763515046,3.4701752349291057
HEL,11152667,-1.5416892011653274,-1.4959921905714737
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-0.613470266425677
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,4.025968909783127
Granta-519,9907093,4.568904425758597,3.4908504565128995
HuP-T3,56946209,-4.563482636842077,-3.8812297557673134
COR-L95,2126,5.99033959567007,4.310599542237767
WM115,216239,1.6966934324307903,2.26678824169963
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,3.102827435321724
BICR 31,6918837,-2.993188010662521,-2.4409915368260844
WM115,3676137,5.1484929308777225,4.263275634608516
COR-L105,5113032,4.587192003158758,4.971671607151158
NCI-H2452,23635314,-2.1133256000938596,-1.6384678733447253
RKN,9887053,4.324470541002337,4.201711955562835
RCC10RGB,11427553,3.4421917630858387,3.2680806199621277
SK-HEP-1,3025944,4.243935374614092,4.409371341081212
HEL,613753,3.431831043675297,2.8470976400137222
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.0393725019817173
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,0.9807195483610102
WM115,6450551,3.3231751041078086,2.7177983594696413
LS180,11178236,-2.7486494175863703,-2.920787408567386
SU-DHL-1,53232,0.8595699071174782,2.529126571672137
LCLC-97TM1,2742550,3.525188493197443,3.8538490043841627
Daudi,1716436,1.8661291896859675,2.571217029525219
SK-OV-3,11964036,1.753508425012185,1.6056100004293774
LS411N,10385095,1.4098978051841675,1.2032251705114196
P31/FUJ,54613361,-1.6350280742113157,-0.749848031776173
SU-DHL-1,638278,2.888532213305057,2.9167898128933496
SW48,11228183,0.7765992306729816,2.153521677571774
Daudi,54596558,3.73872893191344,3.8892794042850216
IGROV-1,44543605,3.88270235241076,4.19700624618148
SK-OV-3,16722836,0.9083609759186712,1.6657906590068856
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,3.2692817042584266
P31/FUJ,168313047,1.7496121138347704,1.927485536025732
RCC10RGB,969516,5.025939213907113,2.871891459526121
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-1.3204049235086814
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,1.5152137837630975
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,1.9946110046676957
LS180,11507802,1.428529607587261,1.504497885047515
SW1271,2746,3.8382249001906814,3.1030071789078657
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.8044109449528852
SW48,6918328,-0.3603149144304291,-0.16016175440791372
RKN,11214940,-1.342915177510304,1.9792509608607636
NCI-H1568,24180719,2.911739165396745,3.6373842682666537
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.8483789759220175
K-562,11234052,2.2960989815513013,3.2600017770255585
SU-DHL-1,107970,1.234326472603969,1.9522302670598324
RERF-LC-MS,5280436,-0.2566098032119844,3.582607128172616
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.2945695885864694
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.5085944853334265
WM115,6184667,1.9705044508079528,3.2880088775565928
P31/FUJ,26596,-2.2448149587984836,-2.4397139863733472
RCC10RGB,216345,4.504390062805713,3.7954769543064155
WM115,3634881,2.5774509186458183,3.1499915924586253
COR-L105,5328940,1.3778120925573558,1.8737889648387778
NCI-H2452,135440466,3.051805385291023,2.3160029079517788
P31/FUJ,51039095,1.7212337572708742,1.7259070788747097
Daudi,135398738,3.444692827115736,2.8276732681118206
MDST8,753704,4.923832713886697,5.094223944570526
Granta-519,23725625,1.8582588361990624,3.4249352199913075
IGROV-1,6438330,2.7487580937365683,2.2552543367916544
BFTC-909,51037431,4.63288955594681,3.289952905568709
LS411N,262093,3.2594677855419456,2.5119749728990484
Daudi,12001922,0.8334324910861088,1.5444689368161204
LS411N,10074640,3.3220574057236876,3.061738254184694
COR-L105,6438330,3.2365890454650867,2.4663444650027175
LS180,3689413,1.3392854552239355,-0.03534592795360378
IGROV-1,53495165,1.3981720287668329,0.5420265172992628
RKO,10296883,4.075814636405189,3.5257623314479782
MOLP-8,24951314,0.5243645664323562,0.45204205583104434
IGROV-1,25126798,3.9275606774720817,3.8981466515172385
BFTC-909,5281321,-1.6266730162675118,-1.1047339287357016
MOLP-8,123631,3.0356710048833446,2.0521679932249497
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,1.8402058972968576
PaTu 8988t,72193861,1.5880501840541692,1.9073693296722443
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,1.778669602052675
MOLP-8,2742550,3.824247044326815,3.268241015340063
BICR 31,10074640,3.67367044204876,3.157211739993443
UACC-812,1750826,-1.5614417963348088,-1.4096268482275212
LS180,9907093,4.718701288752834,3.9637918218105805
BICR 22,25062766,1.615874512669176,2.3113657817847324
NCI-H2452,6852167,1.5258165813873172,2.9644926256593966
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.7520293152190825
PaTu 8988t,52912189,2.515835026596807,2.5466453523130013
KU-19-19,9935249,4.318045076797651,3.315362670178242
KU-19-19,57330099,3.159149106170822,4.393094768690967
SK-OV-3,17755052,2.097752569372091,1.6997857696694891
SK-OV-3,73707386,3.7899266428434233,2.9869504723781954
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,0.24802603702807852
SK-HEP-1,216239,1.5998975447874937,2.4404324661885286
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-3.842343285677978
RKO,3689413,3.093382349703003,-1.0652236342107522
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,1.1342915293897582
K-562,44819697,-0.9868024060185686,-0.9224467658292508
LS411N,322968,4.732979049951269,3.405588543775721
RCC10RGB,3689413,-2.0864832427963336,-0.5604793513959225
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,3.998139935713654
COR-L105,409805,5.8843358134901775,5.283617056401041
ALL-SIL,11404337,-1.8413362349398936,-1.3098927010904031
Granta-519,135398738,2.4818536310203587,2.3744495126954512
IGROV-1,10385095,1.0670946713416192,1.1222186471463151
KU-19-19,5311,0.9327005340349652,1.6140736291070397
MOLP-8,6438330,1.5207659246126146,1.440147457608603
SW948,5351362,1.282672018702937,1.4749096420495003
HuP-T3,54626689,4.821166418142214,4.800293249804378
HuP-T3,16013152,4.473149012747972,4.393957048559101
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,0.9475896104872321
RKN,67156097,-0.5718675734992968,-0.8764454014179688
IA-LM,241158,3.7495123409873528,3.5792198414524785
LCLC-97TM1,644241,3.02487415997038,2.274088675057038
NCI-H2452,9823820,3.552631474664052,4.042519122604423
BFTC-909,2749,2.0212973698927184,2.3920420179590054
Daudi,9956119,3.1347708383856827,2.6664497500748996
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.28974339512374814
ALL-SIL,136227924,2.439460537978413,2.192550178948671
HEL,44507138,3.4784823626806296,1.2015429905913326
Panc 02.03,3634881,5.203302993958793,3.4780222542617674
HCC15,3038522,3.407637609998807,3.348600498183828
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,1.3223352541590605
SU-DHL-1,5311,0.6388765020007606,0.8356439561934308
RKN,16038120,2.2721636156695357,1.2229435103429274
Daudi,6917907,-7.619939635694887,-5.3333216919249935
MOLP-8,3385,2.1758430637220334,3.0253658906278673
COR-L95,2749,1.0184502693195283,1.5786865785626094
BICR 22,56946209,-6.158851096198738,-3.6791659647617116
SU-DHL-6,72193861,0.720057034069739,0.13903009673201439
RCC10RGB,122327,5.581829763733156,4.660598664889815
Daudi,5284329,2.65655795986699,2.848809407553737
WM115,72376,-0.2019485443349478,-1.4768233596339797
HCC1500,4378219,1.8377088226049565,2.5052843039842814
SK-CO-1,246676,3.87632071272349,4.298738657250031
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-2.9057821884165094
IGROV-1,57519531,2.639098862164858,2.659404066119837
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,1.3918544532463535
MOLM-13,1714884,4.557672503718371,2.0253736836147045
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,-0.42094866956366905
Granta-519,72193861,-0.9369484536210768,0.17634665140562553
RKO,5311,2.326095881991792,1.0893269663947325
SK-HEP-1,4521392,4.36382839215776,4.3660797068811705
COR-L105,3062316,-0.8702764318143076,1.3881474835336203
COR-L95,387447,-4.370301659619954,-4.566576604113584
COR-L105,10231331,1.4114577114599935,2.619066841016273
SK-CO-1,637858,1.8597515079418403,2.1163290728118125
SW1573,5282054,2.2636648441362417,3.7423566832990804
K-562,66577038,2.461713560075674,2.661578073606796
Panc 02.03,984333,0.8671961837803726,0.926552700542195
HCC1500,9967941,2.192170342398577,3.381758886661591
NCI-H1568,5281672,4.0091617833462125,4.546546944093079
K-562,11640390,3.4084234644631244,2.5895372625782085
SW1271,60750,-2.442139934484719,-2.0258650636445723
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.5204946058338322
MOLM-13,24889392,-6.717782140097413,3.0445729699910924
Granta-519,11364421,-8.40665244505035,-4.51517069568343
LCLC-97TM1,11612883,2.215690343731866,2.823894309874742
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,1.121480201171728
PaTu 8902,1566236,3.6887913704860535,2.4383554200492843
MOLM-13,16741245,4.189200129622084,3.0216089179199157
SW48,6184667,4.015043076320991,2.96035466541658
RERF-LC-MS,66577038,3.051572744120707,3.084646098470161
K-562,71304818,1.450074212827562,2.101513559474033
RCC10RGB,44489675,4.041451654117508,4.106353878699689
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,0.8498708107318034
SW1271,10074640,2.938380325815859,3.2351965650592756
RERF-LC-MS,11626560,1.1998891680987491,2.0853178669043113
PaTu 8988t,81146,4.470184859000855,4.9056699165336655
HCC15,11178236,-3.9629964965138584,-3.2216940499600177
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-0.7811192428374347
HCC15,11317348,1.1767586352696475,2.8625980756826057
P31/FUJ,9903786,1.0734919883099745,1.6794683629999096
IGROV-1,23582824,0.3287266354391525,0.9057257849838966
Granta-519,3465537,1.1430845598370274,2.1014575179125883
PaTu 8988t,984333,0.9294993195358888,1.023134255947247
HCC1500,11396600,2.707080690171913,3.656136277472815
NCI-H1568,6252,-1.964470857288188,0.8518269854976451
NCI-H1568,7251185,1.379011815458227,2.6505047642999795
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,1.4527490254738766
LCLC-97TM1,55508,4.820744956173848,3.4079743329210395
PaTu 8902,9903786,4.041497343746548,3.0736430044232974
SW1271,12001922,2.1604198968714754,1.9770810810111388
HEL,6505803,1.212867497705534,-0.8198576459628777
SK-HEP-1,216345,4.108495190728752,4.047930488613937
WM115,4705,2.3860154683324897,3.2020050507081175
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,1.11756327410972
COR-L105,126941,-1.5036718028706904,-2.2201804319203955
PaTu 8988t,9926054,1.9241127892750265,1.8923778615607858
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,4.6646099517711574
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,0.9301818421178639
SK-HEP-1,374536,4.396616434658188,2.494753467438639
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.7911063007221366
NCI-H2452,208908,2.397298909776284,2.4068610609804515
SW948,24821094,3.757524617053942,2.5860410907450517
K-562,44491742,3.373435641850853,4.023165467148426
RKO,24180719,5.308193040989237,3.3936185407034944
MOLM-13,56946209,-5.150374128805616,-4.638752796175139
MDST8,54454,0.3151053774213321,2.668019546179094
Daudi,969516,2.18084937908482,2.203074456948006
COR-L105,44607531,0.2442604090297878,1.5192098776513574
SaOS-2,54619267,4.116373312960232,4.052110728635033
MOLP-8,44607531,1.2227606502433142,1.1720281357869735
ALL-SIL,11427553,-0.6859128537837271,1.221575070548076
NCI-H1568,11427553,2.9296384487881166,2.8326343628847765
SK-HEP-1,6918638,1.490993863020431,0.7192147519059826
K-562,11175137,2.6421325977097663,2.0034433003824534
MOLP-8,25126798,3.554030345273679,3.590938355118396
MOLP-8,10427712,3.937375048887725,3.9136696830707103
BFTC-909,11404337,0.4468911705694049,-0.21512217338464754
Daudi,19582717,2.1579117268337975,3.17448536616446
SW1573,9936388,3.0507391751654698,-1.7217533752288952
SW1271,156414,2.097129180606755,1.4477994827757428
Daudi,11213558,0.7122197709980888,0.8277098639644389
MOLM-13,135875424,3.721528356214304,3.168813217571589
LS411N,3062316,3.313525141236135,0.9876833254699818
Panc 02.03,6438330,3.381062774421129,2.377923219844716
MOLP-8,4705,2.7848528520877727,2.869846036242862
SW48,675434,5.164587034175743,4.505646791892064
NCI-H1568,46215462,1.5662565779678703,2.0178866213752538
BICR 22,23635314,-3.9149935419765423,-0.6300316269684304
NCI-H1568,44607530,0.8979533446197012,1.7704942889407413
BFTC-909,89928392,2.1120581393996116,1.3753995723871695
NCI-H2452,8515,2.9816658051225344,4.35503052182817
WM115,252682,5.883677253194902,6.394125733132704
SaOS-2,11507802,0.9759404440699744,1.3652411589101638
NCI-H1568,9935249,0.3822057580098375,3.370593885529708
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,1.8100883162566246
SW1271,65628,4.408026608161547,4.264057382002331
MOLM-13,2742550,3.0943449980031845,2.824898127534731
HuP-T3,56973724,4.820716068374067,3.275093624846628
P31/FUJ,5328940,0.1000739186855886,1.0483631525921269
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.7493527898928076
KU-19-19,9967941,2.4242338826427794,3.738516699501668
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,3.414323027346604
SK-CO-1,5328940,2.280320557186381,1.6347360027132856
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,3.214098818262159
COR-L95,1716436,2.176954941746147,2.6682940178665286
MDST8,46398810,3.011862004714757,2.525036968520051
SK-OV-3,654092,-0.1739817534251795,-0.2511306743193261
SW948,54613361,-2.2535675944820084,0.135112826491142
HuP-T3,25154868,5.141210696949765,4.486375256211145
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,2.946518737347794
RKO,124202324,3.4391315101947386,1.789428071761335
RCC10RGB,9444,4.509247284467684,4.389396893251457
P31/FUJ,135421197,1.0144502005310674,1.3309663228025423
MOLP-8,44487872,4.385798937588512,3.035797278716036
PaTu 8902,448949,2.6032868845304606,1.9872776133240366
MOLM-13,11427553,-2.505370137631637,1.266713559833284
IA-LM,60750,4.549488262081028,-2.082104156451953
MDST8,3825829,4.752817875520721,4.033750939134543
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,0.820811098458834
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,0.9308234058048213
COR-L105,51037431,3.876010066295024,3.462341349931925
RKO,31703,-1.8438289452025527,-1.4716595289227599
HEL,5978,-0.5240559956879017,-3.385746382159537
SW948,168312962,3.6749765666335903,1.6127012483913585
IGROV-1,72734382,4.633226130326536,4.408376398105727
SW48,216468,-0.1130169029097753,2.8440957882263813
HuP-T3,216345,4.480282764347718,4.166618149783636
HCC15,439501,0.3030845703669018,-1.8759154256586585
P31/FUJ,638278,2.9129004591727057,2.746732693539309
BFTC-909,676352,2.5282943369079818,2.163324659833179
SK-HEP-1,60750,5.759979022694095,-2.362957122438504
PaTu 8988t,4788,6.262210396704686,5.585038167341893
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,0.9509753055514567
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-0.789532608356602
HEL,24951314,0.022330385445513,0.2992396234030816
MOLM-13,46907787,-1.536709398859376,-0.8505223816492772
SaOS-2,54626689,4.533352391847383,4.5053492455078485
RERF-LC-MS,10410894,3.034247655874134,3.3709231764368717
RERF-LC-MS,9903786,2.6182355767545213,3.249408418728463
IGROV-1,107985,-2.8971910842184516,-3.230046017654148
WM115,10231331,-3.458943295987183,1.5270501749473349
Daudi,71466578,1.924283792281082,2.8895749910005923
KU-19-19,6610216,4.876021689690227,4.322260916789816
COR-L95,6918736,-0.04136223528326,-2.067796770612649
MOLM-13,11625818,3.232701320691832,3.2352966399113154
Granta-519,16038120,-0.1772437220791911,-0.01018931258334984
BICR 31,46907787,2.190433361645711,2.378726477297386
Daudi,702558,3.2750017094913657,4.122773197568753
MOLP-8,24856436,-0.8263886484359759,-0.23762350354509007
MOLP-8,135440466,1.6989907480456066,1.7207512168632686
SK-HEP-1,46843906,3.844316747572769,3.3134350816530387
RKO,54626689,4.750442055573677,4.350650372255309
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-0.948451223510062
IGROV-1,11717001,4.394306548697183,4.158609090348653
Granta-519,5291,3.886616753428741,2.6556304984926267
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,3.3051714595512025
SW1271,262093,2.7991981503454495,2.8683777288790178
Granta-519,1566236,1.1036082649410253,1.4758210448103495
BICR 22,24753719,4.1427183131543615,4.372376977107463
Panc 02.03,9926054,1.881153725115377,2.030497359356618
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,2.160907505962099
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,2.915822931362649
LS180,54619267,4.074522434074431,4.009246548621689
SK-OV-3,5281321,-0.7098099698865428,-1.6035027663228214
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,2.228009770924458
SK-CO-1,2729026,2.8886798476744246,2.4889957274474668
Granta-519,23582824,0.9303240666722092,0.27244823333385637
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,0.616619516218291
WM115,24978538,1.155471911978994,0.889372581663987
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-1.4217410994335098
NCI-H1568,11238147,2.925799577076833,2.8659852093322824
ALL-SIL,135398516,1.5622324093538014,1.2839241967072619
COR-L95,135659046,3.614564650544248,3.5493321942027882
SW1271,1285940,4.280510054640018,3.3567386671861157
SW1271,6505803,0.8186340021888412,-0.19364019019040765
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-0.9943701425748386
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.3964280187107736
IGROV-1,11626560,1.7276653519578558,1.7677282813731774
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,2.3228590240509406
P31/FUJ,3552672,1.950832295752278,1.8162838131325996
P31/FUJ,67291369,0.7371006748241407,1.0663470333012908
LCLC-97TM1,107970,2.3018486004849907,2.2788844830860655
SK-OV-3,44607531,1.947967745365508,1.4509150888875166
BFTC-909,9936388,1.702123766125507,-1.2330412679675036
ALL-SIL,8515,1.9161675301812888,3.2486031561224746
LCLC-97TM1,25262965,-1.937189863749451,-1.5012674797167842
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.6032762001213406
MDST8,6914657,-1.2463021469195388,-3.5068875907637618
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.6980352355728727
HCC1500,53392493,1.8683885031226253,2.6866161744694823
MDST8,135411,0.5541309628089411,0.6685927948069089
RERF-LC-MS,1750826,-0.5689233588179538,-1.1899285713616576
LCLC-97TM1,5328940,1.525932870405189,1.6004286343630645
NCI-H2452,25195348,3.541594611208225,3.5084293562431417
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.7821417751762043
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.4078701007375012
SaOS-2,53495165,-0.9847313398251484,0.2944580761254303
SW948,11626560,1.2721393744446543,1.4068992867600132
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-1.166522376462209
HEL,25183872,-2.1054192111007657,-2.061815651898213
RCC10RGB,89928392,1.8749323034057075,1.8765784492815438
Panc 02.03,10074640,3.562403354758929,3.2416226731776145
PaTu 8988t,57519531,4.351537289113079,2.554368616484279
SK-CO-1,5281321,-2.128194299198524,-1.1773080539068932
RERF-LC-MS,5311,1.7201713868016182,1.6208354206045175
HuP-T3,11427553,3.1840600229712037,3.0115893631750903
ALL-SIL,4259181,-1.3200126273341632,-0.6450525880687912
HCC1500,11214940,3.550811671890936,2.223954314858057
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,2.0593249947910666
HCC1500,25195348,3.452030504957034,3.17076294551452
SW1271,52912189,0.6284206808713965,2.4925410904207213
MOLP-8,984333,1.0413549547234568,0.005961212037522143
SW948,72734382,3.6940713099503473,4.332296085421194
IGROV-1,46943432,4.105714883822214,2.1033314736434736
BICR 31,25227462,0.4256700478941367,0.5520192622037292
SaOS-2,2126,4.6809882623674905,4.415390887641247
SaOS-2,11427553,2.020035940690151,2.4666528522555033
MOLM-13,6914657,-6.22505002098335,-4.8514726874366865
NCI-H1568,24964624,2.125017418877952,2.2811307043923934
HCC1500,11497983,4.502799578122533,3.5008439488874346
K-562,23725625,5.2530061405843975,4.20580364323432
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.910703495485982
RKO,136227924,3.256787131627037,2.6191282725139957
IGROV-1,31703,-1.792518264692263,-0.8760985932235889
HEL,6438330,1.7062913765539824,1.1890345105416618
RERF-LC-MS,25126798,3.475546322259903,3.8392323336983365
LCLC-97TM1,409805,4.11204743963536,4.809964661844915
Daudi,2708,2.1654486353587266,3.6576710512487915
SK-HEP-1,6914657,-2.911576812343612,-3.5072315871384103
MOLM-13,36462,-3.0478349617512466,-0.561336852065234
COR-L105,208908,1.1794902635628597,2.2946610139594896
MOLP-8,44491742,4.067907034019371,3.5744927344227233
Panc 02.03,89183176,4.957506748320777,4.427675894775436
Daudi,3025986,-1.684737909075286,-1.1981747761561798
PaTu 8902,10302451,3.9687769441396608,2.977628416554424
PaTu 8988t,9933475,2.2874108911255693,2.1273030092535534
SW1573,5281321,-2.072955292880288,-1.180563759956044
IA-LM,2733526,5.6911514373146135,3.7837626147465686
Panc 02.03,6918837,-1.2317043962492993,-2.5478624312043077
NCI-H1568,19582717,3.4209569673427342,4.331710002218215
WM115,55508,6.132181701054794,3.385903411126693
MOLP-8,2871966,-0.632569947519592,-0.20158017595471597
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,1.9928695364442748
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,-0.18343662393815788
HEL,6918837,-4.248380638359999,-4.353897117111811
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.6207352302616327
BICR 22,136227924,2.105383482893856,2.9496887204137794
SW48,135875424,3.469184081134181,3.5257801173168675
COR-L95,10127622,5.649647064343883,4.141300222575862
SU-DHL-1,60750,-4.603947913298721,-3.0183659016090894
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.6145303135831712
SaOS-2,446155,1.978878402700164,2.3498332152613175
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,3.3612760297723736
SK-CO-1,11625818,4.187860927408271,4.289045323245537
COR-L95,676352,2.06388279354012,1.9412134307902462
RKO,11719255,3.406006587740275,2.7690649517034003
NCI-H1568,135875424,3.0063280878885967,3.8376410054390395
IGROV-1,25195348,3.0698662305180275,3.629265767014198
RERF-LC-MS,16659841,3.453543705685564,4.033860434608841
SW948,1641662,3.2658822910658905,3.281219945355386
BFTC-909,5351362,0.3148685714677321,1.625865432226958
COR-L95,24771867,5.320672645408192,0.9355175045324414
NCI-H2452,16725315,3.1677771909290184,4.177364565016757
WM115,9926054,3.0880179510914454,1.8989088005987935
IGROV-1,135875424,3.3275053166921347,3.8172347532899282
LS411N,4259181,-1.386635238211632,0.19723189850575196
SK-HEP-1,24821094,3.809459846332286,3.212965791821945
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-2.8379346256432565
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.691381406546869
HCC1500,11364421,1.8102576985092016,-1.3114411969317288
WM115,11647372,-0.748702419415335,1.5046872623668408
IGROV-1,374536,0.7022324251593053,1.9738422093677273
K-562,5311,0.9288629076778604,0.8249563228593503
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.286735795705466
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,-0.1062711119959999
Daudi,44607531,0.7322116783883826,1.0119224298528493
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.748984781346984
SW1271,448949,2.9810988383972084,2.048572624479194
SU-DHL-1,42642645,0.6641769458510169,0.4225927805548467
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,2.665630627073749
SW48,53232,2.98078944705874,2.451115061398231
K-562,4096211,1.5585244853649294,1.3987020241542762
LS180,89183176,4.9114720653238315,4.315023428048347
SW1271,10427712,4.007366682408904,4.289033938272497
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.5903914955369942
SK-OV-3,72193861,3.227068856168802,1.6366860436860864
K-562,148198,-4.073315546446919,-3.8200002272079603
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-0.7035544008176463
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.5223003723881117
SW948,2729026,3.020599067804879,2.4272429787088527
SaOS-2,3552672,2.445112397338648,2.5920285378034746
K-562,6918638,0.0740833242167517,-0.04018104767072337
HCC15,67291369,1.6613409933263477,2.700989215183583
LCLC-97TM1,11396600,3.6456493290211425,3.7787669949344105
HCC15,6438330,2.907250953014235,2.4947033774466925
SW48,123631,-2.3971553119638553,2.1018377465574876
RERF-LC-MS,6918638,0.4520678244574614,0.7940300339841925
HCC15,54619238,5.509074276782743,4.821926168976185
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,3.1840793540865984
Granta-519,5351362,0.2173676915670352,0.8155879821802853
SW1271,219104,3.9142621703193625,3.7200193979976275
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.2776492523725473
SW948,11497983,1.2110688984787443,2.464543664525975
Panc 02.03,11404337,1.528571500956484,-0.22150318629086718
SK-OV-3,107985,-2.353051363092625,-3.3236276170046217
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.5806845716192746
HCC1500,56649450,4.199956636233384,2.729029530124576
MDST8,54649381,4.2434412709491385,3.928457104714657
SK-CO-1,24772860,-2.764468608226056,-1.6682312441348608
SW1271,2708,3.697662973501111,4.855773065371877
COR-L105,25062766,2.3512127388642865,2.2319955966246443
BICR 22,9826308,0.9832071992526458,0.8012802218044677
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.7716522526055758
KU-19-19,11404337,0.0275069311149896,-0.4470994555175521
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,1.4553903245024724
LS411N,452548,1.178688753001054,-0.01311732253250548
COR-L105,3025986,2.299444367217184,-0.19128824564794106
IGROV-1,25102847,1.7007012555618253,2.344395448810973
PaTu 8988t,24797083,1.3448554408655904,1.2343092861725666
IGROV-1,46398810,2.003787621940583,2.5778856272473742
SaOS-2,2749,2.484303950908632,1.674126504019617
WM115,7251185,2.999080033015298,2.6958110452023436
IA-LM,151289,3.753931026261757,1.1293362938597367
SW48,60168763,3.2354609354554924,1.3612247577557846
IGROV-1,168313016,4.807199318661473,5.041188263578071
MDST8,5351362,2.4401541198795726,1.6711709453566095
RKO,5291,3.391339544898264,3.39331142877694
LCLC-97TM1,23582824,0.7435680585464137,0.9322418256050332
BICR 22,16725315,5.207801943730372,4.115375330784962
HCC1500,44632017,4.723480031494906,1.3273299528052787
MOLM-13,219104,1.3929442819191806,2.5026993144971454
SaOS-2,44202524,1.4210473732360835,1.8837125516370787
COR-L105,753704,5.105702577689745,5.165179242544979
BICR 22,216468,1.2752332856392885,2.9885741337021137
RERF-LC-MS,445643,4.345437949323675,4.0217811320579715
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,2.422727329296034
HuP-T3,44607531,1.7591062122540748,1.4818024216676822
NCI-H1568,9915743,-0.8427224057935273,1.3247715532262432
ALL-SIL,126941,-2.455728969669062,-3.2893895605317134
IGROV-1,168313047,1.93821625738322,2.3130101364136033
LS180,100016,6.005443229591697,6.165706837782242
SaOS-2,60700,-2.625519230364934,-0.25419831828942546
KU-19-19,9907093,4.38040739031281,4.3061789424861985
SaOS-2,9935249,3.097116977919543,3.159034343228114
COR-L95,24821094,3.5692160345671335,2.8798397353490306
Daudi,327653,2.694862581871668,2.500798995079777
SaOS-2,65628,4.208345318362158,4.124771001955023
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.816197456904379
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,-0.48037544142434085
LS411N,24772860,-2.6286287692739587,-1.9688419016166716
HCC1500,15983966,1.4595203856942676,-0.9366108672812068
COR-L95,46907787,3.807595772412777,1.0838440017727575
BICR 22,24821094,3.82687279949815,2.66587205619418
RERF-LC-MS,56946209,-3.4945734927118552,-3.6458037738955733
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,1.0105591059018488
MDST8,49793307,-1.5088082080905487,-2.4745894766552876
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-0.2873029036520048
SW1271,159324,2.241950485620868,3.092377167363314
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-0.819126052453047
HCC1500,135398516,0.4161092034804287,2.2779854849607357
Granta-519,46901937,3.6488183223471022,2.9391069293063232
RERF-LC-MS,5328940,2.240356815676024,1.7625711686988683
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.8499658671213686
Granta-519,400769,-1.7592122365530554,-1.8755045667495682
BICR 22,135421197,2.0438055763788556,1.997307936299447
BICR 31,9967941,4.3746614656618865,3.915411209168973
Daudi,89928392,0.010222000273875,0.7193743143740514
MOLM-13,151289,-0.2275053531847663,0.4044019156361167
IGROV-1,2874250,4.893662837169153,4.372359719994364
MOLM-13,4261,-0.2853779042398361,0.4423654758973072
MOLP-8,5280436,2.785612173209183,2.9729969225256143
RKN,11427553,3.6372919842764424,2.82471352821596
LCLC-97TM1,2828334,6.057082646440782,6.155252878863191
Daudi,11640390,2.7767455060282873,2.61920477708609
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,1.481527104294141
RKN,51039095,3.7797830340785694,2.7218240701038585
HuP-T3,46398810,2.968900053185397,2.679759156337417
SW948,60700,1.1260701186231294,-0.1613983391166076
LCLC-97TM1,168313047,1.50715487575417,2.486454684179267
Panc 02.03,46174525,6.272327915554807,4.336203909751547
SW948,72193861,0.8788999866892542,1.0427423103120548
HCC1500,6918638,0.5709126385335386,0.23062824118977784
RERF-LC-MS,42642645,-0.4358765804877467,0.9109955298668132
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,2.213658589787959
ALL-SIL,12001922,1.676377280214729,1.4724734807713091
NCI-H2452,441298,2.247705741320954,2.6562597431911597
BICR 22,46191454,1.6809351488377804,1.7845080564749478
COR-L95,16013152,4.05038947229277,3.841126783434154
BFTC-909,72376,-1.4314875177558029,-1.7277626915154507
SU-DHL-6,15983966,-6.405792257227171,-3.689583867588505
K-562,11497983,3.839483588328175,1.541649809027081
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.737033331372476
IGROV-1,4477,1.1767656777594142,0.74503935650936
SK-CO-1,9444,4.465837668270579,4.048083730520841
SU-DHL-1,135999136,4.730243036337901,3.5599565409943494
IGROV-1,54619267,3.9701367924453455,3.8922518594649107
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,2.781316619878574
SW948,31703,0.6983000463207195,-1.0309267182180284
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,-1.1764688495417674
SU-DHL-1,BRD-K03911514,2.3803066372148742,2.2690910976940613
HCC1500,46398810,2.5427546617930905,2.521733583555017
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-0.8456768166415067
WM115,51039095,2.786212621210589,2.7870158997575096
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,0.2932641655790979
HCC1500,24772860,0.2838196702204312,-1.5354324726690012
SU-DHL-1,71304818,1.6958772786188914,2.0061270534442652
WM115,16736978,2.885535594388376,1.6731789615686785
NCI-H1568,54618305,4.1006341963066255,4.372753994791339
RCC10RGB,11404337,1.763382313076518,0.26371085802689487
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,1.0537704762335462
HCC15,17755052,4.876160174226561,1.9084481281593628
COR-L95,6610216,4.601423414679649,4.054779573253302
LCLC-97TM1,10296883,3.762301074740285,3.9098415229704333
Granta-519,753704,4.381381177541046,4.06569301026019
COR-L95,3825829,4.2210058836960265,3.7553043075491717
HCC15,51039095,2.370618956781999,2.7467013334229766
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.9052995009691527
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,1.9202809491674275
K-562,9915743,1.457381054045144,0.7236562585439654
Daudi,644241,1.4114598324864769,1.3202399735509855
COR-L105,6610355,4.615259996363044,4.705977520798599
NCI-H1568,400769,-0.2296701698466811,-0.653841047152173
PaTu 8902,4096211,3.3878786245174917,2.0794987901198114
IGROV-1,6610355,3.969940996770339,4.504758819997994
NCI-H1568,15547703,3.0519937502167744,3.3564358113187835
BICR 22,11609586,1.2076158919216122,2.7282818918798473
NCI-H1568,6918736,-3.5744965026463893,-1.421587563842279
Panc 02.03,2729026,3.1511226959620715,2.8812983532850587
RCC10RGB,73707438,4.14323951901879,3.911681000910624
SK-HEP-1,11609586,4.257559552037769,3.0094887657746447
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,1.932069457333534
WM115,9935249,2.3950107716018465,3.3007702899680074
ALL-SIL,9929138,4.286241964174987,4.977257059348443
SU-DHL-1,452548,-2.7499107831448257,-1.9257008104049893
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,-0.33145233228834686
COR-L95,262093,1.2094317801688714,2.4511296311451476
LCLC-97TM1,4788,5.877974617736734,5.748917463504804
LCLC-97TM1,11455910,0.6647050862050086,1.0201467234616934
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-1.794257793465026
IGROV-1,3025944,3.9702787396819503,4.276625915333703
COR-L105,44486219,4.2268301570583,4.342354743802538
HEL,6852167,2.7971477189216207,1.6895225271568968
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-2.6775599589403827
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-1.0044061497989996
MOLP-8,24753719,3.861578571306771,3.7525071094428997
RKN,54649381,4.194319964969153,3.8954084058610157
NCI-H2452,5738263,2.391583749104638,3.5923549570175806
RERF-LC-MS,11612883,2.474683430971872,2.9052701320300707
LS180,67156097,-0.3004464994297747,-1.297110840726344
ALL-SIL,638278,2.4844738615144797,2.5280484374781524
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,1.6865559845130642
WM115,89928392,1.4475546317176564,1.5757981817712021
NCI-H1568,4917,1.9457015565482707,3.143111189623537
Daudi,2746,0.9195319579001202,1.955702306952517
RERF-LC-MS,136227924,4.560045704487339,2.940829133663095
SK-OV-3,400769,-0.3757443057400228,-0.6741086683422418
Daudi,2742550,2.6022450411597764,3.294372665708658
SU-DHL-1,1242560,3.2887270842989285,3.3782946391429602
IGROV-1,1750826,-3.124548162001242,-1.0641209794509396
IGROV-1,3025986,-1.046010021597061,-0.48783474432956003
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,2.0208494208410084
COR-L95,11178236,-1.511835887926392,-3.7517706819566756
MDST8,15953870,3.886262261351445,3.7259775089917007
P31/FUJ,71466578,3.434376258750051,2.7093958290244045
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.897484311842959
HCC15,16038120,-0.3287102193479797,1.0107044915643053
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,0.5917680638557028
WM115,44607531,1.8052962391610108,1.5895558522935636
SK-CO-1,322968,3.708989182542924,3.5886032063465456
IGROV-1,1716436,3.2816872421007375,3.0521746271271333
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,4.078620436962899
SK-HEP-1,15953870,5.227718988850451,3.7465838873078208
SW1271,10231331,-0.1974856956768426,2.6978821396046824
HuP-T3,168312962,3.781886601468438,2.2946212968173527
Granta-519,11238147,3.49055902156802,1.866540225516657
SW1271,54678924,4.1367056407476595,2.080058336375028
Panc 02.03,89928392,1.630028817710481,1.5789876076189504
BICR 31,148198,-3.2373882564770513,-3.093826657143872
IGROV-1,104842,-1.6690343627553987,-2.8090247880415893
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,2.793424686988132
HCC1500,10184653,1.0749855490236058,1.006311516300877
HCC15,44202524,2.021204517823952,2.3212089160660447
COR-L105,9866186,1.0648092573013754,0.8181735632084677
COR-L95,285033,-2.430535969260308,-2.6219172130690844
COR-L95,23635314,-1.8010937940640896,-1.8860603334968327
SaOS-2,11364421,-5.8107581348158,-2.8384902105962713
BFTC-909,122327,4.590877432942681,4.781036156532113
IGROV-1,54618771,1.2456991772210466,0.8815464284733455
P31/FUJ,675434,4.075878142833804,3.975589060629403
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,0.9017196767095647
NCI-H2452,5328940,1.966899609603824,1.7849834324000275
RCC10RGB,72376,3.207429090732714,-0.7476001108388531
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.0555300012064386
NCI-H2452,4917,2.7944300449003907,3.1997076032076484
BICR 31,1716436,3.7157300626912617,3.1844395108802654
MOLM-13,1239801,3.478439984806631,3.201955677778139
HuP-T3,10296883,4.266239948990751,4.052866865989542
PaTu 8988t,107970,2.530920724052233,2.353971888651115
ALL-SIL,675434,4.0400251875066715,3.8972018442045817
PaTu 8988t,16736978,1.6582336139520693,1.719523942305107
LS180,5460769,0.3293841533128088,2.1133875031534366
MDST8,11612883,2.4942536836786635,2.9174908079762334
COR-L95,46191454,2.009346014708409,1.2291022748102283
MOLM-13,451668,-3.798095624109847,-1.3764121645936185
Daudi,168313016,3.9002026806644734,4.045634305132791
ALL-SIL,135411,-0.5620485907345016,-0.4194512968967419
RCC10RGB,46215462,3.684591481140594,2.0643472544675516
KU-19-19,4917,3.607977283390518,3.2419979366076324
Panc 02.03,71751553,4.925944110140211,4.706469449927733
HCC1500,5281321,-4.561246998431513,-1.2382009087727608
LS411N,44202524,4.412838675121289,2.0215164605596327
LS411N,637858,2.7012095970179635,1.7556622832962545
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,1.6665834083625166
SK-HEP-1,24797083,1.0035545042427043,1.2583451450008691
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-2.8695679069941478
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.443705232568095
BICR 31,387447,-3.4745770631768553,-3.89812392608568
SK-CO-1,452548,-1.5551413224098238,0.3023575444373208
SW948,6914657,-4.288216532991124,-3.8122520443325856
SK-HEP-1,216468,4.223762462623231,3.5703594604456517
ALL-SIL,71466380,3.7861137397034255,3.3284528128308177
ALL-SIL,66577038,2.592918053791083,2.5572396238985298
K-562,46174525,4.631327159993839,3.3291172933527444
SK-HEP-1,11404337,1.0852289139958715,-0.15164663991691812
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-1.6448232788870287
COR-L105,156414,4.037454349539868,1.4522579904286965
P31/FUJ,5351362,0.932451869978648,1.0816851345690637
BICR 22,57519531,2.122776388957543,2.5289533045642703
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,2.2081904829294823
SW48,156414,-3.5613148313114293,1.1537128249545863
BICR 31,24180719,3.9564262696237096,3.63807374650687
KU-19-19,11222830,1.7129831318158657,1.5827983546543773
HuP-T3,9911463,3.677427040789425,3.979084105640037
Granta-519,56649450,2.820913380280981,2.5275677284498927
BICR 31,5328940,1.2878315189706533,1.6918204985441287
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,1.8329781731466408
IGROV-1,19582717,6.764352444432722,4.1810522197326945
IGROV-1,24951314,0.9075718706849548,1.1311820619315318
Granta-519,9911830,2.3469616146388033,1.8781058023317514
RKO,3038522,3.342495330103654,2.5209481170666597
P31/FUJ,135440466,3.423250795887436,1.4360825698065072
IGROV-1,6918878,1.6706182189896102,2.758796416739406
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.1807005294853774
SW1271,136227924,3.2074421772411372,3.1184306029094335
IGROV-1,16722836,0.856484234547582,1.3854263834907874
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,1.8917558012922677
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.5990056613896375
IGROV-1,168313016,4.807199318661473,5.041188263578071
Panc 02.03,9935249,3.920507280118285,3.277575572844461
UACC-812,19582717,5.3439559865445245,4.004394221661716
SK-CO-1,54619267,3.100073010472608,3.9329472149542726
LCLC-97TM1,56973724,2.3842885859021985,3.0472626053990797
P31/FUJ,44185566,1.65624467652309,1.7302663173374546
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,2.49983942186862
LS180,568763,0.2796957344404436,0.4303743016203738
HEL,5281321,0.1504430999261452,-2.247376244374751
COR-L95,168313200,1.9910859109269063,2.80817865718888
NCI-H2452,100016,6.6405878618594985,6.51569047491368
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,1.194711072536542
SK-HEP-1,71751553,4.559763777433237,4.699000212534412
COR-L105,6450551,3.13458936271996,3.005265658579999
MOLP-8,227681,1.7901539797099055,2.973799560544371
LCLC-97TM1,24951314,1.6929873886763296,1.1360562583095584
LCLC-97TM1,20959075,-3.5903877814282836,-2.940837267265311
Panc 02.03,11964036,1.263021853424522,1.5441838027002228
Granta-519,54596558,4.099782953798094,3.583855896459712
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,2.1279321947761063
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-2.519372674627721
IGROV-1,246676,4.485924799339535,4.4593645210278146
HCC15,25126798,3.760529318413009,3.9028974774486023
P31/FUJ,67156097,-2.27730723064269,-2.239268890941687
KU-19-19,4788,5.856744699338042,5.768435960213254
MOLM-13,44507138,0.4726740823031857,1.101820046384395
COR-L95,5281672,3.930459616892441,4.312812816188934
HEL,46191454,2.0114602406157487,0.05340103200632939
SaOS-2,25227462,1.0053365829052552,-0.3138635098748711
NCI-H1568,327653,2.9538763640308403,3.1278537669539417
MOLM-13,126941,-4.1996343959718665,-3.3934615736414226
SW1573,23582824,0.5044187481506299,1.114363264148974
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,3.3720585544181914
RKN,46199207,3.372714950884571,3.1424823775309703
MOLP-8,2113511,4.489524818659998,4.67841005589466
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,1.0421460670109912
MOLM-13,9907093,2.467705892800055,3.4725097368636137
BICR 31,135398516,1.997761003126595,2.3903326958850624
SW1271,216345,3.992520329028928,4.080618348541126
SW1271,49766530,-1.8216621121390524,-0.8871365078438613
BFTC-909,44819697,-0.8003395289407239,-0.2982814162794691
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,3.513672647467605
COR-L95,24951314,1.2848618182948477,1.0248820227002116
Panc 02.03,11427553,3.85172253134883,3.154577586223502
RERF-LC-MS,11955716,-2.426679724944883,-0.6150924108967984
LCLC-97TM1,168312962,4.14705930417905,1.838280940318776
LCLC-97TM1,984333,1.7706091320352773,0.8565467980608061
RERF-LC-MS,3689413,0.4263782886644774,-0.15857509244244658
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.2850340124671984
HEL,72734382,4.138558929268269,3.6793328231429983
Daudi,5281672,3.0556000328651267,3.9219223422553324
Granta-519,73707438,4.294812737502366,3.9143792947994807
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.9605134368924737
BFTC-909,3465537,1.8561429441463555,2.526388512210523
MDST8,53232,0.2243602329572143,2.7138795728691703
PaTu 8988t,54618164,4.622822732421989,4.205273074545331
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,-1.0164802302591036
BICR 22,241158,4.423333712203234,3.8594586395672854
IGROV-1,25150857,3.031865110078871,2.443204365613249
MDST8,2729026,2.783400494590182,2.5355449323725536
IA-LM,56649450,5.159895082661475,3.312152249298178
RERF-LC-MS,44137675,3.373454428855253,3.684143512569073
HCC1500,11612883,3.8728122953700113,2.702067306724483
COR-L105,44491742,4.003695029376484,4.272208372623771
SU-DHL-1,17759555,3.5507610454949177,3.2421232508266753
PaTu 8988t,2828334,6.317024230854033,6.222923693199398
PaTu 8988t,168312962,3.961414669504744,1.9281920679072753
NCI-H2452,15953870,1.9726746369071917,3.796467562143812
LCLC-97TM1,54626689,4.751501808909531,4.526468805668682
PaTu 8902,136227331,5.567107594748722,4.2402466665032135
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,4.03700043314412
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.6788555785699552
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,3.402596980640937
Daudi,11317348,0.8828508555827204,1.491045543224041
IGROV-1,26596,2.910298792762654,-1.0534713817801566
K-562,2742550,1.8061055262772656,3.517045382656645
IGROV-1,25062766,2.144848161581278,1.9908743518579846
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-1.9358306854706862
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,0.9926168658162914
SW948,123631,3.5700289871060327,2.1129350264990387
COR-L95,168312962,1.6965693753889812,1.2585888884372023
IGROV-1,9956119,3.7231415872817024,3.829276599402854
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.6152714098457392
HCC15,23725625,4.984445415553906,5.0497750241891834
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,1.181273010017105
RKO,2708,5.0364138660049935,4.304052052477334
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,1.8590682652959154
IA-LM,148198,-11.384967135346804,-3.3354566839400785
PaTu 8902,44202524,5.539571067533291,2.5038207724163946
SK-OV-3,10127622,6.3662035368843535,3.9110052750892232
PaTu 8988t,16038120,1.6913300198770496,0.9761669537902555
HCC1500,6610355,5.5539350619643395,4.4720345756659405
RKO,9956119,3.3077949428120195,3.326003699854474
MDST8,8515,5.547245054967808,3.9730000411236888
HCC1500,5978,-3.1049031694332183,-1.300533364346682
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-1.4547905911666856
BFTC-909,262093,3.5924629632259792,3.055359217446552
RKO,23635314,-2.140231911981244,-1.6855881581280088
MDST8,11626560,2.2403804115384207,1.8927430290660245
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,1.2359758089714987
COR-L95,44819697,-0.3616253875757693,-0.9740660910736955
BICR 22,5351362,1.2051272382141311,1.8401402063202763
K-562,9967941,4.015535149970178,3.2481550847103757
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,3.371861423962005
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,1.0424271840771262
UACC-812,25102847,4.053875686762356,2.700081413598923
SK-OV-3,6610355,6.222226160480143,4.583801794537958
IA-LM,11152667,1.0642318645878492,-0.0676866104521602
BFTC-909,6918289,3.427790661189136,2.299102674220158
Granta-519,11167602,4.36712443545526,1.8443433439190509
BICR 22,60700,-0.4008092990404712,-0.15399584483609094
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,4.266134218185809
RERF-LC-MS,241158,4.36087401910034,4.031694784362663
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,0.5260054428228785
HCC1500,24951314,1.2674136228128516,1.158704089836412
K-562,65064,5.606410384518605,3.9228983259985943
PaTu 8988t,6852167,4.186106645973286,2.970132529908192
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,3.0605301772703815
RERF-LC-MS,25154868,3.293982375318642,4.563007621461654
Daudi,11719255,1.9605498566152704,2.5991073434299654
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,3.166784776584838
P31/FUJ,9907093,4.323796399268767,3.6453950527352417
SK-HEP-1,56649450,4.110961369423777,3.692489348129294
SW948,11238147,1.5812364597614252,2.738289095084209
MOLM-13,60700,-3.6931560077615337,-1.586191633177188
SK-OV-3,54618164,4.236989567252486,4.014089328747292
WM115,53232,2.2909547616931243,2.542779801325998
Granta-519,11213558,2.214733921051264,0.7865481279749439
HCC1500,12001922,1.110118640671234,1.9017749714277874
MDST8,12003241,0.3559193403256231,-1.0718652219161606
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,0.6339102790173528
MOLP-8,44819697,-0.0313402586892576,-1.4326129015103362
COR-L95,136227924,2.879022500990784,2.7418884753116095
Granta-519,135421197,0.2234065586927925,1.3753156839569514
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-2.5245403897656296
SW48,6505803,-3.5264924347891897,-0.5597886667987992
IGROV-1,8515,2.1861539315976053,3.9872983018790573
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.6077124384815336
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-0.8087999686829497
MOLM-13,25102847,-4.845176201807707,1.7975430547479578
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,1.2877648947086717
SW1271,53481919,3.611390941951582,3.6910074288754555
RERF-LC-MS,24964624,3.0594292113466515,2.7753470476039945
LCLC-97TM1,969516,2.175595213634207,2.6735730409259753
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,2.0011543318937766
RKN,49793307,-1.2643121180608,-2.824161716104127
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,2.097157638316641
SU-DHL-1,15547703,1.7605543364675147,2.7562245864690857
COR-L95,11625818,4.182153411947424,4.137848832403407
BICR 22,12003241,-0.4808187565312439,-0.8745633267101524
LCLC-97TM1,124202324,2.4863882679536133,2.3133871406314706
BICR 22,24797083,1.5794716057353129,1.4830150249983571
WM115,136227331,3.7917327546536983,4.231808047645451
MOLP-8,23725625,3.090240324780466,4.0103238373926375
NCI-H1568,3552672,1.826953477138791,2.57265656071561
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,1.0311146387574905
IA-LM,51039095,2.817946248906647,2.786932453917189
K-562,11964036,1.6077176524784418,0.883100836578858
HCC1500,5470400,-1.7385310235308598,-0.5350275640525891
SU-DHL-1,11396600,2.533401176626175,2.636485257490627
BFTC-909,216345,4.226804426652683,4.043292983690621
Panc 02.03,71304818,4.256945507775637,2.6975996497629904
Panc 02.03,219104,4.2068478561753375,3.976810453199542
SW948,23582824,0.2041553679799947,0.8415472408244284
NCI-H2452,5287620,-2.107035322199283,-1.843502156373549
SW1271,15953870,2.918493523161381,3.3849407525563104
IGROV-1,119182,0.2112476135388779,-1.1191571335053059
SW1271,11656518,1.475105479065936,1.8275774292096818
Panc 02.03,49766530,0.9655059796360064,-0.24609233248255152
LS180,89928392,1.7442798189695845,1.1978845015489528
SW1573,53495165,2.229023421141798,0.6369495432725906
WM115,16659841,5.127619480623103,3.6619019307268736
SW1271,3552672,3.981050843991283,2.707186415842449
SW948,9926054,1.8406028662949705,1.9713400791369642
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,0.39759474459585825
RCC10RGB,71466445,4.397911896340776,4.004502631021992
WM115,7326481,2.374260909001927,2.9960840918803324
SW948,44202524,1.7116279237548724,2.259801505297387
RCC10RGB,46907787,5.224507823938942,2.390747614056558
LS411N,9936388,1.997277136132151,-2.29586544694114
SW1271,135423438,1.1699634662635283,2.355275671042843
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.7642633205245088
COR-L105,123631,-0.3749766708664047,2.2857319052838947
MOLM-13,52947716,-3.8827491455655694,-2.8399169757015255
HEL,36314,-3.7348038354216593,-1.7081508635520504
KU-19-19,54454,2.6957608866389866,2.6838597961255863
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,1.2509214174909806
MOLM-13,71680916,4.890723285268907,3.879285465583635
SW1573,65628,4.136448104244246,4.4210503786352335
HuP-T3,11178236,-4.0067645508863174,-3.3850803847933197
WM115,11364421,-5.628114250516673,-1.2306885837756107
K-562,613753,3.252228295501032,3.0190552068933774
IGROV-1,24771867,1.9944882740161016,2.317720973193553
ALL-SIL,11152667,-2.075218964097288,-1.7653588437397778
BICR 31,3081361,0.7844567898788304,2.320993705917737
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,1.9573894270738847
RCC10RGB,4788,6.17872638158586,5.7622292839639
Panc 02.03,11626560,2.1710424521283427,1.9420296178831682
IA-LM,11175137,3.357915620650256,2.3597120886938776
RCC10RGB,11626560,2.6825909392900376,2.3448711101922917
SW1573,168313200,1.7327341920391253,3.2678163884178435
Granta-519,2828334,6.191507302277889,5.764890096343786
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,2.82797157318939
MOLM-13,5460769,1.2989705913507943,1.386260283053139
SU-DHL-1,216345,3.4378126257341406,3.6864801661427378
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,1.3542211341316874
MDST8,9926054,1.8075400364112937,2.048243364952528
WM115,676352,1.7628184284101875,2.050650440286214
BFTC-909,55508,3.078625314561866,3.59786723868651
RKO,100016,5.817852214634293,5.664653857306056
MDST8,46943432,3.6174081091701886,2.2708970423651054
SW48,5978,-4.7084088584036525,-1.4902059429471095
ALL-SIL,44491742,3.700418914769662,3.644634363984358
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,-0.1773304273573989
SU-DHL-1,11178236,-5.1175240313736845,-3.828856341380269
BICR 31,11955716,-3.162575487986667,-0.8261079505027841
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-1.5495486673943037
MOLP-8,374536,-0.3332412159105151,1.048262166271647
BICR 31,66577038,3.1838871840280745,2.976349836861177
MDST8,409805,3.941558883413243,5.084711077975001
K-562,6918878,0.8571724386049573,0.7372059742484727
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,3.2409571081645026
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.74661396208924
NCI-H1568,5281321,-2.717480517336961,-1.0215089900772045
LCLC-97TM1,374536,2.574075324433214,2.348196325345372
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-3.5485172076804004
HCC15,66577038,3.417660968254761,3.01874611454208
IA-LM,9911463,2.6703246121465436,3.758272924756286
SW1271,1566236,1.9677070098040983,2.270493710218491
IGROV-1,11238147,2.1723642292765084,2.730042107366019
SK-OV-3,11364421,-1.984047807336832,-2.0798177403216265
SU-DHL-1,54613361,-0.1121754666598921,-0.13269432258633296
COR-L105,119182,0.6226208228567816,-0.5392843132655777
WM115,3384730,6.229532895174781,2.7537971287546053
COR-L105,9967941,2.071649254258539,3.8434259084399347
RKO,72193861,0.7735395045157347,0.702455193454532
COR-L95,753704,4.781559661696253,4.587904984612629
IGROV-1,49766530,-0.195540678413639,-0.21986491870464098
BFTC-909,8515,4.73152093133166,4.139376535738153
Granta-519,31703,-4.611611754102639,-3.032872609411679
SW48,19582717,4.381046957550593,4.14122239466598
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,0.6633348501175547
HCC15,15547703,3.515422457694346,3.264872639073463
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-0.5349950744134767
SU-DHL-1,BRD-K58730230,4.384837032763104,2.6170953166931317
HuP-T3,2858523,3.211348955084378,2.9947117543552
LCLC-97TM1,24901704,3.846855123751057,3.156238253968776
NCI-H2452,44607530,1.9759156929339727,2.049227561895051
HCC15,9936388,-3.3305479025951783,-1.3681472507070191
RKO,46191454,0.9841477576830012,1.1797332305186838
SW1271,3081361,2.248142117307072,2.5394900450019953
HEL,100016,4.260371486080393,5.261195315153879
Panc 02.03,327653,3.634511095206161,3.1396354972576455
NCI-H2452,25062766,2.439590704022921,2.2009016472921603
SaOS-2,44607530,1.05170222821091,1.9091525462608314
HEL,5335621,4.9483155198907225,4.308778852858815
BFTC-909,6852167,2.133526407129769,2.8763660749586797
MOLM-13,638278,1.880317910461832,2.5143994503024123
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.6817831706665907
SK-CO-1,387447,-5.86001644251988,-4.389777735235488
MOLP-8,10113978,2.697897563265303,2.4853581688974447
MOLP-8,216239,2.6519870661660803,2.0367862051491925
NCI-H1568,46174525,4.305444868539079,4.39546723833997
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.8167026531897578
LCLC-97TM1,44607530,2.097748917507136,1.679759393840911
SaOS-2,9911463,4.168030006572111,3.812999163919173
Daudi,24889392,0.6157424479011876,3.009588369498159
PaTu 8902,51039095,3.3801139171258976,2.4460171337029193
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,1.9591321480501642
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.0111169618059879
Daudi,387447,-5.635352264179238,-4.949532034410744
IGROV-1,5702613,4.420745339537274,3.1831876775102432
LS180,375860,-0.0541765269880971,-0.36496793279704015
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.41693475314396766
MOLP-8,241158,1.846975252387852,2.7160471891052795
SW948,44819697,-1.5719383449848416,-0.47967846932388364
NCI-H2452,5951923,4.988154330604512,4.7990993071948225
MOLM-13,54613361,-1.833470941599732,-0.669370471419936
SW948,148198,-4.802987893737634,-3.1907905783035773
BFTC-909,4261,3.835594401773327,1.7842269777671367
Daudi,45100481,4.914271492759253,3.6561915690607503
MOLM-13,3384730,-1.9717967977442377,1.1742924868912084
IGROV-1,5566,3.174346862827938,3.0610436860351147
SU-DHL-1,10302451,2.2731723403274535,2.9020535482392105
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-1.1151619360478013
RKN,24797083,0.944322820476056,1.3446866352619296
SK-HEP-1,148198,-3.434194259121147,-3.0056990283930727
SW48,16736978,1.8227831775957584,1.2201114492192944
HCC15,2708,6.122532058448304,4.909287763406641
SW48,5335621,4.0461877603353855,4.434332831954611
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,0.8937725740788582
NCI-H1568,71304818,2.2110745175145876,2.668509282312335
COR-L105,5311,1.9211659995219237,1.6249373808703365
SK-OV-3,5328940,3.4311724872159903,1.717495875420794
RCC10RGB,1716436,3.489109378341682,3.2514560152438157
MDST8,6918878,1.145593411739036,2.811482232662415
RKO,11364421,1.233720517884939,-3.5281538637967405
P31/FUJ,65064,5.109694638799521,3.881505528383043
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.753145858989878
PaTu 8902,3025944,5.120505038776715,4.245415012059876
Panc 02.03,12001922,2.5444953584324193,2.017641417073152
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,1.8964640225168534
ALL-SIL,54454,2.130103786841792,2.038201351152659
Daudi,11238147,1.1945947480643642,2.047054616240919
WM115,148124,-1.9357807696466565,-1.7880329405570319
PaTu 8988t,25262965,-2.4539636298097376,-1.4975337275217169
IA-LM,49766530,-3.412847117105243,-0.9981807733533395
Granta-519,44185566,0.7632366174102183,1.593591788051595
MOLP-8,44607530,1.0628729381864028,1.68773127555071
K-562,409805,3.7514940654800064,4.211825975490118
BICR 31,89928392,2.942196417475874,1.540518575486733
SW48,23725625,4.606874242451815,4.935094300760022
RCC10RGB,16038120,1.536821218292656,1.295056402432489
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.745268689254166
RKO,148198,-2.1467795088860875,-3.8460676153263313
SK-CO-1,409805,5.790109243945559,4.971740350215412
HuP-T3,7251185,1.9415241444855404,2.7302303541244184
LS180,11612883,2.759028826688456,2.62314847887675
WM115,11507802,3.278245549501506,1.6499778963240193
IA-LM,168313016,4.257474229118996,4.784564100319831
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.138242559737723
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,0.9325396067383906
SW48,10302451,2.1638159560649157,2.7916144777885794
Daudi,65064,2.8809848507042095,3.564892913577111
LS411N,11612883,3.0472980958623705,2.4192312649482175
NCI-H2452,11214940,1.2392722713501154,2.052543200779116
ALL-SIL,984333,-1.3370961884574026,-0.564303545842129
P31/FUJ,1641662,2.802136916275355,2.878216694351579
MOLM-13,25183872,-2.142456248879295,-1.940018156371346
K-562,969516,2.7986550178028216,2.449964222551187
Granta-519,54143018,0.4327684951223574,-0.46699107085946806
SU-DHL-1,44819697,-0.3444138900100821,-0.9131759628464542
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,1.0768983247485775
Daudi,9933475,1.2993243126142855,1.4668124418761088
SK-CO-1,10427712,4.208191107568486,4.247871253580474
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.4379642645884214
HEL,2841722,4.805306475973069,3.8217213439975377
COR-L105,9926054,1.7310748902984938,2.087358758627
RCC10RGB,15983966,2.263334704673794,-0.7574901020791759
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,2.4560601707468575
IGROV-1,46174525,4.5083762186279595,4.298011751453728
BICR 31,11175137,2.7548462189262817,2.9011885511910624
COR-L105,11609586,4.426382611322312,3.0000633563193237
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,5.026106973094676
IGROV-1,107985,-2.8971910842184516,-3.230046017654148
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,2.7439874438374177
IA-LM,71466380,4.547922152882383,4.378237873156778
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,0.16805450587757492
K-562,11612883,3.292128537791773,2.010453671262298
HuP-T3,15953870,4.533958601099395,3.6416920067074954
NCI-H1568,219104,4.078417481216408,3.770607590219463
RKO,65064,4.5178366082525,4.238109058148519
NCI-H1568,9911463,2.564901149372131,3.7863502083935163
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.36865396002768164
ALL-SIL,6852167,2.025737624061405,1.3851920402217908
Daudi,16065773,1.627011760718674,1.9899097511269588
MOLP-8,10410894,2.1334782114390425,2.8544671365096317
RERF-LC-MS,73707371,5.9060077591992375,4.842462883738691
RKN,1566236,1.687441004968786,2.431873030608531
IGROV-1,439501,-2.1510551928674557,-2.473451669973042
MOLM-13,57519531,1.2030375936335158,1.1095126943144162
Granta-519,11625818,4.458439944218401,3.1558722890630686
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.880133604816811
MOLP-8,3689413,-2.303477592076259,-1.4442270349900153
SK-HEP-1,54596558,4.485352352092043,4.4193697642443635
SW1271,4705,3.86061099620112,3.1353427426737817
Granta-519,9927531,4.885085469625254,3.7240912725894613
SU-DHL-1,11427553,0.3775832797434548,2.0884489187104887
ALL-SIL,15953870,2.429039509996585,2.680478137531714
COR-L105,4259181,2.2372065992854133,0.49492185290178403
HCC15,17759555,4.480266922784899,3.5711599000419967
COR-L105,10184653,-3.6529884694455608,1.571046094419879
RKO,72376,-2.4980018930037673,-2.215470465702653
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,3.208625098654582
RKO,613753,3.427719504210608,2.954515946241636
LCLC-97TM1,10302451,3.3699574981481217,2.9799079265382544
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.935881953038893
MOLP-8,3634881,2.730356562919761,2.883412682179854
SW948,11612883,1.2539645440532456,2.5646540965137383
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.598418106971455
BFTC-909,10074640,3.0053798884123837,3.249978319319404
LS411N,24901704,3.828527152917887,3.157481092520236
SW1271,51039095,2.010271277744507,2.950187486645506
K-562,9935249,0.8993678101188762,2.211950913160811
COR-L105,462382,1.111643181026989,0.782322700231388
Granta-519,10385095,0.7144131323279258,0.87454119358789
COR-L105,5281321,-2.635307184860664,-1.2402366927358326
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,3.520240280231649
LS180,11234052,4.148077533652898,4.061251850529227
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,-1.1380576448116348
COR-L95,25154868,4.601001468087818,4.255753053396762
Daudi,3025944,3.5610963405625267,3.758732362631386
SW48,24180125,2.6937498240420457,2.8407007594363933
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,0.8550127402289196
PaTu 8902,168312962,5.583922762984923,1.8459468490066757
COR-L105,5280436,1.8180108392693488,3.5690692057892694
SU-DHL-1,44507138,1.5242294298964132,1.5625556150609758
MOLM-13,10302451,1.7245492330691454,1.9127186509645875
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-1.7239069787033647
SK-HEP-1,44607531,1.6636821475505756,1.648257397337864
IA-LM,15983966,2.169762444969255,-2.4713513417149504
IGROV-1,56946209,-4.416985130578084,-4.065076124998485
P31/FUJ,25126798,3.55669651950966,3.274489003159019
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.7507126770416006
BICR 31,15983966,1.7355748159582445,-0.6120015453699216
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.4916445627584056
NCI-H1568,135421197,1.29303587511011,1.8512438752351486
HEL,374536,0.3200488785786777,0.5151714033300745
NCI-H1568,25161177,4.305259269080427,4.102880892136027
Granta-519,24951314,0.3336244464551668,0.056848942093862244
LS180,400769,-0.7559227838025858,-0.8783410694108198
MDST8,44607531,3.32682409463767,1.6250177537822672
WM115,46843906,3.7194943725295992,2.5809324387540578
RKN,24771867,0.8860225124393014,2.834751794175521
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-0.9779807406380943
MDST8,72734382,4.130038178532864,4.561209827942342
SK-CO-1,1750826,-0.0283504159212216,-1.0571644738094266
MOLP-8,10184653,1.0374255182903005,0.4788333606362115
NCI-H1568,46398810,2.1853633940590966,2.716467238710754
PaTu 8902,6438330,3.32865710338655,2.3594625950951165
K-562,60700,0.041873955903415,-0.922289072647111
KU-19-19,23725625,4.865374475902274,5.054497251980804
BFTC-909,6438330,3.0201113942824436,2.0979769883654544
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,1.3010166904928904
HCC15,65064,4.883028365063005,4.880257980906532
HCC1500,285033,-0.4229420433590342,-1.986896427126597
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.5978229587034928
LCLC-97TM1,5479543,3.538440111241957,3.445009213820797
PaTu 8988t,613753,3.3970334474933495,3.3153394026510825
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.7209528787049959
SW1271,2949965,2.7362256869687895,2.792360761687487
SaOS-2,4705,3.668938036329027,3.0823236293633327
KU-19-19,11364421,2.01242470272022,-1.3355256005169729
SW1271,676352,2.2943086949623885,2.055149143336566
RKN,24856436,1.2279395925477072,0.4234903381226164
SW48,159324,-1.9628962598081805,2.567239398091944
ALL-SIL,568763,-1.7129740739789223,-0.6789793019573358
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.4185544438001856
WM115,9907093,3.0763750955907883,4.467866292789472
SW948,637858,1.5262532123254355,1.8019444875660071
PaTu 8988t,24901704,4.232615528659116,3.5004845345257314
SU-DHL-1,11238147,0.4308170484254632,2.3328847309822116
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.42511553757122583
COR-L105,3634881,3.59150153069964,3.46598246159287
BICR 31,49766530,2.6564815829329236,-0.3289292942567373
SU-DHL-6,439501,-2.4303946334698057,-2.5601053410754355
SK-CO-1,6438330,2.884853035173295,2.5133891883587385
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.3621006379106673
SW948,23635314,-3.685869994463448,-1.7645357269938748
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.4664498581273033
RCC10RGB,24753719,5.18895385781671,4.412069865498092
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-0.9503392782682871
HCC15,53481919,4.945944641956239,3.4022345791992605
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-0.07014956820161558
BICR 31,11612883,2.9886930364048387,2.888109434080834
HEL,20959075,-3.3486318540939535,-2.942188304983931
SU-DHL-1,24964624,1.891650824203322,1.5412422501164826
K-562,11609586,2.0906528510972775,2.0763264886201913
KU-19-19,89183176,4.239044338938638,4.510988124909429
MOLM-13,9927531,3.44947203831576,4.040726110242624
COR-L95,10302451,3.773437494355592,3.0498243963537015
SW1271,10385095,1.244878723840673,1.2395002115442286
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,1.1257004322626059
IGROV-1,17755052,-1.0246415273055465,1.5039672617535274
Daudi,3634881,1.264969339465191,2.649852037762851
MDST8,46224516,2.508010817025431,2.378606265282257
SK-OV-3,65064,5.055886881526936,5.063719107938734
IA-LM,11364421,2.389092199855664,-2.6974625157568495
P31/FUJ,6918878,-0.2487475841908946,0.4579971461848412
SaOS-2,426756,5.396474834861055,4.474844160709477
MOLP-8,25150857,0.9011737742745826,2.010423574289864
BFTC-909,11167602,2.8757137848929006,2.465172241484634
RKO,10302451,3.926970734642152,2.8297299929423896
HCC15,6252,2.2097348223357396,0.7686628881909889
PaTu 8988t,135421197,1.788370067257354,1.8481462188676059
SW48,42642645,-1.378549292450493,0.7617446712091942
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-3.2745121424905195
COR-L105,73707398,2.56355231698926,1.4627337601964043
Panc 02.03,3854666,5.373190444337423,2.44267019443079
WM115,11404337,-2.7813606850874595,-0.4298641523533492
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,3.371012349881988
K-562,9803433,4.389269041756261,4.385828856951273
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,1.118842994705721
SW48,11152667,-1.5089069748808788,-0.4817028212292103
MOLP-8,BRD-K55473186,4.200306440270822,3.7099490504429595
MOLP-8,3854666,0.8063321236158104,0.915437480165565
WM115,156422,4.742483160763306,4.060915631561434
BICR 22,10302451,3.218470138701286,2.549070391680369
P31/FUJ,3815108,3.712799909664185,2.219316809735262
SK-CO-1,5280436,3.963354946284049,3.332779037655228
SaOS-2,11625818,4.3669462586555055,4.164379070552421
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,1.843592757759135
NCI-H1568,24856436,-0.7402646666066086,0.6036651020938634
MOLM-13,19582717,1.836192229041244,2.923800000092267
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.392973559618539
LS411N,65064,5.143309491248943,4.712189481664051
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,2.9434281335185206
SW948,1716436,3.337695569228523,2.918889885696387
HEL,60750,-4.342121097179363,-3.611515439195389
SW48,5738263,2.8832489904283207,3.303906880483016
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,3.309886688160733
LS180,135984461,4.839780886141452,3.8561088955411567
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.458265177426546
SW48,3634881,4.093042888484318,3.194634604975545
WM115,82146,3.7974591517158,3.662577623041638
MOLP-8,24901704,2.731912612856625,2.7074661979246946
SU-DHL-1,9826308,0.1808938529022712,0.16768358738561037
SK-HEP-1,60700,1.3088528574816594,0.1913067715393046
SW948,49793307,-5.1176222473357775,-3.1534133756247034
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,3.858945413823841
P31/FUJ,15953870,2.7000087530897776,2.809596702035
SK-CO-1,24901704,3.265743022928408,3.2952264839618004
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.570527137188319
Panc 02.03,100016,6.582809568040202,6.46460787516212
RKO,168312962,-2.5117583451491012,0.8682952239557009
RCC10RGB,25126798,4.759098567819552,3.9277879338408535
SW1271,24964624,2.7126751219569147,2.376129944801328
ALL-SIL,9444,2.1167841583667277,3.620664396715382
SW1271,1641662,3.842487885295187,3.3968346391158737
BICR 22,676352,2.452861704781308,2.2533912776085874
K-562,54596558,4.166105900128149,4.053964306062366
Panc 02.03,9933475,2.3025810529048205,2.0826153196192836
NCI-H2452,374536,-3.751500666928139,2.7025481120094237
SW48,9825149,0.0451584979105152,2.0801260685844967
MDST8,3634881,2.8722303311625006,3.3539473937918514
SW1573,24180125,4.83914798243841,3.2259262273452043
WM115,42642645,1.5932691238490415,0.8810027822358991
SaOS-2,24753719,4.762341084721446,4.042772257860683
SK-CO-1,25062766,1.7088187930933407,2.1163653347186164
Daudi,71466445,1.7957550148901065,2.4078959667547077
K-562,9903786,3.6050720376028105,2.30684743324029
MDST8,5281321,-0.743993786053836,-1.2369118716420067
WM115,216345,2.152490626678771,3.7143607581745397
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.608318589303709
Panc 02.03,44566777,1.8066319547984584,0.9986840262486167
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,1.1054069893172949
SW48,1716436,3.2732206570492512,2.712059464987529
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.1812548606940325
COR-L95,5281321,-5.086788267908354,-2.2751561779036438
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.567840964039106
LS180,5287620,-2.159393408078438,-2.231308065079652
HCC15,24856436,0.7194572205096856,0.6701953523184123
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.3892696352566833
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,3.959475646256409
K-562,54613361,-1.429503199294265,-0.4509749785986972
PaTu 8988t,5311281,3.776140248734943,2.4247808990884487
HCC15,10090485,4.457627969814505,3.8585478977622447
LS411N,1242560,3.5784744482633526,3.3962832488600685
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,0.45864071282552077
MDST8,3854666,1.4298592595361392,2.117688759409192
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,0.9458356130816413
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-0.8996377102419476
SaOS-2,448949,2.4147534872316916,1.847260764470015
K-562,44607531,1.5533391017282614,1.3268117809759912
RKO,656346,1.2468664563159324,1.0376429437712664
SW1271,54619267,4.215254166837184,3.992853388569959
PaTu 8988t,107985,-3.7439330143768106,-3.3421316781773815
Daudi,107985,-4.311158471957254,-4.044522461885571
K-562,89928392,1.1726799483120014,0.83139098015001
BICR 22,2828334,6.182973514514405,6.413648165327991
PaTu 8988t,462382,0.0850922030405946,0.5091660171461144
COR-L95,54619267,4.025082196689936,3.822315876645839
SW48,44486219,4.521255071137468,4.100903903712326
MOLP-8,136227924,1.5113872866650588,2.4168615304234122
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.6968328973810545
LS180,176870,3.0513508415646644,3.0690236587508846
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,5.052420052153656
NCI-H2452,60700,-2.076184021255351,-0.1817527708697444
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.3978435573889856
Daudi,2749,-0.7661278600765006,1.1303889159706666
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-0.7230777854266773
HCC15,11364421,-3.377820549130246,-1.716791406506224
ALL-SIL,135984461,1.7193250250744925,2.711079738401584
HCC1500,1750826,-2.1124887265082255,-1.438743666174928
RKN,53392493,3.005817826052642,2.609903832466799
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,-0.0602555016248714
BICR 22,5287969,-2.619429839358568,-1.9266937484746764
BFTC-909,24978538,2.589526114093726,0.7174007887175913
SK-HEP-1,2828334,6.264472809398218,6.173871860824432
Daudi,4705,2.565440722309658,2.765805316436586
HEL,11485656,1.96241131365886,1.4901200048196688
BICR 22,23582824,1.0399288647056628,0.8405676794795831
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-2.6074651657627936
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-0.7904445424982481
MOLP-8,11364421,-5.744944118703229,-3.6027243227149244
COR-L105,374536,-3.312479831607182,2.4197376162331725
SK-CO-1,56973724,0.9140094173628892,2.873288053511311
HCC1500,135440466,3.12374064827048,1.8859211481611309
COR-L105,24978538,1.189273057385404,1.2044000095418388
SK-HEP-1,45279963,4.052806603396004,3.8160095691767926
K-562,11317348,0.8853213314815674,1.4898676615847273
RKN,6918837,-0.6134153399361431,-2.6716067108333084
LCLC-97TM1,285033,-3.3608842191269104,-2.0623725557413146
HCC15,11455910,-0.3399110905288865,0.8975766608395769
SK-HEP-1,176870,5.630942733934813,3.6760872153167408
RKN,23635314,-1.997093039658799,-1.6800435565241656
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,4.168588676787896
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.0757025010074917
SW948,969516,2.384481795832599,2.62652609824983
WM115,24180125,3.7433275341391057,2.8354653056996546
SK-HEP-1,135440466,3.4774178685499324,2.302805692030129
KU-19-19,11626560,2.7733848967135017,1.900906301625954
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.792548283948543
LCLC-97TM1,44507138,1.7278080476353117,2.5324684647034483
SK-OV-3,25150857,2.8200349544845045,2.4981648779712016
HCC15,44491742,4.47716804785037,4.122386368335089
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,3.1319630713092907
LCLC-97TM1,25150857,2.1625900659079296,2.4694025409228555
P31/FUJ,124202324,0.9428129005296164,0.9800392492775913
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,2.5319485928214043
COR-L95,6505803,0.0712785503404296,-0.30368085173485837
HCC15,24964624,3.0755429715166063,2.4903866761902593
MOLP-8,11647372,0.2904161448795228,0.3042911093787795
BICR 31,11977753,-1.0341786941527915,-0.9238526466158258
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,4.140653617101579
HuP-T3,5282054,2.779269170716028,3.9140357908543217
SW948,54618771,1.4567685239775812,0.9874018475339923
Granta-519,24797083,0.9051026865971544,1.0490535907418423
SW48,73707398,0.6331221198690845,0.8030102835050785
BFTC-909,135411,0.8518885281649031,0.6670241845241774
HCC1500,675434,3.977739266447536,4.556560349387257
SK-HEP-1,6918328,0.8938731782790444,0.3643666113632626
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.769870443777587
LS180,159324,3.258862193159196,2.4167320665848298
HEL,168312962,0.5016152377841688,0.2697759737510562
SaOS-2,44607531,1.4975746891341548,1.329706729453341
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,1.0937129210366594
MOLP-8,6610216,4.187822370904977,3.9837874974902006
HCC1500,5278396,3.6802956879537856,3.599365385912916
K-562,445643,4.07029800941494,3.683198927379324
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.187938321727966
Panc 02.03,5351362,2.6810485074832,1.5027552354024132
BFTC-909,23725625,7.000464253417552,5.232820973368175
SK-OV-3,8515,5.143916520422132,3.9898928588319147
RKO,24779724,5.847036108864024,4.237797321013284
MOLM-13,65064,3.286890258414819,4.169639337869366
P31/FUJ,9868037,1.2869642230829814,1.9537445955182133
MOLP-8,52912189,-0.8757353744499203,0.3343301166792552
HCC15,2113511,6.327015395869061,5.723086417832482
IGROV-1,25183872,-0.4560099928976716,-0.5920999760229775
MOLM-13,44259,-1.8425758706378912,0.7016227163931087
P31/FUJ,9911830,2.020541196825024,2.0694743927355357
NCI-H1568,11455910,-0.0792581795853734,0.8087255316485372
Granta-519,409805,2.9966967612339417,4.027969827025761
IA-LM,7251185,3.003277248553597,2.4598644267936747
LCLC-97TM1,24771867,-3.13973757551719,2.071515830610547
SaOS-2,387447,-3.480142635313653,-4.248027979365558
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,2.436317767673271
HCC15,71466380,4.492977556176778,4.557017128880729
KU-19-19,11178236,-2.578122805273377,-3.00507412333481
SK-HEP-1,107970,2.7276242080982405,2.3133118350500683
SW948,3503,2.019264798250741,2.1739344868077852
MOLM-13,11455910,-0.3133362084586128,0.47713331772583195
COR-L95,216239,1.9606601522489808,2.048049325535367
MOLM-13,20959075,-3.627453597088981,-3.0832757569632725
SW1573,3543504,3.864321270652805,4.484310574106325
NCI-H2452,16722836,1.367876124233394,1.780819822391431
LCLC-97TM1,2949965,2.4577774402858203,2.7707163672284736
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.7610394445160846
SK-HEP-1,9911463,4.3683168964450125,4.029360147566319
P31/FUJ,11404337,-0.879305702132212,-1.1285461533417238
RERF-LC-MS,23725625,5.011639185934848,5.271066574335699
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,0.11864788026482642
SW48,126941,-4.535727103151088,-2.72803573899499
BFTC-909,6184667,3.207156937684644,3.0842293640054277
KU-19-19,2945648,2.475372674219151,3.0556109844123074
HuP-T3,387447,-4.787053098216054,-3.936673572375724
Panc 02.03,44493528,4.298055948100647,4.426536560120486
Daudi,4788,4.597613323137637,4.94727367622699
K-562,46907787,1.0881737362577,0.3536994649797565
HCC15,6505803,-2.813846830430111,-0.5732347249564127
MOLM-13,3503,1.2246558483585983,1.6922364981364446
NCI-H1568,136227924,3.032081072579533,2.9591536062907666
RKO,9444,4.448790979485227,4.00270019301164
Daudi,107970,1.216737596928884,1.7700153286065399
Daudi,5311037,3.4563783042396015,3.2861767675872096
SW948,10184653,-0.1197105127119604,1.0138920754214
HEL,89928392,0.5480178499310975,0.455978913831642
SK-HEP-1,5566,3.210365271342881,3.1002441221722887
NCI-H2452,44493528,4.324080951064212,4.433605482402647
SW948,24753719,4.222068008445673,4.183628249736341
K-562,11717001,4.3318290739670555,4.076691407732029
HCC15,11647372,2.6612404016221824,1.0925582949933648
COR-L95,11214940,4.129361910595318,1.920061800347483
P31/FUJ,57330099,4.216278217816623,4.008674263623644
COR-L95,24889392,4.336996294263524,3.6018896473680133
ALL-SIL,16725315,3.2612856597636064,3.340472960075542
SU-DHL-1,2749,0.1348057545057474,1.518586527439672
IGROV-1,6918736,-0.950858733923241,-1.6701384622065065
HEL,46398810,0.908204113249262,1.731579243595519
COR-L105,969516,2.680370673187369,2.986062133942091
MOLP-8,613000,0.7667530859484226,1.968376083212052
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,1.0164289270930709
SW948,375860,-0.5776308885037049,-0.02446076004325028
Granta-519,6438330,1.446800550416973,1.117964232622342
SaOS-2,3384730,0.9471099210722488,2.617086651964067
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-0.557392414276947
SW948,10127622,1.0689347689119728,3.349764284420209
SK-OV-3,104842,-0.359869843998673,-2.9868594846429692
HCC15,2733526,3.237047771361035,4.08686286464134
ALL-SIL,9884685,1.523019065964201,-0.812759306562912
HCC1500,31703,-0.1591983874970776,-0.9834450965029
MOLP-8,24785538,-1.5077289265748457,0.6045216207909434
COR-L95,6918328,0.296514622397876,-0.3179443562349066
LS180,24964624,2.8898766327054153,2.094916821899197
PaTu 8902,2945648,2.947030382730425,2.987330138570776
IA-LM,16038120,1.0865848932778794,1.0641617183800516
Daudi,54619267,3.035333918034676,3.452765644116805
Daudi,5284373,1.725683673378691,2.237946435893257
SW948,56946209,-4.45606402023299,-4.185945369063436
SU-DHL-1,9956119,2.7884192993685666,3.109102006593214
PaTu 8988t,3689413,2.4784022576221836,-0.612958959400569
WM115,44241473,4.443917717257507,4.775255998981066
HEL,11507802,0.749942791895586,0.7290514331891024
LS180,25150857,2.6595729662678846,2.3158142466094342
ALL-SIL,11964036,0.9057184864624424,0.15055406234243676
SW1271,5351362,2.529410314371741,1.5347946614340697
KU-19-19,151289,4.45756440863607,1.1703616440365394
MDST8,24785538,2.8042557252914597,1.8806785823876169
LCLC-97TM1,11228183,2.6499520646531254,2.3618299429164256
NCI-H1568,10127622,5.078058454742808,4.433981710303021
RKN,676352,2.5860960344205175,2.220218052647443
WM115,6505803,-4.475953396274594,-0.254999622181445
MOLM-13,5278396,2.870927952465231,2.8407771884813995
SW48,1641662,2.4016053281737544,3.2526027025922932
Panc 02.03,5329102,3.1751218779490404,2.07732563523179
P31/FUJ,136227924,2.3905530687579497,2.242309758028024
LCLC-97TM1,5281321,-1.0764177966981967,-1.2261742437727703
SU-DHL-1,23635314,-2.2508595154996844,-2.3250357738858862
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.5801792802307351
MOLM-13,44494015,-5.247330257185634,0.24553725523309136
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.3982883953151837
HCC1500,46199207,3.053954841618667,3.2343476699865374
NCI-H1568,6610355,3.436001375430949,4.587687751217546
HCC15,54618164,4.329878027642837,4.080795946159095
RKN,969516,2.6409066030454804,2.846127829399665
COR-L105,71680916,4.738410817171978,4.715480037552749
SU-DHL-6,3634881,2.3700422517918653,2.727018975640098
Daudi,374536,1.069903440531545,0.7938736310292568
K-562,322968,4.0833948777840225,2.7636897297792085
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,3.4188206800178382
K-562,136227924,2.737847329779252,2.518940945298818
HCC15,15953870,3.1000423449826275,3.6592354125673023
BICR 22,6505803,-0.8504421983690468,-0.5220123917775225
BICR 31,409805,3.7719372874267982,4.994437342860093
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-1.94347508326592
KU-19-19,71304818,1.8280747292346609,2.6002748945770793
SW1271,6917907,-6.616351101315701,-5.052936052998765
SW48,44589607,2.4172125993075335,2.6579244499806367
KU-19-19,3854666,3.1161318305167995,2.3072867505175143
MOLP-8,11404337,-0.9705317414577028,-1.2344458843741015
SK-OV-3,11152667,-0.6824217491873509,-0.06573949272221039
LCLC-97TM1,72199292,1.0139745528188595,1.0483881116100506
SK-OV-3,5566,3.179406871626594,3.009283705774643
SU-DHL-1,11683005,2.624367478757415,3.6090574112576363
PaTu 8902,71466380,4.078142681912824,4.639095409928851
Daudi,56963564,0.012925039709307,-0.10157144351354594
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,1.3438993248571587
SU-DHL-1,25195348,1.1859308431356896,2.8794035687899036
RERF-LC-MS,11494412,1.0302757077826894,2.2005112939669274
IGROV-1,3634881,2.769147818550815,3.3833270354696223
SW48,445643,3.7110082204631545,3.9318018606156113
IGROV-1,3854666,2.3355254440561137,1.8699164720467873
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-0.18819069623339657
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.308372363255146
PaTu 8902,387447,-3.44390255134181,-4.026778042268525
BICR 22,25150857,2.1797682691439233,2.3792877439999303
SK-HEP-1,54618164,4.274964046269975,4.179046625691532
BICR 22,44493528,4.288893884195869,4.293792467456396
NCI-H1568,969516,2.3539842482072353,2.8756429373708023
HEL,52912189,-0.3930066433927971,0.19168347193138427
BICR 31,53392493,3.0187901836288824,2.7289521130639764
Panc 02.03,6610216,4.56797737488032,4.356004068851217
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,3.4123727144084754
SaOS-2,445643,3.906030165734591,3.8390053174825005
SU-DHL-1,9967941,3.123701665105139,3.119350611614684
P31/FUJ,10113978,2.718593007254544,2.1814351620957777
K-562,54618771,1.1969173800987956,0.3394827923386047
SW1271,445643,4.255849699563793,4.0866501038414755
SU-DHL-1,16741245,1.9818901112506189,3.6289207815070523
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,0.5639968525816077
SU-DHL-1,9935249,2.376788737359572,2.533751551807593
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-0.718632228760159
Daudi,11625818,2.088957631704298,3.435171213670044
IGROV-1,11213558,0.52356811652227,1.6434736931597151
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.0646485327880852
SaOS-2,9907093,3.731287417721421,4.343247291146989
COR-L105,54618771,2.0419110046350135,1.0950418357208287
RKO,9935249,5.020114551473781,2.4607086118497223
RCC10RGB,54649381,5.891551456540707,4.024329373153215
RCC10RGB,11228183,3.0224846047699288,2.266648559663449
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,2.1555462765059037
ALL-SIL,11683005,2.0727325774258794,3.4344213365609164
RKN,9935249,4.428036529076262,3.126615665681986
SK-HEP-1,6918837,-2.2229066751457345,-2.4937206612531635
Panc 02.03,36462,3.4500230117265933,2.2251611708836965
SU-DHL-1,9866186,-0.7631869517914462,0.3016327800418509
LCLC-97TM1,448949,2.0046135576158637,1.9833624066747852
SW1271,2858523,3.03244629786768,3.040797896291283
SaOS-2,46398810,2.449640817433895,2.3359523344413553
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,1.919549512090095
COR-L105,16013152,4.074366111138725,4.32056989494264
SW1271,10127622,0.8769341404821704,3.970694416263131
PaTu 8902,24951314,1.6215809376037376,1.4831802668148706
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,-0.24840237047243197
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,0.5679129021720385
Daudi,72199292,0.1565760694605324,0.5997998124916256
PaTu 8902,409805,5.142449436796194,5.035524113410573
BFTC-909,16115403,-3.993091010962378,-4.072950430335506
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,1.970285201330918
NCI-H2452,6505803,0.3706171048891257,-0.21337314471357594
K-562,123631,1.7867714727142892,2.096343859615478
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,1.7589023617593154
SW948,56963564,0.1376223024943695,0.548261791996921
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-2.2576747690739483
KU-19-19,25183872,1.353604037781074,-0.6247571250631309
K-562,462382,0.6666012292356907,0.3747447318593129
BICR 22,216239,3.622359576149126,2.1956092394017874
SW948,72376,-2.235310823117723,-2.4570453623596347
SK-HEP-1,16736978,1.840110323821058,1.7378924561819273
LS411N,135440466,2.8415058675889,2.005046561170724
BICR 31,2871966,0.8542621552894032,0.8153545094803973
NCI-H2452,5311281,2.597680352332147,2.510941531506989
HEL,25195348,3.2451646073619416,2.242351670732687
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.44870769242896524
SW48,24856436,-0.3608375787119608,0.6026570953369552
COR-L95,23582824,1.713723586402061,0.8115711253388679
NCI-H2452,400769,-0.2625889565980605,-0.3596879184488156
Granta-519,6610355,5.056177796240837,3.9071837760219355
RKN,135984461,0.6080422026652917,3.7862716956472933
IGROV-1,9956119,3.7231415872817024,3.829276599402854
SU-DHL-1,24856436,-0.2626900450765423,-0.29440151886260923
BICR 31,9911463,4.617619725588035,3.9987594020974613
BICR 31,2742550,4.742856926113666,4.163223731809954
Daudi,6450551,1.0042642679666238,1.5497763299053582
HEL,57519531,1.593967479342305,1.5426349384034688
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.4258330091310555
RKN,216345,4.602972623005823,3.944609336597138
SW48,46224516,2.362473255058207,2.3744459645678884
RKN,10184653,1.939164173873933,1.4797054367472962
MOLP-8,31703,-3.4249459011432912,-2.4197975885437337
HCC15,9911830,1.9028880277746671,2.6633559509462934
P31/FUJ,24180125,3.650250525491935,2.398385223406076
HCC1500,11427553,3.400784702269924,2.7945006671734944
WM115,4378219,1.986798403927216,2.8163513737676675
MOLM-13,445643,3.334033231716822,3.3882565414699104
HuP-T3,135440466,1.565116417651368,2.258403554526528
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.227904807007204
SaOS-2,5284616,3.138246393599145,1.5332299827740619
LCLC-97TM1,156422,4.251965697410575,4.163780170276012
Granta-519,71680916,3.9040498639791226,3.8985797789354772
SU-DHL-1,16725315,3.3729799888412257,3.813177761564079
P31/FUJ,20959075,-3.3972839651855207,-3.209385365171211
K-562,16720766,1.059873963232806,0.012059705016907903
WM115,9915743,2.6223908273409515,1.2458893107866766
COR-L105,11238147,3.8255779395664065,3.034728684828149
HCC15,6918878,1.2461206152093485,2.8720934337025072
SK-OV-3,11427553,3.3243369937323877,2.903075594190035
RKN,6918736,-2.1202784612128416,-1.8902845092777534
NCI-H1568,10385095,0.5241849666466598,1.3168553679026886
LS180,6623618,2.712323731600185,2.097842642468571
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,3.3486510940413403
COR-L95,5287620,-3.7742892062529183,-1.7614337618979328
Daudi,11977753,-5.803293235753203,-2.634400552172602
NCI-H1568,375860,-0.3746562160702436,0.033279041234948716
Daudi,1242560,2.7879344365615633,2.984079423542758
RKN,2729026,3.0549768432694377,2.822911008204173
SU-DHL-1,56963564,-1.155496663147979,-0.08349040452179805
SK-HEP-1,42642645,1.5394057036271682,1.069371705057091
COR-L105,9935249,3.5389604716579175,3.456061916102511
SK-CO-1,107970,2.4721550322855843,2.2559205248478227
RKO,5113032,5.90165838842917,4.879069842376825
SW1573,135411,2.599466343128946,0.591186283950178
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.1881963652891283
RCC10RGB,6610355,5.214940260192328,4.717423754395248
BICR 31,5287620,-1.513974949921974,-1.921011382895568
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.3035438545399645
RERF-LC-MS,72376,-2.3536044208150644,-1.4333701675682229
UACC-812,7326481,2.606201441290427,2.8471038560799475
MOLP-8,11717001,3.6554432811683824,3.9519876877587574
P31/FUJ,1317464,4.709019850634407,3.397512190942413
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.7909807437354033
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.7335806976957873
SaOS-2,44507138,2.054017263478066,2.546785481312387
IGROV-1,445091,5.8777802446160825,4.381545172690848
RERF-LC-MS,54613361,-1.445874788963763,0.4877386193404146
RERF-LC-MS,72193861,1.0218744083195843,1.7307906344876085
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,1.3189093163369856
HEL,56963564,-0.4081404928481738,-0.2173419663009971
PaTu 8902,136227924,3.2072125986231117,3.132539484870999
SW1271,25183872,-0.9123448839798644,-0.821106185373082
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,0.7475692644901488
IGROV-1,25154868,4.833387840688245,4.312047867710801
LS180,107970,2.4480125060803077,2.25793586147876
RERF-LC-MS,9840324,5.508232790936476,5.9442611845556845
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.453277517376634
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.19679955138387
COR-L95,60700,-2.695152938475503,-1.2678225954233064
HCC15,24785538,0.0662714662573936,1.486920377606451
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.1633965022983888
ALL-SIL,73707398,-0.324762560862376,0.1963396952080533
HuP-T3,23725625,5.187021863055133,5.222098704901208
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.247048755357649
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,3.6557614722007887
MDST8,6505803,-0.0816923181525763,0.020573175227877237
SK-OV-3,5351362,2.7626479495985765,1.6078421927105837
IGROV-1,36462,2.313632721410001,2.019502426955063
BICR 22,54618305,4.315554591509874,3.939594724162487
MDST8,5311281,0.3396864368094036,2.292571711406516
MDST8,9866186,0.4787443726889831,1.0448796048244733
COR-L105,9840324,5.89386509883338,5.8330584033974375
SU-DHL-6,9887053,3.723065049771557,2.41043735865592
SU-DHL-1,10113978,2.4232665022526154,2.4954845664863843
K-562,6610216,3.734328570580528,4.018476230648112
MOLM-13,9936388,-7.059788369591511,-4.17168372991141
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.0450700440427139
WM115,135659046,3.4373276092449667,3.7545676387791516
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.589666893994721
RCC10RGB,2708,5.228545547030361,5.258549268397997
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,-1.1618961284405775
HuP-T3,969516,2.913535439683091,2.840501396731926
P31/FUJ,135398744,5.7727848933678,5.615284258539589
SaOS-2,168312962,3.518591614256865,1.757637182442191
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-2.809694735515566
Panc 02.03,11364421,0.2085573081853932,-0.6882338020645904
SU-DHL-1,3385,0.1709309619587451,2.9576082759070697
COR-L105,3854666,3.5309487733662923,2.4235464273722274
K-562,3025986,-1.372296763308674,-0.9429035666058603
PaTu 8902,25183872,-0.4459453921876214,-0.8166814173530424
BICR 22,25022340,5.75714905141274,2.9388819070916927
SK-CO-1,71466445,5.862416915369376,4.043356729296811
HEL,159324,1.7687894675630291,0.5816866927457075
P31/FUJ,135411,-0.6620772647112111,-0.1683133011428814
K-562,11455910,-0.068399521398108,0.4935290695269521
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-0.6034835545229467
SaOS-2,135421197,3.6760992974277817,1.932404545188121
RKO,54678924,1.753529637740366,1.7892512227968753
LS180,9926054,2.059729849775666,1.7949766054436551
PaTu 8902,3081361,4.091517551590367,2.5293764751089802
HCC15,54618305,4.644823264977023,4.276565895744805
SK-CO-1,135421197,1.070123520764916,1.8171374153511295
MOLP-8,5282054,2.3704039128819603,2.9703845868826786
Granta-519,2874250,5.483813332492178,4.003298385189224
SW948,15547703,2.460178853059974,3.065713277767346
RKN,11175137,3.1657803092866224,2.6059225323158723
HCC1500,15547703,2.6330912213710693,2.950146452421651
PaTu 8988t,3503,2.8268609009838706,2.5461648472744516
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,-0.9137562671188377
NCI-H2452,409805,5.262030999116563,5.171861835220305
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,4.880027851319545
K-562,107985,-3.1543528536618175,-3.8465476588382974
RCC10RGB,6918837,-1.099435459858538,-2.1131535874220937
HuP-T3,2746,4.662800576379415,3.3012290326561198
Granta-519,135928012,3.1328015926823065,3.3747986597891497
HEL,2733487,3.1527152778808794,5.765789635006061
RCC10RGB,11175137,3.603105896683611,2.668348761979025
RKO,51039095,3.7257826703811014,2.2643566144035567
WM115,3689413,-0.1044392328624619,-0.181380281946158
SaOS-2,25154868,5.397428200613107,4.302431207470381
RKO,25195348,3.4491832635970585,2.885403009909414
BFTC-909,49850262,4.237463012213885,3.6684200793196236
SW48,168313047,2.500888470511616,2.283839490598566
WM115,444795,4.375682835505768,4.533567568741315
IGROV-1,5738263,4.037832478240785,3.404896724443838
MOLM-13,24748573,1.5626639761830592,1.0911036792295712
UACC-812,6917907,-5.293133909322777,-3.222886852639535
IGROV-1,168313200,3.9938362637732983,3.134403304106126
PaTu 8988t,262093,3.2462588578894587,3.039553543382886
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,2.2976569574770425
WM115,3543504,4.159835009416132,4.572091019248355
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,1.9162804305664116
SU-DHL-1,9903786,2.5464454731205777,2.620236827545816
ALL-SIL,6438330,0.5772640537372373,1.000891904050605
SK-HEP-1,322968,4.726859452680793,4.020509192197605
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,3.1515148089888965
WM115,2874250,4.6839306454467975,4.274959039209127
HEL,327653,2.969363674974165,2.7569344762771175
SU-DHL-1,11625818,3.655247454502854,3.4272440672422873
UACC-812,49766530,0.2629782697340875,-0.47027881201544797
SU-DHL-1,3815108,2.229733806447586,2.224084559753644
IA-LM,71466445,4.189377103287156,3.8701070226066565
HuP-T3,1716436,3.1901993610711092,3.141332408717202
SW948,44566777,0.0218128389697893,0.9813832757863286
SaOS-2,24821094,3.1556587771151117,2.988106865222502
Panc 02.03,135875424,4.996461687769912,4.00243392310831
COR-L95,3136844,6.4544258549997675,4.130754877233328
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,1.889032232891819
LCLC-97TM1,3385,2.7516430893834696,4.034960835270023
K-562,135875424,2.7247406179323055,3.4016398826504997
LS411N,5329102,2.797825403975713,1.8038035406329627
MDST8,24964624,1.7196440159479949,2.3747034118724013
KU-19-19,10090485,5.355458016675434,3.960594329493172
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,1.0368668661346643
RKO,89183176,-5.254565057669901,3.739142419703208
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,1.4735276001286537
Daudi,24775005,2.5651956502981093,3.422939932354984
SW948,46215462,1.7533079238953375,1.6907057043269962
BICR 31,6610216,4.499990209090508,4.358582184891471
ALL-SIL,89928392,-0.8842785165403505,0.18801423259659467
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,2.7696074950168423
SaOS-2,9933475,1.7767718055197024,1.8194982738745191
LCLC-97TM1,16722836,1.3652485758433368,1.8618426378657094
LCLC-97TM1,49793307,-2.6941720612695814,-2.7317507552195917
SW48,10127622,-3.686333454689576,2.912854330017367
Daudi,451668,-1.5751627659840317,-0.8498669445153757
NCI-H1568,135398516,0.1447365774963497,2.4136462798801723
MOLP-8,11178236,-5.22072808334844,-3.7594148292269285
NCI-H1568,46907787,2.5747387573296425,2.461964522227267
PaTu 8988t,6914657,-5.535111189097384,-3.7603319585056716
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,0.205580187431603
SW948,3025986,-0.0730103520402185,-0.70185149403218
IGROV-1,11612883,1.8715405446213529,2.7482254476974917
RCC10RGB,3081361,3.5981013353753464,2.68825777761376
MOLM-13,73707398,-1.293008226929777,0.20402442184741254
RCC10RGB,9915743,0.9759946846108524,1.4723544939348268
HCC1500,24771867,4.066345817331682,2.525259440300904
K-562,44137675,5.346911467461658,3.0458752796065043
BICR 22,89183176,4.4276408454646,4.316509433641469
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.7326589817106491
BFTC-909,54619267,3.991913685478571,4.0125384683255065
RKO,71304818,0.9175289508752972,2.1629297679637176
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,2.134945449937726
BICR 31,25161177,4.144120396566418,4.327132671692029
SK-CO-1,6918328,0.4731277879927994,0.20675314130298283
RERF-LC-MS,6914657,-3.1593675222943896,-3.4724110607450083
NCI-H1568,44185566,2.743919877007031,2.533649043894036
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-0.6529612037527304
COR-L95,6852167,3.112371536345172,2.530623763483858
P31/FUJ,5113032,4.875284905433655,4.465540943681034
BFTC-909,24180125,2.699370118217823,3.251762184734938
SU-DHL-1,6252,0.3334498529847555,-0.49635719284458046
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-2.8501327423898526
LCLC-97TM1,322968,2.924684365208183,3.8001670325195804
Daudi,60750,-4.624244800464318,-3.005780251280925
NCI-H1568,3385,5.30334090203815,3.95729514004024
COR-L95,5978,-2.5997235685562026,-2.0413745049697845
Daudi,24856436,-0.3602858360333429,-0.6229532644881934
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,1.019478163180233
MOLM-13,445455,3.1473640199222386,4.050604141009324
SW1573,135421197,1.3915330004591782,1.9579679345484542
HCC1500,16065773,1.504426355167742,2.3033055155475353
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,2.8074916486918653
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.2453682817979765
Daudi,9826308,0.3207715704810925,-0.26713452693466877
RKN,17759555,4.047966260499275,3.6472619772941304
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,1.1621598263479784
PaTu 8902,9911463,4.390925153080421,3.9296025357051634
LS180,54613361,-0.777399447336216,-0.12603553761198172
COR-L95,11396600,3.695258257335492,3.6650185404850157
SU-DHL-1,9911463,3.067527187401269,3.152082600230734
COR-L95,4477,0.8356196347588036,0.5647129434711085
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,4.286527315007852
COR-L105,12001922,2.476912212032941,1.957106135442283
NCI-H1568,25154868,2.392234118098981,4.40436347040581
P31/FUJ,24964624,0.604485461730223,1.0026906452692743
RKN,11507802,1.1392194525963166,1.591399796900983
Granta-519,2746,3.996696473436098,1.5197434965326888
BICR 22,6918736,-3.590209831667407,-0.8667209167001908
IGROV-1,135423438,0.764137689665023,2.191668657879789
SaOS-2,5460769,2.263492155098724,2.8376988095396793
MDST8,3025944,3.984610722170807,4.248953154322623
HuP-T3,9935249,3.692881062494191,3.322282448794921
BICR 31,54618164,5.999146696375086,4.121518061503884
MOLM-13,3552672,1.8354180523958712,1.7532476345599557
ALL-SIL,24889392,1.2675997647257198,2.8118745279266495
P31/FUJ,5470400,3.6840145170482383,-0.4739041874203172
RCC10RGB,68056272,3.770230744947895,3.956663791506443
K-562,135440466,2.878154323162211,1.8638495773195793
KU-19-19,16038120,2.2784541929956563,1.3187415868722892
IGROV-1,969516,2.460805405371151,2.82163648875191
RCC10RGB,54596490,4.957303932772775,4.694765487228348
SW48,54618771,0.2213541125267267,0.624841050207949
SK-CO-1,56963564,-1.3743653333208103,0.8145268084557972
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,3.148630507647513
SaOS-2,4096211,1.593922478920674,1.8732798466500613
WM115,11317348,4.689716075377342,2.4859590489778327
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.6204070198198974
LS411N,387447,-3.952629374311597,-4.270894137124503
SK-CO-1,11396600,4.255124433433546,3.648249156202004
RKO,2828334,5.934464187728916,5.988602575736886
NCI-H2452,6184667,2.981030320075281,3.2716625184689763
MDST8,119182,-3.087899770061731,-0.9425116939856119
NCI-H1568,5282054,2.3545727551586744,3.7395879374168675
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,3.3331995935476613
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,1.8556383976513544
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.5300883326776308
MOLM-13,5311,-0.2452037316548625,0.4073990960388039
Panc 02.03,119607,6.223236877281167,5.377647863882218
P31/FUJ,5566,2.621678413077409,2.7039901191085858
RKN,5311281,3.300248210659573,2.5662151371390785
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,3.2688369731470157
K-562,11152667,-1.0937594737206502,-1.22657802392711
WM115,241158,3.4880777915567496,4.065923050435063
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,3.396206286635605
SW948,11707110,-5.12001559624384,-0.18561861766867815
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,-0.07804075505162676
RKO,3503,2.683687073265507,1.8925750986859495
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,2.4957662838026975
HCC15,3081361,2.87617011057776,2.5144323034930833
SW1573,25102847,2.4268351657646874,2.3800071426483753
SW48,24785538,-2.175303706573729,1.386252991522321
NCI-H2452,5329102,1.9284891088724192,2.0867344635897287
NCI-H1568,56946209,-4.312547212322036,-3.605562212349024
SU-DHL-1,23939,4.934189555353841,4.074467864310234
IGROV-1,2708,4.438419625543199,4.808439460074109
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,2.096082376014237
K-562,44489675,3.6585617881709585,3.7711691517280705
SaOS-2,23582824,0.6839328831098858,0.7184448673022795
WM115,1242560,3.734530534800184,3.3337120894584094
BICR 22,89928392,1.801349914013067,1.825006808261911
MDST8,375860,-0.0509298762434446,-0.10989856951690166
WM115,387447,-5.543981096917634,-4.092900067180083
PaTu 8988t,46215462,1.6929329300119484,2.0748121484866298
SK-CO-1,25150857,2.4521914239487965,2.4626368505571117
RKO,46843906,3.289277038806309,2.631515911522203
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.7310355469920343
SU-DHL-1,3062316,2.138301047480956,0.04153561182656063
LS180,31703,-0.5385699496513472,-1.0484672327356848
NCI-H1568,54619267,3.44714412714971,4.138069074323663
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,3.010427353606045
SK-HEP-1,5351362,3.433378240202124,1.7489599440628623
Granta-519,119607,5.75770191278477,4.4648304061280735
HCC15,2729026,2.745990777117554,2.6878271374713942
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,1.5285449676941014
MOLP-8,24797083,1.4809895165463562,1.1347592153014083
MDST8,446155,3.7715450651151854,2.579959949318166
SaOS-2,11317348,2.7618337203443377,2.4408162918012066
SW948,67156097,-1.6378764151549952,-0.8772282428786532
ALL-SIL,448949,0.3821166271144734,1.4063412019184238
SW948,5287620,-5.231918659547503,-2.279700429942398
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,3.364626939747835
RKN,159324,4.081844329649501,2.9052927880839885
SU-DHL-1,6917907,-5.829381256855267,-5.283337981117096
BFTC-909,3825829,4.25128930140834,4.1369770336859935
SK-CO-1,119607,5.49560679798916,5.004002322434872
LCLC-97TM1,6450551,2.230680139016655,2.5188057884612305
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.7272472166537112
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.7271764255705615
HCC1500,54626689,4.657243866783195,4.668217253116903
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.501154279288455
IGROV-1,9866186,0.4571266497661056,0.5806058206610459
K-562,24772860,-2.920105669473321,-2.6192747726457286
SW1573,9956119,4.0915863238100645,3.702280908374092
BFTC-909,5280436,4.2143472852581025,3.446175916933766
SK-OV-3,5282054,5.04615494272688,3.7869295827152967
SW1271,24180125,2.511417012575286,3.144950254752753
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-0.9118756377031398
LS180,46398810,2.878388522539818,2.2782546541466733
P31/FUJ,2749,0.384854271149864,1.0632345904593974
NCI-H2452,5281321,-2.0767365956379944,-1.3068874743505765
SaOS-2,9927531,5.410264314347966,4.651300507132407
WM115,156414,1.595819692541897,1.5583479000023235
COR-L95,15983966,3.7167583960216897,-2.1117809866728234
SU-DHL-1,10322450,2.9485372728674473,3.6438559849705605
HuP-T3,66577038,3.287519898796673,3.0419877578516554
Daudi,6505803,0.7229387165377155,-0.694111131452007
COR-L105,46926350,-4.1614749205792565,-3.7014985213139817
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,2.1753020985422684
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,2.9296756845348724
MDST8,24901704,2.355370692316459,3.3064283413622144
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.6448897504426225
NCI-H2452,25126798,3.2665335299764298,3.977496215129956
ALL-SIL,107985,-3.6188373708521495,-4.121902093219862
P31/FUJ,5738263,2.6277017246063252,2.7291375410487753
HCC1500,2742550,3.2494473825713026,3.948192255032927
LCLC-97TM1,54618771,0.7707104681824843,0.9281366588041178
MDST8,3062316,2.63216781392049,0.9156594830374442
K-562,100016,4.034095210213227,5.636587055523084
NCI-H2452,136227924,3.4253193575490695,3.1692601826540283
IGROV-1,3025986,-1.046010021597061,-0.48783474432956003
IGROV-1,135875424,3.3275053166921347,3.8172347532899282
RCC10RGB,400769,0.8506758933165035,-0.37071627576591093
HCC15,44241473,5.510013950441446,4.675732761383439
SK-CO-1,26596,-2.200264316257102,-0.9454391649032649
HCC15,613000,1.6197134073445976,2.727725237744878
Granta-519,10427712,3.8202730219655496,3.6046129466660046
HCC15,5479543,3.813478020040636,3.4613880912868473
PaTu 8902,135423438,1.708930423466824,2.58383586450643
Panc 02.03,24964624,3.328827283539013,2.560707944226284
LCLC-97TM1,25154868,4.98783448400422,4.30430353685127
RERF-LC-MS,5113032,4.48589538963195,5.0336521594033545
SK-CO-1,168313016,6.229837204453753,4.764721156578214
SW1573,9926054,3.1618263718643513,2.031920008117367
MOLP-8,451668,-1.0880279758209197,-0.15309293251270586
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-2.499682954995304
SW1271,46191454,0.8015154670027128,1.7270371200348231
IGROV-1,156414,1.4212019235656712,1.1535031814450174
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,3.1706240122599842
NCI-H1568,11647372,0.9090690740398496,1.0367902432033418
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,0.2033809082798906
HEL,5394,4.33544579006292,3.5184793420368177
Daudi,23635314,-4.750280690911186,-2.3378703407704737
SK-OV-3,3543504,4.529917197725731,4.494877238719371
NCI-H1568,51037431,4.33384460889792,3.4950150653056773
SU-DHL-1,2708,2.612747958759665,4.0577566061095665
SW48,151289,-0.0884278513227002,1.4632331231928923
SW1271,24772860,-2.1080107772753607,-1.726699516803557
SW1271,675434,4.352597318848774,4.4648863937722565
Granta-519,44632017,0.2326960109936577,0.5660969421453588
SaOS-2,11955716,-1.373693500458253,-1.1824510648721371
KU-19-19,159324,4.255883770522122,2.9995885347922355
SU-DHL-1,4261,-0.6665613942828803,0.9281708066298036
COR-L105,10302451,1.2881684147693646,3.393894484520584
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,1.0105591059018488
ALL-SIL,4096211,-0.2650943934034739,1.0358297283248643
IGROV-1,216468,0.5330864756407336,2.9779092189375684
Daudi,46907787,-0.707382985228944,0.012173831080299435
ALL-SIL,11175137,2.2895463411974597,1.5425652485036372
HuP-T3,7326481,3.4338903427833674,3.056241591653859
SK-OV-3,11626560,2.736987670099794,1.7208001810235831
NCI-H1568,5978,-3.194054905017319,-0.97755162484208
P31/FUJ,25062766,0.5108470478058419,1.496849683692262
LS180,4261,0.8191216854939201,1.6474472459287883
HEL,71304818,2.1837189642761645,2.043653973198208
NCI-H1568,71466445,4.632148673172368,4.027634565879969
PaTu 8988t,5282054,4.412677005920707,3.834204339818397
SW1573,54686904,4.039437320121271,3.954381391420098
RKO,53392493,2.7606647137416616,2.210426011227828
PaTu 8902,156422,4.606541116596145,4.254937770104868
COR-L105,54454,1.772071227552003,2.7383350284317323
KU-19-19,9926054,2.3371072555508445,1.962468062427598
IA-LM,3136844,4.47285753340146,4.132632713603151
Daudi,3854666,0.3283534306514684,0.8704082762201114
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,-0.019326275821954054
SU-DHL-1,72193861,-0.6645199564816581,0.812514987229782
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-1.2960171391246638
SK-CO-1,44202524,0.5946445627983161,2.548413361553121
K-562,1750826,1.7671131923879069,-2.9751298745841326
LCLC-97TM1,3854666,0.8191923722369518,2.1134719635636348
SK-HEP-1,4477,0.3599343153867445,0.7834869248697628
BICR 31,5282054,4.622453961920413,3.901235910484823
ALL-SIL,3025986,-1.187507928097146,-1.4239072640719865
BFTC-909,3062316,2.03384364484094,0.7662214564787979
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,4.079407028641342
Granta-519,444795,4.599812836973149,2.7919535089337155
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,1.8596881292775216
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,0.9768402712687112
RKO,1566236,3.4833841973625725,2.058904263941363
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.9299681562734565
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.2329107396631205
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,2.465364124674245
NCI-H1568,8515,2.0721444777555327,3.966637663964507
MOLM-13,24978538,-1.2743594434772367,-0.8276345735045304
SW1573,23725625,4.357604161446221,5.03531949573936
HEL,15953870,2.2428109686656295,2.8302857947507776
Daudi,52947716,0.9938257746380776,-3.0952380889359166
BFTC-909,44259,1.3269924163099676,1.2697482900921877
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,3.188589892822077
SaOS-2,6918328,0.1895131607356872,0.08697877887132431
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.5182988581747354
NCI-H1568,3503,1.1278876480867208,2.323614917055264
IGROV-1,72376,-2.111352545322758,-1.8398078290707869
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,3.1984411986335988
SK-CO-1,654092,0.6285789884023978,-0.10394914239853874
SU-DHL-1,44589607,1.246014317818898,1.9575663785632151
PaTu 8988t,3552672,2.097731757890035,2.7736165455225033
HCC15,5282054,3.6050373222028815,4.024268584205183
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.580542299657625
WM115,16013152,3.8161355323039,4.236357408884151
ALL-SIL,54618305,4.365324809283883,2.942955523896821
SK-CO-1,25195348,3.743308569883415,3.2893205775666483
BFTC-909,123631,2.8792987518934403,2.4878428298195407
NCI-H2452,25022340,5.0430378131248785,3.2308677722410364
BICR 31,11719255,5.311316415457661,3.42740225282374
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,1.2141743586591276
HuP-T3,568763,0.3762081962980199,0.7497276549566834
Panc 02.03,71680916,5.6819891784443595,4.652667768609067
SK-CO-1,44484440,3.788843022204708,2.7772987565691363
HCC1500,60750,4.75355506285403,-2.233875249934745
SK-CO-1,44607531,1.475264767684201,1.4239122619709426
MOLP-8,1317464,4.425962710369034,3.391601116735375
BFTC-909,107985,-3.700699007813787,-3.34665114584987
SK-CO-1,3025986,-0.6416687634539443,-0.5141497140466175
BFTC-909,44493528,4.370300807083883,4.371340995299207
SW48,49850262,3.202043440642355,3.556799358057274
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,0.9304742495186418
MOLM-13,5746,-2.6320399073484633,-0.8239637278416534
NCI-H1568,36462,0.6787379731584755,2.0158709483513637
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,1.097564398587388
LCLC-97TM1,31703,-1.7062756219896058,-1.076559637518458
BFTC-909,54454,2.6967031082973527,2.4274496120466003
BICR 31,5351362,2.0722735669158876,1.6130717884707897
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-2.579136211779216
HEL,3543504,3.6690825601144064,3.667756954336367
IGROV-1,11178236,-2.8618715106425725,-3.625490883182926
SW48,176870,1.305545107688616,2.8966234902178405
LCLC-97TM1,3062316,0.5973926668956511,1.5505851153015582
HCC1500,6852167,3.541859976914812,2.539823468879179
MOLM-13,54626689,4.673711949381485,4.172906503660227
RKO,11175137,2.9264569639519906,2.16356574289088
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.8621174616394263
BFTC-909,73707398,1.325657316242966,1.3213889361927413
SK-HEP-1,11485656,3.3898088020096324,2.455875851272238
SW1271,637858,1.8302889918552376,2.110779412709086
P31/FUJ,151289,0.3376751835645198,0.5112979520734853
MOLM-13,6918289,0.5846893448973186,0.682089977378975
RKO,4096211,2.0568907070726397,1.487186544408506
HCC15,42611257,3.545791426903468,3.372428665215168
RKO,51037431,1.443783779144223,3.0672620691523367
RKN,1716436,3.648262431092988,2.9607752147643334
RKO,216345,4.0768365061219525,3.332734153364409
MOLP-8,54454,2.3030156333842533,2.1407122849488265
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,2.1569415652789035
SW1271,11719255,2.0964009449704335,3.259838521713316
SK-HEP-1,5328940,3.1706915881362097,1.8852403187029927
HEL,6914657,-6.908409772348001,-4.791978227432952
LCLC-97TM1,6918878,3.384977217975284,2.62869119780599
HuP-T3,46943432,3.2592232125577665,2.425141960329137
KU-19-19,11152667,0.8748891502312,-0.38759328316897246
MOLP-8,5278396,3.6007551773478093,3.0882711108326766
MOLP-8,71304818,1.8062780808091792,2.0615386388540555
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,1.9316274804311035
SaOS-2,5280436,3.62212536353362,3.414321599039139
IA-LM,71751553,4.579394980470846,4.406603972522593
COR-L95,374536,2.031472802797221,1.721045198532488
HCC1500,1716436,1.6304357372897462,2.697678772862283
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.287039609915322
SW1271,9967941,4.951865473173475,3.6054784957542783
KU-19-19,6918837,-3.3861016705907203,-2.5782199916769946
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,3.531524154770667
RCC10RGB,54626689,5.11978438920743,4.727616304018739
COR-L105,24964624,2.7213287093015848,2.6176306665792697
RERF-LC-MS,10184653,1.661334722418144,1.506057569085493
COR-L105,9907093,4.049740181744662,4.148444050710478
WM115,4917,1.7802954819592542,2.8480958275458836
Daudi,25262965,-3.918146889356354,-2.886669445633004
RKN,9926054,2.8101544562472056,1.9874970425232634
COR-L95,969516,2.641832541585458,2.5260710225401946
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,3.5401216129815545
LS180,60700,-0.831384616867798,-0.2436637468403162
HCC1500,25062766,2.7449885477672136,2.2577921252351603
COR-L95,11640390,2.478695805138082,2.9942846686530693
HuP-T3,54618164,3.3933985234085755,4.143288341193817
SaOS-2,25105715,3.6317688538247968,3.4610423134292088
SW1271,5335621,2.365445027841909,4.620092626601451
NCI-H1568,72193861,1.9818580959671683,1.7064111435306133
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.9123945024027558
SW1573,10385095,0.5068001344623563,1.0900718245281484
ALL-SIL,2841722,3.706104916487932,3.9490020628318665
P31/FUJ,71466445,3.0287439983851225,2.23581449583941
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.3986617199610945
COR-L105,4917,3.658916006838,3.128490020043534
RCC10RGB,9903786,5.708919982977709,3.311027185981521
HuP-T3,25161177,3.646148401953212,4.37000476191389
K-562,71466445,2.3693775657442373,2.4936811713554285
K-562,11977753,-1.2336845020581693,-1.9521164367981894
LS180,16725315,4.563180557999628,4.297386872620388
NCI-H1568,66577038,1.9593359628641709,3.099105999066986
SaOS-2,3465537,1.5281169625539155,2.4744177857332823
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,4.0694245830993925
MOLM-13,17755052,0.2343645648969551,0.7824298225017076
RERF-LC-MS,67156097,-1.006688958645714,-0.6323739302926353
SW948,5470400,-3.941225454290086,-0.6131384019036619
HEL,44185566,1.408371464536178,1.4955316080468097
RCC10RGB,3503,3.522457107356278,2.5615817923715922
BICR 22,9866186,0.6641273098552615,0.9561258904588712
K-562,52947716,-5.609155633475852,-2.8350110518627236
SaOS-2,1641662,3.0320316508312883,3.446037035108543
SW48,5460769,-0.8804369809799648,2.2482527559433065
MOLP-8,11625818,3.354870459420626,3.5860219146491232
KU-19-19,3025986,-0.2897675094370045,-0.7574716374600148
K-562,9444,4.095192274458736,3.7376297592912953
IGROV-1,5329102,1.2794664511054334,1.9709742844099276
LS411N,11427553,2.839596649209722,2.414922149532049
SU-DHL-1,10385095,0.4695713178913991,0.9149305798812344
SW1573,124202324,3.209850220678193,2.6720265620262493
BFTC-909,2949965,3.0294119536880197,2.8092362791261496
Panc 02.03,44589607,4.606435993835204,3.2381645999352946
LS411N,25126798,4.124739072985443,3.8301336888949336
RKN,24785538,4.869460471506453,1.7886343746343727
SU-DHL-1,31703,-2.5255735182995203,-2.311313436207948
KU-19-19,6505803,0.0199416611110358,-0.21141497892422778
MDST8,5281672,5.754114909876849,4.940889614680457
PaTu 8988t,9903786,4.140175125497243,3.0069498209826184
SK-CO-1,11717001,2.027201802005241,4.192692030602163
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,0.8805496368814871
HuP-T3,54454,3.567661200928428,2.4857113885335647
MOLP-8,262093,0.615798330418347,1.9635966147674915
SW1573,6918328,0.8267852089643692,0.23738706139649918
LCLC-97TM1,73707398,0.638027637531153,1.1944672161709544
SaOS-2,11719255,3.097989779485228,3.19781488678981
SU-DHL-1,73707386,2.8817783064824773,2.630714547672448
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.444080301832773
LS180,9915743,2.834892961755663,0.34516449540875443
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.5733931813201892
BICR 22,4578,4.285603675470092,4.422359709436006
SaOS-2,24951314,1.4499530102948022,1.430802447352483
RKN,6918328,0.5495182279950256,-0.1847783100777367
IGROV-1,66577038,3.2148239132520455,3.021533146429839
COR-L105,15547703,4.316721747481802,3.3470937901250237
HCC1500,753704,5.032412058463686,4.8419750427348545
RKO,44819697,-0.2126149769206573,-0.6223410291049329
HCC1500,16013152,3.952751911590144,4.080335998493679
SW948,89183176,3.757757719513151,3.8166607286944214
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.6968547453322942
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,3.017403207122324
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,3.097734016783954
IA-LM,44819697,3.529669119404179,-0.07421701913142167
PaTu 8988t,148198,-4.283282973565046,-2.994049662289903
HCC1500,5287969,-0.1960949732639439,-1.8612749675287676
RERF-LC-MS,5460769,5.094680634820597,2.624665754765071
BICR 22,10113978,3.5652875556244923,3.3696977742413385
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.2025720329442844
LCLC-97TM1,6184667,3.4160200622822736,3.031120114328021
SK-OV-3,44507138,1.930427516054787,2.8642473031421822
SW1271,54626689,4.884226988721356,4.5064369181636925
COR-L105,25195348,2.918205578273492,3.3660800757324587
MOLM-13,49850262,2.0503909100702873,2.4214206770485944
LS180,104842,-3.608354535822108,-2.9555909123223336
Granta-519,6184667,3.6411271735359207,2.265719339821217
IGROV-1,49836020,5.658436828096057,3.18213640232068
HuP-T3,54619267,3.893027602521098,4.020599694225521
SW1271,409805,4.993473873943069,4.857050849222253
NCI-H2452,2749,1.5209092727807076,2.1681312095128757
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,0.45874180878873594
SK-OV-3,119607,5.6958068077620405,5.426701191970571
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,-1.0223156876517452
SU-DHL-1,6184667,2.253300303827536,2.6183948072287144
WM115,2871966,2.231269661110087,0.7271796477065732
SK-HEP-1,219104,4.349330089087446,3.9988884797975843
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,2.7604286605171517
SW48,8515,2.6507036204950256,3.515214153375976
MOLM-13,241158,1.7093626682651633,2.6462401711458647
RCC10RGB,71576739,5.1028364410536735,3.5477937707276923
LS411N,54619267,4.196494516067777,4.051091763766908
Panc 02.03,637858,2.766769284687194,2.1496530282530126
P31/FUJ,25150857,2.053516150415863,1.8119939785070154
P31/FUJ,24951314,0.294555023880993,0.2018352507722369
SU-DHL-6,16736978,-0.092754907722646,0.32131684150630846
RKO,151289,1.190219151105647,0.7533670567792224
NCI-H1568,1716436,2.664872339798973,2.8897767209875203
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-0.5793970910600633
LCLC-97TM1,49836020,1.9924259842665932,3.061711233440854
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,2.093238897148686
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.5243250217990623
SW948,11647372,1.3621251009964823,0.6437666725602574
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.82983296602184
LCLC-97TM1,56963564,-0.6229750501206363,0.477122625081733
IGROV-1,11427553,2.926316692603687,2.744396092492394
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.3525773542681785
SW48,24951314,0.6660870475429757,1.1950876675343542
RCC10RGB,46398810,2.467266718263722,2.6891137749690124
NCI-H1568,16720766,0.7309820541773976,0.7352735089450626
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,1.7093064060648004
HCC1500,6918878,3.8452122267855544,2.49821515166872
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,0.8685973366988315
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,2.4978720144318753
NCI-H1568,9840324,5.648333485386012,5.7241316650935925
SaOS-2,24772860,-2.2454069761524416,-1.7958253379744036
NCI-H1568,12003241,-1.4870303892505918,-0.7525340063654457
IGROV-1,135411,0.626702113064729,0.20235512318425683
SU-DHL-1,123631,2.2104669936854817,1.936205877403773
BICR 31,676352,2.5344425849235472,2.288893910478381
WM115,2828334,5.840169576442124,6.135916712181582
BICR 31,16722836,0.993439631718574,1.7522817811925162
LS180,71304818,2.5144465721497573,2.23518863486738
HCC15,176870,4.3801450304989835,3.282956924597004
SaOS-2,44137675,2.8908105588075537,3.35064123368145
SW48,57519531,1.1891467216952898,2.358573357625207
LCLC-97TM1,46943432,0.977611384475134,2.0858322803740337
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,2.974105841716152
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,-1.3375989026955408
UACC-812,52912189,-0.0403441295384107,2.104845379911041
HEL,638278,3.1804055556137394,2.6411119903927402
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.5525173055349324
UACC-812,45279963,4.1756281682233185,3.656558269517981
MDST8,12001922,2.1068751805520423,1.9522422926224845
HuP-T3,11626560,2.4663043755994094,1.7212496798973445
HCC15,9884685,1.2743229964902805,0.8111001483208692
Daudi,82146,3.751797413920901,2.8408009207647313
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,2.8768403830648674
BICR 22,969516,2.807563254821311,2.975517856302636
RKO,6917907,-7.36544436443182,-5.154393441837893
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,4.2792749901552165
P31/FUJ,54649381,3.661627004097492,3.089104403048879
P31/FUJ,15983966,-4.570279214878008,-4.010566639417193
COR-L105,49793307,-0.7736136433109717,-2.365317744834296
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.3564081614426162
SK-CO-1,57330099,5.774767561552264,4.298429130439484
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-0.9739828712622461
Daudi,36462,-1.782907247885185,0.1720598067185481
SW1271,10077130,5.262255440725952,3.523789148374775
PaTu 8902,124202324,2.5191853508509823,2.3710486929530123
SW1271,4261,2.1417567232825157,1.8478218827321324
SW1271,568763,-0.4148311333850545,0.5986627155469757
IGROV-1,44185566,2.2104732991243248,2.549310576875425
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,2.14958869086796
RERF-LC-MS,54678924,1.4734481784853186,2.324077896883499
SW1271,17759555,2.4829827438054104,3.573668817110367
HCC1500,2871966,-1.8945265193529464,0.34086413011869615
RCC10RGB,119607,6.074674808773517,5.403818094483585
MOLP-8,5566,2.8349074996791295,2.8642257194750873
K-562,24901704,1.0460453676907424,2.4156203826457245
SK-OV-3,44607530,2.4027946355264507,2.0177290222931488
IGROV-1,44589607,3.0909001492794377,2.796391946896969
SU-DHL-1,44185566,1.07324922266726,1.9948815650747906
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-2.6729882050258897
SaOS-2,42642645,-0.01972406793895,0.6722905938144134
SaOS-2,327653,4.165382989627235,2.991920605069952
RERF-LC-MS,44491742,4.380479941679622,4.172268864717531
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-2.760828784815107
K-562,3038522,1.918387146447148,2.664313741228091
HuP-T3,702558,5.633624519144866,5.199230803313051
ALL-SIL,2858523,2.9846374491002376,2.675747895427343
WM115,44589607,3.0632481185375933,2.670472741182381
LCLC-97TM1,11977753,-2.2409153175434953,-1.0048662786264955
Granta-519,7251185,1.138949301849667,1.6408288142957772
MOLM-13,446155,1.5984418257641329,2.0463150439448246
SW1271,11455910,0.4702460968788743,0.9090868409036791
WM115,10184653,1.7306018843706388,1.5880798239460643
SW1271,12003241,-1.4062779923685875,-1.0962687654136087
SU-DHL-1,3038522,3.3518104703058467,2.838391256469161
RERF-LC-MS,44819697,-0.3406635094896507,-0.24690089630036322
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,2.034760432612187
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,1.9828417144757977
RERF-LC-MS,3825829,3.876424055067748,3.95931078559326
SU-DHL-1,208908,2.168834483257838,2.121181374128898
COR-L105,4378219,1.9356703916494296,2.926787436178955
SU-DHL-1,44489675,4.002710700308593,3.679277613584945
BICR 31,5329102,1.5123342757929257,2.155280742469892
BICR 22,72193861,1.1787223619968317,1.495850286988343
SK-CO-1,4259181,-0.2853622975740302,0.22620215863542104
RKN,5278396,4.050807510430523,3.4877974972482324
LS411N,3543504,6.407278726964401,4.1904588550772015
Granta-519,2749,-0.6711865738648753,0.8723377254762138
LCLC-97TM1,11222830,0.9756157307321038,1.613100410244894
HCC1500,49766530,0.4188049276678212,-0.25185515870156616
BICR 31,24821094,2.272776200428542,2.759998867610957
LS411N,15953870,3.79326986504028,3.187790529877867
KU-19-19,15547703,3.5460273004695364,3.2415206948665904
IGROV-1,10410894,3.2660402181528263,3.3968964084837587
SK-HEP-1,9936388,2.725726666175631,0.1083713302496993
SU-DHL-1,68056272,2.8441937668208297,3.0925142798258154
BICR 31,107970,2.625018410874988,2.3725806524975566
RCC10RGB,24978538,2.2083570886635258,1.0462036973897932
MOLP-8,42642645,0.4027543307161444,0.06788088562780838
IA-LM,6438330,0.5920782597943414,2.258332408112612
HCC1500,25102847,3.871994319987046,2.7486309263969586
SK-CO-1,9903786,1.8148473241522671,2.8740028580467767
SK-HEP-1,51037431,1.9503987957256583,3.009078913254633
SU-DHL-6,15547703,1.663295720719241,2.6274847247763127
PaTu 8988t,42642645,1.5127014290808742,1.1099585984352602
Daudi,4578,4.14840859618435,4.281912026177556
HEL,73707398,1.0006953763352662,0.017037087302388277
RERF-LC-MS,3634881,4.923247717838372,3.4637766989502263
HCC15,9907093,4.55737056946543,4.139730015970923
IGROV-1,16725315,4.890680859998698,4.184004477774753
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,2.2554733340411364
COR-L105,107970,2.936160881286492,2.3261681615058136
PaTu 8902,11485656,3.4031855994132663,2.3208868001475764
BICR 31,5287969,-2.0848564793948423,-1.5551152450718189
SU-DHL-1,3503,1.2104794697541517,2.0217096335723976
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,1.9592070816358982
RCC10RGB,107970,3.009214725762471,2.4934648158624753
KU-19-19,51039095,3.4730458815699743,2.923370147201695
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.1406684886550917
IGROV-1,16038120,0.2864038103759729,1.0711185756193322
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.2131862210521756
SK-OV-3,1323703,3.751791158325908,3.622085411518964
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,0.3705127242578509
LS180,56946209,-4.291807545115399,-3.9890988383882364
BICR 22,16741245,4.124711805224883,3.7522390074069034
Granta-519,11396600,3.399615682634249,2.3303372787861893
LCLC-97TM1,4378219,2.0431586025336332,2.7713201614044825
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.684309081670065
PaTu 8902,3062316,3.1999770976977966,0.7934134095821066
MOLM-13,9825149,-0.4975121245832732,1.2891920331158138
PaTu 8988t,36462,2.8739750906545263,2.115945205575136
WM115,4261,1.0617223830766982,1.5590903606000563
BICR 31,54618771,0.3365869204450262,0.9893609300882089
IGROV-1,6918837,-2.9804518885508635,-2.5907816122069596
SK-CO-1,49850262,4.729060483840123,3.7183745534910115
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.307680873933914
SK-CO-1,49793307,-2.625714785229563,-3.136050057585476
ALL-SIL,159324,0.7144692186053382,0.09852896510344504
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.3630663483817463
RERF-LC-MS,24821094,3.899392046553833,3.079074486823922
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,3.441961987752411
ALL-SIL,54613361,-1.2150310590443698,-0.6338622248156119
MDST8,54618771,1.2096098448968695,0.9329921022645883
MOLP-8,26596,-2.4791577040777812,-1.7976794858232075
RKO,4788,5.372325515812119,5.418065892544361
P31/FUJ,44589607,2.3901798108348533,1.8950254570957652
SK-OV-3,613753,3.56222269809742,3.3313504783977224
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.8563587511677835
SW1573,2858523,3.1892649395611556,3.088361196156144
LS180,72193861,-0.0461725132802377,1.4515621671394525
RKN,25126798,3.956068538327861,3.7065706487806676
MOLM-13,6917907,-6.412365954060792,-5.429917779776885
WM115,50905018,4.954075896774319,4.582589526551178
HCC1500,54619267,3.954111090910006,3.924594589963147
IGROV-1,6252,1.1284141516966473,0.7256103181493835
Granta-519,49766530,-2.591856607816134,-1.988805156572615
RKO,400769,-0.364727826621167,-1.0178241081264647
SaOS-2,5113032,4.015669070835574,5.068112429902705
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,0.0011737934980630095
BICR 31,400769,0.3553213589698107,-0.5223773557401945
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.8358317049549558
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,-0.3113296190301485
RKO,24901704,3.90150667551114,3.0489773900260504
K-562,675434,4.134192231732703,4.158401110588878
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,3.176658358223307
IGROV-1,60700,0.4424479122017752,-0.1811381159181215
RERF-LC-MS,439501,-1.3704502050640626,-2.0981786649721137
PaTu 8988t,3081361,3.3861147832051004,2.5977889018470806
PaTu 8988t,11507802,1.1782523393568187,1.6755541968773695
RKN,25154868,3.091821445991922,4.39656992174777
SK-HEP-1,3384730,4.617019540739567,2.750683166887007
IGROV-1,135411,0.626702113064729,0.20235512318425683
RKN,44202524,1.6880658914716755,2.3755631966568034
MDST8,10127622,1.4568360900186117,3.65902984421426
ALL-SIL,5978,-4.2912860791141725,-3.505097682217685
LCLC-97TM1,25195348,3.14182472834864,3.2273414321542786
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.7253426156207146
MOLP-8,2949965,2.304667717892232,2.2018387306729563
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.28974339512374814
NCI-H2452,11485656,2.991875358712002,2.4480722713209047
Panc 02.03,2708,5.654354843286421,4.959884795474611
SaOS-2,15953870,3.7774839542606617,3.3772528025293673
LS411N,11238147,4.220683195687341,2.6108071247056626
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,2.2128132134740364
COR-L105,11404337,0.9270352493146456,0.024510371751184094
RKO,20959075,-2.9107192765247536,-2.6244195926730884
IGROV-1,452548,0.0422661560146271,-0.043882482067293595
SW1271,25062766,1.8071163488926476,2.066107738982657
SK-OV-3,24180719,3.148638094054939,3.617750059031776
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-1.1564572087221412
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.9800229902107295
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.1583636618035262
NCI-H2452,25150857,3.315566378385427,2.54348647344851
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,2.892197135816595
LS411N,216239,2.6090534487015953,2.077843014668302
SW948,2828334,6.27053385486612,6.049091336881979
HEL,25262965,-1.9607005706581808,-2.5502766171405367
SK-HEP-1,46398810,3.2056962377986333,2.76803934322717
P31/FUJ,46191454,0.7861082656977861,-0.23367484660611343
SaOS-2,11404337,-0.7935370479535776,-0.290384482270019
LS411N,6918878,3.507421995092854,2.3747791079202867
COR-L95,5566,3.0030322186541754,2.970633334638352
NCI-H1568,2729026,2.4592472427928795,2.6393252336088624
Granta-519,5566,3.1418180472473023,2.803311559691439
SW948,15953870,3.980690301912255,3.3503321043653704
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,2.210884914217486
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-0.7977248951671828
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,1.9813372612111129
PaTu 8988t,4096211,4.042256121680771,1.8916385263601634
HCC15,638278,3.5096393014384346,3.4031135762590434
LS411N,44185566,2.59688005994845,2.0484537593717977
WM115,15547703,2.53174585982074,3.2001654964821857
RERF-LC-MS,46907787,3.883745984979501,2.576288182281809
RERF-LC-MS,49793307,-1.4864117200972382,-2.4706073778556568
LS411N,6918837,-3.511331359252859,-3.349617639498157
HEL,2729026,2.9938268289747394,1.6898811912701615
SU-DHL-1,9911830,2.4926956672938543,1.9069725467533234
RKO,6505803,-0.9276151073099124,-0.4710360220510792
HEL,5351362,1.012542471793317,1.146469519488197
SW48,448949,2.118847083295334,1.813323396072069
LS411N,3854666,3.592971008902542,1.765508655115813
Daudi,55283,2.1333092426313143,2.0094954388333965
WM115,568763,0.4176363376103466,0.5932258632609946
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,-0.9156595876176733
K-562,54143018,0.8143265967368298,-0.24817002903916482
WM115,6914657,-1.139050920215431,-3.6064414511198453
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,1.2276476697172323
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,3.0102208021433694
Daudi,57519531,1.0816397392331083,1.684000366253304
MDST8,9840324,7.1320098113776185,5.769452235767709
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,2.4130855383298044
NCI-H2452,67156097,-0.4931697978204585,-1.033286761122218
ALL-SIL,11507802,-0.6218585688390301,0.4283467571742716
MOLM-13,9926054,0.378361077880871,1.3930474346216497
LCLC-97TM1,676352,2.332754642745106,2.0700256062476283
SW48,6450551,-0.0066484474606689,2.6845522043244854
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.7208716679996424
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,3.3109274088765734
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,2.9778611760124267
KU-19-19,46191454,1.4474607873871597,1.8039067061315002
BICR 31,135440466,1.3506373291640237,2.3181282871411515
SW948,44632017,0.8619787858061628,1.2644648720026195
NCI-H2452,159324,4.677055932941875,3.314054869758633
WM115,60700,0.0008203329731028,0.0659043527705996
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,1.9612653072604609
RKN,9936388,2.306220468641662,-1.3277060648425771
MOLM-13,2945648,3.0282797197343374,1.819214381015015
P31/FUJ,135875424,3.622681212031297,3.2260830669080303
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-0.779204399751377
BFTC-909,24964624,2.4776408698208003,2.4583213878792805
HCC1500,3825829,4.205963950909598,3.802180594926576
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,1.1787138675831228
SU-DHL-1,135984461,1.9491307161872016,3.2126141491690645
NCI-H1568,409805,3.8387714265583592,4.975538838304172
COR-L95,2945648,2.3261820103406183,2.635172382809115
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,2.542610839244112
IGROV-1,5746,1.9055212643377857,1.1260675797963584
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,3.0741270324884664
HCC1500,104842,-2.1208898309536073,-2.553627518906123
IGROV-1,148198,-2.659972993252853,-3.5261471220085974
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.500386333686146
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,1.108112206618942
IA-LM,5746,4.310443233142937,1.092354220870052
WM115,10427712,3.357641117907952,4.298861077565382
WM115,31703,-1.493876478932265,-1.4387938764777917
K-562,10296883,3.719487542859837,3.293653400933985
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,0.4691493506905841
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,4.098536149673814
IGROV-1,10184653,0.79276129336756,1.346027504117971
K-562,5287969,-0.8630520858269013,-2.1876749529410957
MOLP-8,148198,-4.437033387624053,-3.771897919842772
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-1.0107019172892295
BICR 31,24951314,2.26082148142024,1.4849766298897802
COR-L95,9887053,2.0711365362831193,3.347100360626233
SK-CO-1,2841722,4.495379043063509,4.200289108383283
COR-L95,54618164,3.8157010413732406,3.88833872680818
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.424699251766228
SaOS-2,25262965,1.6840235781335875,-1.3349181300803223
MDST8,25150857,2.921484336528134,2.596596739483865
SK-HEP-1,984333,0.8474815446030621,0.5690558928316998
COR-L105,5311037,4.270584574919318,3.932536487977401
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,0.47041505559216806
LCLC-97TM1,3825829,3.858617243526108,3.972022286467539
SK-OV-3,24951314,1.413681041410239,1.4628871073372807
NCI-H2452,9903786,2.1501841215173396,3.388465982858634
PaTu 8902,56963564,4.5637436248697565,0.32657982741122493
SaOS-2,262093,2.7398792490382244,2.850654015276487
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.717539919271623
BICR 31,3854666,2.26793763186435,2.3040711417789144
SK-OV-3,15953870,4.452396287203901,3.578442055768406
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.221810947029562
BICR 31,24785538,2.8976650742045127,1.8445629139379272
HuP-T3,9903786,4.0743016574038915,3.198459466564547
Granta-519,11175137,2.0306520437568767,1.6977529537165705
Granta-519,25105715,3.663648488967505,2.984550904714341
NCI-H1568,49867930,4.553956635433513,4.934410726329622
HCC1500,16038120,1.5738549040879308,0.8896660923453823
LCLC-97TM1,227681,3.759896348853487,3.531912400049235
BFTC-909,49867926,6.076136735210805,4.427494320277182
ALL-SIL,5278396,3.0589186731365814,3.0518277337801636
HCC15,2742550,3.2685764522673972,4.045392351527786
RERF-LC-MS,44486219,4.018485879154908,4.501872397345791
RERF-LC-MS,462382,0.9319597157341816,0.8493720319398015
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.458546785112799
SW1573,3854666,2.927116287337192,2.315490867798105
Daudi,9935249,-0.0031627785077317,2.082101281895723
MOLM-13,10231331,1.9024628033326092,-0.0025342698350358252
SaOS-2,6918837,-2.9214939411920593,-2.6513803046433098
HCC1500,11507802,0.960722132601806,1.7858507184444372
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.5301485108319943
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.9051255852756472
LS180,9911830,2.83226076921101,2.4207904194414227
RERF-LC-MS,11222830,1.7620759794741472,1.8098394426495366
MOLP-8,6252,-2.041702184925406,-0.39818416842460347
SW1271,5978,4.916909360273371,-1.0834938320725827
MOLM-13,5479543,2.5400848053862264,2.2700181730660485
NCI-H2452,11612883,2.7546488169018963,2.942078959791088
NCI-H1568,44493528,4.1542795967274175,4.223051931944147
RKN,46398810,3.1612721401313792,2.6256878024657935
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.229951664244017
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,-0.060923441108399964
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-0.4725281734625321
SW1573,31703,0.7694714266266048,-0.6734363238479619
BFTC-909,11238147,5.503103761619835,2.8907401906441303
SK-HEP-1,637858,2.866868896175592,2.2832658557592707
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,1.912746938731661
KU-19-19,2828334,6.071698785304069,6.200830629322194
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,1.534284358141405
RERF-LC-MS,2828334,5.9123201087220325,6.168079455067276
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,3.4890766666626187
PaTu 8902,54649381,5.340946431274584,3.931519725169207
RCC10RGB,11214940,1.429625683961422,2.165812225034411
NCI-H1568,25195348,2.211268152441431,3.462684785582357
COR-L95,10184653,1.5221413196357014,1.0595107615975956
BFTC-909,3634881,3.6308731463535704,3.3096176083492814
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.6956772116970126
SaOS-2,24785538,-0.4134197784310965,1.186252717683065
RERF-LC-MS,4705,3.292681011259135,3.283418448147552
MOLP-8,10127622,1.9499981558353492,3.6556237887060847
Daudi,11626560,0.3779689739853294,0.6020638348374149
MDST8,168312962,1.677679532849221,2.195965948279102
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.2522689501913358
MOLM-13,10113978,0.7724135376915046,1.7006776058383326
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,1.9455900113510871
HCC1500,216239,1.4805608336728902,2.1498583361049883
RKN,5281321,-0.4803497212669658,-1.4498272869570463
PaTu 8902,11175137,3.538788964844938,2.745231285999322
Daudi,10113978,1.6179427120332186,2.272593953203616
K-562,26596,-3.6076758496321832,-1.7477175634712843
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.13282021227364185
Daudi,5291,1.8632614405000685,3.214568366461536
NCI-H1568,2874250,4.364133169191667,4.477735635679339
LS411N,984333,1.2324204412799928,0.5545882756998352
PaTu 8902,11222830,2.39915227633331,1.6617123173295056
MOLP-8,54678924,1.6307832002497362,1.3436862661768005
COR-L95,49793307,-5.549400502924621,-3.7158272181116363
HCC1500,45279963,3.5713917460093434,3.6183484206749976
WM115,54765302,3.574934655958074,4.175030523021643
SaOS-2,136227924,4.496792726095474,2.9916889276482483
NCI-H2452,107970,2.3345640718356364,2.333370921893868
LS411N,16720766,1.2713952174238143,0.5583692354714102
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,0.199899523042175
MOLM-13,216239,-5.069803023561943,1.1595742269192508
RERF-LC-MS,44241473,4.536869636330491,4.876684926280462
LCLC-97TM1,10074640,3.2021543880531156,3.0369009325715974
Panc 02.03,10296883,4.297264305827386,4.03829069749959
IA-LM,3689413,-4.432004355370191,-0.8318429221104492
RKO,375860,-0.2095842697906711,-0.3713313348201578
HuP-T3,676352,1.9029965224961456,2.293747970958581
SW1271,5470400,4.349220092525355,0.44705974449596086
NCI-H2452,656346,1.056906556032961,1.2617606138224045
BICR 31,56649450,1.7574149169243078,3.2698186333421506
RERF-LC-MS,24785538,0.8057743011820994,1.869418526151334
SaOS-2,9825149,0.8893885919981879,2.1926779581677085
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.8412469444270743
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,2.790009447891206
SK-CO-1,638278,3.4780853527987854,3.049672890542632
WM115,4096211,3.685037910266886,2.126861738908557
RKO,126941,-5.081226966265268,-3.0167323432164643
RERF-LC-MS,54618771,0.9955970244631366,1.0032065381135877
Daudi,50905018,3.9297282000687312,3.8683254038349846
WM115,11609586,3.058244435077658,2.8064589662262636
BICR 31,9926054,1.721382648019371,2.0465896156323247
RKO,24821094,3.7157598247146977,2.6069677007193777
IGROV-1,135440466,0.9791523710816318,2.1411341907688235
NCI-H1568,44202524,1.0522971592210668,2.522618818100905
HuP-T3,9933475,3.0776536859408807,2.084917269451679
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.605117112283415
BICR 22,11612883,2.729453217725868,2.958044717423138
MDST8,25154868,3.4078840547236333,4.587610726251096
WM115,12001922,1.1273981641266086,1.768638844565224
SW48,2742550,3.28553671385033,3.682493795455492
WM115,445091,3.8598878691820886,4.4351384355011865
RKN,135875424,3.6230459419726526,3.907533902267847
BFTC-909,2708,5.254338200716292,5.030949753593421
SaOS-2,2871966,1.7918423486815835,0.46735305391180954
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.1004321968706954
HCC15,44632017,0.3758817607479284,1.380365761839348
COR-L95,2729026,2.664378744829576,2.4542099743242085
SaOS-2,1566236,1.7620742085681662,2.297092420153464
BICR 22,11955716,-1.4294009955010087,-1.2393055339793695
BICR 31,2729026,2.966794528433677,2.7608906304880336
COR-L95,119182,-1.6347192148686482,-1.3521802827273413
LS180,5328940,1.742567210928755,1.3582446037903568
Panc 02.03,46398810,3.420081587494409,2.58469576624673
RCC10RGB,60700,3.171193268028763,0.3407584525334667
SU-DHL-6,451668,-1.4332734905345434,-0.8409730245588721
Granta-519,16219061,2.116318709414125,2.449387771280323
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,0.914890669088863
HEL,53232,2.5038982548529747,2.5350256238781905
RKO,44507138,3.480554434186059,2.067245035810198
NCI-H2452,3081361,2.98247650375621,2.602524644723073
RERF-LC-MS,44202524,1.2785968032229695,2.4273214586163085
RERF-LC-MS,16722836,2.4162442447682193,1.8068013468848767
HCC15,637858,3.032734575357801,2.219223457107026
IGROV-1,11396600,3.99372654279783,3.7382466468386273
BICR 22,44202524,1.658152527320416,2.6116584156378173
MOLP-8,54618771,0.2679151571300236,0.20617904274380577
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-1.2932376589586152
LCLC-97TM1,54678924,1.535359034662644,2.147179649867555
BFTC-909,49793307,-2.946331542038894,-2.666747677829641
KU-19-19,5738263,3.812580710038467,3.5553297676221667
PaTu 8988t,24821094,3.93253598055128,3.213444653265688
LS180,148198,-2.644013472885731,-3.423440295698745
HEL,409805,5.92709656224454,4.103154472174648
RKO,11612883,3.106052261550285,2.1425137242868115
SW1271,122327,4.37632222345113,4.607769985988757
MOLM-13,44241473,6.124350775268443,3.8619239528418143
HuP-T3,2126,5.715410620657667,4.779831899539771
K-562,5291,-1.1872539047134878,2.443841013984119
RKN,5282054,3.624299707956654,3.8014106747500396
BICR 22,613000,2.6534426018316277,2.837032999513434
HCC15,49850262,3.6300454046422774,3.701196297676495
SW948,613000,2.5939391420023212,2.299862435538513
COR-L95,135440466,3.0574476104836914,2.1280842888619107
SK-HEP-1,262093,3.158620019748703,3.0735844420066547
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.32470123770917697
MOLM-13,123631,1.0914116119684203,2.0167856514678117
BICR 31,4378219,2.049792351388142,2.7942225778137977
LS411N,16722836,1.825979837410603,1.5142163541410754
SU-DHL-1,10074640,2.3568880289385654,2.6366229990505765
ALL-SIL,6918328,-1.7903684912223865,-1.8302908692848388
SU-DHL-6,3384730,1.0298608560692932,1.5920751706115
SU-DHL-6,11485656,1.7981230616770194,1.7176029984527765
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,1.8440078229679657
NCI-H1568,176870,1.641159934282528,3.2577073081888184
HEL,5280436,3.9989145330348896,2.747010844742247
BFTC-909,5328940,1.2290524134113243,1.7207669393007938
SK-CO-1,151289,0.7492352886663923,1.086764416177006
RERF-LC-MS,104842,-3.024577047260716,-2.457394047783873
PaTu 8988t,46843906,4.444995617536364,3.394586239645438
BICR 22,24856436,-0.0251718817877118,0.5806429763007577
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,2.257702538380852
IA-LM,67156097,4.3159050642226,-0.7753156177176482
HuP-T3,6438330,2.3942211080747837,2.503423817462849
HCC1500,10296883,3.843895309810077,3.5970897204307164
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,1.3679924749337773
SK-CO-1,56946209,-3.7989193199280016,-3.9374100617003926
Granta-519,148198,-4.763660659469611,-4.145518782605365
HEL,4917,2.9031193377759603,2.6372266480405675
RCC10RGB,66577038,3.312011612499516,3.0415241398575126
Panc 02.03,3689413,0.2165954212360822,0.01531456586567207
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.820996958772299
SW48,241158,3.5185545260205364,3.6989267472453524
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.8417980342127753
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.7984604210719994
K-562,11167602,1.4540526159902811,1.9302035107521198
HEL,9911830,3.2406370139452134,1.4233738551244068
SW948,25150857,2.687963392787196,2.1760531781006414
WM115,44137675,0.4260207876885596,3.6788780980229796
SaOS-2,4917,3.064827494863108,3.0247470414425175
SaOS-2,3503,1.987605483793098,1.8725060837805183
LCLC-97TM1,9840324,5.858053248657865,5.752685697227755
RKN,11178236,-3.061903912386503,-3.264568854514602
COR-L95,46843906,2.16387123849571,2.588718169042131
K-562,46191454,1.7723208241237427,0.742937897552692
LCLC-97TM1,5746,2.627938158922912,1.0002392288500799
RERF-LC-MS,613753,3.34976336152667,3.3452999016868263
HCC1500,9823820,4.617789125102065,3.56411116769382
PaTu 8902,49793307,-1.5016152541437175,-2.60707992467966
LS411N,24964624,2.837560916730962,1.8961291392961344
Granta-519,42642645,-0.7384711962533689,-0.27142938963754376
Daudi,156414,0.7854974484116999,0.6622162319706516
HCC1500,9840324,5.570797833564005,5.603654903702481
HuP-T3,6914657,-2.995276103152913,-3.690577434134931
SW48,11178236,-2.976969958039468,-3.0909705517980215
Granta-519,11214940,1.149911870185247,1.2897020064202294
Granta-519,72734382,4.317814968690637,3.3382764832800746
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.7133433048755384
SK-HEP-1,15983966,0.8278271069258164,-0.7061610025116213
BICR 22,6610355,3.5129220888937622,4.516138360395848
HCC1500,44489675,3.6836892776405854,3.809938425112946
IA-LM,3634881,3.385658224323674,3.127004239426134
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,1.0110186730380655
COR-L95,4788,5.892645370038274,5.330693411482695
NCI-H1568,11717001,4.19629869858104,4.286068081796018
RKO,46224516,2.430810450928805,1.950843216156266
LS411N,6505803,-0.6536233604701492,-0.7449716583111753
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.252598638587159
HCC1500,16725315,3.090868252599208,4.149054951740306
Panc 02.03,5287620,-2.132468814908427,-2.234043478340902
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,0.1522183132327738
LS411N,5351362,1.130738510814583,1.4217232746858237
IA-LM,168312962,3.008218706470952,1.848585857899971
SW48,9887053,1.6385742110161594,3.8279122150423706
HCC15,2945648,3.8992008266513305,2.9082244030061934
WM115,10385095,0.3137764342063494,1.171127027149601
SW48,11213558,0.38171338020492,1.5482024583134208
IGROV-1,9911830,1.9130562323799436,2.581080133406977
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-1.7082993831597433
LCLC-97TM1,5284616,3.038958191933125,2.4593511450763477
SW948,5311,0.5245292911924586,1.286164172497661
PaTu 8902,2949965,3.498586647815041,3.027176541378471
PaTu 8988t,53232,5.050646647161413,2.7734750835533
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.5830511343382849
P31/FUJ,2729026,1.895106624580685,1.9989518244812285
SW48,568763,-0.0201118962331156,0.4826053880590924
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.0297774236669726
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-2.8526839292774446
SK-CO-1,54454,2.352526453014332,2.714038805645069
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,1.349686684080045
SW948,151289,0.9927868711009586,1.077720301548539
RCC10RGB,676352,2.417271143726191,2.374817941091438
LCLC-97TM1,15953870,3.316413299321368,3.593445415503007
HCC1500,252682,6.335850466863892,6.326842609326778
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-0.6267692729572905
SW1271,702558,5.67814751001827,5.019397293958059
HEL,3503,1.2339935625044716,1.7134808497155354
SW948,6918328,0.2458443826474451,-0.17938231378397262
ALL-SIL,124202324,0.3755400921280209,1.0109144180621343
SW1573,2729026,2.4001203305493397,2.6924960112546232
SW948,57330099,4.403961221202979,4.1576463806009
UACC-812,42642645,2.375397400257474,1.0423153155880132
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-1.8878372391574745
PaTu 8902,984333,1.3011106079808883,0.5506271268379307
P31/FUJ,135398516,1.7387657861081838,1.3912127220817332
WM115,46224516,3.0669076127990276,2.533288291915858
SW1271,24771867,3.777194428597206,2.6750488641778474
HEL,73707438,4.0836720937600175,3.6890442858294334
MOLM-13,16038120,-1.7825288578452578,-0.08476741500475776
IGROV-1,10427712,3.944243047938238,4.1936635120178885
LS180,3815108,3.93048377981505,2.8750210467619413
HCC15,1750826,-0.4775912601104041,-0.9262133199996722
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,2.939427579435854
P31/FUJ,42642645,-1.1469220315427042,-0.11206953187239124
HEL,1750826,-3.7677259179114047,-3.3994480255733674
NCI-H1568,25183872,-0.3156837582718859,-0.40736802737409383
SW48,54143018,-1.2192841502688678,0.46513921817062576
SaOS-2,441298,1.6833347099113902,2.3054067359171997
SU-DHL-1,119607,3.7964753700545546,5.029622003454348
LS180,654092,0.275565618798522,-0.1421776509687436
RKO,6918736,-1.762610939534952,-1.7355242615806037
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-2.200723382232922
SK-OV-3,168312962,4.003119281373622,2.3588652640516283
PaTu 8988t,3062316,1.6786738127042626,1.2666165121366553
P31/FUJ,5746,-1.0128835373821496,-0.1200549114187194
ALL-SIL,46943432,1.7359798293614472,0.9992866521610574
IGROV-1,119607,5.004384040905396,5.248768694090532
LS180,135440466,2.758543039731734,1.9417480871402157
HEL,15983966,-4.130179752932702,-4.345959411664927
SW948,11228183,2.319596035574442,1.7616333294709603
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.2400274504204636
NCI-H2452,219104,4.089454197150707,4.078386671404348
LCLC-97TM1,24856436,-0.9719468010392746,0.44136059270526373
WM115,1716436,2.084402062067542,2.9779482012854284
WM115,54596558,3.929397107249587,4.278237561885259
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.3748321174191651
SW48,2828334,6.103861625006206,6.1102077764161775
Granta-519,5335621,4.386788840750005,3.8642495406459987
NCI-H2452,25105715,3.487348959516136,3.5176980035013754
LS411N,11152667,-0.1489697958567156,-0.4618939536941617
HCC1500,4259181,0.9827468065480526,0.25758993931295754
SW1271,1716436,3.164329770032204,2.827678397120545
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.47794213487774906
KU-19-19,637858,2.3404288739792314,2.0742796016779232
SK-OV-3,3081361,2.5908903164469317,2.715520264090976
BICR 22,10322450,4.612637955736889,4.158047705544297
ALL-SIL,44819697,-2.9345943950607136,-1.8995411514887115
LS180,4259181,0.5796574720850999,0.2793451386064802
IGROV-1,6918328,-0.5330006254346346,0.329236118728103
RERF-LC-MS,11178236,-5.98494163410248,-2.6952254024305313
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-0.9683226574996462
IGROV-1,11485656,1.900409616013456,2.1509280772549495
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-1.202418376782622
BICR 31,16065773,3.973194001978765,2.7192809453377778
IGROV-1,6252,1.1284141516966473,0.7256103181493835
SaOS-2,135398516,5.990406168261382,2.1396599307378366
RCC10RGB,11485656,3.364959979667133,2.513237563899546
NCI-H1568,46926350,-5.085925204635643,-3.9089521389644255
LCLC-97TM1,123631,2.4246211789463445,2.451358983656497
BFTC-909,44185566,2.75887016136311,2.6661674103272213
BFTC-909,124202324,2.9321657702899295,2.6260435025052242
LS411N,4917,3.429074291339912,2.9141642219049406
BICR 22,135440466,2.8663984884678513,2.0645501213212216
HCC1500,10127622,5.201205269222406,4.214183025269109
WM115,24748573,1.2650334763374356,2.2709728499219954
LS180,17755052,1.7669119525953814,1.5767765475537499
HEL,5278396,2.941082820113368,3.0692313219634593
K-562,6917907,-5.621792844351372,-5.509516274677434
WM115,11175137,1.8074191527620995,2.3259952510170065
ALL-SIL,6610216,3.679901693613009,3.969414142918706
IGROV-1,3815108,1.915722485757852,2.8964244376762123
IGROV-1,44491742,4.406671418311328,4.167595100528765
NCI-H2452,11647372,3.7610160121318055,1.4095703070909207
Granta-519,25262965,-5.6090339200635375,-2.740028896537803
HuP-T3,5287969,-2.0305885584054693,-1.8210586856035937
Panc 02.03,4578,4.394890119629889,4.542764733477264
PaTu 8902,46199207,3.581196343990194,3.196658456605941
MOLP-8,5329102,1.1360795478534944,1.531672617465266
SW1573,24797083,0.9725439959134782,1.37950703761194
COR-L105,11507802,4.378208095645504,1.9483387934347807
SK-HEP-1,10385095,2.0924930980552148,1.2291003962458416
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.637846753151331
MOLM-13,54618164,3.841266236609366,3.510586310759092
SW1573,5287620,-0.7347028317725576,-2.081390121342029
Panc 02.03,24821094,4.183998590604807,3.1955573772333645
NCI-H2452,11977753,-3.0535753971711617,-1.2359557421112704
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,3.096374394769337
K-562,5278396,3.2143611477277325,3.2802707811477
MDST8,46907787,1.4338285439483007,2.5132929597995517
MOLM-13,16219061,2.363003680724254,2.3705141530399096
IGROV-1,3854666,2.3355254440561137,1.8699164720467873
LS180,11175137,3.0855574956004506,2.581315243272503
PaTu 8902,24180125,3.5735575491444505,3.3279468274193493
Granta-519,135440466,3.2501433765769097,1.6854028488735089
Granta-519,3634881,2.8250958488191533,2.6144908848048267
BFTC-909,24785538,3.0409365635840433,1.6152175124967956
Daudi,9903786,1.3988461789185107,2.010378531393206
IGROV-1,126941,-2.246216453812328,-2.5557702043974597
HuP-T3,327653,2.4979616286385573,2.921199072383093
KU-19-19,24785538,4.6207321752497545,1.766910193311835
PaTu 8902,11238147,5.651020754323713,2.847872061292808
P31/FUJ,24772860,-2.926152167827307,-2.656103756960917
SW48,969516,2.6010409472277303,2.6792588832355055
NCI-H2452,11656518,-0.3763326461825258,1.9433641278718514
LS180,156422,4.137124258725139,3.984867268034892
K-562,16038120,0.8140588279430221,0.3298061138295967
HEL,9956119,2.2634866876643924,2.8456764585146526
MOLP-8,16013152,3.9032026583920656,3.5427887954894532
SaOS-2,7251185,2.1177882155213488,2.658331740266571
SW1271,16722836,1.1489272284540188,1.5678679450348114
SW1573,1750826,-4.895155026964416,-0.9824037152796347
COR-L105,6918878,5.053406021852451,3.0242942028739104
HuP-T3,44566777,1.596285673654969,0.7284667657715224
RCC10RGB,11167602,3.5267453541831695,2.8831905762178622
KU-19-19,3689413,0.155027117273248,-0.21187132195343064
LS180,262093,3.1953995116592826,2.775282532832543
HEL,168313016,4.358661125075543,3.8867513420238935
LS411N,448949,2.5849168666236273,1.8231153736953347
RERF-LC-MS,11507802,1.168612691302407,1.7575609946464945
RKN,3025986,-0.1432368238740909,-0.5343578738115565
LS411N,5566,3.1552423609786153,2.9658926522148312
MOLM-13,168312962,1.173226591058953,0.2947620816469194
KU-19-19,16741245,1.8623441782077492,3.828781470773472
BICR 31,5746,2.9612823230829592,1.0966581728963778
RERF-LC-MS,448949,1.7883798522328354,2.146898626160346
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,2.112532676654865
K-562,135411,0.731253239019591,0.14303981473939772
WM115,3825829,3.803690072721518,4.053783882934915
PaTu 8988t,1566236,2.792784501487116,2.3427318028670556
SK-HEP-1,25102847,3.375423501622406,2.4660860953662893
RCC10RGB,4378219,3.5112219508307017,3.1364559716139047
IGROV-1,46907787,2.182756719431072,1.9640193710784752
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.5069768252756
COR-L105,9903786,2.948812050867326,3.463358760761967
SK-HEP-1,5287969,-1.6185163943497696,-1.9746869966016698
LS411N,66577038,3.114674219164565,2.7973276319665192
LS180,11152667,-1.0678137233062412,-0.8610895308146812
SW1573,10322450,3.835483834832597,4.118599327966475
ALL-SIL,4369359,5.632204520937589,2.331956048628919
P31/FUJ,6918289,5.395091759648689,0.22043550099345155
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,3.1648611145716554
BICR 22,54626689,4.975060177279609,4.815766245231166
RKO,11455910,0.1271196393609195,0.6956915372166793
NCI-H1568,2749,1.8950065449811435,2.4176656118580975
SK-HEP-1,2858523,3.173409588420467,3.06677856645607
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,2.1784635519556503
NCI-H1568,16736978,1.0202421307584555,1.9515320124423783
NCI-H1568,11640390,2.883529605834316,3.691006715629071
SaOS-2,375860,-0.2844076074043694,0.029892094607595298
Granta-519,9549297,1.4990763156673828,1.4300579576427939
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-1.219990364684673
MDST8,9915743,3.1722151191536607,1.1180695326855048
HCC1500,7251185,1.592161448601532,2.231052187514382
PaTu 8902,654092,0.4014878659730266,-0.01182330809200177
HCC15,36462,0.276886424919507,2.218684757342178
HEL,11222830,1.7664464656365049,1.0002397525568518
LCLC-97TM1,6918328,0.5489211755624944,0.005540494130342442
SW1271,11427553,2.280233400826346,2.821737924370839
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.73447260010512
SW1271,216239,2.3992651597700805,2.308149183628653
LS411N,52912189,2.124177170278397,1.173179216110321
RKO,262093,2.7220373961576834,2.3446608724891167
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,2.835032328040727
SU-DHL-1,24180125,2.3898229933344193,2.8362236823682734
P31/FUJ,10231331,0.360402840185862,0.5194057539351089
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,1.1923300070874587
HCC1500,4705,3.1720127097688073,3.133439185860624
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.8236980104476097
ALL-SIL,49793307,-3.5976005593324607,-4.32963527048113
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,3.809172896217765
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.4963146108735557
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,4.789986474554292
ALL-SIL,44489675,3.868517697091687,3.4964482274926216
COR-L95,9825149,1.4009706639997015,1.7841771997859317
SK-CO-1,25102847,2.4259034566713087,2.4936206982402074
COR-L95,36314,-2.5383774872687743,-1.779963798775985
IGROV-1,1641662,3.5854177848263675,3.4518126093513994
BICR 31,16720766,0.8786813091838682,0.8758589867912145
BICR 22,51037431,2.6213243445689254,3.1861591821104844
BICR 22,2742550,3.9616050819266326,4.0348059778584
Panc 02.03,46843906,3.852893526574364,3.450492112190261
NCI-H2452,2708,3.4614923437122704,5.174277848285833
RCC10RGB,15547703,6.556615668020641,3.403173548752591
RCC10RGB,5311,2.218274000934613,1.9048474395218522
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,2.7077386959227483
LCLC-97TM1,24964624,2.5877637900313384,2.3607374720651917
KU-19-19,107985,-2.420790531142743,-3.1523593470396145
PaTu 8902,67156097,4.866613623772486,-0.48352896289779523
KU-19-19,676352,2.681008284282423,2.164456296507469
NCI-H1568,67291369,4.628091486396258,2.6180657670837943
BFTC-909,54143018,0.6300785047889099,0.38521029808683416
BICR 22,5329102,1.9183442886017033,2.1918818408784997
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,1.1748429045067252
SU-DHL-1,1641662,2.0867851207635044,3.0863138566887636
SU-DHL-1,54143018,-1.2287450259829942,-0.028323250351040104
WM115,3552672,1.460151745141153,2.6178539822464155
Granta-519,6505803,0.3707466177802866,-0.8415070916015108
BFTC-909,2733526,3.41724914482818,3.801110715963538
COR-L105,445643,5.447871607768224,4.110007490685056
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.6010061844881096
COR-L95,135421197,1.4504202802892363,1.6137252292666935
BICR 22,4096211,1.2113689067872688,2.4468749330670434
Daudi,241158,1.9180708700138325,2.5450013297596032
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-3.66343781091487
COR-L105,44543605,3.798835657012519,4.182243568875956
NCI-H2452,1641662,5.47511848960003,3.5645437310461596
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.2201500569649495
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.45699062942660246
MOLM-13,44489367,5.70063080501961,4.084692078295555
MDST8,9936388,-2.5080849755955485,-0.30494487724297153
Panc 02.03,5311281,4.827416145020449,2.5675372098922993
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,1.2577102638382172
Panc 02.03,71466380,5.929652601038649,4.612421880996625
BICR 22,148198,-3.168643556299537,-2.745334024842799
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.901010433385249
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.3347999558846118
MOLP-8,36462,-1.3356090090333852,0.5505038787863026
RKO,168313200,3.1169425006108455,2.8056263474354557
SK-HEP-1,24951314,2.4991128927954063,1.524695451991401
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,-0.15349011553514683
COR-L105,71304818,2.509036292239667,2.64055603629223
LS180,11485656,2.0322073649322716,2.0368671561257825
SW1271,44185566,2.531281599529394,2.5685596446958696
P31/FUJ,49836020,4.674155414221834,2.357190644336631
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,2.6955241754945147
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,2.426322103286327
RERF-LC-MS,9933475,2.253072026550434,1.949360852289211
SK-CO-1,24964624,3.1718881088721735,2.25984642085451
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,1.2822799612936342
LCLC-97TM1,54619267,4.094508182091097,3.976251472122991
SW1271,53232,2.609582991635379,2.637727742929926
COR-L95,5282054,2.7623794331923293,3.319626495339808
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,0.6742668529966818
ALL-SIL,2749,0.4174204822378836,0.7009146486375997
MOLP-8,11455910,0.4759456923848041,0.5449372762821173
SK-OV-3,5329102,2.1848030817162427,2.1506358329173496
IGROV-1,5978,-1.5618214380165825,-1.8536393558125368
BICR 22,135411,0.5903998872112299,0.5441880442660696
NCI-H1568,6610216,3.52063980115584,4.31678460879635
SK-CO-1,176870,3.965368978694832,3.2617607688692787
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.3132894689602272
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-1.0700539042796071
IA-LM,9936388,2.150111055311291,-0.7962021864715768
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.5676313700747233
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.676197090246302
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,0.9854437858565087
P31/FUJ,11214940,0.6332731592867608,1.2788802810675592
WM115,421610,3.513747492259629,3.181056969289648
SaOS-2,227681,4.210698048028356,3.3084048316068015
BICR 22,25102847,3.5270600092516444,2.64236309738897
BFTC-909,46199207,3.2760821272908753,3.2726200663830864
IA-LM,25154868,2.8804249714329537,4.4130729481944115
SaOS-2,5738263,2.656867973667437,3.3467673213949802
BICR 22,5738263,3.828959854789421,3.472736307561234
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7955400842695028
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.4477385185332796
Daudi,24771867,-1.2539165255857252,0.044847758484083844
Daudi,446155,1.8075236258569949,2.4184574065511635
LCLC-97TM1,56946209,-4.83981355951691,-3.9871488216225788
BFTC-909,702558,5.601571619782522,5.099766103420165
LCLC-97TM1,24797083,1.6672233423539589,1.4887334889846702
IA-LM,2945648,2.6647419367463794,2.9440887980607213
LS180,11717001,4.39666521822979,4.093241340399059
LS411N,42642645,1.4293896003043414,0.6130256422309912
SaOS-2,16038120,-0.4228492368909831,0.9282905610879932
HCC15,387447,-3.5284625014182556,-3.9654433366265534
K-562,24785538,3.0712560410264436,1.0332414360995172
PaTu 8902,6918289,3.1585202712855196,2.7661899626605813
BICR 31,11404337,-0.6318210319309021,-0.16891669542725996
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,0.8769644916532359
LCLC-97TM1,5460769,-2.8089441547625067,2.480604515291767
IA-LM,25150857,2.846024040084871,2.392263667338845
HCC15,56973724,1.575466068691269,3.285533318775486
ALL-SIL,3384730,0.9130815120154347,1.4038620331142224
Daudi,426756,2.2442144831253383,3.9791455074568036
NCI-H2452,6918328,0.3371182351616307,0.1886340525413434
SW1271,11364421,-1.228057709924225,-2.6427651269971237
HCC1500,9911830,2.253316240952314,2.4425334479287706
COR-L95,60750,-4.239654973449372,-2.720241053131166
COR-L105,675434,4.897128449999278,4.734332964280965
RKN,5978,-1.5379865785523688,-2.0915979533452718
BICR 31,1641662,4.3069637553272715,3.440102926181697
SW48,5281321,-2.141746406212142,-1.5864892763393101
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-1.128297842859821
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,1.2522572821144553
K-562,12003241,-5.632155645383806,-1.311640323818112
IGROV-1,11455910,-0.2792640061206097,1.0139357818805728
COR-L95,10410894,3.9632969340699735,3.318716189567265
SW48,5351362,1.0988845715277948,1.4849235204679234
HuP-T3,9907093,4.467626530245781,4.356008007952562
IGROV-1,16065773,3.3717508464278585,2.3267038517978325
Panc 02.03,439501,0.4668648826805023,-1.6524156799722802
COR-L105,11427553,3.315123926488956,3.129799104564583
IGROV-1,119607,5.004384040905396,5.248768694090532
BICR 31,151289,1.9519908762907336,1.152241923844195
SK-CO-1,60700,-2.5556595153787915,0.05621301777336608
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.286270793839489
BICR 31,3825829,4.543850483279072,4.082468026527286
SK-CO-1,65064,5.377201033407044,5.026801245312411
HuP-T3,613753,3.2946831222357233,3.340575944919271
SK-HEP-1,89928392,1.6602086186634375,1.7779555756042706
NCI-H2452,5291,3.747673065274588,3.7609492838167866
NCI-H2452,24964624,2.8171716992687967,2.539192904145005
SU-DHL-1,654092,-1.6609972231677514,-0.6723877857249428
LCLC-97TM1,327653,3.202975625508304,3.1602436653940065
LCLC-97TM1,11507802,1.3666879232460134,1.6214282574837942
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,0.762447396782064
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,3.06818264624461
SK-CO-1,11222830,1.7982943188317977,1.7026074063344174
WM115,24951314,1.781657055553587,1.3211269333297972
WM115,135421197,2.9135607351561883,2.2999274333038953
LCLC-97TM1,136227331,4.3740550996774745,4.1406972666887745
BICR 22,24951314,1.8959621159637303,1.2837639307578335
HCC15,15983966,-4.250826265389746,-1.3086053822969277
Daudi,24964624,0.5895170730703193,0.8746304964572005
SaOS-2,11257553,0.2323229130258903,1.3229182138763695
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-1.0395024307998701
RKN,46191454,2.1430961760764897,1.638597938349446
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,-0.13623583772181988
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,3.227794564955576
BICR 22,10410894,2.962619033825151,3.2581308371532085
NCI-H2452,168312962,2.634597095527088,2.4369954146515025
MOLM-13,452548,-4.1979459883625045,-2.2523829966555518
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-0.7388001607032365
SW1573,44185566,2.872643000979188,2.496944874403912
SK-CO-1,5470400,-5.490738264790885,-0.3913784653744724
BICR 22,9933475,1.970614134756263,2.0005593513976523
BICR 31,24753719,4.233476426959058,4.403426359593446
HuP-T3,4261,3.8165819220848767,1.672212121288811
COR-L105,7251185,3.034502689275401,2.8067660956218727
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,1.08988941973736
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,1.7490985484203299
SK-OV-3,49793307,0.1269396758315965,-2.7191333070910186
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,1.4278483967516433
KU-19-19,216345,3.688803948438149,4.045132164126881
LS411N,638278,3.5631537252490917,3.0090782991896337
SK-CO-1,374536,2.850215581982446,2.234658502898006
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.976289765626857
P31/FUJ,11178236,-2.454576103037029,-3.6220922495993166
SW948,439501,-2.1692174321648174,-1.7411059427096356
NCI-H2452,9911830,3.1691750432917645,2.6969907192807328
IGROV-1,9911463,4.195269991960018,3.77683101507799
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,1.2009788249658555
KU-19-19,46199207,3.5920417522591723,3.2696849226867215
IA-LM,25102847,3.5065737869109017,2.5643467244281637
SaOS-2,10385095,0.9171223668306429,0.990688080592244
SK-HEP-1,285033,-0.6546577384402199,-1.6590155829214124
WM115,1566236,3.8332358430398847,2.4708787318355183
LS180,3025986,-0.3657173630682503,-0.6425563622825677
HCC1500,11625818,4.269459310239442,4.307197683117913
HCC15,44259,1.006506996100477,1.2716209551099837
RERF-LC-MS,285033,-2.0574538896256587,-1.8246229081871113
IGROV-1,241158,3.288496474515495,3.7828809886524435
BFTC-909,6917907,-4.2174557642594035,-4.905068195610643
BICR 22,375860,-0.6251605141105395,0.10828029550994628
BICR 22,119607,5.438520616053313,5.277040818169885
RERF-LC-MS,676352,1.6328584527608256,2.2720170239316193
HCC15,6918289,2.816502870816243,2.9237311951812974
RKN,241158,3.8611150596916577,3.6461243834801405
COR-L95,3634881,3.005165393659793,3.2319636332616244
IGROV-1,11626560,1.7276653519578558,1.7677282813731774
LS180,3385,1.8718372753364907,3.748996531351571
SU-DHL-1,56946209,-5.3778659012875325,-4.490105931400509
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,3.833414707836097
NCI-H2452,448949,2.771204919609998,2.0853463915098156
SW1573,5113032,6.532830278238065,4.987650042022765
SK-OV-3,11485656,3.3782074628341894,2.350244616331387
BICR 22,81146,6.036644504914818,4.787319951775269
P31/FUJ,76446078,4.256026108364254,2.9004447697200577
Daudi,2113511,3.606563716227827,4.632179822090509
HuP-T3,5328940,2.3682781464336147,1.7044563874850978
RKO,6852167,3.601912647929868,2.24114514844118
SK-HEP-1,1750826,-4.478019715406424,-1.3687673021305122
SU-DHL-1,25102847,1.7846654255237482,1.958674784480824
KU-19-19,2749,1.0704171129437314,2.151449643450353
COR-L105,136227924,2.729950058152846,3.0088366772705553
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,2.251517134656573
RKO,25154868,3.654559992823761,4.077219222255618
HCC15,5113032,5.023051877119823,5.04466512890963
LCLC-97TM1,3815108,3.2576294300862867,2.845196234961478
SU-DHL-1,6610216,4.061950863639378,3.9810529505469225
LS411N,136227924,3.1900427132689724,2.683842671962197
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,3.6002039209130414
KU-19-19,51037431,1.6044173216619535,3.300393267981812
MOLM-13,637858,0.5048034575879493,0.9884736069945032
SW948,5329102,1.476566645762777,1.99935719114682
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,4.717375320331485
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,1.4623536268696657
SW1573,1566236,3.3872191513469025,2.460252636596434
IGROV-1,46174525,4.5083762186279595,4.298011751453728
SW948,9956119,4.230492181635778,3.4702414556357697
SaOS-2,100016,6.565789067704999,6.172460085103932
WM115,11152667,0.9737214532192616,-0.2576158713529153
HCC1500,439501,-1.4156205398968564,-1.8021995743442907
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.393252183043778
NCI-H2452,49793307,-1.217787389832333,-2.4632295785364353
BICR 22,208908,1.938925459708866,1.8638955858392603
KU-19-19,675434,4.307992798559183,4.488838199239139
SU-DHL-6,168312962,-0.817402334599034,0.6806574874290674
RKO,4705,3.750134101835121,2.9207603959540296
MOLM-13,72193861,-0.3301410770598842,0.08801811926916683
SU-DHL-6,11497983,-4.838706392617486,0.597397557548652
IA-LM,6610355,7.432350505906943,4.352147567094547
SU-DHL-1,100016,4.0163007651424945,5.405893860411363
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-0.5345050052794731
BICR 31,11717001,4.942461846011657,4.202008107655314
MDST8,452548,1.517979290481689,0.55052057843507
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,3.163793431711332
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,3.3765989556012475
HCC15,216239,2.699139377969599,2.37572070225994
SW948,54143018,1.1269042701713536,0.5424794871667885
PaTu 8988t,2871966,0.7913795837456433,0.34346121105669236
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,4.1051003026414925
MOLP-8,702558,5.64086941386953,4.331002219740749
SK-CO-1,9926054,2.0008566323964576,2.095054715365015
NCI-H1568,208908,1.6425276108518176,2.1007432535118804
BICR 31,11364421,0.6668909809197356,-1.2590380270004702
RKO,6438330,2.4839059464581785,1.6882157872224601
HCC1500,11717001,5.16685929391629,4.086695690390772
NCI-H2452,5335621,2.361346054519045,4.861739102945979
SK-HEP-1,168313200,3.8713243832650335,2.9711207050330195
MOLP-8,5281321,-3.090542457479921,-1.868641555269837
LS411N,5287620,-2.7795044954925423,-2.0421963577071383
BFTC-909,42611257,4.384387627976705,3.088526826383496
MDST8,135421197,2.23565927197073,2.0829459892159448
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,1.108936339449341
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,1.9979445172700812
SU-DHL-1,136227924,2.1802521862386395,2.5272430161810635
HEL,9929138,6.278460484472286,4.99002295282705
BICR 22,100016,6.157225392196351,6.3393202048079775
BFTC-909,6610216,4.898578232775107,4.404998587996856
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.1190848173244383
P31/FUJ,2708,3.1798246734444535,3.65357008062689
SK-HEP-1,11222830,2.864448489509693,1.5476964306694418
SW948,6450551,1.190778779915613,2.404841689654831
P31/FUJ,3503,1.1912257572322915,1.5473061503068408
SU-DHL-6,11214940,-0.480666123434414,1.1979232586155868
Granta-519,3101542,4.848909880356854,2.3145164207631033
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,1.2038189252504066
SK-OV-3,54613361,2.1799599530092597,0.20663387463947203
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.8408314933255551
PaTu 8902,9866186,4.760639543290191,0.9850221452964597
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,3.4718883891789885
MOLP-8,445455,4.348825488954634,4.124818235683989
LS180,327653,3.1909584751660973,2.916208802288141
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,0.9126076693161943
WM115,24889392,3.868386170167097,3.765988696607173
SK-CO-1,54618771,-0.118181134306818,0.8976954757344926
SaOS-2,9868037,3.691858985861763,3.520014444551774
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,0.06755184480446212
HCC15,10385095,2.335943691067567,1.3800559695953811
MOLP-8,2874250,4.289349020932475,4.194478329804028
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,3.518840493883236
SU-DHL-1,44137675,2.905771721153928,3.028963147324282
SW948,16038120,-0.173493225813213,0.6281439854692389
SW1271,387447,-4.431171658059158,-4.242178328733365
HCC15,71304818,2.608087345638841,2.4401446376180487
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-1.1044538321456185
SW48,44259,-0.1330653223053438,1.3912626316455947
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.4591371755394427
BFTC-909,216239,2.6603594422751136,2.397317268699608
MDST8,9825149,2.535214047656483,2.335314760117954
BICR 22,11625818,4.758067302616356,4.30613699046463
LS411N,6852167,3.3651093558735035,2.6917070513062615
BICR 31,7251185,3.1852875333924415,2.80187905535569
ALL-SIL,25195348,0.8279476297727174,2.211968698677771
SaOS-2,73707438,3.8840228628110336,4.237805365380569
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,1.1552450654108377
BFTC-909,17755052,1.7621152527207813,1.8158816405762699
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.3267731241008383
SK-CO-1,3815108,2.810447278858876,2.8754346548310314
COR-L95,3025944,4.2211844332657344,3.9859798456139646
RERF-LC-MS,9825149,2.3136516136403595,2.2205053566290043
KU-19-19,72376,-1.7461965003174784,-1.3149400746125293
K-562,568763,0.3044566284292496,-0.06809771461614378
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.488190902585988
Granta-519,6917907,-6.07944377191165,-5.4151309008617545
SK-OV-3,4788,6.178998906779571,5.712863518297253
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.513162515334385
RERF-LC-MS,6852167,1.8897499878184068,2.8944436520944223
RCC10RGB,2746,4.042085650474663,3.324147490976147
SaOS-2,54143018,-0.9786223984268784,0.6671461646394379
HCC15,451668,4.7728580097586635,2.5225484458524408
RKN,135999136,4.319110081529012,3.8596012472440266
ALL-SIL,11228183,-1.4217334963731665,0.5289568118362464
RKO,568763,0.6942409100068829,0.331367500414715
SK-CO-1,71304818,2.179260281615582,2.428083072051885
SaOS-2,151289,0.9278405880660672,1.1510303259710262
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-0.39510114012287156
MDST8,241158,1.799926141571129,4.029907015947152
BICR 22,11214940,1.8032425349242045,2.2051972139668328
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.416533924380418
LS411N,9825149,1.7370452341191267,2.0642545245293595
K-562,72193861,0.1570904811456113,0.549688000270827
RKN,89928392,1.2442310560485252,1.528425969464547
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.5717872254382272
RERF-LC-MS,44493528,4.358183394704722,4.368938493462653
COR-L105,5738263,4.054674337055045,3.71602502233167
P31/FUJ,5280436,3.1830796623136832,2.846101693398579
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,-0.7974544723116552
LCLC-97TM1,135398516,2.1563049020997593,2.0369856523792382
COR-L95,25102847,2.826830714185171,2.3900608829835637
BICR 31,11427553,1.8414471938085448,3.0845574986084894
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,0.07193828090577715
IGROV-1,15547703,3.339928221860449,3.390111105257537
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.6607635193425716
LS411N,6918328,-0.170211770014818,-0.3280375907303882
Daudi,3136844,3.4483363469146098,3.738843203578128
MOLP-8,10302451,3.559537910744256,2.802828612449468
LCLC-97TM1,24772860,-2.203105978452304,-1.8400329450145696
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.8111165764274992
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,2.26544448446277
SW1271,119182,-0.4023310904747799,-1.0047271760318928
RERF-LC-MS,135398516,2.452363199699896,2.3890997881651863
SK-CO-1,44495899,4.504236306700641,3.4276193471735774
IGROV-1,10127622,3.2581804056600165,3.9205214407589466
SK-CO-1,44491742,5.1736211152382285,4.154245644807121
MOLM-13,4477,0.1750371811238646,0.6633792682515369
WM115,25183872,-1.8696572442850008,-0.6093349368395525
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,0.6648727588757352
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.444338185767767
HCC1500,5335621,4.362965892261437,4.543062332490248
P31/FUJ,1716436,3.053886593694114,2.418999457635389
Daudi,9915743,0.3665260221427978,0.28296107374498974
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,1.9727395745085905
SK-CO-1,5311281,1.7217135985324663,2.297267735591731
IGROV-1,3503,2.453392942972796,2.250229495848225
SW948,17755052,0.6738246482480579,1.6553585413351355
Granta-519,5329102,1.3717145166802862,1.3817332668861746
HCC15,25183872,1.7330298559310635,-0.5024379955186415
IGROV-1,23635314,-0.611739968448912,-1.7511822063848477
HuP-T3,46174525,5.4457837824532245,4.684905598220038
IGROV-1,46199207,3.293579955374855,3.1013169307672745
NCI-H1568,11656518,0.902462789439692,1.8250295654062436
SW1573,12001922,2.294011710402099,2.0004465487186742
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,1.2991316792037972
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,2.742699572533533
SW948,2871966,1.833559506117821,-0.014189703385363907
RKO,42642645,1.3055497818976145,0.44612436160262975
NCI-H2452,6450551,2.947106204512916,3.031661588396729
P31/FUJ,10302451,4.186780329312711,2.5249548718376307
P31/FUJ,6918837,-4.676526715032863,-4.4420324285176855
HuP-T3,3552672,1.4793505278318,2.71289669675154
BFTC-909,25105715,3.3944682152224455,3.456737799487458
HEL,44197249,3.8651368484410056,2.1946759505087843
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.9985559803586868
BICR 31,46215462,1.6669957894505008,2.096061535436484
HuP-T3,9866186,1.729562359157257,0.7552937617659816
HuP-T3,11717001,4.25253085122872,4.131547641398777
NCI-H1568,54618164,3.652866089784218,4.026248811191246
WM115,441298,3.225500618866892,2.5178970002954
LS411N,71304818,3.0616651991102697,2.3326708375798746
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,1.717926580600992
SK-HEP-1,10184653,3.249474772070569,1.7055034578031143
BICR 31,12003241,-1.4237270953299652,-0.7014684648286624
RERF-LC-MS,25150857,3.1332692975488934,2.619118759347765
COR-L95,24964624,2.1587115359420994,2.1614265613352663
SU-DHL-1,44241473,4.633491620971472,4.49882626329984
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.422838527237007
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,-0.2088694926590989
MOLP-8,6918878,0.495059053850733,1.0590054307658856
RCC10RGB,448949,3.406339167429426,2.144306444164913
HCC1500,148124,1.3380754252474834,-1.437205592283404
HCC1500,5280436,1.8565158203383687,3.2914718268370122
IGROV-1,10302451,0.4135234554742116,2.9477168757168237
Granta-519,285033,-4.09305161448312,-3.42802486179508
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,-0.6672252328577687
Granta-519,71304818,1.7993370678919798,1.816959462344142
NCI-H2452,3689413,1.184555113675537,-0.6210960406280841
IGROV-1,2708,4.438419625543199,4.808439460074109
SW1271,49850262,4.063818012025616,3.7139891233241356
LS180,6918736,-2.1262365465987907,-1.7838259789079007
PaTu 8902,10127622,6.3250626499292295,3.8962430265549375
SW1271,57519531,1.4534695216386555,2.486306180986738
HCC15,57519531,1.9577451103636032,2.377208927834741
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,2.1175326902586993
SW48,44185566,0.7812235367324193,2.246295505843543
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,-0.3164144743084851
KU-19-19,241158,4.34083218708613,3.9200011140302204
NCI-H1568,11404337,-0.63897934294681,-0.592645614414861
Granta-519,219104,2.15431657191886,2.497665159348925
SK-CO-1,5746,-2.8271360432483035,1.0575550914021405
WM115,6918837,-2.450050091846588,-2.669262062863236
SK-CO-1,11152667,-1.1935109806009474,-0.6049393998292889
SW1271,9825149,2.2012182796133084,2.4398197142764935
SaOS-2,208908,2.5337103611164893,2.2436582735414166
SW48,5470400,-1.7303817372543355,-0.4215064486532258
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,1.9884612855119626
SW48,15547703,3.0370188863847414,3.175983238001986
SW948,46907787,2.3709287142369555,0.8805608628034676
Daudi,5113032,4.739966647777949,4.5486685434351175
SaOS-2,135984461,4.8186429168984475,3.790523827659614
MDST8,168313047,3.800021027786958,2.4065255079455685
RCC10RGB,11964036,2.4986740771219673,1.6857873284766998
SW1271,24785538,1.505278847517323,1.6874961249918203
BFTC-909,3676137,5.055523871435828,4.518404902628544
SW48,9868037,2.459515994210572,3.0353488256690286
KU-19-19,10231331,0.2937024112037242,2.0528370611318816
ALL-SIL,54619267,3.6744484896003713,3.255458591075633
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,3.486905468675717
RCC10RGB,24951314,2.138755705452886,1.6908301156777987
SU-DHL-6,26596,-1.882707371112463,-2.258856986411672
COR-L105,46843906,1.9821208299636863,3.5034458140368643
RERF-LC-MS,4477,-0.1141702320643991,0.8575920975220329
MOLM-13,49766530,-2.4914272268054107,-1.8846633005849451
SK-CO-1,4917,2.9299888563447163,2.9831413584282376
Daudi,72734382,3.17690285998388,3.550928977455357
LCLC-97TM1,11625818,5.063433550011292,4.371171424032778
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,0.9426016185666453
ALL-SIL,451668,-1.1904263441284522,-1.1440809532020357
SK-CO-1,219104,3.537047767593632,3.6509149637294063
NCI-H2452,65064,5.258935158123576,5.043446703441779
BICR 31,25062766,2.0025728701089904,2.345853194024953
LCLC-97TM1,4261,1.8883571230172835,1.8026437160291398
BFTC-909,54618164,4.281231487810877,4.094263338595889
NCI-H2452,16736978,0.9447398024439234,1.531563015992036
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,4.421784919996588
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,3.5917427391916394
WM115,6917907,-5.049795628811172,-4.387771759862803
HuP-T3,5746,1.6464242063318688,1.3156920920795454
MOLP-8,327653,2.384727852533787,2.7003960556059825
SW48,72376,-3.1415011638088144,-1.8899057557337167
SK-HEP-1,23582824,1.0257570544783106,0.8272349356952244
K-562,12001922,1.1213264373636214,1.6114736639292588
WM115,10410894,3.2188686198907743,3.4081900048042577
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.2025720329442844
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,3.695862262581377
KU-19-19,44819697,-2.543386759740491,-0.7564664314270392
LS180,46199207,2.9384583216685023,3.1196749210663044
LS411N,56946209,-3.80128700519076,-4.289170067093882
LCLC-97TM1,6918289,3.014261251605047,2.603021068445899
KU-19-19,107970,3.004209688555129,2.3963893523404503
MOLP-8,72376,-3.958595065171294,-2.616845662642226
IGROV-1,5291,3.6852809555447985,3.751763404660661
Granta-519,46191454,0.5060764897707477,-0.27114795069065206
COR-L105,24901704,3.8942422617258714,3.501279031871479
NCI-H2452,24797083,2.030715286150645,1.395205103806196
NCI-H2452,124202324,3.032884210730814,2.6656402786541116
LCLC-97TM1,4259181,-0.2611730486969081,0.3112099293669764
KU-19-19,73707440,5.592820593626321,4.271512186002074
RKN,5460769,5.79272629497122,2.947753090897188
RKO,10184653,1.6814092199651305,0.9322851600408303
PaTu 8988t,24180125,3.300808715406375,3.1828066222853617
COR-L105,2858523,3.082532365215724,3.0742077203738463
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,1.6953707771059399
LCLC-97TM1,16065773,3.044024356255971,2.4295000319497606
MOLM-13,16115403,-5.622868208190141,-4.53503988322793
Daudi,104842,-7.567274671559235,-4.218372122229123
PaTu 8988t,3825829,4.270364787448243,4.067765411181555
HuP-T3,227681,2.514870644267688,3.3895064281638962
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.7937786516525827
COR-L105,11964036,1.2117851204645589,1.4864791118476464
SW1271,135659046,3.922158232881772,3.647445942628965
IGROV-1,4917,2.985904350427039,3.048938308112887
HCC15,9826308,1.2579647962340863,0.38319468764765113
SK-OV-3,46199207,3.479599233509405,3.38019227500599
KU-19-19,2729026,3.069520174525383,2.7179132159387387
COR-L105,25102847,1.810865395215699,2.539136949904167
SW1573,9935249,2.8664920450292852,3.3337021035368752
COR-L95,1714884,3.7968274989469992,2.7207350423928767
PaTu 8988t,7251185,3.286029674356028,2.7019705284461355
SK-CO-1,24856436,0.7128954142297991,0.4673837904842895
HCC1500,5738263,2.955373895930653,3.293432925891368
SU-DHL-1,6914657,-4.020831804674196,-4.294961552446239
SW48,638278,3.16751315896482,3.1406725872703896
LCLC-97TM1,135421197,1.517750954289076,1.8395630378082053
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,0.12742371622151022
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,3.6319172319535373
NCI-H1568,6914657,-5.120590256929669,-3.67621386463956
NCI-H2452,3676137,5.703513737309888,4.573135510106585
PaTu 8988t,11238147,3.9795465318298526,2.866505021866085
RCC10RGB,5113032,2.807854627845623,5.096384211926535
IA-LM,44607531,1.5934898700442923,1.5808282295840501
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,3.8792563680531758
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-3.6127304308303216
RKN,3815108,2.827407220517517,2.8936200294751773
IGROV-1,448949,2.098499309472767,1.775308239208118
BICR 31,5426,4.483861121335425,3.6383378594705946
SK-OV-3,322968,3.987773865251791,3.943511010479578
BFTC-909,15953870,3.192835350037467,3.6605596187941
BFTC-909,4378219,4.497242068417329,2.8640036545320373
COR-L95,54143018,1.379812266453913,0.5569761700720964
SU-DHL-1,11612883,2.467580560997241,2.1958402467465765
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,0.8308207455270745
LS180,5978,-1.0800938866172374,-1.8272768321401947
NCI-H1568,44566777,1.438409258191859,1.0053675899833454
BICR 31,42642645,1.5553576315566706,0.9645938579776455
MOLM-13,654092,-2.113392174262404,-1.3520997099892773
LS411N,124202324,2.3656166654970137,2.2188161948776717
SU-DHL-1,5329102,0.4187283879213827,1.5595323936623264
Daudi,51037431,1.7669670215364446,2.7907451190107615
RERF-LC-MS,45279963,3.7797867340420215,3.8401034038152293
IGROV-1,49850262,4.068828647042517,3.4509962685761293
BICR 31,12001922,2.662375748901725,2.053754149687305
IGROV-1,49793307,-2.5291790820063538,-2.8746014141601735
PaTu 8902,2828334,6.440933390339598,6.237114630023701
SU-DHL-1,24951314,0.6018835624310062,1.0467442064194326
MDST8,676352,2.6149374435458643,2.223004390829043
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.3716237873034696
MOLP-8,44185566,2.3020252385384747,1.7449017752187985
RKN,44137675,5.459450119186335,3.6882255003228166
SU-DHL-1,216239,2.4334915471860064,1.920911635198462
RCC10RGB,5328940,2.5920229504771264,1.7221256919953978
MOLP-8,5351362,0.578803181676615,1.2463538093026292
KU-19-19,4521392,6.281175440463305,4.4413462190720665
HuP-T3,219104,4.090562015064086,4.0219595049733945
BICR 22,16722836,2.37465920140225,1.8335161350208862
Granta-519,54678924,3.4908303220152512,1.216305950357336
SW948,5738263,3.889172676108031,3.168520062005378
SW1271,9549297,2.1335240165820606,2.3130070167535606
MOLM-13,5280436,3.611781786093365,2.7965496301019783
BICR 22,3062316,1.4778056821676904,0.6964820344030929
HCC1500,46191454,2.281809335685502,1.5626176230547204
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.728544415762444
SW48,9549297,0.4487326680785643,2.138980740453944
SK-OV-3,46843906,3.785109660734252,3.143298268638251
NCI-H2452,5351362,1.571040634520482,1.5655971421894967
RKO,56946209,-3.445993729976747,-4.388773579028027
SaOS-2,56649450,2.657103116813459,3.068991557762969
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-0.8090912855872449
LS411N,23725625,5.218761480016774,4.9375444798444
RERF-LC-MS,4578,4.625372786711685,4.533748951721789
MOLM-13,11507802,1.0337656748409854,0.7175135964108885
SW48,65064,5.106206142410259,4.817994422902012
HCC15,2828334,6.579413009448801,6.237504028415739
SaOS-2,4378219,3.572923749570723,2.4087453430808763
BFTC-909,23939,4.493588141952023,4.317508884151281
RCC10RGB,439501,-2.548266242367821,-1.7167374533987507
SW1271,3815108,3.2377532103389832,2.8393428944588237
P31/FUJ,5287620,-2.889875327880449,-2.3020966584190354
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,2.070978025909006
LS411N,5281321,2.872375461605106,-1.631834480262423
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.1517404660005934
MOLM-13,16736978,-0.7178102164081313,-0.017872381150706333
HuP-T3,24964624,2.5347495437600753,2.5568736888059784
SW1271,3038522,2.6397404309625574,3.090141837764735
SK-OV-3,6852167,3.0870556066687076,2.8641035199096905
PaTu 8902,25262965,1.559985123462204,-1.4026003093185537
PaTu 8988t,89928392,1.7442497788257625,1.5299832951219472
RCC10RGB,5494449,5.764110819730859,2.893650595853143
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,1.3096958602409245
Daudi,5282054,2.334684985175564,2.8902735061751867
SW1573,9866186,2.2605214925080035,1.0074595543570322
SK-HEP-1,16013152,4.2454363352103925,4.1407720776612145
IGROV-1,11647372,-0.6595372928368528,0.941963313128303
RKO,60700,-0.2024014556335324,-0.7246439065666579
SaOS-2,66577038,3.461550546017496,2.888865021018266
BICR 22,6918638,0.0558003797401064,0.8186571327579202
NCI-H1568,6918878,3.5715267618547832,2.886575224316834
RKN,17755052,4.615024850417848,2.0552378859295954
RKO,10385095,1.2981289243482117,0.9352759123161245
NCI-H1568,25227462,1.3523005990409367,0.03255143103931992
IGROV-1,168313200,3.9938362637732983,3.134403304106126
LS180,52912189,2.5201251776162454,1.727768388279908
SK-OV-3,446155,4.068831864004445,2.6586189195009338
SaOS-2,2729026,3.0079080963172573,2.5401874052468365
COR-L105,24785538,1.9787344511962284,1.662948779446824
WM115,9549297,1.875565618317202,2.2027064153206863
COR-L95,53392493,1.7864953470488698,2.0693349819106213
SaOS-2,219104,3.933074432676362,3.6761805973079347
WM115,3854666,2.6196721416111024,2.1092917141080774
PaTu 8902,11626560,1.9806688551606229,1.9193006867518454
P31/FUJ,24901704,1.8625310117446785,2.246185512403391
IGROV-1,9911463,4.195269991960018,3.77683101507799
LCLC-97TM1,216468,0.7418366776466117,3.1937471282721175
MOLP-8,387447,-5.214034261316855,-4.703904111752461
RCC10RGB,16722836,2.017391543442539,1.823238265007428
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.9946093591753971
SW48,5311281,1.5627745937535438,2.291976367288055
MOLM-13,11497983,-4.003769607545663,-0.5246932907056824
KU-19-19,2858523,2.990442019675252,3.0319491396161307
COR-L95,11626560,1.5180153972734145,1.4154527176790825
WM115,123631,1.7981952102566006,2.23822701116648
RERF-LC-MS,2874250,4.628157945253743,4.771308820072789
MOLP-8,65064,3.020382379730844,4.154465966123459
RERF-LC-MS,3854666,0.8294073497518095,2.249532831104009
HCC15,3689413,0.3467742153458734,-0.39664058346248315
HCC15,25150857,2.8177810894811786,2.491881641030942
LCLC-97TM1,46174525,4.403281113181967,4.116161426831239
SK-HEP-1,31703,0.3185055118054912,-0.7579627065893944
BICR 22,123631,2.0553358195001383,2.2746968142251363
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.297186611848521
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,1.291027932981293
COR-L105,11213558,1.6245415685033464,2.0531115833054385
COR-L105,3689413,-2.1605707630353708,-0.07550250002272554
MOLP-8,4917,1.932746630984224,2.6567618654230047
HEL,11238147,1.9261110470981635,1.891496943760173
HCC15,46907787,1.7788170946404287,1.9578023260520485
HCC1500,3062316,2.994925150114549,1.846819681130985
MOLP-8,9935249,-5.983061984872936,2.141108104312973
IA-LM,135398516,1.3190430503048431,2.045800178332283
NCI-H1568,6917907,-6.013699668749745,-4.5497294887462525
PaTu 8988t,25062766,2.121196656552597,2.003995783304478
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.4753131606352743
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,2.0990908897856455
HCC15,3825829,3.261310602619802,3.9980274598092067
SaOS-2,36314,-6.649536011740597,-1.7108371737318069
BFTC-909,54613361,0.5481358040879688,0.35505172484812275
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.8571378068252846
KU-19-19,135999136,4.912207411852192,4.279258705804466
HCC15,126941,-2.714458984381298,-2.7017595800189
K-562,387447,-4.172741798582805,-4.6701925240808295
BFTC-909,400769,-0.3884900564724624,-0.5654824993833931
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,1.909866235140938
K-562,19582717,3.29667086675107,3.24896497541681
LS180,676352,2.815097827506973,2.103906211696565
SK-CO-1,5278396,2.886619996042885,3.4041739736800336
SW1271,654092,-0.6724961197062129,-0.6958458258084771
BICR 31,984333,1.688597902845401,1.0186931211465637
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,2.309321492500526
PaTu 8902,6918328,0.0837665640709721,0.2944413435483733
KU-19-19,25126798,3.8528221502524262,3.9349678474336893
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,1.9979370862597463
K-562,984333,1.160515473081413,-0.1753792231932724
BICR 22,4261,1.6582900308021409,1.9321241129069873
P31/FUJ,24753719,3.279397605233023,3.653577165329759
RKO,89928392,1.6264666324972337,0.8837174828262756
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-0.7479440667435407
MOLP-8,2746,0.9128995235322724,1.9178815554185136
PaTu 8988t,44589607,3.069724280166482,3.036802325986292
Daudi,55508,3.074140286884227,2.5858753017718277
IGROV-1,53232,2.4872106086763393,2.543715750483633
HCC1500,11178236,-0.8618797474299623,-3.2115487225635917
SW1573,11228183,1.3544411199442492,2.408702747957561
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-5.56356616234081
HCC15,151289,0.5818248951012718,1.439771039514355
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.691976013742991
LCLC-97TM1,9956119,3.701469228999412,3.617574636072204
LS180,65064,5.333283055182179,5.014819528238942
Panc 02.03,1566236,1.9322803720882225,2.448685552650387
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.607814805346255
COR-L105,5311281,2.5909348271223833,2.5978128292434857
COR-L105,4261,1.037866526492344,2.019417565882995
MOLM-13,6505803,-3.0527041000310255,-0.7101030428366534
SaOS-2,24797083,1.1743557883271736,1.321147159202385
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.6579179712059042
PaTu 8988t,44819697,-1.4855632158782932,-0.3380530262501249
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.9946093591753971
MOLM-13,136227924,1.704251401840426,2.167852890216191
K-562,11955716,-2.44804051648688,-1.58801754209903
PaTu 8988t,119607,6.161307312166748,5.203088015647486
COR-L95,71466380,4.385390307812106,4.059747854520136
SW48,400769,-1.161678790289576,-0.7091512464006565
SK-HEP-1,54618771,0.9570801540222316,0.900328431237609
Daudi,10410894,2.7348964142664096,2.6666373682433995
P31/FUJ,8515,2.4023085754769133,3.245022697297323
MOLP-8,12001922,1.340541943266141,1.606736089885895
SaOS-2,24180125,2.5037581025896896,3.109260513264569
LCLC-97TM1,11497983,-3.4928977535107872,3.711357456735381
KU-19-19,54618771,0.4920305765445359,0.9643847843648363
BFTC-909,9826308,0.9467806471528852,0.5127089287118551
HEL,6252,-2.3526628041976547,-1.1483624384192725
PaTu 8902,1750826,3.002378182351502,-0.8191276676677565
HEL,375860,-0.4243086466742362,-0.7997342643475613
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.9620260009425516
LCLC-97TM1,44137675,2.6535109564984403,3.4764233374698845
BFTC-909,4096211,2.208598833058293,2.3415720319241653
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.9261632908311
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,2.0266108149364133
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,1.916437154822875
SK-CO-1,10231331,-0.7210930575000714,1.883346935812974
RERF-LC-MS,9908783,5.63449812951243,5.054760177857494
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,2.762683807378063
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.5338218755514503
SaOS-2,54618795,3.185724709117328,3.204442773362756
PaTu 8988t,637858,2.5993481939897314,2.2127991090192882
HEL,984333,-1.1600295079037413,-0.6389777400424983
HCC15,2841722,4.4106331963661285,4.387331873113867
SW948,676352,1.6772543111300298,2.0540590287074245
BICR 31,24964624,2.1782924417506235,2.664300326357428
MDST8,984333,1.6302493723588198,0.838296811705965
SaOS-2,25102847,2.0054521503393956,2.307728640902409
NCI-H1568,11396600,3.496587037401377,3.7423577626225546
SU-DHL-1,25126798,1.813712960287442,3.546685688392817
MOLM-13,445091,4.269392983422825,3.9258660676152317
IA-LM,6918328,0.468629569752011,0.1847332404430148
RKO,16038120,2.1201165412688385,0.7869735349250054
Daudi,3689413,-4.376822515219121,-2.0735712325608078
LS411N,1750826,2.0365622567800985,-1.6797241773771667
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,0.5481241539096203
LS411N,11640390,3.2208706785393972,3.1740770168195125
SK-OV-3,2729026,2.529477515357917,2.7203898793160737
BICR 22,1317464,3.72634745746102,3.753745284049483
PaTu 8988t,6917907,-5.027469783550181,-4.158350929748335
BICR 22,168313200,4.032164885313491,3.0076757623568606
WM115,24180719,-0.1236916700903925,3.2169529123134306
WM115,2708,4.839353437835411,4.937902027078456
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.6151353113634412
SW948,135398516,1.5329637117305952,2.3416672504364
SK-HEP-1,15547703,3.182423809990023,3.243003229643078
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.749411193219226
SW1271,400769,-0.393739366900267,-0.6629597609666885
COR-L95,11657048,4.451680892653422,4.195473438467117
KU-19-19,5470400,0.4514058362673593,0.2355510112123459
SU-DHL-1,46199207,2.2603615990150803,2.9177861444388005
LCLC-97TM1,452548,-0.620032222833134,-0.011160346734884894
COR-L105,216345,3.681753487249753,3.916795943899686
SK-CO-1,6918736,-2.135863333000623,-1.237114395045339
SK-CO-1,5351362,1.1244803572081656,1.761790013719563
Granta-519,451668,1.0102660805443675,-1.2392049281287503
RCC10RGB,71751553,5.18764953581067,4.597789952673274
SW948,44137675,3.8395253943289553,3.4014117720892134
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,0.6144479820106412
LS411N,654092,0.6196619744838121,-0.09134817326717279
HCC15,11222830,1.5967166138936082,1.6514198162779337
RERF-LC-MS,54143018,1.1379926617289184,0.5282294314180082
HuP-T3,107970,2.2315719384591133,2.342629498012115
MOLP-8,462382,0.932516774133838,0.2614371251499301
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,4.1559839972287085
COR-L105,448949,1.923777772079977,2.188411125469857
SU-DHL-6,5311,0.0847535344452709,0.28048468046133246
COR-L105,65064,5.250674314711081,5.087759624743095
RKO,9908783,5.5436232623995805,4.634294927399522
BICR 22,1566236,3.7080344976190434,2.3680859512247934
SK-OV-3,2708,5.531711784720637,4.928734195535638
RERF-LC-MS,148198,-3.5927713028936834,-2.906930886236424
K-562,10127622,4.587499993681003,3.712935083098034
MDST8,3543504,4.366917593553272,4.428767878663826
NCI-H2452,675434,4.57874791360699,4.601651632936887
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,3.1238043988090287
K-562,73707398,1.1020172598138147,0.6267912270846793
BICR 22,11178236,-2.3138277354389176,-3.0690057139267655
KU-19-19,53232,3.650570649303299,2.756913115383189
COR-L105,2126,5.6436039579971045,4.765633408585785
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,-0.4342994769345572
WM115,984333,1.7219326558446977,0.8252027220800602
Daudi,6918878,-0.3078198284611306,0.8611123492503089
HCC15,16725315,4.804384009366738,4.426694565053279
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.76984958066197
ALL-SIL,56946209,-4.755076906810128,-5.1655755427818875
P31/FUJ,25195348,1.3039046822632598,2.3480125236525016
NCI-H1568,4261,1.7177455985107426,1.9732706737087173
BICR 22,11238147,2.160553784520482,2.513562558052932
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,1.8372835582267928
LCLC-97TM1,25126798,4.007107372760091,3.978985130329508
PaTu 8988t,11612883,3.2937262662044424,2.7795964823787465
SW48,44507138,1.5733509414979852,2.282110353784385
SU-DHL-1,66577038,2.452346655400699,2.512966482688473
ALL-SIL,60168763,4.204461937910143,1.4821752911290056
Daudi,25227462,-5.495402710114509,-1.8245128382858278
LCLC-97TM1,613000,2.0466318432711708,2.678018077793508
LS411N,2828334,6.327786282136184,5.998555307089031
IGROV-1,9866186,0.4571266497661056,0.5806058206610459
SU-DHL-6,72376,-4.568822946856545,-3.6554679601381865
P31/FUJ,984333,-0.8646677641211812,-0.39508230512299747
COR-L95,123631,2.8240072692867915,2.1701082325016285
IGROV-1,11497983,4.37450324471555,3.55695816928922
BFTC-909,5281672,4.401358042981416,4.758222079148471
PaTu 8902,44607530,2.9609228636650826,1.8749077990906877
HuP-T3,5566,3.0002994658008935,2.9962089820705238
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.9609550051485554
IGROV-1,2729026,2.3541792737160296,2.620986473598322
COR-L95,11222830,1.53452681839189,1.3676697838428475
LCLC-97TM1,66577038,1.6013450181273698,3.041485743351194
IGROV-1,24772860,-3.2892316801587835,-1.620644623931283
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.465261454797478
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.9062894458279707
NCI-H1568,54678924,1.274078635657008,2.1580888446911644
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,0.9749382527638205
RCC10RGB,9908783,5.908182650801537,5.20658304204116
IA-LM,66577038,3.3956332242260765,3.1367284573119516
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,1.4913017534182638
COR-L95,9935249,2.976260244275784,2.6509968219749163
SU-DHL-6,9868037,3.231553190440303,2.38516629110026
RCC10RGB,11640390,5.2605770793622275,3.8157704650317394
Daudi,285033,-6.062056136351362,-3.4535940818666573
BICR 22,11626560,2.057582050988773,2.046736659398955
NCI-H1568,60750,-4.838669884752028,-2.0097428193417177
MOLM-13,2708,1.6215518677504634,3.5036959115195567
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.6750455561751911
K-562,10385095,0.5975872383647969,1.005967911340795
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,1.1111806773938182
ALL-SIL,9887053,2.3955838154567703,2.2737773542874495
RERF-LC-MS,151289,1.06337646711186,1.212525795408579
LCLC-97TM1,71466445,2.7974721848465025,3.8485515833021617
RKO,15983966,1.976330033309676,-3.393366212893922
SU-DHL-6,54143018,-0.9166021499884252,-0.3237466574049317
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.581438755519092
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,1.7571654999901176
IGROV-1,49793307,-2.5291790820063538,-2.8746014141601735
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,2.0577872632046614
SW48,9866186,-0.0602537260044697,0.6117780724273398
ALL-SIL,24753719,3.3195109491118635,3.224162073052391
PaTu 8988t,409805,3.676693079768219,4.864615258043576
BICR 22,11175137,1.6412636442827269,2.69442613930677
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.420901995150124
MOLP-8,9887053,1.3364969406129874,2.647552588996136
Daudi,81146,4.468898659357518,4.054032925301213
NCI-H2452,6438330,4.066979701794873,2.4752528132126543
SU-DHL-6,73707438,4.161722925172636,3.537682313801365
SU-DHL-1,9825149,2.3972801394012415,1.7775052617115223
LCLC-97TM1,1242560,3.1698209685240832,3.5795409284306046
RKO,44632017,0.9673312213076444,0.6294335116124538
ALL-SIL,10184653,0.3156525087572682,0.7367498829672405
MOLM-13,15953870,2.45012914744678,2.382030391842408
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-3.169331241138682
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,3.143827720237241
Daudi,9908783,4.64363842559646,4.4071677265672955
BICR 22,2746,3.5358057095338404,3.274825175862149
SK-OV-3,9903786,2.611217845094376,3.061404866172647
Granta-519,446155,3.3236756015859266,2.473369977285653
HuP-T3,46843906,1.6260119885378777,3.4466842642311093
RCC10RGB,25102847,4.4790627708666255,2.553022111124622
SW1573,119607,3.675967979424282,5.325023944314606
NCI-H2452,36462,2.3648017756260327,2.520985566429955
RKO,9926054,1.883626680074333,1.8233579132371447
UACC-812,11396600,4.679415745859403,3.4031358560950036
LCLC-97TM1,67291369,2.1623476689900527,2.2000463289184666
SaOS-2,9926054,1.5065280757428428,2.032756018512628
SW1271,11485656,2.5257448561020053,2.3159463649080667
SU-DHL-1,65628,3.0805404655500843,3.441421627821106
RERF-LC-MS,24889392,5.73600211591012,3.971836476855001
IGROV-1,16720766,-0.0562020789376145,0.5478155259467438
SaOS-2,53392493,1.7453499080757628,2.4150148957241595
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,1.7831301770643058
LCLC-97TM1,71466578,4.4967812415195025,4.73104772396838
MOLM-13,135440466,-1.1165614244178856,1.1102739658121632
IA-LM,1566236,2.064855820915055,2.1968199185261583
SW948,3825829,4.076553662425885,3.682427334584155
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.0319925555964575
WM115,322968,4.566671406107956,3.679998080843274
RKN,637858,2.0099352926359533,1.9700107856625766
COR-L105,135398516,1.4567379833558207,2.4090196317759394
LS411N,15547703,3.407600768992332,3.045304128703693
SW948,6918878,-0.2941800388813576,2.172311388222331
SK-OV-3,31703,-0.6007067740148971,-0.6736112209385269
BICR 31,16038120,0.7865824758597759,1.317381171922518
SW1271,46943432,0.8939870827443378,2.014994450550301
Daudi,67291369,0.2775886597323658,1.3557424835556808
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-1.2626951238459498
BICR 31,11455910,2.0785566961581186,1.1087213887926326
MOLM-13,25150857,2.0975264071969075,1.917652117996553
COR-L105,46174525,5.553907170062061,4.5200678306436375
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,2.0868773049914706
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,1.7767039234585063
IGROV-1,135398516,1.9751898057484376,2.1970834181079133
PaTu 8902,3689413,3.662647678116459,0.02778689072740427
Daudi,31703,-5.42156315939604,-3.0582949947880262
IGROV-1,24785538,1.106246320450551,1.3954443160685017
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.1890372883515023
PaTu 8902,676352,2.5672836386659625,2.290023236542005
MOLM-13,426756,3.5583078181784504,4.144772750716499
WM115,64971,1.594754361798162,2.5868329570913677
SW1271,4521392,3.9428497415690713,4.385983995990395
HCC1500,19582717,3.689290387765622,3.9698232109793827
BICR 22,71680916,5.5411632888305755,4.192423830773278
IA-LM,462382,0.6444148679919928,0.825170747462979
P31/FUJ,24856436,-2.072993507389728,-1.0381201716461532
LS180,135411,0.2951252953722391,0.36675549833902144
MOLM-13,72376,-3.7215877343251456,-3.4461141159943907
RKO,6610216,3.958403220086871,3.9351450221323163
RKN,452548,0.7515073582009456,-0.20953591281313566
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,0.2902163860928878
SaOS-2,3038522,3.0360203721983257,2.858274302918274
SK-HEP-1,409805,5.808157500863876,5.124191881455911
BFTC-909,44137675,3.23817368119839,3.7226102128939083
SW1573,25183872,-2.56928333929943,-0.460597736054798
HCC1500,23582824,1.5666293035108128,0.7881680065456382
MOLM-13,11612883,-1.8374573083034769,1.6874939440139927
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,0.7888778720465303
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,4.103108809183316
KU-19-19,135421197,1.2163789616721166,2.0151041335768243
SK-HEP-1,49766530,-2.8567737760804324,-0.9943456767420997
Daudi,46843906,1.1534141628569738,2.0978477384026046
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,4.094730159533447
IA-LM,11494412,5.732457488131999,1.6498303619172643
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.343310576466156
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,1.7749211669857965
Granta-519,46943432,2.0409318821812477,0.9191218110286868
MOLP-8,46174525,3.423634821116614,3.3886088988611243
RCC10RGB,19582717,5.580606305911862,4.546665213316263
NCI-H1568,71680916,4.3779497666633915,4.605059338979446
SW948,3689413,-2.2648112033429824,-0.6499312081206802
RCC10RGB,252682,6.528801566934436,6.565370235369596
Daudi,135875424,2.734623655159311,3.0108372143429123
K-562,4788,4.09681667300412,5.353895750816925
BFTC-909,66577038,2.856590203747272,3.1100369371927057
BICR 22,56649450,1.894872176339528,3.283941588287224
LCLC-97TM1,23635314,-2.2617116518456792,-1.88261982581326
SaOS-2,16013152,4.240825830990255,4.195812008374521
MOLP-8,5738263,2.3540234006064424,2.883650795225866
IGROV-1,3552672,2.134472496867482,2.6071931960984664
BFTC-909,6505803,-2.7076869289136147,0.17252488253180612
NCI-H2452,9952709,3.912471204941481,3.285252367817575
SW48,4477,0.2937974315698831,0.6992245755342438
IGROV-1,10113978,2.874171865860951,3.1459484489768514
Daudi,3465537,3.6729414318228697,1.8053499292264867
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.5393005966234189
WM115,60750,-0.3155979924811316,-2.5773149457170006
LCLC-97TM1,3552672,1.9872160910848609,2.5352958315029763
P31/FUJ,16720766,-1.2973124396101832,-0.4507598625740634
PaTu 8988t,16722836,1.7927006401716397,1.7624052117176587
RCC10RGB,24785538,4.443576486987547,1.8872886598187688
LCLC-97TM1,54454,2.264936650655555,2.7234670050011234
BFTC-909,44202524,2.4582417316930916,2.5016603995115476
NCI-H2452,9956119,4.089312834038711,3.6738970430045548
LCLC-97TM1,44589607,2.470818031732135,2.8572244932896753
K-562,9911463,2.5078915917546336,3.548299050632088
RKO,12003241,-0.2410566552434749,-1.0865908350492581
SK-CO-1,9887053,2.665990529661509,3.985342691101353
HEL,9444,3.6260707724362113,3.671973272287722
RERF-LC-MS,54618164,3.9158352593779377,4.074803802091694
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,3.1843560051564204
MOLM-13,400769,-1.4398892181534526,-1.5923854445798629
RKO,54454,4.6965621210229225,2.427417586209568
HEL,3815108,1.7280464955300685,2.2769912466075484
HuP-T3,400769,-0.02490432142157,-0.4571938710176393
COR-L105,439501,-1.395093001857319,-1.5454041483129723
P31/FUJ,11717001,4.27266863837082,3.7314793719258033
WM115,44566777,1.1755609042254629,0.7555715900995699
Daudi,9823820,1.816535221490948,2.7539525421158406
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,4.154455395272532
SaOS-2,11178236,-4.192404287761835,-3.686008781096739
RKO,107970,2.3673735748138265,2.164171573812074
Granta-519,3384730,1.8851059301538475,1.620213526072897
Daudi,3081361,1.2348545680767924,1.9428168444861476
COR-L105,11656518,2.8708923278875846,1.9607977402366048
SK-HEP-1,4261,2.0689452694586596,1.9899271281385271
IA-LM,4261,0.3595729013120086,1.352026755908748
SW1271,5282054,4.135247135343962,3.8891109594818545
NCI-H1568,44491742,3.692908194165655,4.129383216851867
K-562,10074640,1.329135681779355,2.2914857669900788
IGROV-1,9908783,5.873270433212515,4.984752061789001
MDST8,24951314,1.0921901869172437,1.6599962240457256
ALL-SIL,3081361,0.1962192778787347,2.1073393147305453
SaOS-2,4578,4.61303870633514,4.431390740014398
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,-0.10848147097532809
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,2.062788872212743
IA-LM,25227462,1.9658589227885097,-0.013471561186979373
MOLP-8,71466578,1.6771539715617054,2.9780240145055807
HCC1500,11977753,-0.4307765862265268,-1.1534914537352443
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,3.33847819569085
BFTC-909,568763,0.745825262149274,0.6002786174220185
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,4.135947360623837
RCC10RGB,613753,3.3201179844199498,3.365244475035977
BICR 22,421610,1.881248812005912,3.149948717716718
COR-L95,55508,1.7090560645840305,2.9489700271639148
SaOS-2,2945648,3.259308629519986,2.7834888642709315
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,1.2977960955066794
RKO,409805,3.580644131410829,4.668568432140606
COR-L95,53495165,-2.3377393798516395,-0.3272170486555774
SK-HEP-1,25154868,3.1824362497542182,4.557522163377779
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-0.8200796806710429
SaOS-2,5978,-3.9287237947590494,-2.469819058651037
COR-L105,4096211,2.67395928769434,2.214057424015568
LS180,15953870,3.325208983942858,3.285112808413858
Daudi,66577038,1.2731684674623205,2.6569839057732274
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,3.118626251378069
RKO,6918328,0.803085247134139,-0.18357773768788402
SW48,4259181,-1.8199657809061969,-0.05821339036595432
SK-CO-1,44185566,2.2410285456889176,2.4421604240298116
K-562,5978,-3.1400031562505393,-2.6885896942920238
SaOS-2,613000,1.0847199338514617,2.407675292267889
LCLC-97TM1,9826308,0.172966057550933,0.42333607504604637
Granta-519,5311,0.5114694341413046,0.2692144640319056
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.6527720654672624
SW1573,4788,4.2029613497215195,5.667556274460873
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,2.9542898701788958
WM115,2729026,3.0250773642114175,2.5230977203832263
IGROV-1,23725625,5.712368491237602,4.819147751632328
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,4.051963426302715
SK-OV-3,24964624,2.562140083880341,2.538431242078734
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,1.7151013518513774
MDST8,5278396,3.853168516309647,3.5982092334333684
RKO,119607,4.75876667689532,5.0179809362428465
MDST8,65064,4.754326425577863,4.9685086022967235
MOLP-8,54596558,5.109397009340411,3.989882427600096
WM115,9911830,1.4636751787761997,2.5892510162173297
SK-HEP-1,44486219,4.3977685724309215,4.377723674404094
BFTC-909,15983966,-4.834157449814871,-1.720132694391336
SU-DHL-1,24901704,2.0463171426909086,2.6942731414110237
NCI-H1568,3025944,3.938114410703908,4.289591829759044
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,3.1921800536804583
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.6441419066197974
RCC10RGB,16725315,5.2458056955252275,4.450769490975714
RKO,53495165,0.8925500623489324,-0.3145497529045342
HCC1500,71304818,1.489157695167493,2.2975248315834476
COR-L95,135398738,4.3251787986630195,3.6911695559226674
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,3.187455560361974
SaOS-2,56949517,5.721423210410403,4.268379217297761
ALL-SIL,644241,-6.056766449232899,0.7879383157039311
MOLM-13,42642645,-6.876168570605093,-0.4574127341962433
RCC10RGB,51039095,3.636696049778912,3.045118404058339
ALL-SIL,60700,-4.240130526526249,-2.5075856216152776
PaTu 8902,15547703,4.581249636071297,3.012328381330597
BFTC-909,11609586,2.9417391320909134,2.723736770473621
SW48,11455910,-0.1633281652990052,1.0853646219722044
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,1.6353975230788302
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,0.9374532623335696
MDST8,11364421,1.2673702676732186,-1.2646223389634386
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.6394360810285733
IGROV-1,23939,4.412541857664819,4.151528261924184
HCC15,11626560,0.3588759938830249,1.914806887213214
MOLP-8,1750826,-2.6273703880538166,-2.5446925629016244
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,1.798177024759552
SaOS-2,3634881,3.4478485283346454,3.0956326266937397
KU-19-19,65064,5.4276979548790285,5.1497682333646955
SK-OV-3,53392493,2.9853646548342767,2.6347594549427424
BFTC-909,44607531,1.7004331217528663,1.4134283996671886
RKO,9915743,2.8851858618766957,0.279122051590186
WM115,969516,2.5733075045080405,2.9023788755375652
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,-0.4491599797139029
HCC15,1641662,2.7903081608832743,3.6094514542191325
PaTu 8988t,24856436,-1.0780184146975675,0.5916665845708335
BICR 22,151289,1.1052603945032196,1.3891417257224135
RKN,10302451,3.971829298943927,3.2169984140642027
Daudi,9840324,5.326423492349393,5.539939252857952
Granta-519,24978538,-1.4483375486726318,-1.1980385142003767
IA-LM,969516,4.593397144463051,2.7477149681724926
LS411N,16741245,4.421981695824733,3.906326451264273
SaOS-2,241158,3.6917409878316136,3.58181131288061
HCC1500,49846579,-4.075833194843517,1.2134928724195964
LS411N,11626560,1.8283516183370416,1.6811560765446787
NCI-H1568,2746,2.7741418395417163,3.3043420160587833
PaTu 8988t,375860,0.0559535091713014,-0.08246958664596978
BICR 22,613753,3.418897622092284,3.1773992281630683
ALL-SIL,52912189,0.8155728349845486,0.21171727986754552
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,2.9944536149563934
BICR 22,3634881,3.8771660288779457,3.2430213050987025
RKO,3543504,4.836700902585943,3.8917446967262195
Granta-519,6918837,-5.331886820340028,-4.434768698071436
SW48,56963564,-0.9893979738252238,0.30452846013859475
Daudi,4259181,-0.0890599021012781,-0.49953088075194446
Granta-519,7326481,2.8185757173328927,2.416276238785526
SK-OV-3,4096211,3.632564776557465,2.224075378229273
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,2.8535160453412036
SK-OV-3,24856436,1.946601057004947,0.5541365833557866
Daudi,613753,2.7401651571031618,2.8043749282817765
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-2.325938250324467
BFTC-909,452548,0.7682850038212578,0.4534404171875939
P31/FUJ,409805,3.653161003579303,3.939010985839346
IGROV-1,11404337,-0.7659238947812715,-0.35652535156911436
SU-DHL-1,24753719,3.670729792524347,3.859429735144512
BICR 22,24901704,3.9299918475898408,3.5834122144010796
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,4.060894348652954
NCI-H1568,135411,0.4069452326541798,0.7747688668107351
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-0.798546155829999
K-562,126941,-4.461586339574126,-3.0899047881845663
Panc 02.03,2113511,6.868929428825361,5.702444353918764
NCI-H2452,44241473,5.273016525632626,4.947504042589009
RERF-LC-MS,135984461,4.284403636339015,4.179204545847165
KU-19-19,5329102,2.6076401407195355,2.1353747243605836
SaOS-2,49867930,4.412008076102657,4.717375698740804
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,1.973671976190088
IGROV-1,54618771,1.2456991772210466,0.8815464284733455
BICR 22,7251185,3.2802016727508105,2.4591674133082733
WM115,11178236,-3.130587173648645,-3.0813895371248194
BICR 31,168312962,4.404506435623785,2.5832082152650635
BICR 31,135421197,2.236076370585341,2.0589709295690675
K-562,72734382,4.39493075447737,3.7612425695912406
Daudi,4521392,3.754955104648716,3.987299350924904
NCI-H1568,9903786,2.4011050725962115,3.2129012118836626
Panc 02.03,1242560,3.876690059869664,3.859548947429151
SaOS-2,24771867,1.911103494547597,2.514298450440326
NCI-H1568,46224516,1.8217130718981496,2.600366231466038
HuP-T3,637858,1.096014734488476,2.217121915919921
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.4935498449043143
HCC15,9825149,1.99442718669858,2.368206803024375
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,3.9152441471184507
LS180,9967941,3.3265068520356227,3.53105600262498
BICR 22,15953870,4.283514914534557,3.5305560439532213
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.659280728929025
P31/FUJ,49766530,-2.577046245506879,-1.835223712416115
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,2.9415616246813143
IGROV-1,5470400,-0.2457809435208252,-0.3792983765171124
K-562,3025944,3.938999685525622,3.994532882523889
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,4.0211518117353044
Panc 02.03,1641662,3.717230762709902,3.6123098667147726
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.5863081980878229
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.13279782675938423
SK-CO-1,613753,3.569116813952151,3.237614846866724
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-1.5178656510685449
LS411N,73707398,1.3643081745247092,1.25175352672738
RKN,60700,0.8209474049972991,-0.14616892395109246
P31/FUJ,52912189,-0.0654684439378525,0.1972883034406674
Granta-519,49793307,-5.0235824363471675,-4.192477337339795
LS180,439501,-1.9142457865624176,-1.6150067640636037
BICR 22,19582717,3.5857042125142247,4.45851328091273
P31/FUJ,11612883,1.4537759753270971,1.7845143737344082
RCC10RGB,135423438,4.4299924289236055,2.408593679400545
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,1.8166876889440764
IGROV-1,24797083,1.5319862293819655,1.3679882591269616
WM115,11657048,4.298694485616108,4.478223134695104
SaOS-2,5328940,1.8581375817896455,1.7697880592266122
K-562,11427553,0.716330793964625,1.7595616717029205
BFTC-909,60700,0.4554202898414442,-0.1844676480029983
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.710544816577743
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,1.255374776534584
HEL,656346,0.4971755704716853,0.4894385886449889
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,3.04286135549517
SK-HEP-1,25126798,3.9918710327668503,3.9967223716281772
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,1.1145012240964751
HCC1500,568763,-0.919346546730658,0.33960131912957664
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,1.8701572868571201
NCI-H2452,71466578,5.120149615089657,4.680445925362419
COR-L105,2871966,0.4959639880090196,0.8242973567260943
SW948,5746,1.511438037719251,0.8005193964029961
WM115,10172275,3.759074377781229,3.399749887015543
PaTu 8988t,11964036,2.992263460840089,1.6451432020708967
SW948,16219061,3.499504842183279,3.1142029153941446
LCLC-97TM1,53495165,-0.6427926162361222,0.316150438720316
UACC-812,3081361,1.9829916627298712,2.414197999004627
SaOS-2,5287969,-1.655987163162804,-1.97021439899788
IGROV-1,25183872,-0.4560099928976716,-0.5920999760229775
IGROV-1,44607530,1.2936443589937894,1.7255647077945502
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,5.093469777173797
SK-HEP-1,57519531,4.12625544642691,2.6095365631800376
BICR 22,119182,-2.736639797021525,-0.9938909342762439
PaTu 8902,4521392,4.129468839379376,4.5023818747744
LCLC-97TM1,60700,-0.7670870439402468,-0.4416771110413187
ALL-SIL,44607531,0.7892287314343482,0.9654742107611161
SW48,16720766,-1.213948450866439,0.5469061725766181
LCLC-97TM1,9911463,3.937478558519083,3.6562425929929314
SW1271,6918289,2.985913038733717,2.4475822146551214
SK-HEP-1,25183872,-0.6604608842788147,-0.6566905698408019
P31/FUJ,5311281,0.8046363155731003,1.858980286966394
MOLM-13,107970,2.204740997332017,1.7948830028117144
PaTu 8902,44607531,2.4953979740561136,1.381102397496677
BFTC-909,5978,-2.385180460490498,-1.5447204951158247
IGROV-1,9926054,1.8111808945519428,1.8435459493634383
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,-0.3056132246032162
SaOS-2,44632017,0.980304929421305,1.4916368101747672
WM115,23582824,-1.5173797182891284,0.928922537086693
RKO,5746,2.147448518007633,0.612794952021717
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-4.694348574882589
COR-L95,11234052,4.796206825131301,3.9427744950207018
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-0.7622432460258277
MOLM-13,46199207,1.8343479247638497,2.426083803216621
SK-CO-1,216345,2.2578794962248403,3.7841641107254738
LS180,24951314,1.284825385865239,1.049988487334995
SW1573,71680916,4.0865163925225385,4.6462774124898045
LS180,11427553,3.214146965067504,2.7037192978527633
HuP-T3,17755052,3.4304742988115366,1.7765300476747632
IGROV-1,44607530,1.2936443589937894,1.7255647077945502
HCC1500,11964036,2.769497384705972,1.357343477379584
LS180,446155,1.950458971830876,2.9398136425244714
SK-OV-3,10385095,3.0219456492917485,1.3617534695511038
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.1891244770245084
LS180,23635314,-2.728761007932067,-1.7751612664283405
ALL-SIL,25262965,-0.0785584741633136,-2.749956873885233
MOLM-13,9956119,3.465056755214706,2.48697314779343
Panc 02.03,54619267,4.6873070757127335,4.137428244285057
MDST8,45100481,5.670163105184411,4.731574562418578
P31/FUJ,11427553,0.2126015278922564,1.1642832173667446
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.504296973506095
SW1271,123631,1.9601206845091983,2.4851233583879075
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.388748202946408
SW1573,11626560,2.096503053081923,2.0036074551616214
COR-L105,11717001,4.401406695561914,4.290236466881248
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.4667588379524426
IGROV-1,135984461,4.285945029851472,3.5967598847391566
HuP-T3,16725315,3.145396972494799,4.388918563834438
SK-OV-3,5278396,4.0115131897954175,3.4996063995916504
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.336521538489036
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,1.9582481032152672
HCC1500,7326481,2.1911838281348897,2.770589383266085
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,0.2997281704785324
RKO,11485656,2.16906736756012,1.8009140336242764
HCC1500,17755052,3.708779056995352,1.6556182490626876
RKN,16720766,0.5941206863048918,0.3401636530359962
SK-OV-3,49766530,0.1985460846164677,-0.5995829993606727
NCI-H1568,11178236,-4.756412327662482,-3.489500138233099
K-562,613000,2.5009117496842292,2.024452180933691
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-1.1100307097335933
Daudi,49867930,3.141108082189553,4.342402060231373
P31/FUJ,451668,0.4769801026955246,-0.8919619094393376
SU-DHL-6,2708,3.434249932793118,3.5206677194818394
RKN,11497983,4.544575984994342,3.9648611079137277
IGROV-1,23582824,0.3287266354391525,0.9057257849838966
HCC15,2858523,2.7763462118547833,3.1284042410639286
RERF-LC-MS,3025986,-0.71270364092759,-0.691090524848897
LS180,984333,1.4840791700280882,0.6201479562340477
COR-L95,24901704,3.9540534266274183,3.0766059781897237
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,1.8095952371227013
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,0.6573968333515492
COR-L95,409805,3.71634228772174,4.563326608569136
PaTu 8902,9823820,4.420414335239228,4.049725242273118
Granta-519,24821094,2.4908648032560183,2.361770552466535
SU-DHL-1,26596,-2.3613305357908625,-1.7731041332046025
RKN,285033,-0.0275118271199953,-2.1416518651999157
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.6601127440485378
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.7549578411149933
NCI-H2452,9936388,2.1806204942966803,-1.0134784334531763
LS411N,54618771,1.0517408544895162,0.7796093842350238
RKN,72193861,2.3331130274465313,1.422384711577706
MDST8,46843906,2.4704071908178844,3.2182143607485934
HCC15,11485656,2.480533785053976,2.0972905353342313
MDST8,11977753,-2.9914432786855305,-1.117897312953977
PaTu 8902,168313047,2.1566405666580963,2.462776006861126
MOLP-8,135928012,3.056644501758044,3.474974346514064
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.1296043200408232
MOLP-8,10074640,3.1436066614625173,2.3974888618414387
HCC15,12001922,1.9087360775911748,2.030777585511039
LCLC-97TM1,3025986,-2.553955076787079,-0.7186750880552316
BFTC-909,2842253,5.585220688564769,5.384658310951296
RKO,216239,1.9979551619375524,1.792098177374216
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,4.015566069022623
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,2.300947187417692
Granta-519,135398516,2.1425852334349575,1.2284262564309585
KU-19-19,10385095,1.1563887024661463,1.4490770890415434
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-0.7773815918779802
SU-DHL-1,9803433,4.734138876460479,4.164441344393893
HCC15,135999136,4.472611779685761,4.0991189642685075
SW48,11238147,3.1100916590750045,2.8015665171302033
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.5637895510143481
BICR 22,409805,3.8456212820768214,4.9953081639283194
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,1.0391886356085869
P31/FUJ,24785538,-0.2737810661065927,0.6068704390651718
Panc 02.03,176870,4.923826321280428,3.4321550425140774
RCC10RGB,322968,3.1449149812629877,3.9970238114465104
HCC15,107970,2.678547076190946,2.38422868239486
SW1271,71304818,2.7682192858067385,2.527496395140585
LS180,3634881,3.5372782333734696,3.235560059074187
COR-L105,11214940,1.6414587299435788,1.9972916009474992
SW1271,5287620,-1.7165830209074355,-1.7629267682531802
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,0.957861015046213
COR-L95,49766530,-0.268325836176492,-0.48668784025739953
P31/FUJ,6450551,0.3392586382091512,1.4642257548034296
PaTu 8902,5566,3.0665407385312182,3.053393728642245
SW1271,6610216,4.395476769861187,4.398996897968741
IA-LM,4477,0.1872236957364025,0.8006525135998278
BICR 31,6917907,-2.0849244140580683,-4.283919423465618
Daudi,56949517,3.615784656128556,3.402771347249262
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.106521243970817
Granta-519,156414,1.3767921664113123,0.7067448208411267
SW1573,60700,0.5293530759970745,-0.14423499132392442
PaTu 8902,11404337,0.5155229173062875,-0.3192164044535388
BICR 22,52947716,-3.710960782083666,0.3130380027257165
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.5172688761412942
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.5461040796263976
SW48,216239,2.7420558854204105,2.195875544485948
HCC15,136227924,3.0147456858017923,3.1268597926798423
MDST8,400769,0.2052239388954162,-0.4959989241255599
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.7313962398291503
RCC10RGB,4917,3.4531775579708044,2.9983333669267904
RERF-LC-MS,73707398,2.0319367406190483,1.467662232387005
LS180,4917,2.9590600733191272,2.7597195525349543
Granta-519,46926350,-4.5411361861126,-4.930347186333299
BICR 22,1716436,3.778329286476686,2.827903310274432
LCLC-97TM1,55283,2.725406070596606,2.6884402420554134
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,1.6377457315864563
RKN,168312962,-2.199105388969794,2.5873230786422483
MOLM-13,54619267,3.3881439662249657,3.2762203755402317
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,-1.5083873670261523
COR-L95,1239801,5.40725658561935,3.707703902675969
IGROV-1,10184653,0.79276129336756,1.346027504117971
HCC1500,16741245,3.4170657459529865,4.083842175870007
LS411N,44491742,5.693616041532359,3.8793613746054088
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,3.8011726692151484
Granta-519,24753719,3.151565571990212,3.3958519765198156
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,1.9488890799064746
RKO,107985,-4.24085601271806,-3.7176033618171527
HEL,322968,3.0393820993226535,2.7006614652947882
Granta-519,46224516,0.9242838162777752,1.4851672528067408
LCLC-97TM1,9823820,4.2474508710721315,3.8654882978064484
MOLP-8,23582824,0.4015956903029024,0.4521361128164268
NCI-H2452,60750,1.245026450810127,-2.3267638838662945
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,1.9793589944546932
COR-L95,54596558,4.049100773357865,4.207753414319324
SW948,135398738,3.916695667859345,3.845132458290625
SK-CO-1,9936388,-6.4137542305703015,-1.6081507499391363
Daudi,60700,-3.752408099295295,-2.054437416515735
COR-L105,11612883,3.356288934915157,2.945610644928065
PaTu 8988t,10302451,4.044762571435361,3.3205524532330775
SK-CO-1,44507138,1.8454813707467936,2.7432291467487575
COR-L95,44486219,4.398500193784116,3.963496231333449
LS180,1242560,3.670855291471482,3.3913564143241457
PaTu 8988t,25102847,3.84691315859083,2.689955823368347
SU-DHL-1,1750826,-3.9186889861650713,-1.7448501027376568
IGROV-1,4261,1.934016649932683,1.7786444711693636
IGROV-1,9903786,1.7387584479757865,2.961895593063502
IGROV-1,9935249,3.330117761231163,3.2010142090905096
COR-L95,446155,4.383849487789403,2.738709527780715
COR-L95,9967941,2.195306027237361,3.135841085154517
BICR 31,49793307,-0.900639036765476,-2.2466821330888855
Daudi,52912189,-0.5619081020202099,-0.06400898529216667
MOLP-8,9911463,4.2009596294807245,3.29773297165932
LS180,44589607,3.154958497437342,2.537738375951089
Daudi,24821094,0.7293316215174883,2.5850680364574132
RKN,12003241,-0.3350096455718494,-1.055028913023396
LS411N,148198,-2.2204558676981576,-3.3804478630818675
RERF-LC-MS,446155,1.000000375050646,2.663557449434504
MOLM-13,10127622,2.24693559354045,2.618565717035882
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,2.5720504641772237
P31/FUJ,72734382,3.508076038929844,3.5748931530574497
SU-DHL-1,568763,-0.4525318049600722,-0.0098053285712393
SaOS-2,11977753,-0.3684170228919589,-1.7256073018507951
SaOS-2,969516,2.4754458532868067,2.6550492791582325
SU-DHL-1,54619238,4.649416356939895,4.287022648976408
SK-OV-3,6623618,3.404966669354166,2.3125063551222693
WM115,9952709,2.366340614566085,3.022149161680163
Panc 02.03,10184653,2.526680989613479,1.2855961654524584
SW1271,3634881,2.897813479014186,3.2835840721173084
P31/FUJ,72376,-3.3088434861533704,-3.0779329207149093
P31/FUJ,46907787,-0.8407426122417735,-0.5169534270750582
IA-LM,5351362,3.020488284300014,1.6242809022285698
NCI-H2452,676352,2.443862996701222,2.191882033784782
SU-DHL-1,56973724,1.0008411647005613,2.346085778235893
PaTu 8902,1716436,3.3992265902353425,3.0094327194780717
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.3275754118018965
MOLM-13,11717001,3.6418982852877457,3.289910501545429
MOLP-8,613753,2.6774354597179,2.9339259540192675
IGROV-1,44137675,1.8406125640672395,3.6312928321466513
P31/FUJ,6914657,-6.361388893160888,-4.8341567554099
LS180,60750,-4.478139976515186,-1.9542952517485623
SW1271,3062316,-1.9256219632112692,1.2198411173530133
RCC10RGB,219104,3.453227771477981,4.084030845695285
HuP-T3,6917907,-1.7519392074642692,-4.747739212097104
SU-DHL-1,11656518,1.4392799669460994,0.8900279519451979
MDST8,54626689,6.955475194588027,4.655337330062856
SW48,10410894,3.4061289364485794,3.063346673140536
HEL,72193861,0.4910118925931417,0.13395256888779813
Panc 02.03,65064,5.367712415574159,5.076132064042883
BFTC-909,984333,1.0937084793466407,0.9099796412708665
IGROV-1,426756,6.142776526139055,4.528644308375763
RKN,11152667,0.0617927102225113,-0.47090679219519843
BICR 22,3025944,4.210034761741456,4.289776673406052
SU-DHL-1,11640390,4.597120644825806,2.987089077048679
RKO,44589607,3.597229089573096,2.1189806937780826
IGROV-1,56963564,1.8260986108097368,0.40264567613736907
Daudi,24180719,3.437659555986817,3.22246284446579
BICR 31,45279963,4.353781648061694,3.8032369007548716
KU-19-19,445455,4.442962740031222,4.843481824757116
Panc 02.03,5281672,4.500820026656837,4.8694958676408255
Granta-519,675434,3.9057117034292976,3.8861791166107746
WM115,46398810,3.009678027858605,2.5149249199579926
BICR 31,119607,5.814089022953436,5.461862260447252
IGROV-1,23635314,-0.611739968448912,-1.7511822063848477
HEL,44819697,-3.010940469478465,-1.3657635494911573
ALL-SIL,5282054,2.788902246408387,2.6383299392526647
WM115,5328940,2.031963430852867,1.755329339169471
BICR 22,11455910,2.0554057071158303,1.035152542059243
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.3515249471943505
P31/FUJ,4259181,-1.476581151251805,-0.3853778366011668
MOLP-8,54619267,3.766514987830834,3.3841576075919324
P31/FUJ,44489367,5.126164790260484,4.20888720461629
RKN,11625818,5.974552631000589,4.556317904781646
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.5613883161764253
BICR 31,5470400,2.045329114611378,-0.01715662340726549
LCLC-97TM1,5738263,3.894572665100205,3.493093306188477
SW48,2729026,2.3283979545053155,2.5014335994210124
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,2.26316579797902
COR-L105,11167602,4.878993593502554,2.6230627175650505
HCC15,9549297,1.5760835884765407,2.576621587421648
HuP-T3,448949,2.1685596620814565,1.9744821746809382
Granta-519,9915743,0.9460784198503543,-0.018207062114040978
MOLP-8,51039095,1.4019996450160122,2.0972242611781713
COR-L105,56649450,3.0558986692826595,3.2943788885177723
WM115,16038120,1.6321211746217177,1.1251164563523113
K-562,31703,-1.219746708928784,-2.3376990444150154
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,2.2852658671674275
SU-DHL-1,11609586,1.5538406664396571,1.9205227724915162
BICR 31,3025944,4.108701914406302,4.3695922672720675
SW48,66577038,3.1598846844687545,2.6659418278832216
Daudi,24180125,1.1000611971852634,2.218387310349283
SK-CO-1,6184667,4.676967004326267,3.1798858891470876
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-2.9379596166756325
SU-DHL-1,67291369,2.039504043535649,1.3301580145829985
IGROV-1,3815108,1.915722485757852,2.8964244376762123
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,5.049288521522969
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.5861920312674074
LCLC-97TM1,68056272,3.7652459105524585,3.693775044594478
NCI-H1568,9926054,1.8156743035592564,2.003134865290862
SU-DHL-1,2113511,3.6581551041454823,5.083700977850653
HCC15,3503,1.8764785687467953,2.382070967027073
SaOS-2,3062316,2.2990980703822115,0.9964221002234894
K-562,16736978,2.075477087199636,0.870193160789078
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,2.014498603317199
RKN,135440466,3.1815161125023033,2.1572353723009816
SK-CO-1,89928392,1.2451759556756246,1.346714051042423
NCI-H1568,54596558,4.146513733670967,4.368522204305105
LCLC-97TM1,4477,1.1810793422928998,0.7677468770004034
LS180,16741245,4.152630132762677,3.778564474628374
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.7950988566174644
BFTC-909,159324,4.114702101808939,2.936666292601753
PaTu 8988t,2113511,6.37119394515457,5.558512018054883
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.7896639807295365
IGROV-1,5291,3.6852809555447985,3.751763404660661
PaTu 8902,16038120,1.215016097060631,1.0279502217002399
ALL-SIL,10302451,-1.1728976190372558,2.3175804747371522
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,2.617877587232891
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,1.0062888757819053
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-3.2745121424905195
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,0.18677107402893103
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.78312157543892
SW948,7326481,3.486606738365962,2.7391338825352096
HCC15,44507138,1.6295786006094204,2.6327919255904977
RERF-LC-MS,16725315,4.583339442818838,4.40948933696028
P31/FUJ,148198,-3.664233852608881,-3.9735306502139336
HEL,49850262,3.2265871136708997,2.647610862371912
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.7881291534300874
BFTC-909,60750,-1.7298046099952136,-1.88925099690463
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-0.8665077302433077
NCI-H1568,675434,4.067969537829177,4.563574190237145
COR-L95,19582717,3.635233206850296,3.75295223393398
COR-L95,148198,-4.800055382400855,-3.9634349650339544
BICR 22,44819697,0.2156040754176,0.2129632854624468
SK-OV-3,46224516,3.444215787907748,2.688763121529372
HCC15,5281672,5.6563329698974965,4.839103483392177
HEL,6918328,-0.4966077251990671,-1.4817189631400216
NCI-H1568,24785538,0.5698046292147018,1.7360923313245238
RKN,23582824,1.7370647325872666,0.8612292621423044
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-0.819610705851796
SU-DHL-1,322968,2.585334286015635,3.3820157482707343
BICR 31,24797083,1.8361324304615187,1.4515334894005705
SK-HEP-1,3062316,3.432714145613195,1.2996536782164447
PaTu 8902,2729026,2.7803221257085884,2.782210705873549
SK-OV-3,11609586,4.251063762376387,2.9643391612188568
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.252179378977496
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,1.668728388458635
Granta-519,44607530,1.7224857333943702,1.5045094614383923
NCI-H1568,15953870,3.42403550557497,3.4873673125710836
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.6019181352917315
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.2890788908818007
MOLP-8,252682,6.161004481234046,5.993834817476251
SW1573,126941,-1.0305779796426808,-2.7356166792386545
BICR 31,9927531,5.661036072082279,5.042799235576014
RCC10RGB,441298,3.7731685554529384,2.91914736959893
MOLM-13,387447,-5.119095777855545,-4.858022922965681
Granta-519,216345,1.0997896286755158,2.9947978244630735
LCLC-97TM1,107985,-4.222636663811031,-3.6143817612989744
LS180,3384730,2.894746509752001,2.8109666285646835
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-0.9997939008763533
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,3.364450570530295
KU-19-19,44493528,4.383684457454455,4.4720853076749005
LS411N,53232,4.5193815700089655,2.9550169510659288
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,2.534301320087467
LS411N,6438330,3.3380693145982816,2.011507949917545
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,2.6482192776768505
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,2.1564506560772108
BFTC-909,16725315,4.495652912061774,4.190775675402627
RKN,124202324,3.704376342602573,2.3985282371490366
LCLC-97TM1,10127622,3.458194652659875,3.84259727193561
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,2.6596073492194376
SaOS-2,5494449,1.7356769079300427,2.6898862365954357
HEL,702558,3.166026376934585,4.131681211105663
KU-19-19,11612883,2.975593545287462,2.9203207793292587
BICR 31,6914657,-2.1990076047646703,-3.5673301568683424
PaTu 8988t,2858523,3.414247843041017,3.046855858655059
SW48,9911830,1.5953282800372102,2.719165670734547
Daudi,11178236,-7.583909031047052,-4.218749157708149
Granta-519,44819697,-1.094231558387569,-1.7442339168587189
MDST8,2828334,6.077771510152207,6.237437632448777
RKN,9911463,4.114615883902867,3.8901719159256007
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,1.2006254969160064
SaOS-2,9903786,2.3206358959344264,3.089394254065322
RKO,44607530,2.6096687798301677,1.701797165028794
SK-CO-1,11455910,1.152685438196598,1.0160764867242817
SK-OV-3,25183872,-0.070614613180641,-0.5587224791406306
WM115,25227462,1.5125525407178182,-0.01528010936005627
HCC15,2126,5.047391044285817,4.8694244391714765
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,4.013662491070005
HuP-T3,11238147,3.6375005285241033,2.8002880231959932
SU-DHL-1,168313047,2.0629090722275945,1.9814705145844402
BICR 22,5335621,5.24838502551373,4.750478019444775
SK-OV-3,135398516,2.140261030425796,2.2249703537311696
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,3.048434560144343
RKO,11214940,1.6564081526645635,1.6815672491927247
SW948,9935249,-1.8483271913214137,3.0533667286668655
NCI-H1568,2871966,-1.5477941874243064,0.45083090092488426
WM115,54626689,3.4845925362433,4.553979066747172
IGROV-1,46398810,2.003787621940583,2.5778856272473742
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.6667165784995011
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,3.6781483609019068
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,3.3025726313602153
BFTC-909,3025944,6.464154930724253,4.342639941543544
BFTC-909,10113978,3.8739618499623094,3.1721835350101504
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-4.058086146504775
BFTC-909,24748573,2.672786285704278,2.2120715973036233
MDST8,23582824,0.3553467044538872,0.892042345252746
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,1.075663143347971
SW948,53392493,1.921137473015096,2.4825293217842166
LCLC-97TM1,5287620,-2.537847801025228,-2.2877041988191595
HCC1500,3552672,1.623977684405255,2.64323114558789
SW1271,2113511,4.856200971437617,5.69340346757055
RKO,11238147,3.3996395604326977,2.46704780577008
MDST8,56963564,1.9609696235744132,0.9264638965520756
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,-0.24076732841360374
MDST8,73707398,0.930898424190815,1.4607144502257312
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.242788515099676
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,1.6643399268373928
HCC1500,107970,1.6380228058856745,2.256857797501662
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,2.9212195182474567
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.901073155437277
MDST8,11222830,1.739834123793711,1.5929647329959626
MOLM-13,11364421,-4.614262921489179,-4.452938881639197
MDST8,89928392,1.3331112546959425,1.4818823111705688
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-1.274173768072136
RERF-LC-MS,148124,-5.592640359076286,-1.7826421699482444
PaTu 8988t,219104,4.30352428274638,3.8824418710243065
SaOS-2,16659841,3.6368059645085737,3.768811080627678
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.1696181713406038
ALL-SIL,25183872,-1.1896517316661384,-1.9273149389810373
HuP-T3,3503,2.6961085729175465,2.514261168510631
SaOS-2,148124,-5.379251304292956,-3.3260634535621425
SW48,25102847,1.5289459974072863,2.420578712081807
PaTu 8902,6852167,4.282216220168943,2.7810169973836256
ALL-SIL,11396600,2.960335319566646,2.775483829933993
LS411N,54649381,4.0879656113234315,3.713210127131264
LCLC-97TM1,56649450,1.9268896253969057,3.2212714370580797
Panc 02.03,42642645,1.4849485241267697,1.1765851284671411
PaTu 8902,5328940,2.100447742300893,1.7447283574819459
Daudi,10127622,5.05479511248997,3.7293101814689367
SaOS-2,15983966,-4.612114381732812,-1.9027010809353382
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,2.934890837038216
MOLP-8,11214940,2.188017762346292,1.70784335372266
SW48,44607531,-0.0703962424187993,1.5468266586002528
IA-LM,637858,2.795809218533269,1.660039993394648
LS180,119182,-2.2864715680735603,-1.4128223327942138
SK-CO-1,135411,-1.9906675184189948,0.7409334755421176
SW1271,15983966,-1.9627382742922743,-1.1528991279282468
LCLC-97TM1,11485656,2.4293249862604913,2.2269798801438965
Daudi,135984461,3.9990978127252728,3.063082209435388
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,1.015328438928709
SW1271,24180719,4.447587763279296,3.615051413080637
RERF-LC-MS,4917,3.617944790726347,3.193763853618585
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.786711213059772
COR-L105,44185566,3.03526972595121,2.6186186188335863
MOLP-8,8515,3.727464051425151,3.392004876314811
Daudi,11656518,1.0836561052202376,0.9990146621588113
MDST8,10302451,4.267643132743765,3.073417051029288
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,3.1362193521014787
MOLP-8,135398738,4.11621412508813,2.7408288704654176
RCC10RGB,568763,0.4218853975706897,1.0507669234612627
SW1271,285033,0.340737243750418,-2.1650287126691388
Granta-519,67156097,-3.3327998752636483,-2.417724348158317
WM115,11964036,0.4423113132234746,1.4715645786514313
SK-CO-1,156414,0.1991331726980137,0.9781151915245617
BICR 22,568763,1.1340411223212885,1.0107869978347876
P31/FUJ,176870,1.9707243184949097,2.584962180633579
SW1271,24748573,2.5868513601661336,2.001003191835074
MOLP-8,72199292,1.2541603744267094,0.6985605994299593
RKO,5282054,3.8735499096789856,3.1416540071137677
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,2.530643332165507
HCC1500,16722836,2.402902940836366,1.6043318534822615
Panc 02.03,46199207,3.8452319744534886,3.2386190639590096
PaTu 8988t,71304818,2.8353343090304257,2.54586859483906
IGROV-1,241158,3.288496474515495,3.7828809886524435
Daudi,71751553,3.830487233171358,4.076088197660999
COR-L95,46174525,3.763282126483136,3.8030503830422355
NCI-H2452,2126,4.762499509878762,4.694198596056456
HCC15,11228183,0.6025691709173914,2.3947480100210368
HCC1500,11404337,-1.1638452247583002,-0.28674057406330106
PaTu 8988t,16725315,5.4103858057829095,4.123259697653552
MDST8,4378219,1.9480435949418269,3.110156046781407
IGROV-1,5351362,1.961059142684053,1.5845084948344867
HuP-T3,44489675,3.6946366435409352,3.9090411141822012
SW1271,4259181,0.7411137136724786,0.008801228027170996
RKO,5978,-3.7617282032773582,-2.7299130030158576
MOLM-13,11485656,-3.968420003132376,0.9313994014962711
K-562,24821094,1.908113699718487,2.733832669354017
SW1573,89183176,3.862510153781557,4.352447459379258
K-562,24180719,3.2747438118023533,3.198158359179189
LS411N,4788,5.997281207159956,5.706825597928227
IGROV-1,66577038,3.2148239132520455,3.021533146429839
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,3.920046001173512
Daudi,9549297,1.403366421117492,1.6222274952783742
UACC-812,11427553,3.574449796486334,2.796973398583467
MOLM-13,52912189,-1.0667663091505395,-0.0025496816385134104
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.4212847569477842
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,2.9273705150838207
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,1.7660700065232637
IGROV-1,24821094,1.720998716331183,3.224276293083715
Granta-519,11427553,-0.9723301484726812,1.5463789776839494
MOLM-13,208908,2.7636340376000317,1.646316356087223
IGROV-1,9915743,-0.4757488934941289,0.8657374090463829
Panc 02.03,241158,4.402915180139186,4.002303532818755
IGROV-1,24748573,-1.0654275876710166,2.005874950984885
COR-L105,5287969,-1.8496230723467,-1.7948631871683525
MOLP-8,10296883,2.725727750190508,3.2454011289809004
SW948,241158,4.5321951743877005,3.6558933325698546
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.584431127098611
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,-0.21492616338074902
SU-DHL-6,10302451,3.370117636140473,2.7025576791799177
IGROV-1,9936388,2.10108466287406,-2.718363449887523
HCC15,72376,-1.512462057486854,-1.5665872304244366
COR-L95,6450551,2.8920154707175776,2.1569956777795856
NCI-H1568,5738263,3.2402226460817323,3.4732155399060844
RKO,54619267,4.028311361432676,3.5320125777993154
RERF-LC-MS,4261,2.068565192175152,2.096004950022548
K-562,73707371,5.645446798773975,4.182262826983877
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,3.109947111088027
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,-0.018157547109175762
WM115,122327,3.780637240577924,4.826525938448927
WM115,25150857,2.4679229997528394,2.3364192258737044
SK-CO-1,11178236,-3.2010052407962215,-2.9482125224923963
RKN,753704,4.966407297087677,5.005007309803279
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.5029890884404034
SW1271,227681,3.2917347097405725,3.4095538398342042
MDST8,568763,0.1407924711645573,0.7931831231071083
BICR 31,5566,3.2898773587253096,2.972462260093428
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,4.47034031921842
RERF-LC-MS,6450551,1.967154760545028,2.868790301726214
IGROV-1,2874250,4.893662837169153,4.372359719994364
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.8643212992695074
HCC15,56946209,-3.385198311974778,-3.8761842477566706
BFTC-909,136227924,2.3418993883842134,3.046758149418567
Granta-519,1750826,-3.7858867937492984,-3.7622122964083906
P31/FUJ,11625818,3.2136174191857174,3.4373377575222537
COR-L105,10322450,4.112392966182136,4.264779075545794
HCC1500,5566,2.905130044911903,2.930209705316793
SW48,51039095,1.7096770563148074,2.672735985533983
SW1271,8515,5.208985199998064,4.1062311349894465
KU-19-19,73707398,1.7453733414385195,1.393294730482012
K-562,11707110,1.6681367726124623,-0.1239864716290036
COR-L95,16065773,1.8842547212847705,2.255619476731864
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-3.1412185473023015
IA-LM,11178236,-6.720771550362321,-3.32615403956512
MOLP-8,54596490,4.413151323823571,4.141704467911575
ALL-SIL,44202524,-0.4119558263455749,1.345185671268017
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,3.1853815650310198
MDST8,6918328,-0.3527629143091293,0.49315969842451357
BICR 31,104842,-0.0442586507462943,-2.8343614561283443
BICR 31,6852167,2.001013365002547,2.617531521951201
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,1.2371716482861528
IA-LM,24821094,3.0699000024292293,2.9882276959227623
IGROV-1,73707398,0.8848064516600974,1.2572712297714388
SaOS-2,46191454,1.8159544721998524,1.8498175427312278
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.5517734781352706
LS411N,25150857,2.959758413524705,2.121660348912808
HuP-T3,11175137,3.603877049706456,2.540015643849567
LS411N,135984461,5.061110843141604,3.8009300625644973
IGROV-1,4261,1.934016649932683,1.7786444711693636
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.0145586984968986
HCC1500,9952709,2.298703589628035,3.1335102927894223
SK-OV-3,176870,3.5610869734905255,3.104925314717584
PaTu 8902,9952709,4.3707417693645745,3.207949344717485
P31/FUJ,56973724,0.796880831995934,1.5590974613664534
RKO,2729026,2.3662843020346753,2.4514238201946394
RKO,387447,-4.452540898932811,-4.468877830949318
SK-CO-1,135398738,3.5773200936681584,4.380894403706011
BFTC-909,3552672,4.498195948808332,2.8262834304796227
Panc 02.03,7251185,3.0530850004567767,2.6852518043432614
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,-0.5294747662513545
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,2.2084068521398894
Panc 02.03,53392493,3.617637281515077,2.96349664162921
LCLC-97TM1,446155,3.780165105352184,2.725781967303839
BICR 31,23725625,6.004496967521932,5.3903537846437235
RCC10RGB,11612883,4.41570881394896,3.131881275798004
WM115,5280436,2.216411919293008,3.321995658215315
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,0.829607454556744
NCI-H1568,10184653,1.3826991243685076,1.3344613764976438
LS180,10427712,4.740953715848998,4.147845863875022
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,1.1005025010094491
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.4946077269617178
HuP-T3,12003241,-0.2833744856936582,-0.9680111164369706
Daudi,9884685,-1.7998414591903729,-0.36439657709453166
SK-CO-1,44259,0.6005082969424771,1.1109047264226506
MDST8,10231331,0.2022855962524302,2.266454610833606
SK-CO-1,4261,0.7789911540114764,1.7214571913956878
P31/FUJ,10074640,2.9862675466657764,2.5107865223775847
SK-CO-1,12001922,1.782153173177779,1.7178572753883556
SaOS-2,16720766,-1.9505026731708328,0.5103995594176738
RCC10RGB,216239,3.3222265979679375,2.592959035461586
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.7090386832012391
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,0.8813601232876422
COR-L105,72734382,5.425179503032161,4.785826727755191
LS180,11640390,3.36619781023128,3.220915376904453
K-562,25262965,-1.232298297425116,-2.3494167221597975
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.631624760054916
LCLC-97TM1,135411,0.5874500365845237,0.7160292979323895
SU-DHL-1,46398810,1.696894130738712,2.0414383683089032
P31/FUJ,6610216,4.336076332167018,3.8097552929303107
BICR 22,5291,3.723640910280853,3.7380735198900163
HEL,44632017,1.0842639602191189,0.4417506616305272
Granta-519,4261,1.1412453306659267,0.2964805531877382
Granta-519,56963564,-0.5609340564012296,-0.37475531765193876
MDST8,53392493,2.9375507482716334,2.9002135181713053
LS411N,44819697,-0.923326266781905,-0.4671375405824566
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,4.0683332664977385
NCI-H1568,5291,3.770643134542437,3.8792467343694943
BFTC-909,11612883,3.5324782187628827,2.935330677731496
RCC10RGB,11955716,4.4260489213830425,-0.6150954420336049
SW1271,11626560,1.376954486231794,1.8837055942749938
SW48,46943432,0.8743166493146273,2.252711219154582
HEL,3062316,2.2727573444408633,-0.4090726687061956
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,2.1803256349673306
RCC10RGB,5329102,2.357265375302505,2.2324485249458683
ALL-SIL,9866186,-0.4181259896802407,-0.3997685825342825
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,2.4599738089034813
HEL,23635314,-2.6594801266287154,-2.3219805540088805
Daudi,10074640,1.7373836938395748,2.519694590076729
RKO,26596,-1.341584325458414,-1.2845618165809334
WM115,11167602,1.5239005360441813,2.690017782358195
IGROV-1,2746,2.8413672686351212,2.9158917790920516
Daudi,24978538,2.467871482925033,-0.8718888588655512
RKO,2858523,3.1569923390566332,2.6187896516102196
LS411N,15983966,2.6804451752833978,-2.70920366103343
SK-OV-3,452548,0.7579906967862455,0.16670296127804157
MOLP-8,25262965,-4.805551534468427,-2.467971752451974
LCLC-97TM1,46215462,1.4949685345148778,1.904996025948036
BICR 22,439501,-2.4052901035443,-1.9575945828578996
SW48,10184653,-2.0074491437034094,0.8872968142699239
P31/FUJ,168313016,4.690131242833582,3.7447276864404864
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,3.3736384332179794
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,1.6918891879336426
LS411N,54613361,3.867376577775082,0.17575141690066368
COR-L105,24772860,-1.435746068442861,-1.2267039026432336
K-562,11222830,1.892206265748428,1.2534566756250194
Daudi,10385095,0.347773175212431,0.9117571867608802
HCC1500,44137675,4.199849963716895,3.6082712515095947
SW1573,11404337,-1.3449252751203844,-0.08177874464856241
SK-HEP-1,46191454,1.8876467264614776,1.7425060971292206
P31/FUJ,135999136,4.068676884464422,3.0281570656998076
RCC10RGB,25150857,2.370598483016253,2.750054176190823
NCI-H2452,57330099,4.302779847582817,4.20117499631427
IGROV-1,10127622,3.2581804056600165,3.9205214407589466
COR-L105,5282054,3.9571885951378505,4.053191918151831
LCLC-97TM1,53481919,3.8027519676947232,3.3033643687793677
NCI-H2452,3025986,-0.5496531660815697,-0.3625689010917105
WM115,11955716,-2.4505472507691013,-1.1716489557911953
BFTC-909,637858,2.264716830291231,2.024964756644511
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.8729645435265638
Daudi,1641662,2.995591169153073,2.523627144791966
MOLP-8,446155,0.367312642153156,2.522678881427263
RERF-LC-MS,135999136,4.400683337930441,4.1461075926745075
WM115,5738263,3.851280366828244,3.4333951685515154
MOLM-13,65628,2.9573007313246924,3.321064124286977
HEL,9936388,-3.337900467930123,-4.459137314985186
SW48,104842,-4.777281812432541,-2.634677304435231
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.05809502132396038
Granta-519,11626560,0.2073830225530282,0.516841138080439
SK-CO-1,969516,2.7975557975376035,2.8177309955895113
SW948,11640390,3.051257470103826,3.181545581646438
HCC15,10302451,3.767869991537956,3.2427307476153038
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,1.8049988805693917
PaTu 8988t,46943432,6.478561461465468,2.2308526994722673
K-562,208908,1.7214906675478436,2.1161254097453
NCI-H1568,11612883,2.467781963295413,2.731179111276583
LCLC-97TM1,9884685,-0.6945268748645868,0.565149440802015
Granta-519,6918328,-2.2526378564537355,-1.9010498830386209
Granta-519,5470400,-3.2597420844446163,-0.7312842603406957
LS180,10231331,0.7625893939503741,1.4973154073578216
SW1271,46199207,3.134892747913181,3.23597890403275
HEL,11404337,-0.835651629585067,-1.1397319869977465
Daudi,216345,1.872370108624604,2.9322815152668125
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,-0.9693293991672224
RKN,54613361,0.2026815444056028,0.3245739815784306
LS180,452548,0.7544699085550369,0.029539099009714805
RKN,44493528,4.408823872302737,4.444002298239741
SK-HEP-1,11238147,2.1467729161342524,2.8866999965608113
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-2.4055543609401853
COR-L95,11364421,1.7062947816433405,-2.5472561492988786
KU-19-19,452548,1.4010535434747853,0.42637405593905475
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.299544536245391
IGROV-1,44819697,-0.8326420176056434,-0.7643294581485303
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.411093750476495
RERF-LC-MS,2729026,3.1361811776879644,2.78233379162857
RKN,4788,5.902938799554125,5.667478523354498
K-562,216239,1.6121414929675577,1.7016077533323053
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.795647248065681
IGROV-1,2746,2.8413672686351212,2.9158917790920516
IGROV-1,637858,1.814476597989254,2.0256914833326585
HuP-T3,11214940,1.8541641961456377,1.8567098408529017
IGROV-1,46907787,2.182756719431072,1.9640193710784752
P31/FUJ,445643,6.117258311867223,3.4879500399585925
Granta-519,3854666,0.1662242620713641,0.8909484499720872
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,0.5947969100780273
LCLC-97TM1,135440466,1.105929023295497,1.9652863096476296
RERF-LC-MS,56649450,3.38813984116235,3.555149934594247
SK-CO-1,11612883,2.4661452350243493,2.741895549865904
SK-HEP-1,44137675,4.549525792934436,3.5927835404482282
HCC15,72193870,4.3690783386047025,3.3790887246326453
HCC1500,2746,2.6069735713089006,3.005219179255766
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,0.578131354175254
Daudi,11222830,0.8543881776084605,0.7583353610565335
WM115,2749,6.3303951951253445,2.1823790201821445
K-562,9840324,5.675524269237515,5.5561965917612826
MDST8,10113978,3.624916965791189,3.151405269289336
NCI-H2452,44507138,2.753685109279225,2.6212167222292897
MOLM-13,5282054,3.1361279245897857,2.8027626032537882
BICR 31,9911830,2.2138272662609064,2.8547137064287
HEL,6917907,-5.38656193144065,-5.587877335253442
IGROV-1,2858523,3.196384505087132,3.0447671525884927
MOLP-8,322968,-1.2094679469942695,2.6477753424612276
BICR 22,3503,2.960513829073252,2.2862558122005305
ALL-SIL,10113978,1.6173510565910796,2.1921839253769604
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,1.8643622357964713
RERF-LC-MS,119182,-0.645974794966856,-0.8815554827074622
LS411N,4261,1.591263829932159,1.6110825368759236
SW948,4096211,1.12279899109382,1.7131377977381164
K-562,11485656,1.7795111963017332,1.7830034015153686
MOLM-13,53232,2.182263698942312,2.0363600539671705
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.4985995009894982
IGROV-1,3689413,-0.3633634632064185,-0.7862045967913389
RCC10RGB,12001922,2.277970650057297,2.1208766247167294
RERF-LC-MS,246676,4.480243243269967,4.575748513192817
HCC15,374536,0.7951987879889547,2.3594621394162427
MOLP-8,11977753,-4.876868381891939,-2.5295665932978193
Panc 02.03,2874250,4.438896474206821,4.881638205928761
COR-L95,613753,3.031049367391043,2.978237264336976
SW1573,9840324,5.095993559480237,5.70551510556514
SW48,24901704,1.780712261537264,2.956036840109184
BICR 22,6918328,0.5113628660513942,0.2176301830028118
Daudi,54613361,-0.5183638298018372,-0.3700285818931499
LCLC-97TM1,25102847,2.141917897082315,2.298308403324136
HuP-T3,3081361,3.872954779649628,2.3869379098060506
LS180,969516,2.6818241036299275,2.603322052029932
SW1271,2945648,2.4921907486938646,2.965084120801075
BICR 31,25126798,3.691910729857057,3.688137747868011
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-1.3203901402186833
Daudi,262093,0.7533038243356376,1.9498433052056867
RKN,20959075,-2.033811748726601,-2.4214741287052335
KU-19-19,702558,5.449368171937104,5.334152663535423
SaOS-2,2842253,6.143936300195383,5.228605932636182
RERF-LC-MS,26596,-1.2372341703529914,-0.7963667888222821
PaTu 8988t,5329102,3.3339986936080717,2.2117640187473198
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.6533274111134981
SaOS-2,73707398,0.8491853151273433,0.9900729146342551
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,0.9124273629536859
SaOS-2,984333,4.259432573695519,0.2792078907216435
LCLC-97TM1,53232,3.007779101776312,2.813395024375626
KU-19-19,3503,3.0769201112014803,2.3347962529925246
WM115,57330099,5.984461482923693,4.251715747826648
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.694865895215127
LCLC-97TM1,44491742,4.237702230509644,4.16559938812231
SK-CO-1,9915743,2.0474134916136184,0.4816091749980058
HCC15,73707398,1.6988346513711203,1.477566887331784
HCC15,4477,-0.3802251277588812,0.6021406885407109
BICR 22,26596,-1.8883514509946957,-0.5424367685478186
SaOS-2,445091,4.479630914494518,4.348819070426999
HCC1500,3503,2.0705498046235817,2.3413320381543383
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.927780067983028
RCC10RGB,71304818,3.488257335656729,2.4404224343690135
RKO,241158,4.5302703569847305,3.34154180134632
SW1271,168313016,5.582938604018868,4.940613362675213
SW948,10385095,1.3660359707166476,1.413120042820863
RERF-LC-MS,3543504,3.1700226881436193,4.386700666290493
LS180,5311,1.1738972820475675,1.2810132758547512
RERF-LC-MS,5291,3.9873816513243785,3.7888539043561984
RCC10RGB,53481919,4.9196370953200805,3.5022496810505688
Daudi,44241473,5.233980827552566,4.286585118363745
Panc 02.03,10127622,3.4148938287456776,3.9674879655550574
BICR 31,49836020,4.313223650735915,3.45834708504096
Daudi,54618305,3.9105424608095847,2.8617849335647283
SK-HEP-1,5746,3.319924463812582,1.2650318341477234
ALL-SIL,67156097,-2.3407546390754037,-2.4381135807926118
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.4591106477832785
P31/FUJ,613753,2.9305719806169432,2.761714957395111
PaTu 8988t,1641662,3.634680635371761,3.6046544369368627
SU-DHL-1,15953870,1.992339234699044,3.0285044698560086
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,0.9446710015496881
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,2.340035565482823
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,0.3333580447407848
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,2.1272524756540023
SK-CO-1,11364421,1.7180407971266538,-0.9488509773623701
COR-L105,16722836,1.79329711252707,1.8516907197608146
IGROV-1,439501,-2.1510551928674557,-2.473451669973042
ALL-SIL,50905018,3.9646846974495418,3.6451034292348736
SW48,25126798,2.5731969050098993,3.5114092935130112
PaTu 8988t,10113978,4.3652834043747335,3.394293499716869
SK-OV-3,12003241,-1.2313805329375749,-1.2054000557586324
Daudi,1317464,3.6966432302020817,3.3144212603160113
WM115,5978,4.185238310426041,-1.3027700816065473
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.8481895711318646
ALL-SIL,24785538,-0.5874123218373029,0.15757505066052532
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,0.9412550925300053
IGROV-1,9967941,2.9735049794712545,3.6468630012599887
SK-HEP-1,11977753,-1.1270659898133608,-0.8067995724259336
COR-L105,676352,1.9469411585028615,2.2426525628975535
MDST8,11485656,2.867381561993162,2.534109722970284
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,3.4339847954965683
SW48,6918736,-2.164113269607571,-1.7480698479740693
SK-HEP-1,445455,4.37046727572682,4.829088001347195
Daudi,4096211,1.4831417361144643,1.4448201840933967
LCLC-97TM1,16038120,-0.9192372639718316,1.055820389648826
BFTC-909,3384730,4.46542670181497,2.691153352391087
K-562,36462,1.3855340321895664,0.39485722647508303
SK-HEP-1,5329102,2.506246240472525,2.2726853479703135
WM115,25161177,2.874219730459086,3.9607249833175313
HCC1500,119607,4.730010050453825,5.022793231734842
IGROV-1,24964624,0.5052308994941754,2.1215309591522162
HCC15,421610,3.960173561996767,3.341842165974627
ALL-SIL,4788,4.920956242868583,4.633677043535641
IGROV-1,49766530,-0.195540678413639,-0.21986491870464098
SK-HEP-1,11175137,3.0126176485486114,2.8101631211438693
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,1.6047652607503076
K-562,54678924,1.7343444538293111,1.6203827572195348
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.0187024158202567
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.7544592716072382
COR-L105,6505803,1.059348129706536,-0.18435603342360168
P31/FUJ,25183872,-2.108478877482417,-1.94809653778561
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,-0.16399164663142288
NCI-H1568,9444,4.259676436179719,4.151028691155079
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.335651205058011
KU-19-19,19582717,2.992815973528006,4.165721172676618
RKN,36462,2.460575122343829,2.3166295075721868
P31/FUJ,3062316,2.2346133515561415,0.2693338039310342
MOLM-13,36314,-7.769941141611737,-0.985904702829851
HEL,44484440,3.2564839193688524,2.471689563105594
RERF-LC-MS,168313016,4.277512101574917,4.9300192069433795
HCC1500,637858,1.1010846881251866,1.861766523771631
COR-L105,11178236,-3.064044900311784,-3.101834013881783
IGROV-1,44202524,1.8303703172382677,2.2073173276404976
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.1986235921509726
MOLP-8,11175137,1.914718066408171,2.012782469748154
LCLC-97TM1,1641662,3.5570250788057187,3.213073068271014
SK-HEP-1,46199207,3.772137058295689,3.3143932517875694
SW1573,6917907,-6.296104468024424,-4.909299490276403
HEL,89183176,1.9576500820122449,3.026285951608847
SU-DHL-6,49793307,-4.306431914357451,-4.292682581429518
K-562,6918837,-4.262812875828109,-4.196805687185867
Daudi,44493528,3.680262260756896,3.810561673690886
RERF-LC-MS,5311281,3.366561586065275,2.4710142621568236
IGROV-1,675434,4.336225379212549,4.458043325592122
NCI-H1568,216345,3.8344110950672823,3.940567320247443
SU-DHL-1,9926054,1.6936537424309908,1.5951112845732909
Panc 02.03,9911830,3.8856260346392903,2.6988442151839784
HCC1500,2729026,1.749867272011919,2.5511871145878198
ALL-SIL,42642645,-2.33031271995146,-0.21119984707684908
Daudi,9911463,2.4252044126403915,3.057261305524085
NCI-H1568,45279963,3.534456091536717,3.8384279466999196
RKO,135999136,6.045591123054076,3.5816084045137937
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.1498983822299587
SW948,9903786,1.6902329933335576,2.4649413687703063
RCC10RGB,9956119,4.44093701823858,3.602807630181216
SW1271,25154868,5.0403607075499375,4.399125720143738
K-562,65628,4.517417686157834,3.677024173508544
SU-DHL-1,613753,2.797885663964736,2.9676770841453743
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.5060815650738918
HCC1500,44566777,0.0909506116020526,1.0171016414591652
NCI-H1568,54454,3.61375646412465,2.7179603672830286
SW948,44507138,2.949706410080911,2.3227316593673386
SK-CO-1,17759555,4.047587343089958,3.204252523736267
HEL,568763,0.2288469977463405,-0.4252793663463024
BFTC-909,3815108,3.5118939741133075,2.863156436089692
ALL-SIL,24901704,-0.1489296834412312,2.3109099951990135
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.3968849191791972
KU-19-19,24772860,-1.0696999794461075,-1.5991333198720836
MOLP-8,9866186,-0.5209158528959533,0.6564671826989986
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,1.7943898477882363
HuP-T3,71304818,3.5647709327393287,2.6237424812366434
MOLM-13,11683005,2.7238157220539345,3.0779455985252855
HEL,54618771,0.7283869495698151,0.08862670075036261
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,2.9488077579786363
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,2.373941683512091
NCI-H1568,25150857,2.4294918673251416,2.5348176445624087
RKN,6438330,1.1013294242613172,2.358171243722966
HCC15,644241,2.326085716096255,2.467690822501793
LS180,2708,3.937371430907984,4.859477532766682
LS180,51037431,3.4786862718788747,3.198107601787392
K-562,16741245,3.9224206604880583,3.4931422050611673
RERF-LC-MS,44185566,3.014427147988128,2.7397498190550778
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,0.8433036915423738
RKN,5566,3.4992110401170944,3.0746009084584505
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.295210646076541
MOLP-8,216345,2.155670358283386,3.25653953227822
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,2.0546335720721625
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,1.083504738212242
PaTu 8902,46224516,2.4477060426075723,2.7603916962347936
RCC10RGB,241158,4.984223152954295,4.192624152632195
HCC15,11612883,1.9950389922708311,3.0000172805725884
HCC15,969516,3.14053560758236,2.7749300411290183
LS180,9866186,-0.1716689837079009,0.601822142131046
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,0.7542634799923982
RCC10RGB,24964624,2.93015987785669,2.458189755094135
MDST8,216345,3.5638732818875094,3.765723795722535
RCC10RGB,10302451,3.839480938635774,3.0539919781663243
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,6.158528491921882
WM115,44491742,3.78432787650886,4.163005540535819
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,2.311801954450698
KU-19-19,262093,2.7281718696395303,2.8364493041868
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,3.2058304298891214
COR-L105,1242560,3.3237423881291233,3.78489158876468
MDST8,16736978,0.980275670291684,1.5695554674937722
NCI-H1568,16722836,1.2045551605263336,1.580746794407892
WM115,5282054,2.577591804396212,3.727622919799525
IGROV-1,25195348,3.0698662305180275,3.629265767014198
PaTu 8902,148198,-2.774580136562139,-3.067871111238857
HEL,26596,-1.8679385890512872,-2.3638518543802176
Daudi,25126798,3.548189682848153,3.245992767450991
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,3.3671663926289743
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.9640971824786733
PaTu 8988t,56946209,-4.946927234389905,-3.8739831400762705
SK-CO-1,2945648,3.4071568821077993,2.9705856019697645
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.6183738242445135
BFTC-909,3136844,3.2427360302120403,4.312814177680572
IA-LM,71304818,3.3887828048220094,2.4832029668934625
NCI-H2452,122327,4.606448802646307,4.791742520312439
LS180,12003241,-0.6460664270988897,-0.5577341137149355
SK-HEP-1,16741245,3.65273757252914,4.1071563625361485
RCC10RGB,6918638,2.235907203261483,1.1060665944221815
WM115,16065773,1.4979025411384967,2.355155456134121
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.3542748260822393
Daudi,54678924,0.8831010429483725,1.3304310404635882
MOLP-8,9903786,1.299688823902182,2.13367036237307
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.7297801676601305
WM115,219104,4.514482202684108,3.74241988880828
Daudi,25150857,0.8259987709661276,1.7900628887047216
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,3.923320740577539
BICR 22,25262965,-4.220207088048826,-0.8223675168351001
BICR 22,25126798,3.759096897040898,3.563698998049708
HCC15,11717001,5.339668805105819,4.554144156015337
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,1.5501963794070652
BICR 31,6918328,1.2499033439512497,0.3971530410750406
COR-L95,25150857,1.208080540357677,2.200611482002811
ALL-SIL,104842,-6.679847729141338,-4.967788650201971
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,2.974414667473489
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,1.1772348170062257
IGROV-1,11612883,1.8715405446213529,2.7482254476974917
HEL,9926054,1.596813412273358,1.5788441628793064
HCC15,11404337,-0.219975280966356,-0.3115882807226516
LS411N,168313047,3.2811764574410893,2.331564453468142
HuP-T3,168313200,4.289513738947004,3.2425560174734476
RKO,216468,3.08027711257304,2.2630431950051615
HCC15,5566,3.133848096057735,3.083347672109548
SaOS-2,2130404,2.752105467907615,3.0645583966623646
PaTu 8902,6623618,2.257974787323956,2.359504872353702
Granta-519,45279963,2.8131243875516097,3.1756153433929226
BICR 31,6918638,1.4401869695378149,0.6787223292241503
IGROV-1,2729026,2.3541792737160296,2.620986473598322
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,4.3683341527102275
PaTu 8988t,126941,-4.347732149803542,-3.137603504413084
BICR 31,44607531,1.4420456412349776,1.4022535889870718
RKO,227681,3.9032876810461814,3.054954444978355
Granta-519,5278396,3.331153353007608,3.040714359779598
MOLM-13,11214940,0.2452206847669268,1.3749090672450759
Granta-519,6914657,-5.464946920891912,-4.790431275238805
SW1271,72199292,4.741032264194907,1.4659195080459162
LCLC-97TM1,3676137,5.47833794075875,4.431147760070938
BICR 31,6505803,0.2507928346620714,-0.29615942133343476
NCI-H2452,9927531,4.529523169776047,4.836216292648434
HEL,107970,2.2652057864285893,1.864539086354883
P31/FUJ,73707398,-0.9687174770786582,0.424126317824822
SK-CO-1,3634881,3.2176217097393867,3.3683212387038197
ALL-SIL,71680916,4.0231197218666015,3.8495098365570506
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.957981245609637
NCI-H2452,54678924,3.78052585603054,2.1653282346262226
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-2.716226745918558
RKN,9840324,5.059199694090175,5.770285747602668
LS411N,25195348,3.7393125277208608,3.2511354299870736
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,3.518339145617242
BICR 31,11497983,4.106423080888053,3.8637446280498167
RKN,3825829,4.2934517576030276,3.9907955089419653
Panc 02.03,104842,-1.6275579890051994,-2.638883085135707
SK-HEP-1,4378219,1.9889575503272792,2.722123461221132
NCI-H1568,11609586,2.169671625299293,2.8303351672337094
NCI-H2452,24772860,-2.067021978185303,-1.5645965064856135
HCC1500,2828334,6.090675120485649,6.0548883754228875
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-0.2611233109266611
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,2.3063813384451732
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.8732168993843477
SK-CO-1,426756,3.753929508081783,4.576047768028615
SaOS-2,46215462,2.3169135098646483,1.7854890739396005
IGROV-1,216468,0.5330864756407336,2.9779092189375684
RERF-LC-MS,25262965,-1.1343637554659964,-0.9395987406461888
NCI-H1568,53392493,1.829675716879907,2.5977318526326187
WM115,6438330,2.009543324889134,2.411205081139563
P31/FUJ,9908783,6.361014450142155,4.413612257496943
HCC1500,5291,3.388112901698238,3.702187453587614
HCC1500,216345,2.2086555393223293,3.713027500938188
SK-CO-1,16722836,1.1930735523198912,1.7964357709613161
MDST8,2858523,3.149165485885388,2.9806554270403
IA-LM,44486219,4.346993548383093,4.3193775146374715
P31/FUJ,10427712,4.089067276268696,3.5684975214543626
K-562,24771867,1.7261535062160185,0.0870787676579438
SW948,2742550,2.6149964231270166,3.7157816223951006
COR-L95,2113511,4.880906118348224,5.194717220739931
BFTC-909,82146,3.493415453952883,3.7760138924324713
BICR 31,4261,2.904745052497421,1.9685042604883751
BFTC-909,119607,6.015893315993201,5.422819930357126
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,2.0158297994779777
Granta-519,262093,1.5974758737964725,1.5299919251132734
COR-L105,4521392,4.261553030698096,4.419484187568504
HuP-T3,52912189,2.4400429797195065,2.2794074106761917
HCC15,168313016,4.627209757330862,5.051995497934626
MDST8,15983966,1.9809932367095728,-0.7517295534367244
Granta-519,9866186,-0.14818829969678,0.033764413711455166
SK-HEP-1,462382,1.018219313736715,0.7138321988280986
Daudi,7251185,0.6493905196982933,1.7638651011048199
HEL,3385,2.274300648457042,2.5626397302402166
NCI-H2452,44185566,2.4757676958398824,2.731445175027119
SW1573,9884685,-1.2788581073527363,0.8211587527299011
RKN,6505803,1.4092626649390017,-0.172531319733858
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,3.4475964593093225
RERF-LC-MS,11427553,2.91041132641442,3.0406584204182865
SW948,107985,-3.1361927230844255,-3.3089336818183237
IGROV-1,24951314,0.9075718706849548,1.1311820619315318
IGROV-1,753704,6.461140333581179,4.8567923714659385
LCLC-97TM1,54143018,-1.232378656007133,0.6222225371166527
SU-DHL-1,16038120,-4.191759239414132,0.02660670754339828
SK-HEP-1,65064,5.472205201006758,5.138075364975092
COR-L105,2733526,5.6711261994322,3.929654965359001
HuP-T3,56649450,4.499318873015619,3.6193472793922496
SW48,16741245,3.865069024996995,3.7231789067835903
HCC15,89183176,3.7013914070621903,4.3181394716194585
SU-DHL-1,135928012,2.7237506411412427,3.635525694506762
HCC1500,24901704,3.772063812557438,3.0535330466218062
K-562,6505803,-1.797722788015983,-0.5426287992029314
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-4.680623937800587
ALL-SIL,9936388,-6.364749169872344,-5.3713225476063124
P31/FUJ,5284616,2.141886646431612,-0.7120882652169476
RKN,654092,-2.299209260296745,-0.6639267683908191
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.7449091867492144
Panc 02.03,462382,1.1832417961450334,0.7309607453384747
P31/FUJ,11609586,2.709581392176905,1.8497179200116776
COR-L105,322968,4.452130073523545,3.989666461336676
RKO,135398516,4.318914396092429,1.7396858144567877
Panc 02.03,44185566,3.1312758482446976,2.6555468167146525
NCI-H1568,72376,-1.5373297187690371,-1.3834679825441978
Daudi,11494412,-0.3802447608890573,0.6865883478329496
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,2.905193352109157
SW1271,2126,5.27764055734565,4.4515355525271545
RERF-LC-MS,10296883,4.230661493555322,4.013828471218219
SK-CO-1,53232,1.9491581074450712,2.7908892865558075
HCC1500,11222830,1.0956735100670385,1.469010154509504
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,1.1624125019664178
LCLC-97TM1,16219061,3.747043694071086,3.568849971793104
HCC15,3543504,4.297283358198234,4.390884012546701
SW1271,6918837,-1.9255423784418917,-2.7794098525046906
SaOS-2,53301938,5.583232766578932,2.8822917717296774
UACC-812,9866186,1.6792636289805696,1.0164142154691052
RKO,5278396,3.510721289362286,3.1386168879705396
K-562,16722836,1.308803334400655,1.199490406479737
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,1.1322161295551738
P31/FUJ,9935249,2.700947453739227,2.130994037155981
IGROV-1,5351362,1.961059142684053,1.5845084948344867
IGROV-1,44819697,-0.8326420176056434,-0.7643294581485303
HCC1500,5746,0.8617369744590151,0.8328257036298963
BICR 31,15547703,3.2095649219178006,3.2344031217720164
P31/FUJ,72193861,-0.3659416399435479,0.2500265281228136
PaTu 8902,24964624,3.11499425545507,2.510220395120653
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,1.190248999266853
SK-OV-3,24901704,3.989938255280614,3.2555325314220935
LCLC-97TM1,2113511,6.012866888022406,5.732996027797738
SaOS-2,3081361,3.085781742119062,2.35442731110462
IGROV-1,15983966,1.7101486625531308,-1.6566795340985425
MDST8,6852167,1.3374988720553735,2.980201227182139
MOLM-13,67291369,-0.0488061328139809,0.6174251177826996
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,0.04884273086990427
MOLP-8,9926054,1.7939353525170396,1.630163783798229
SU-DHL-1,168312962,-2.257405592485961,0.5005091853478897
LCLC-97TM1,219104,3.650486733954163,3.7016376961813715
HuP-T3,984333,1.5721860041126483,0.9714004230486607
Panc 02.03,4477,0.984097917718396,0.7744652354789774
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,2.419803617475101
IGROV-1,9929138,6.483056540257463,5.713428114818895
SaOS-2,11175137,1.9690729540796783,2.2738656756876714
LCLC-97TM1,9915743,-0.0836077976930932,1.155102978353045
PaTu 8988t,9907093,4.39010034793255,4.425727493105854
LS180,73707398,1.191690395470446,1.1047884698601051
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.603911238394085
Daudi,11960529,3.700971671461623,3.0418522722186623
RKO,4259181,-0.4049041326260317,-0.010931625891175988
MOLM-13,31703,-4.683228669920675,-3.0239470839087117
SW1271,4477,0.3648589081307944,0.6338941729570391
HuP-T3,216239,2.9976543037230665,2.3643287717048524
HCC15,9903786,1.5576741113339283,3.1628635660809317
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,1.5368794909391872
Daudi,1239801,3.0112900662314717,3.3469705195550556
PaTu 8988t,25126798,4.088623680113087,3.8856708985691273
RKN,227681,3.7901732699912585,3.605210899065455
K-562,216468,1.7844503846326911,1.8261845382012922
NCI-H1568,11234052,4.07711650557102,4.437662000528403
RERF-LC-MS,17755052,1.8057357372617977,1.989925811039414
HEL,135999136,1.6019096984193502,3.0679002413960204
HEL,9887053,3.0781159437380974,2.4496606456911034
RKO,11625818,4.5581118700811105,3.900999212172233
HuP-T3,322968,2.6241189840020787,4.034378260679403
BFTC-909,11317348,4.568727931072339,2.632462818908898
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,3.2291164012769173
MDST8,1716436,1.1500764778734351,2.8971992261178254
ALL-SIL,16741245,1.8101156107911176,3.4346333677356453
Granta-519,16722836,1.0937584859115594,0.9382546433188688
PaTu 8902,10385095,2.391345219233966,1.4956833804310612
WM115,3038522,1.9104775831242309,3.0093072727393366
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,4.126460602653868
RKO,11497983,5.954072388877685,1.833041657839988
BICR 31,46174525,4.37434163277974,4.3659006190624
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.5502552460309025
PaTu 8902,73707398,2.5949502925816397,1.324597964564959
MOLP-8,1641662,3.485304007232308,2.865306072724356
HuP-T3,11640390,3.629059315953643,3.81628860054867
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,3.561831979623542
LS411N,49850262,4.021647044836445,3.381002479438077
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,3.1226378941896975
SW1573,24951314,1.273840217876839,1.6196925866455376
RKO,441298,2.3183923582018107,2.309190320722165
COR-L95,5335621,4.389010810876702,4.281223886454494
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,1.7130029718185995
MOLM-13,24785538,0.0261170120397283,1.1012172773236364
Granta-519,374536,-1.3755413186728007,0.6779882608281967
HuP-T3,9911830,2.533690069517969,2.5818620703101773
HCC15,11640390,4.25082988279064,3.769852843299302
Daudi,375860,-0.7416229308895455,-0.789351417734816
BFTC-909,16722836,1.424017650466323,1.8359836578513806
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.524287431120822
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,2.031217513077638
LS411N,46398810,3.253541487295017,2.3984197773398024
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.1438849258396204
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,2.086005048231868
BICR 31,136227924,2.8140968842668923,3.0689997879449895
SK-CO-1,24753719,4.51149350773187,4.287218219641297
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.295769901308361
SW1271,57330099,4.656552081384507,4.277056614116089
ALL-SIL,60750,-4.149254188873004,-3.4328975945806506
MDST8,42642645,1.1052716804296012,0.917653026227934
ALL-SIL,25062766,1.575972356073685,1.5744383804332096
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.993236067067465
SW948,11455910,0.6774609071475187,1.0283309555539282
SK-CO-1,11485656,2.076616779710352,2.3233871648845668
P31/FUJ,387447,-5.269499156732966,-4.9736195431394865
SaOS-2,54765302,6.138432086002101,4.031369111021603
KU-19-19,3384730,2.4463371108200995,3.086184431096541
SW48,56946209,-4.8342224094221455,-3.9883940738472416
RERF-LC-MS,71304818,2.1402027844306986,2.5296125820255493
SaOS-2,5351362,1.054118918695375,1.2868475363812055
SW1271,60700,-2.0966401571631805,-0.4009327271486064
SK-OV-3,12001922,2.3689117655248197,1.9048862943907325
BICR 22,11222830,2.7513096778080293,1.5747784188569867
HEL,637858,1.821308587756956,1.0556766906451407
LS411N,11609586,3.7769222068832384,2.36801259761443
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,2.0223342308095247
SW1573,53392493,3.256582971351183,2.7330463535507623
IGROV-1,71466380,4.863636874274779,4.299147394761865
SK-HEP-1,119607,5.888068080296772,5.435281355184615
K-562,5329102,1.5928854941533903,1.5784452999367389
RERF-LC-MS,24901704,2.6292316786888295,3.4780424707319963
RKO,54649381,4.449908747747005,3.5424396532444975
KU-19-19,6438330,3.038685724131264,2.319200644975226
RERF-LC-MS,6917907,-5.461995819879327,-4.717152313193335
Daudi,6852167,0.8630196090584432,2.028867555918902
RKN,2708,5.19327789915259,4.73874476688067
SK-CO-1,51039095,2.6345691844177006,2.7537520431713203
HEL,9935249,3.1121102066484827,1.9733946386138823
Daudi,6184667,1.7615544136572183,2.2541225556852513
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.5634742150708827
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.744659672475014
LCLC-97TM1,5978,-5.540378308178224,-1.125909820930501
SaOS-2,135999136,4.306712196094447,3.9326481980391144
IGROV-1,5311,1.0068816368200209,1.4637901996748877
PaTu 8902,10184653,3.3664490630517023,1.2488352264181797
IGROV-1,54678924,1.4704159748793169,1.8817998324752545
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,0.18694472325989722
IGROV-1,16720766,-0.0562020789376145,0.5478155259467438
RCC10RGB,31703,2.24368059098483,-0.4162406109353271
SW48,4261,1.3708847234833408,1.684405892031481
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-1.183319713949121
Granta-519,11494412,-1.422706675432074,0.43663697375409444
BFTC-909,10302451,3.622269240471498,2.8806553453671535
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,0.2774038622352104
SU-DHL-1,11497983,5.985793176782232,1.6751076879312499
HEL,44486219,4.241945120616936,3.6437661512604147
HuP-T3,9926054,1.9266750805140576,2.037204589227758
Granta-519,5281672,3.715092894597705,3.9023000110304484
NCI-H2452,568763,0.2251625503779925,0.6396740291674649
Daudi,15547703,2.9729250708388815,2.6284920711824107
RERF-LC-MS,1566236,3.687566928717542,2.46596789411299
SW48,3689413,2.066117060158584,0.07100076550705951
RKN,11396600,3.670395083293249,3.543140567878948
COR-L95,25227462,1.0954609187473372,-0.7926522756888075
P31/FUJ,11497983,-3.9754433923569295,-0.06680130083867007
COR-L105,11977753,-3.381629820862821,-0.5061827970385869
SaOS-2,10302451,5.268852772808677,3.1777730932013153
WM115,25126798,4.207732195436686,3.9473221028898826
HEL,6918736,-2.4872933380365483,-2.376571205873495
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,1.904581189423635
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.5358269158129412
BICR 31,11626560,1.5769037831027732,1.9322728063953745
SaOS-2,53481919,3.9662352208904,3.595416710836958
NCI-H2452,4378219,4.095695943124218,2.9043302987152075
RKO,135440466,3.093117295091816,2.101783891642245
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,0.5576107192309192
IGROV-1,4521392,5.131794979216607,4.362022143503702
WM115,6610355,3.646348527159068,4.638250472374236
IA-LM,46199207,3.643614442277753,3.224807089015605
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,1.2279773139641035
RERF-LC-MS,4259181,-1.273108977623296,0.537288500779715
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,3.9530303198320036
LCLC-97TM1,9866186,0.636434294421894,0.7905073970161444
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,3.3856115276797807
BICR 31,285033,-1.6333817403557132,-1.6848758949760383
SW1573,24821094,3.391149888356164,2.9071847584474124
RERF-LC-MS,984333,0.876742343627688,1.006384466112507
SW1573,2828334,5.538488922798482,6.246214251414622
BFTC-909,11214940,1.666026285351028,1.7196410208438269
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-3.0064112968302923
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.702501740960058
MOLM-13,16722836,-1.8349401857846608,1.0160562662181747
MOLP-8,135398516,0.6877200142840878,1.5674707734796067
NCI-H1568,56649450,2.3390116545362956,3.3644284496631642
COR-L105,5329102,2.9490674090485007,2.197328552483397
BICR 22,104842,-5.460039616101889,-2.6024573540240628
ALL-SIL,44507138,0.0905903694215729,1.232052440788776
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,1.9320979617807086
Daudi,252682,5.82526834825694,6.101291729459835
SK-CO-1,24785538,-2.301834394825824,1.4940281021211623
HCC15,4788,6.208189927463216,5.774780382718819
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.873284528051688
SK-HEP-1,5282054,5.2464488654660935,3.985755302900423
K-562,2729026,2.90327889883348,1.9450687914601474
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-4.214110944868663
IGROV-1,135398744,6.402844237905131,6.279602239746169
Panc 02.03,44819697,-0.6097657869730747,-0.5438234478178746
COR-L95,6252,1.2572884944075156,-0.01594990211559753
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.7937336602838765
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.4873242722479299
RKO,135411,0.3039750611139232,0.5453650768709845
SW1271,5284616,3.4240840801047825,2.2754272691594846
Daudi,9803433,4.921870042846492,4.26348839542068
HuP-T3,1566236,2.433067651410228,2.450682842040144
NCI-H1568,11364421,1.3511041801335055,-1.550746671877225
SaOS-2,54678924,2.353285364311993,2.034478881990264
NCI-H1568,6438330,1.052967118553252,2.306171426563485
SaOS-2,56946209,-2.927880316628738,-3.8726929065595113
MDST8,71304818,3.102141708789901,2.7016179875879724
MDST8,16722836,1.8236379945665244,1.8479935337908848
COR-L95,5460769,3.3963309413836815,2.61689107255625
SW1573,5328940,2.8151731448483424,1.7439558461335531
P31/FUJ,44486219,4.066329818545256,3.5283523647288364
SK-CO-1,44819697,-0.0659450585917303,-0.09512246871321374
NCI-H1568,3689413,-2.0602171008804935,0.15738850256499387
SW48,4788,5.795432827385499,5.508867048187451
IGROV-1,11625818,2.877471533668122,4.469666775530476
HEL,5282054,3.8014373831294073,2.5217796439421827
Granta-519,2858523,3.0573334835342725,2.6058572231535497
Granta-519,2708,2.6467102550113357,3.4636306769444865
SaOS-2,10074640,3.1546787022314264,3.146342468117958
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,-1.8206469539144956
NCI-H1568,462382,0.4864277786958156,0.6207531679565105
PaTu 8902,6450551,4.419968438595772,3.0173209487551276
NCI-H1568,89183176,4.755399227223714,4.355381764336904
SK-HEP-1,89183176,6.199387598364303,4.391831860009021
COR-L95,3689413,-1.01311028513846,-0.26291306337591414
SW48,322968,2.620984302451229,3.6307516995106885
NCI-H1568,2113511,4.994259934049027,5.57967672815369
RERF-LC-MS,10074640,3.277461458690314,3.2547265883180994
P31/FUJ,11485656,1.9746673234827223,1.4777778286416443
NCI-H2452,24978538,1.4440845227299357,1.1921178925661209
SW948,46398810,1.81837356763434,2.3194637083462792
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.8378227395195844
SW48,5280436,3.9386259808510737,3.203015307571406
NCI-H1568,16013152,3.794215458313736,4.2054537198347735
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,-0.08098453643232328
SaOS-2,72193861,0.3662001709486771,1.3367418192284939
SW1271,6623618,2.240401111492455,2.3288933316210834
BICR 31,11964036,0.7129684858082154,1.3861233648747506
MOLM-13,71466445,2.28410988708537,2.186790945348328
SW1271,5280436,5.166796757102748,3.593076738543814
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,1.0300333135121482
SK-HEP-1,5470400,0.5577708849126581,0.4664329300495851
SW1271,73707398,1.637161284255629,1.2079593692417476
Panc 02.03,24771867,4.320948526904658,2.9547744151252617
K-562,11494412,-0.907204058397288,0.7934744494742589
HuP-T3,4477,0.7500067469313434,0.7544495220536155
WM115,44489675,3.6522428576041888,3.930135243291713
IGROV-1,10074640,3.2681490579824426,3.139481013052144
LCLC-97TM1,387447,-4.752686001320434,-4.323415372704258
NCI-H2452,136227331,4.192235498443636,4.2080705566709575
BICR 22,44566777,0.9464577594296588,0.6690238168261717
Daudi,44462760,2.2846011846998184,2.750106152759992
HuP-T3,11222830,1.7699584455080513,1.5341036701979995
BFTC-909,10184653,1.6906150005550105,1.3785423588875354
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,1.8676225714231347
SK-CO-1,5460769,-0.7722931098274061,2.9187712897470277
IGROV-1,9884685,-0.088911709267569,0.28496798068071444
SW948,10074640,3.6458957710098927,2.997087262838099
RCC10RGB,2729026,3.187414345119047,2.7660949500681715
SU-DHL-1,25105715,2.6102250612439857,3.204187129767109
SaOS-2,2708,4.307882235107384,4.607390222739189
SW48,11485656,-1.6768123952056315,2.1589473578963347
LS411N,5738263,3.6843208102291127,3.167000893340681
LCLC-97TM1,89928392,0.9843618500255806,1.5247131580609348
IGROV-1,5328940,0.347812751869877,1.687007816023055
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.46951064346963
MOLP-8,6184667,3.7618917164892296,2.537133908665783
HEL,9907093,4.271492923268933,3.6902691947106434
SU-DHL-1,409805,5.150132871505728,3.967985134022678
IGROV-1,5287620,-1.5394168430569777,-1.6522119307221979
HCC15,6184667,2.403880665872793,3.0862390656320127
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.449400969832222
BFTC-909,11152667,-0.3524603871752078,-0.12811349469080158
BICR 22,10427712,4.255154443676342,4.297653182462399
RCC10RGB,73707398,3.9170227295506304,1.7144305808900222
SK-HEP-1,4788,5.857315027837397,5.793353462154567
SaOS-2,11167602,3.026359974607451,2.4378629872139648
IGROV-1,3825829,4.144093606877803,4.029102566058425
Daudi,53232,2.2893399383043116,2.703320084178593
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.124878780427837
LS180,5470400,-3.6342626980574657,-1.1200350737697848
NCI-H1568,322968,3.6220797151302673,4.024871241389043
SU-DHL-1,25150857,1.7165355924738273,1.8413606438336112
NCI-H2452,9926054,2.7849990975548726,2.003057214879882
RKO,5280436,4.655813696583822,3.145659641048557
Panc 02.03,25126798,4.246913180768056,3.956876432206245
BICR 22,5460769,-1.4539525700949456,2.4936044548210563
RERF-LC-MS,4521392,4.229663793191115,4.238360723009938
COR-L95,65628,4.016533332946612,3.8171436240820795
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,1.3321657484998601
BFTC-909,11507802,1.7199271215311116,1.89569682446764
HCC15,16115403,-5.315255617661217,-3.9331981144127384
Panc 02.03,24797083,1.7288458125332262,1.5883355258437544
Granta-519,16065773,1.8580334509866892,1.7528684692361127
MOLP-8,67291369,0.6739245689833524,1.1808034671382
LCLC-97TM1,71304818,2.70820846116735,2.459773980826821
COR-L105,10113978,3.5062120769458907,3.427531052423047
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.529665915245831
ALL-SIL,5460769,0.8731159867521163,2.0101388225140755
MOLM-13,89928392,-0.0278317389216686,0.236055247799129
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,3.2913669023771646
SaOS-2,6852167,2.181246544986129,2.4886405121133977
SK-CO-1,135999136,4.853872243910513,4.227314252958504
LCLC-97TM1,5329102,1.5800226001590805,2.132957475481046
RCC10RGB,3825829,4.92777419243283,4.16665761973917
WM115,16722836,2.5522609953991577,1.5747945042348996
KU-19-19,6610355,5.477302473020379,4.574454241767899
HCC15,5311281,-0.1593612251340344,2.2870931491290194
WM115,11656518,-0.7680829336702796,1.3554910306128658
IGROV-1,675434,4.336225379212549,4.458043325592122
BICR 31,322968,4.229982613329669,4.19548144861367
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,2.0863935553249466
MOLM-13,409805,3.504188648592109,3.7530939800791145
NCI-H2452,68056272,5.088176766324353,3.9767988731090673
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,1.2468692054524584
RERF-LC-MS,25102847,0.6953191965745218,2.4648094204847073
SU-DHL-1,5278396,2.36959409949266,3.2938800962668235
HCC1500,9935249,2.2800833668468266,3.314777720472809
HEL,46907787,-1.2802643066913908,-0.26701204309733606
Daudi,64971,1.9256728094608813,2.30818817231615
KU-19-19,168313047,3.3084179069540696,2.4820092903809483
HCC1500,9903786,4.21203406645071,3.0106535086439083
BFTC-909,3689413,0.9841636034152118,-0.8671879132585198
MDST8,9911830,3.786562744766562,2.469400922110482
WM115,262093,2.5199436905866905,2.80094059902151
IGROV-1,5311281,3.3250623444804206,2.407616153397923
ALL-SIL,4261,-0.4593745111072439,0.25799529845719094
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.5411396598795752
NCI-H1568,25105715,3.512540774448481,3.43114764930573
COR-L95,12001922,1.5177554079359803,1.6415512439365427
Granta-519,25154868,5.041568583050757,3.792580200755741
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,1.0831010173036395
SK-HEP-1,3503,1.99172511033101,2.442805016857011
BICR 22,2749,1.4483580801045477,2.0341547450758504
SU-DHL-1,10231331,2.149159497852676,1.0529777823193591
SU-DHL-1,132496,3.861580575323874,2.18648451360068
NCI-H1568,11955716,5.84501437277453,-1.2770616847179197
COR-L105,11647372,1.8386560750541856,1.2741625396910732
PaTu 8988t,702558,5.248840045640507,5.171242081512299
RKO,219104,3.7756995047121658,2.997340344771842
RERF-LC-MS,119607,4.38818595494476,5.3156352646373985
SK-OV-3,969516,2.624811361400939,2.8732399935440553
SU-DHL-1,67156097,-2.1897423830418155,-1.5458853465180635
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-0.9343566820762128
MDST8,10296883,3.644541291105843,3.974678391115317
BICR 31,135411,1.1842135795155395,0.6232713741609683
NCI-H1568,17755052,1.5920713080731803,1.51054854621154
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,0.2982851144692475
Granta-519,3062316,1.222650334372554,0.15495403202257815
MOLM-13,11609586,0.2693262849825738,1.4653645074135815
MDST8,65628,4.39024768664476,4.439397751188356
LS411N,11222830,1.85641131377126,1.393291619056246
P31/FUJ,5278396,3.2564464707559786,3.1929671841129164
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,3.4417416566837273
HCC1500,11228183,-3.1075364778620544,1.4909899838070029
Panc 02.03,3503,2.8594786206641514,2.3918573315048004
MOLM-13,12001922,1.648284949914827,1.38234960768455
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,-0.4499207057653278
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-0.9678947748659025
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,3.277526258091105
RCC10RGB,135875424,5.859031260595621,4.082980439830739
LS180,44491742,4.531352051294965,4.147232303263614
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.555025183671888
SW948,5460769,-0.6640669541383749,2.2774476359408022
BFTC-909,9866186,1.150003196853964,0.8171062775662477
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-3.161821431076969
Daudi,322968,1.8489038189519929,2.3464749358022328
LS180,135999136,4.321194581518088,4.02899153572399
MOLP-8,4259181,0.2540996075245788,-0.16480265541883984
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.4562751636795557
BICR 31,17755052,0.616652074058669,1.8161088104335945
Daudi,10427712,3.475831712716563,3.733932605647741
ALL-SIL,6252,-2.462384672511242,-1.879064566522017
IGROV-1,57330099,4.391385744785918,4.314720005917076
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.670083898576133
LS411N,5746,2.615146419652584,0.7846049953544504
WM115,11625818,2.666283825244439,4.431555511864853
SK-CO-1,17755052,1.6143754050867285,1.6385204932480417
BFTC-909,4788,5.986704833543041,5.725209855527834
BFTC-909,613000,3.1980696015333137,2.914164556244531
RCC10RGB,9933475,1.608288384582936,2.0281096107109957
COR-L95,11964036,1.1862097811542611,1.0800528310419757
IGROV-1,12003241,-2.0122972114546904,-1.1809399157809688
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,-0.6378009911682397
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.8157887005366886
LS411N,676352,3.0047981548436873,2.1023253598545026
NCI-H1568,6918638,-0.3782949656582497,0.7504510016165042
HCC15,654092,-0.5163256778254894,-0.09601536852660847
MOLM-13,72193870,3.075841334601934,2.3487034841288814
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,3.200474490627388
SK-HEP-1,1716436,3.791424957504218,2.964773520140789
IGROV-1,637858,1.814476597989254,2.0256914833326585
IA-LM,44137675,5.685431340913792,3.584451309280138
RKO,49793307,-1.4433237106321422,-3.7063884687746467
Panc 02.03,1750826,-0.0877771412327358,-0.8884184314283352
P31/FUJ,216239,3.114152508734425,1.6166219051395136
BICR 22,9911463,4.403388511465592,3.7411120891071015
LS180,3503,2.1233569957286673,2.119442299726978
NCI-H1568,135440466,1.9451121966001212,2.3737992338603466
LS180,6917907,-5.898955627831861,-5.543567178721774
NCI-H2452,3503,2.8949427881039367,2.4846939200560243
LCLC-97TM1,9952709,3.284131025623194,3.142489089053264
MOLM-13,168313047,1.872191765635252,1.673965951306058
RKN,65064,4.855719732775604,4.764774883169628
SK-CO-1,1716436,3.109025551437123,2.8847306413945573
Panc 02.03,322968,4.613737356937267,4.130452857257041
SU-DHL-1,16115403,-5.307217729681928,-4.345274799906806
Daudi,5738263,2.220866513982768,2.705201991532567
SW48,10074640,2.891302128524984,3.0448280759101856
SW48,3552672,5.820012420560967,2.5385681474693538
Daudi,568763,-0.9358982895655849,-0.07353106679779732
HCC1500,11234052,4.300499145525321,4.255989040864491
WM115,16741245,4.109793610684897,4.189331692502486
SK-CO-1,6917907,-6.103253673111458,-4.882248088234226
SW48,100016,6.031440310304127,6.182124335323866
SW948,12003241,-1.7903806895013192,-0.6449242039702366
SK-HEP-1,9840324,5.848573782723059,5.804297668582993
ALL-SIL,5328940,-0.9694628184696558,0.8180337176128866
BICR 22,2858523,3.373464702278958,2.8020042931360756
NCI-H2452,17755052,2.4746667711045514,2.0795406998852197
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-3.072494133836845
P31/FUJ,654092,-2.277731190350674,-0.9054485625430447
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,3.8699890201558214
BICR 22,16736978,1.4452527998079976,1.683202930629885
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.5563915587941195
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.2448519807306118
ALL-SIL,9843750,4.4328493438561845,2.4772670786192443
IGROV-1,168313047,1.93821625738322,2.3130101364136033
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,1.9183379941279415
RCC10RGB,24797083,3.688734393817597,1.6108487208843842
IGROV-1,67291369,1.8066430555976296,2.289182331347584
SK-HEP-1,135875424,4.97106166770821,4.032187754777394
SK-OV-3,676352,2.4999853996447423,2.2297290225377266
IGROV-1,3689413,-0.3633634632064185,-0.7862045967913389
MOLM-13,2126,3.944929409626795,3.8050787387492644
SW1271,25150857,2.216244024484901,2.4435784681310837
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.189442008770646
Granta-519,3689413,-2.6080640580656977,-2.2117613422935034
UACC-812,11955716,-3.4049141440551765,-1.1315712207381516
WM115,6918638,1.2765614986990457,0.795663180619819
MOLM-13,119182,-3.013346002661584,-2.1893305719154195
HuP-T3,25150857,2.779922499061356,2.573637036962125
RKN,400769,-0.3685197718994141,-0.7421114199821376
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.8179216209066928
COR-L95,9927531,5.207677506691081,4.344378394303386
RKO,439501,-1.8401322759847645,-2.436518365382508
COR-L105,135875424,4.584511127602178,4.045114576902517
MDST8,67156097,-2.036194319435593,-0.242458183074971
SK-CO-1,11640390,3.1287755311468715,3.340070914291859
NCI-H2452,9915743,1.4140850498548845,1.1916977251185754
COR-L95,54626689,4.626807564914302,4.336004810655774
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,0.7667080595452563
SW48,15983966,-4.810478602921179,-0.9280493152097443
RERF-LC-MS,53495165,1.4938275665549956,1.1009794835811173
SW1573,10026128,4.237670104162456,4.136283361403945
BICR 22,5328940,1.2238467278980267,1.7188051420762447
IGROV-1,25150857,3.031865110078871,2.443204365613249
SW48,54649381,3.6753624817280706,3.6223393498379317
RKN,11485656,2.343665915939472,2.332435139878439
IGROV-1,216239,2.21703825410177,2.1823616333312903
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,-0.39330068039034066
SaOS-2,675434,4.709862103920263,4.554647857811017
WM115,439501,-0.2667789802830004,-1.5780916614139415
RKO,11152667,-2.010180339323448,-0.7109065776223663
BICR 22,702558,5.841545864846151,5.205980361163446
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,1.4338251209904869
IGROV-1,52912189,2.3966568144845666,1.9951983966956808
SU-DHL-1,219104,2.7039031158758395,3.1071130039345265
SW1271,19582717,5.373754052547774,4.467666308586999
IGROV-1,119182,0.2112476135388779,-1.1191571335053059
SW1573,25150857,3.3863948467965717,2.4440947181853003
LCLC-97TM1,1566236,1.804143498427706,2.594894758033894
SW48,6252,-1.782590172996294,0.5151352996953682
MOLP-8,168313200,3.062868142984741,2.6849595820121697
SU-DHL-6,969516,2.321858620209541,2.190000977273329
K-562,44632017,0.5936262556123562,0.6532724054374474
BFTC-909,56973724,3.22598802973391,2.950072909871002
NCI-H1568,24180125,3.319632294157453,3.1463481216458593
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,1.0709260225101997
RKO,15547703,3.988071110220001,2.923424150994878
COR-L105,446155,1.2274898824574871,2.825605854343002
WM115,25062766,1.993857010637035,2.126686489530216
HCC15,42642645,-0.8684016042996798,0.9927655342590295
IGROV-1,3136844,5.214591389089975,4.644571238491572
COR-L95,16659841,4.2643844802603725,3.499167958866682
NCI-H1568,107985,-3.6136890416333665,-2.90285655339739
HEL,9967941,3.646907071964301,3.1170108009168267
NCI-H1568,5311,0.289477139532769,1.5574184931418202
HCC1500,24964624,2.92457410282952,2.0339011566486875
LCLC-97TM1,44185566,1.2712415312804253,2.369990522930613
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.28602238993756396
RKO,135421197,1.472175761257966,1.6729053981349804
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.3943566918566799
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,3.114895890958887
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-4.590777522591031
P31/FUJ,119607,5.165578068786105,4.700610402509289
SW1271,44507138,3.04083255973368,2.5211118593893302
MOLP-8,72734382,2.92105223846654,3.641061456996854
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,3.4972461738383247
RKN,12001922,2.582060834791438,1.963734765885706
MOLM-13,3025986,-2.268401268397509,-1.3193921686848267
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,0.46068009519267455
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,4.9309364246665295
BICR 22,387447,-3.632542993789297,-3.493980353973823
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-1.5079103730158243
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.334226670911893
MDST8,44819697,0.5968481057166135,-0.16551258800860716
COR-L95,54613361,1.8571878459944453,0.12343187900913226
PaTu 8988t,25183872,-1.065851307698322,-0.6471061284304401
HCC1500,969516,2.5012208253247374,2.848686948592988
LS411N,51039095,3.380080993968732,2.5378265736868424
IA-LM,10385095,1.8174613436578264,1.2581056001508952
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,-0.14172621975684702
MOLP-8,44589607,1.928632926439859,2.041523751269297
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.7586962040091791
SK-HEP-1,5311,2.3418360503567386,1.7063467524913962
NCI-H2452,24889392,3.037712354939189,4.15717408265954
SU-DHL-1,4378219,1.8683369375684944,2.4192697698200365
NCI-H2452,2858523,2.6943426896823284,3.131115981358679
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,4.380355072270858
IA-LM,119607,5.918153428689206,5.219550883094253
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,1.877167690970016
COR-L105,46224516,3.053099263199949,2.587436920307837
SW948,3062316,3.151526592835161,1.3707678596958284
BICR 22,6610216,4.672862717569176,4.363650647451314
SW948,16736978,1.371465793072688,1.0980990409610392
IGROV-1,2828334,6.070696247039626,6.073680577107041
RCC10RGB,44185566,3.1564704709707856,2.504814910318003
Granta-519,135999136,4.28714374371566,2.95230719459296
BFTC-909,654092,0.6323398211983356,-0.41994490335836054
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,3.0484820860532063
P31/FUJ,17755052,1.7010190253681206,0.9693886895549975
SU-DHL-1,2945648,2.120687124348465,2.394447392746292
LCLC-97TM1,16720766,-2.0806199642234704,0.6680621173990144
HCC15,3025944,3.8616867083103648,4.287789571240912
LCLC-97TM1,53392493,1.9813066602409652,2.772243168135938
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,2.7510598370820234
COR-L95,675434,4.0325297307826125,4.268808840536557
SaOS-2,11213558,1.0641156085827448,1.8784915005008467
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,0.20792383950750196
KU-19-19,1716436,3.531012736022478,3.0529689526746093
SU-DHL-1,11485656,1.6397040363022437,1.6994741863300087
SK-CO-1,16736978,2.1510378918389415,1.596287351388255
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,1.5040976276220137
HCC1500,136227924,2.675203690625814,2.7804928844891994
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.8832827822770879
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.497342367135655
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.474982321772071
Daudi,219104,1.6178665476553538,2.7580070302243285
WM115,5284373,2.6004259651165644,2.8813487461890936
SU-DHL-6,216345,3.116690602340157,3.1799734945009868
HuP-T3,5460769,4.291069487745317,2.446476300956839
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,4.7878348804759225
Daudi,8515,3.193004700442435,3.4655009673158044
HCC15,3815108,3.1337581441750277,2.8777905193609414
IGROV-1,5280436,3.2616766817665086,3.4120329828631633
COR-L95,107970,2.0048060228155333,2.0683063833378585
BICR 31,25150857,2.3687059872087217,2.6177112466486303
IA-LM,6918837,-2.975709639111599,-2.9604430013315657
WM115,3025986,-1.3268545497049868,-0.7335175449612323
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,2.785424842366808
SW48,17759555,2.861947497664063,3.100888287904685
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,2.3161699378241973
SW1271,9956119,4.3828310926576375,3.7700445007732504
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,2.043041371762085
MDST8,24772860,-2.900176299695688,-1.4398069629014134
SaOS-2,4259181,-0.1317601722396107,0.25543707686613526
PaTu 8988t,5746,3.0775825889142543,1.3450806870913936
SaOS-2,4521392,4.5837419847316845,4.431920013053669
SaOS-2,445455,5.662681927298568,4.903382880891756
IGROV-1,148198,-2.659972993252853,-3.5261471220085974
SK-CO-1,11404337,-0.5084033800481932,-0.17829301404357378
Granta-519,4578,4.680400709321271,3.8035147041940656
RKO,4261,2.924548439505643,0.9488824249009411
MOLP-8,54618164,3.908946135671936,3.7161995969952915
HCC15,24978538,-1.0517559532383662,0.9742590679392358
COR-L105,2945648,3.0602962908492386,3.021942064411903
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,4.973814689009657
NCI-H2452,4705,3.641149380662554,3.3184526625591224
SK-CO-1,54143018,-0.6826828748975821,0.5957758138406489
MDST8,26596,-1.25574590011264,-0.34392337787124805
NCI-H2452,54454,2.511734775409603,2.4709851507776475
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.3653276308698492
RERF-LC-MS,16038120,1.5599846769821624,1.211656014070012
SK-OV-3,44185566,3.1295797630764266,2.5551455271028165
BICR 31,148124,2.7085675831815292,-1.6050756462634876
P31/FUJ,439501,-2.3575947617146475,-2.624797151789144
BICR 22,11152667,-1.8276171650012312,-0.5328698162480229
COR-L95,56973724,4.268430703602559,2.546028006697905
RERF-LC-MS,54626689,4.221264321270605,4.631538677884629
IGROV-1,1641662,3.5854177848263675,3.4518126093513994
MOLM-13,613753,2.871004682812888,2.604900156124036
IGROV-1,11404337,-0.7659238947812715,-0.35652535156911436
SW48,219104,2.280685064057957,3.6077816931483784
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,1.9929510196215328
Granta-519,9935249,0.0212855082517002,1.8851991982476328
MOLM-13,2749,0.3899767988765278,1.181780816063631
WM115,1750826,-0.9273267035114736,-0.6874514938142058
SK-OV-3,2858523,3.2787147644650716,2.997434430796039
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,1.5086626921512345
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,3.0769600697547035
SW948,25183872,-1.604238480901096,-0.8342515617529734
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,2.1658924051470088
IGROV-1,6914657,-4.141311308759326,-4.375926496130738
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,4.869626215645934
HCC15,6610216,4.23435184261858,4.369852875556691
NCI-H1568,10074640,3.1711026687004855,3.174543939106018
SW48,4917,2.351047632498956,2.7992029299528918
MOLP-8,46215462,1.266580776259001,1.4995781765181777
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.603003754485505
COR-L105,387447,-4.5302496546864885,-3.9600176316278466
MOLP-8,44462760,3.111101001788515,3.0386023842195606
BICR 31,44819697,0.4590360698509347,-0.10100621289754556
HuP-T3,9956119,4.370077084995815,3.870851496032368
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,0.6637085673835383
KU-19-19,66577038,3.864819378735941,3.0748486871856473
BICR 22,5746,-1.0393569299451335,1.1195953876738973
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.378074185845461
SW48,67156097,-2.150931452918296,-1.0060308129685769
SaOS-2,25150857,2.491525195617086,2.364488025345102
NCI-H1568,613753,3.056586098825006,3.290934900547784
LS180,44137675,2.850653785387247,3.121055931787213
RKN,11364421,-3.590581417405073,-1.9527787465943398
HuP-T3,23582824,1.5911146583975455,0.8442801216200309
SW48,446155,2.2181780639059907,2.6846644761444662
SU-DHL-1,44202524,0.8334918459072751,1.575086738918734
RERF-LC-MS,11404337,1.609147033115388,-0.1893406299129445
K-562,44486219,4.057183894108205,3.9718489163029362
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,2.115247398486315
PaTu 8988t,46199207,3.796589685342678,3.204479150396581
LS180,11964036,0.9251272605785624,0.8100049081630901
SW948,8515,3.759025323790885,3.6779771101460272
SaOS-2,374536,3.743747938767685,1.967797670429868
SW948,135875424,4.663257041681152,3.6405690083945292
SK-HEP-1,72376,-0.6035227354554765,-1.555105759444763
SK-CO-1,1242560,3.64748499205759,3.5939315673967944
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.035546723720228
MOLP-8,3025986,-4.599162344151263,-1.2940208087091105
SW48,25150857,2.2099211562472125,2.254622018792565
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,4.770170488813827
LCLC-97TM1,3465537,1.1142431298706064,2.4590713882484216
NCI-H1568,9887053,3.9549233487650666,4.21629413624595
SW48,5746,-2.6538895977275745,0.5860309765964581
LS180,44484440,3.4848015178596343,3.017901737075947
Daudi,25183872,-3.2629659020313393,-1.5522388098568143
IGROV-1,984333,0.6618578113050116,0.4003837724533901
COR-L95,135999136,4.28146486500778,3.423798210708902
RERF-LC-MS,4788,5.0822281264538365,5.771765263992169
HuP-T3,2828334,6.159425491986346,6.191521499531312
RKN,3854666,2.132003481112045,1.8809537634739666
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.168717930852851
PaTu 8902,54639665,4.483683562011812,3.12416235645644
ALL-SIL,24180125,1.6553840753953686,2.247512162821746
SK-CO-1,12003241,-0.9578793579943758,-0.6619764091708563
BFTC-909,104842,-1.584917163766509,-2.5967503808517307
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-2.446807271997498
MOLP-8,24772860,-3.493237790177901,-2.517597833712504
SK-OV-3,49836020,-5.2191550029019025,3.127115218664419
K-562,46199207,1.8646546122938352,2.931249324588322
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,1.5870439951136976
MOLM-13,6450551,0.4092106163446157,1.1940569575252058
BICR 31,1566236,4.637821170940002,2.58234172935073
SW1271,54454,2.1914366041236204,2.5473531609355065
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,3.5641189581924873
SaOS-2,9952709,3.1448975558697545,3.022468328137731
HuP-T3,54618771,0.8132197250487964,0.7490249979881151
IGROV-1,6918736,-0.950858733923241,-1.6701384622065065
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,-0.08808064595865893
Granta-519,53392493,1.7904738197895116,1.6850655344402548
NCI-H2452,445643,4.078319116283011,3.965643079952544
HuP-T3,5281321,0.1098786391841839,-1.2020547046642964
NCI-H2452,654092,0.1220899319284023,-0.4140336311188823
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.7337696861219536
MOLM-13,56973724,0.5307136138302019,1.7329265410559467
BICR 31,439501,-2.4499261286992007,-2.0416397783049436
MOLP-8,44495899,4.403173191891281,2.5160651755523764
Daudi,44632017,0.5148090574579154,0.8855109639582698
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,1.4191781903563092
SU-DHL-1,10077130,2.6641926349973875,2.7432646664369873
SaOS-2,9549297,2.000544043325996,2.4004079500960254
LCLC-97TM1,24785538,-0.7280489014481334,1.5872169443921509
HuP-T3,10302451,3.3244038223924868,3.0585968772332093
Panc 02.03,73707398,1.687012904299387,1.5246608562712662
SW948,25161177,4.032512886861284,3.9582598047624935
COR-L105,17755052,1.2153053156846572,2.05782637859367
HCC1500,11719255,2.4435237001116685,3.402779025865172
RERF-LC-MS,5287620,-3.2415128958876123,-2.063700566082746
WM115,72193861,3.0084505907765795,1.371524513089914
K-562,2113511,5.3605896450220785,5.101827455300836
RERF-LC-MS,24772860,-2.3078196081029136,-1.5063136671619413
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,-0.4641515331225332
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,1.9235089219212127
MOLP-8,15547703,2.3372930335131663,2.7293717986031574
LS180,4378219,2.066313424484697,2.4963049404132756
SW1271,168313047,1.8206519834924395,2.3614744827811753
RKO,123631,2.6120370559458155,2.165136983343801
NCI-H2452,3011155,5.255477653901917,4.175228806761451
Daudi,16722836,0.8830828668869325,1.0134439135473596
PaTu 8988t,6505803,-0.6279165545759258,-0.4598020646175746
SW1573,5280436,3.0542460563059253,3.49985441831203
MOLM-13,262093,0.9014616367149992,1.8153881377387409
IGROV-1,BRD-K55473186,4.387806234483854,4.2084651217787155
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,1.4601934469495836
SW948,5287969,-2.4513180825948515,-1.9601820872525473
P31/FUJ,54619267,3.5260071244925575,3.473111173379387
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7955400842695028
SW1271,11396600,3.626770708484224,3.7546504912742864
IA-LM,676352,2.5463710414635696,2.0502119730606214
SW48,148198,-2.7635683141359277,-3.3961396047095422
K-562,6918328,-1.3297822316036851,-1.0031735993817956
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.5935351188340534
Daudi,135423438,1.6157885595086947,1.1390742480942488
Daudi,6438330,0.2626238759101729,1.1292330532226607
Daudi,44543605,5.193449926403497,3.8272174743060328
SaOS-2,71751553,4.337892909522829,4.437305060228237
MOLP-8,23939,4.352572888875192,3.515910851952799
SW48,2858523,2.8468158768410965,2.8927961205045936
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,3.6330030087644536
COR-L105,9911463,4.222864246171191,3.9584665566233825
SW1271,11167602,2.369450835450289,2.4520040568397308
SW48,135928012,3.696922095661256,3.923328593926605
Granta-519,53232,4.0944047749373915,2.372791555867157
COR-L95,2871966,-0.8178907803151099,-0.10509106777908846
MOLM-13,17759555,3.648246486561575,3.093358492765923
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,2.1109132386459053
SK-OV-3,44589607,4.1377534493712265,2.936996872005419
RERF-LC-MS,44543605,4.169252612552019,4.344335019188865
Granta-519,49836020,3.8229564713378057,2.8095583986224266
SW948,5278396,3.777624651516773,3.4151590689568314
HCC15,400769,-0.8695567043490428,-0.8058017090975536
ALL-SIL,3038522,2.34327176020718,2.3926816642149182
SW948,135440466,1.4177296224023617,2.1246036465450717
PaTu 8902,400769,0.6580342998730634,-0.5654240907048975
IGROV-1,5746,1.9055212643377857,1.1260675797963584
COR-L95,25195348,4.044301101066811,2.9911828552826147
BICR 22,24180125,3.296229177015365,3.0680627751252105
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.577141599439175
RKO,73707398,0.9128481241529548,0.9248797150003842
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,2.4548685440119726
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,1.3382831496466454
IGROV-1,15953870,2.712793598656007,3.570040224568836
WM115,71466445,4.303064097958205,3.6005181715794383
COR-L105,9956119,4.279642090153805,3.8414452916074833
BICR 22,168312962,0.5954564951508424,1.9083360270263512
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.6143682712181464
LCLC-97TM1,46843906,2.6060669508648675,3.0735451939865466
HCC15,9840324,6.2076616503129,5.744514167562794
RKN,24964624,2.2448388370498704,2.80162279171501
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,1.9666027449310568
K-562,10410894,3.650757753763785,2.908169551450637
SW48,124202324,1.4616392816877528,2.172428072527788
IA-LM,15547703,3.104636726250569,3.150150446318165
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,0.8173385624049513
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,3.3650984680772855
MDST8,49850262,3.692937134795778,3.6437304668388437
UACC-812,52947716,-6.767186414102593,-0.7882099429813484
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.7243395007356828
HEL,11427553,2.263048189869726,1.2716566588754283
IGROV-1,5281321,-1.4962463697398798,-1.4636750081451422
IGROV-1,135421197,1.96820638017286,1.8202908244170097
LCLC-97TM1,104842,-3.469971777740615,-2.755817792309701
RCC10RGB,374536,3.743226525407361,2.0882996164728516
COR-L95,107985,-2.989419812710682,-3.467806569937169
RCC10RGB,72199289,4.762339751475906,2.995499570810203
NCI-H1568,11485656,1.8106242285910237,2.1927909351713613
MOLP-8,9549297,1.4376511571672042,1.7838876919188098
Daudi,24951314,0.2263717121921743,0.3894084901345549
BFTC-909,7326481,3.4905195575106527,2.931152991170714
BFTC-909,6623618,2.802037410677928,2.2761487568105925
HuP-T3,5287620,-3.5836939395445913,-2.008611503721552
COR-L95,568763,-0.4949329271490838,0.21945393883257702
SaOS-2,216239,3.028726771334262,2.2390432472981048
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.6270588909763575
Daudi,5311281,1.0302556341787754,1.7426853455133116
LS411N,3503,3.033347172376105,1.919238140716667
BICR 22,4705,3.4365696424802477,2.9324456467733997
Granta-519,6918638,-1.0102021398050984,-0.4495544949151794
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.8755491772207624
SW48,54618164,3.7830586534540616,4.081625180012047
MOLM-13,25105715,3.5182090361281326,3.169456467094577
Daudi,11175137,1.084300991963852,1.937020779519026
SW1573,42642645,1.1024283721976142,1.0554625398783062
P31/FUJ,11364421,-5.080526011220062,-4.1794305033110195
MOLP-8,12003241,-1.4499361325619826,-1.4552030594548933
Granta-519,10410894,1.4137063553430784,2.3780481896404297
RCC10RGB,57519531,5.003664553369681,2.7696752725535294
HEL,11625818,4.404342627749774,3.440233168583558
SK-HEP-1,1242560,3.752923936287399,3.6806104339837913
SW48,3062316,-0.5038339303633423,1.2752777774205248
HEL,219104,3.0071408108258253,2.5884068418360857
SK-CO-1,3025944,4.807689572392986,4.139130392719627
SK-OV-3,52912189,0.2062426244094619,2.3298125042724744
COR-L105,51039095,3.4251018662752073,3.079599552958912
HEL,65064,3.1933308972510113,3.9589633282165937
Daudi,9929138,3.458684768924583,4.759551032461922
SK-OV-3,11404337,1.4011927232423718,-0.20182204136594373
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,3.0238649986917334
MDST8,11178236,-3.494725666780331,-3.1444744598370873
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.2366078700547807
WM115,119182,-0.4924283039006125,-0.8369368542194726
COR-L95,56649450,4.0191520211736895,2.904602912543035
HCC15,5278396,3.283293724206623,3.4547192921255374
LS180,54143018,-0.5111931850291043,0.0899423908765786
MOLM-13,10427712,3.427914513597021,3.716074607091352
NCI-H2452,1566236,3.5735792412039022,2.4447670804752515
ALL-SIL,452548,-3.3771532504793194,-2.79258463257675
KU-19-19,409805,5.730069773001202,5.020868827322441
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.9019123486798558
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.357850363372074
SW948,11955716,-2.1355637415890323,-1.3740306750725204
RERF-LC-MS,11609586,3.546222239883878,3.01835382081795
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,2.939427579435854
WM115,5311,1.988201906885666,1.5195604898447663
HCC1500,5311,1.250436307916732,1.3979972190039365
KU-19-19,5282054,4.451216911386669,3.8461755296936553
PaTu 8902,4788,6.453607861068675,5.6265277455150855
PaTu 8902,4261,2.3507697687761224,1.648857565024482
SW48,68056272,2.992212540747962,3.2520562755154976
HCC1500,56963564,1.3630245510511625,0.7394119390900484
Panc 02.03,25183872,-0.079390979301081,-0.7093780947772309
LS411N,11964036,1.3999141622104765,0.9257523908134391
BFTC-909,135440466,2.535274686795805,2.246505850119614
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.2621495018472695
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,4.247213602542289
LS180,25183872,-0.6080839156226316,-0.974648841996854
PaTu 8902,71304818,2.9919229428361263,2.355498569887431
BICR 22,216345,4.525930969601246,4.02452390839775
NCI-H1568,374536,1.2941902477204823,2.1106763147201955
LCLC-97TM1,135423438,1.8911988038183152,2.26798404713684
NCI-H1568,56963564,0.2273202395709376,0.5669911074957064
K-562,9927531,3.3022164605184763,4.063380778138466
SW948,2858523,3.1308292618704905,2.971087494945116
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,0.5989431384507461
SK-OV-3,5287620,-0.5544150043477152,-1.5650775484125687
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.680536207468395
NCI-H1568,5311037,3.1621369524545155,3.705444934598276
WM115,15953870,3.7155207356015207,3.687106532147526
Daudi,445643,2.8458589584694307,3.463854202256745
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.6577815900587771
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.18617916938948273
NCI-H2452,156414,1.7996451609117237,1.4224259612531025
Daudi,53301938,4.372641532954565,0.11503646112950683
PaTu 8902,9907093,4.385383441203628,4.375182264707947
SW48,136227924,1.7122170056378203,2.881219525737776
P31/FUJ,4096211,0.7441609883240002,0.8904862537193385
IGROV-1,6610355,3.969940996770339,4.504758819997994
PaTu 8902,4917,3.0649190232675525,3.08808383554253
IGROV-1,613753,3.483244781428779,3.3005313932332045
SU-DHL-1,3136844,3.883215489826005,3.597640019947337
HEL,446155,2.11086977892158,2.24509475535927
HuP-T3,46907787,1.2763139172323097,2.1194203646176786
ALL-SIL,2729026,2.163276094007301,1.9860535960021657
NCI-H2452,54613361,3.2620625907056744,0.41358836846145847
BICR 22,448949,3.2035793217055124,2.0827497961217096
SW948,5280436,1.724516723779293,3.3468426991925737
BICR 31,25154868,5.458998944130281,4.73678111903041
LCLC-97TM1,44632017,0.6758650901814578,1.0442942128291883
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-3.187327338912137
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,3.9466761228254743
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.9947342500524692
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.989650301847376
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,0.967112553583294
SW948,409805,5.995103866916248,4.915977596456462
P31/FUJ,16736978,2.2012912480094444,0.3586205653962706
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,2.0825851235960506
PaTu 8902,19582717,4.67665303596855,4.4021779395709375
SaOS-2,24775005,3.5680490412807555,3.7189151625277934
Granta-519,327653,2.833903719231272,2.477995329424128
ALL-SIL,446155,2.369103686447931,2.3199981318561878
HCC1500,445643,3.796669497386567,4.008039864335573
COR-L95,7326481,3.0640813007839105,2.815341855858693
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,0.36082673350903444
LS180,53232,2.536426383073758,2.761862932655731
P31/FUJ,10127622,1.4388313131004449,3.039497014117988
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,3.1867182707185497
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,0.7029561403487954
SaOS-2,11214940,4.2656495802712735,1.8302080657572204
RKO,637858,2.400395947377078,1.5674728260322945
NCI-H2452,3552672,4.527548939486843,2.6071428218161277
Daudi,168312962,0.2834059413422853,0.4270259876519177
P31/FUJ,216468,2.1049028903625673,0.9506363875725868
MOLP-8,11656518,1.844531268869525,0.8441635905423598
MOLP-8,5426,4.334733303826167,2.8307504935884844
SW48,54454,2.31662951125423,2.6925838927812453
K-562,4521392,4.220123235241678,4.046940694301049
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,2.925424332279239
RKO,1641662,3.3091455873155367,3.1381793951136125
BICR 31,135875424,5.0736941678127945,4.037845057864417
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.348351251421714
Daudi,44607530,0.9746569917988196,1.5521418087175616
SK-HEP-1,25150857,3.0587845310763297,2.650457875173271
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,0.0688097010234263
Granta-519,23635314,-4.977140911540282,-2.4682500970033714
LCLC-97TM1,24753719,4.6973214087473405,4.187501948300158
P31/FUJ,11640390,3.1324724534083277,2.5269950492691935
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,1.0467408364948987
K-562,6450551,-0.0734681627771844,1.5163239256678194
Daudi,56946209,-7.191237665956405,-5.048375053591184
Panc 02.03,25154868,5.464083731960118,4.449785524562442
P31/FUJ,5311,0.3390662723443479,0.6033019273965541
SaOS-2,11485656,2.155652122560971,2.0706438587923137
IGROV-1,3025944,3.9702787396819503,4.276625915333703
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-4.066102152751633
PaTu 8988t,11494412,2.1257430484232525,1.8658571686529306
IGROV-1,53495165,1.3981720287668329,0.5420265172992628
LCLC-97TM1,42642645,0.0997949580151915,0.655176465151662
HCC1500,36314,3.7134374865247017,-0.5331946950441951
NCI-H2452,3815108,3.5712952235347455,3.0280156132864056
WM115,11214940,3.8761690772861126,1.825638426049408
SW48,676352,1.4830170410483523,1.9300983028494734
MOLM-13,25262965,-3.0495150612642465,-2.764189435151025
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-3.386546602618339
Panc 02.03,148198,-4.053337817942692,-3.1225965791803674
SW1573,71466380,3.629171273590213,4.40278615180629
SU-DHL-1,151289,-1.0536473601541108,0.6055347205516763
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,1.0002061910790732
COR-L105,285033,-1.0049053408998423,-1.6715607635494276
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-2.305824130119147
Daudi,135440466,1.490781603812653,1.8386367360802673
NCI-H2452,6918878,3.5446658281374277,3.0912197944960536
PaTu 8902,123631,3.453096327622384,2.5340769800334093
COR-L95,15547703,3.222652754514603,3.027604133053036
NCI-H1568,123631,1.2596294102093508,2.3777697153975983
P31/FUJ,216345,2.9363986514954203,3.2477614162465693
HEL,4261,0.4865008011530605,0.3773645171722892
SK-HEP-1,5280436,-0.1709015599208282,3.5491104596685874
SaOS-2,25062766,1.5016836694759386,2.1945052654392256
RERF-LC-MS,51037431,2.0455212647735364,3.1380526779664937
HCC15,11656518,2.9308462534519024,2.126832037492639
RKO,10127622,3.209405126939437,3.981992828720266
COR-L105,9927531,5.197941564874311,4.865692216150561
NCI-H2452,6623618,2.534886377212576,2.298005615650508
SK-HEP-1,16725315,5.326615386804391,4.1294490399953006
SW1271,11152667,-1.5987482479879582,-0.38842517547092653
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,1.0623872422542793
SU-DHL-6,3825829,3.5283611337160155,3.3731357811842635
RCC10RGB,11656518,3.9855029209510215,2.4115287954403035
SaOS-2,67156097,-1.585481519484996,-1.160873385160147
BFTC-909,5566,2.8568699448622263,3.0260315344207664
SW948,4788,6.033471365822279,5.620891831441082
LCLC-97TM1,1750826,-2.0890062190589544,-1.2273340025549644
MDST8,3689413,-1.6812703512916511,-0.407749010690197
SW48,9926054,0.5681768331785455,1.951603389780142
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,0.43489002886349665
SU-DHL-1,262093,1.7952973078733698,2.45260491108805
BFTC-909,439501,-2.4866456286351095,-2.1906633996976406
HCC15,123631,2.7523193051058974,2.385079201540935
P31/FUJ,60750,-3.4241008025920396,-3.1178901482223313
Daudi,9927531,3.2507934675389447,3.7073482897319083
MOLM-13,5281672,4.456656164404507,3.8660767629285857
IGROV-1,11222830,1.5703285223102077,1.6423137331870301
SK-CO-1,5311,2.0479844637297617,1.320951746442329
COR-L105,15953870,3.0827686267342957,3.722846902241776
PaTu 8988t,9866186,1.4965239773376473,0.8433585332313943
IGROV-1,124202324,2.2563058955522157,2.5582644839726085
PaTu 8988t,9936388,-7.900053622036252,-1.0912285076996142
HCC1500,11152667,3.4439033763408644,0.5015923637824043
MDST8,54618305,4.422279328619345,4.494093669754975
MOLM-13,3825829,3.189823245525434,3.3809658410527423
BICR 22,3081361,1.798482521796042,2.1156681847577268
SW1271,3854666,4.252835819462087,2.0860576695340014
HuP-T3,285033,-3.1273004056463916,-1.9571202428226528
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,1.980447573332124
SK-OV-3,6610216,4.5015440272840275,4.16771398206122
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-3.4368898842164697
SU-DHL-1,10090485,4.45721233802345,3.436693723511815
COR-L105,54765302,4.547071050564395,4.2443038163649165
SaOS-2,44491742,4.263847553999534,4.095008031438421
RCC10RGB,BRD-K55473186,4.42890698658841,4.354305974457585
SW1271,2742550,3.530952260660614,4.054999508148854
Daudi,148198,-7.679285276133229,-4.131734617591595
RKN,104842,-2.3241286690000265,-2.7429951290158265
SK-CO-1,3689413,1.2567954519757167,-0.04778098587874095
Panc 02.03,24180719,3.694319415808187,3.9122711422505
MDST8,637858,1.7716899628344815,1.994588687466547
BICR 22,11404337,-1.5250786338229352,-0.31132425904838795
NCI-H1568,82146,4.486561599154294,3.967551823294766
LCLC-97TM1,52912189,1.3140510236946998,1.6777608042180723
BFTC-909,6918328,0.6354681535452512,0.2955801950909185
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,1.9666027449310568
SW48,10385095,0.7767009249070084,1.196136786621655
RKO,56649450,4.8662264096692684,2.9561970727929157
SW948,45279963,3.8052773477912782,3.5310643494437484
RCC10RGB,3038522,2.595581097335362,3.1595008385701795
BICR 31,3689413,0.760898743899782,-0.04108889560882703
RERF-LC-MS,5282054,4.065617468844444,3.9078215071786233
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.19953747185167
K-562,25161177,2.405708421255354,3.8748068339337802
ALL-SIL,11497983,-4.396279985993102,-0.7130518534498141
SW1271,446155,1.3369653200346725,2.517937422711154
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.4428165763532381
Daudi,10296883,2.545577320776033,3.3207363798482534
COR-L105,52912189,0.1952406080619365,2.0902803732260975
RERF-LC-MS,36314,3.6884025033565897,-0.33035369521669067
SU-DHL-1,25062766,2.372674975426994,1.7981684502858177
BICR 22,126941,-2.054722221433598,-1.9850256475751429
P31/FUJ,46398810,1.6622931867453647,1.9122016351777518
K-562,15953870,3.5143251027161613,3.0466992157915627
MOLP-8,89183176,2.6780353354925706,3.3690707743576462
MOLM-13,9967941,3.903949930542719,3.1264930820464953
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.8014949833237086
SW1271,5291,3.239071539524422,3.8240806446245283
K-562,56963564,-0.0263606087054764,0.020712698716412757
LCLC-97TM1,54613361,-0.0023609252607709,0.35915381914274747
Granta-519,24771867,-1.6352261980607803,-0.8985032709541662
RERF-LC-MS,5287969,-2.0564845219287555,-1.6781124943401255
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,0.4603906235534188
IGROV-1,168312962,3.022863957843741,1.8466543300469178
SaOS-2,6505803,-1.001039194104569,-0.06853224638674593
Panc 02.03,5460769,1.6540560754425335,2.405131654168571
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,0.9762570151690518
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.897760749273004
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,0.8972994422811573
HCC15,135440466,1.473766152733558,2.260974373686788
Panc 02.03,448949,3.46549633046868,2.280789632183025
SW48,119182,-2.1563748503052103,-1.0057975161839632
SK-OV-3,36462,2.5052417836250496,2.137690897402131
LS411N,46199207,3.2917214979820506,3.0791409057226535
Daudi,71466380,2.956949879575845,3.4386123373412683
RCC10RGB,44566777,1.0790521939265936,0.9020617390044936
P31/FUJ,446155,2.867326521256313,2.401838746729237
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.6687439645275162
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,0.6895523219321575
BICR 31,71576739,4.400142576070014,3.0273673812055324
SW1573,6623618,2.3278245092002936,2.5563927841723535
ALL-SIL,969516,2.19071597716798,2.206235828234166
COR-L105,241158,4.618729119434587,4.125471684617262
Daudi,24797083,-0.0937737057199073,1.1120654652971607
HEL,5566,2.9283259495001133,2.8124918741884812
BICR 22,44137675,4.05989667865121,3.6439585194733337
Granta-519,3503,1.8528122642218805,1.6411509674300586
WM115,5287969,-2.3112325385791093,-1.7446801924372644
NCI-H2452,3062316,-0.5574526988915461,0.8653333484215606
PaTu 8988t,12003241,-0.7673639150441187,-0.6403475674500619
SK-CO-1,44589607,2.7511810771029213,2.7268219774442195
RKN,23939,4.640348748177221,4.174112609591767
IGROV-1,72734382,4.633226130326536,4.408376398105727
BICR 22,46215462,1.5294433170369757,1.8823248207522811
MOLM-13,2949965,3.7040534246432624,1.902065553140644
HCC1500,46215462,1.5254849350202837,1.885105431060833
K-562,25183872,-1.1768480549542706,-1.2919729734988392
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.13355961924803622
IGROV-1,3081361,0.99973562532788,2.3729824120567757
NCI-H1568,9908783,4.863315848037401,4.975403253156784
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,1.8108988579511385
SW48,25195348,3.355247289110599,3.230953170767632
HCC1500,135411,2.801194317933856,0.5787644305530661
BFTC-909,10410894,3.671861694905457,3.3615020947970486
COR-L105,2708,5.5167338716905885,5.160473509893072
SW1271,9927531,4.558020454092029,4.748789568354752
NCI-H1568,44462760,4.02669785413772,4.174798997041674
COR-L95,11612883,2.9601999054336106,2.396369163335828
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,3.116339973021466
SaOS-2,46199207,3.779046434903352,3.337809421983107
MDST8,15547703,1.8320295844693912,3.3335946018981844
SK-HEP-1,23725625,4.972795252846745,5.301455629515638
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.661477318910294
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.3175043312690695
HCC1500,24797083,1.1358144177435396,1.38096502960623
MOLM-13,11647372,-0.8512376057901615,-0.23636193503486702
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,0.6862453706055857
K-562,5335621,4.97915810125604,4.292292545617738
COR-L95,2858523,3.028185885315027,2.9751115678183457
HCC1500,9911463,3.4774936591741703,3.8066113512554325
RKO,452548,0.942587279069954,-0.2739632166964379
MOLP-8,126941,4.086011311839599,-3.202121455321077
P31/FUJ,3384730,-0.5934712638177775,1.6618012653328842
LCLC-97TM1,16725315,3.732120983026874,4.140397268192778
HuP-T3,60700,1.2793809884126126,-0.36293512299468544
SaOS-2,9956119,4.053594307296879,3.6162322623351337
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,-1.2794035917090318
SK-CO-1,46199207,2.9466484543003197,3.260615017381241
SK-OV-3,11175137,3.182781765506491,2.600710490955653
LS180,11222830,1.8684195070218452,1.3193438198176894
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.503782771900824
K-562,23582824,1.4169931108164455,0.5018017102773682
COR-L95,3025986,-1.3264557881304966,-0.8009849769808361
NCI-H2452,16065773,1.9140766169124153,2.570850452045184
MOLM-13,54454,1.7928295036604598,2.2930659404605978
LS180,119607,5.442141379439383,5.143078203403518
Granta-519,644241,4.377614733152813,1.0956394324982504
IGROV-1,46199207,3.293579955374855,3.1013169307672745
IGROV-1,3038522,3.6829378423722416,2.889399378055911
HuP-T3,135875424,4.261865095251217,3.8999015038203977
IGROV-1,89928392,1.4824233552493276,1.2226530040788344
KU-19-19,5280436,3.7375704611092657,3.5111104756279583
SW1573,54678924,1.9184875438403524,2.045200860491642
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,1.3747646806510656
SK-HEP-1,11364421,3.0648019303900624,-1.5058413852576362
P31/FUJ,11507802,-0.4015560413947272,0.7075179967105112
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,3.548049655377866
NCI-H1568,89928392,1.1949851991515912,1.5945521808856145
WM115,11222830,1.2308018153574234,1.5111131998018377
SU-DHL-6,9908783,5.938767725153886,4.407218330424809
HCC1500,25150857,1.1801270031504156,2.2613631536840044
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,1.3802401914987226
NCI-H1568,4521392,3.7910777113602303,4.499293114522157
COR-L95,25183872,0.0728708482253017,-0.9585531395286825
IGROV-1,227681,3.5439813498262347,3.0832793243518326
PaTu 8902,6918878,3.691618711508776,2.8043504059959856
K-562,1242560,3.4884556471232293,3.153654565052887
BICR 31,53495165,2.344314514368125,0.9108829580836735
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,3.0800495580124307
BICR 22,17755052,1.4011116930942769,1.827110094354988
Daudi,17755052,0.1512024273398794,0.9064485098175784
HEL,67156097,-1.6398778776875675,-1.9361811554753823
BICR 31,44486219,4.3544536670303025,4.3386005879703875
SU-DHL-1,119182,-1.9070320733957784,-2.210859711499035
WM115,135440466,3.0586385090162085,2.0844745115819774
IGROV-1,11152667,-1.4116509977729443,-0.4950685120911667
BICR 31,10385095,1.3759128494100044,1.5171136466838429
RKO,969516,2.537841036798478,2.494774727540614
Granta-519,123631,2.886011281362197,2.0541700668038363
HEL,4477,0.140225607998234,0.5165710688143623
HCC15,568763,0.562622735167329,0.5284830309334392
HCC1500,9926054,1.7367797854287812,2.02534711926928
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.391678017093945
SW948,444795,4.960330673315111,4.166115821235788
SW948,119607,5.410714093672246,4.909269159793919
RERF-LC-MS,9936388,-8.273067767637817,-0.4633456811221923
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.36625901782147935
KU-19-19,4261,0.7367611445661113,1.7381054530562878
SU-DHL-6,387447,-5.553627026103078,-4.8415093539285
SK-HEP-1,3825829,4.395950359013269,4.032929802402776
COR-L95,9903786,3.7357721387912513,2.644709370706867
SK-HEP-1,44185566,3.236949395761265,2.626234837546786
COR-L95,73707398,1.0347493154641954,0.918116604233262
SW1271,66577038,2.7134536861777807,3.1188689439109454
RERF-LC-MS,36462,1.1230283698314445,2.255859951719892
LS180,5278396,3.460947025625347,3.376037754490869
Daudi,3062316,-6.775500959037878,0.17376123513021977
K-562,107970,1.9304513771469212,2.0279343685150426
HCC1500,3854666,1.4433352503078565,2.0341582148792767
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,0.6290925416851091
HCC1500,11455910,0.2448151005088887,0.8123644008782702
MOLP-8,46907787,-2.434163875600539,0.12929551463025016
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.7957658065272417
RERF-LC-MS,53392493,1.949934555719578,2.880982020932886
MDST8,6610216,4.3863838734153,4.317168951452327
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,1.3899227446138713
LS411N,216345,4.369072592416217,3.890523822933906
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,1.2538276854591262
SW48,2841722,4.762546821441249,4.001907135663874
SW48,9956119,3.393025538441131,3.40215335493892
PaTu 8988t,44607531,1.764787957031886,1.6111295748789167
HCC15,16741245,4.574628343563009,4.067288148171669
SW948,89928392,1.4444572178844948,1.4393208142464815
SK-OV-3,25126798,3.9960730178767,3.778574904696119
RKN,54143018,1.3184566027416504,0.7365417132474031
NCI-H2452,24180719,2.8480667171601852,3.7719873051689
COR-L95,9915743,0.942320604231091,0.831018370448473
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,2.099832071237441
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,3.139515361222377
ALL-SIL,387447,-4.904935645240703,-5.2134987975413525
SW1271,54649381,4.56488530045006,3.808471573048952
KU-19-19,4259181,2.3072251676522835,0.26362208638160806
SW948,25105715,3.628389782970242,3.3088594710000607
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-0.6453822281291557
LS180,19582717,2.9052461851112565,4.109499036568545
Daudi,676352,1.3635905677607614,1.7356529570764525
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.183682003760722
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,-0.1755854741183888
SW48,9915743,2.691515978939234,0.7629978057632667
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.8428034745402457
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,0.0005401839196623292
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.7298966249325338
Granta-519,3025944,4.149663954634143,3.8794670174671713
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.525203874014394
SW1271,2841722,4.036476035404804,4.221681515726205
SW948,53232,2.3961531254319466,3.0354761501406142
SK-CO-1,25183872,-2.2315902989777725,-0.7802259789780915
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.2494985853437663
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,1.694154162740894
P31/FUJ,6918328,-1.424420935100909,-1.5341250415760297
HuP-T3,71680916,4.329506074723249,4.658975472197484
P31/FUJ,262093,1.035147161622815,1.797547229060655
SaOS-2,11228183,2.7080984165628754,2.2827006788741526
NCI-H1568,6852167,2.376266672184036,2.820192160573613
RKO,4477,1.7070595719756474,0.6509329402370757
Granta-519,46199207,2.493616790778817,2.420163771060607
IGROV-1,5470400,-0.2457809435208252,-0.3792983765171124
IGROV-1,409805,5.990596261907717,4.905079220661316
PaTu 8902,15983966,2.4191743534269463,-0.9685940346561764
RERF-LC-MS,31703,0.0184985959907658,-0.724693809154841
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.1302632430186572
P31/FUJ,46224516,2.421293495972869,1.6896154557240055
BFTC-909,10127622,5.216996592058982,4.248329605289897
HuP-T3,55508,4.397520768584908,3.4660130670396403
HuP-T3,10385095,0.7178899916931367,1.3699091624207795
RKO,16013152,4.038378204585466,3.523799149372587
RCC10RGB,6918328,1.0053978601828475,0.5058009089365285
SW948,9444,4.221430823371368,4.107362572442159
WM115,53392493,1.845382538513501,2.5191410300174226
HCC15,44185566,3.08334642122707,2.563505578942063
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.4457007678640953
UACC-812,25262965,-4.249514707304517,-1.0480404257543485
WM115,51037431,2.6247692404465868,3.404117774847604
SW948,5311281,0.0185560472432188,1.9327587561669555
HCC15,44607531,1.6724658843452191,1.5642384962368967
MOLP-8,6450551,1.973885798572914,1.8458873811334648
MOLP-8,7251185,0.7855879803762651,1.8738800675096667
SaOS-2,5479543,4.655800274360292,3.5155666081317904
IGROV-1,4917,2.985904350427039,3.048938308112887
Daudi,3825829,3.2006002080342544,3.3946806952615844
UACC-812,148198,-2.7739066615342236,-3.7731465495891836
Granta-519,1242560,3.55554960326222,2.6370070521480007
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.2709898413575172
HEL,17759555,4.966386069896687,2.733055228002318
SW1271,119607,6.141140067390372,5.313113696659636
Daudi,3038522,1.648170780235362,2.6586041199720745
PaTu 8988t,969516,4.442820223092304,2.863093420069342
HuP-T3,4521392,4.351966444408677,4.528801763455682
BFTC-909,2113511,5.65564772398506,5.7102629594079755
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,3.243333604684131
SW1271,24856436,1.0602186643720275,0.6347266131822404
HEL,24180125,3.3188099636510495,2.670487627369962
WM115,10077130,4.784184630126653,3.418378276364068
SK-HEP-1,5281321,-2.075735756673856,-1.110834423603199
UACC-812,10184653,-4.111635019949291,0.5467686189056031
BICR 31,55283,4.60336009153674,2.432309183843115
MOLM-13,11178236,-3.317575610691226,-3.661040199070543
COR-L105,57519531,4.553300256365288,2.488421480985057
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,3.0045139071554363
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,0.8256662394492318
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,3.322391497595927
ALL-SIL,11317348,-1.373590167325895,1.301936510079451
LS411N,6914657,-4.299110458286086,-3.665836543854059
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-0.7332167422071117
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,2.9754556923366366
LS180,57519531,1.9809210286085912,2.362798185537552
LCLC-97TM1,60750,-0.9490237417659374,-2.125219998203922
SU-DHL-1,49850262,3.2383746822480384,3.18400255479162
SK-OV-3,9911830,2.8997016876614863,2.728285743496522
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,0.6733550890694986
RERF-LC-MS,15983966,-4.090154567310139,-0.9069917815595381
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.15748549067513
RERF-LC-MS,24951314,1.4075693116182684,1.5278550536314264
SK-HEP-1,11494412,3.332434654266433,2.0761549553717407
BICR 31,51039095,3.0794813668201546,2.864805870533225
Panc 02.03,11178236,-2.8028080099743624,-3.2293208600067347
SU-DHL-1,24772860,-2.736237819232434,-1.9380468925413832
Daudi,6610216,3.2134188501838494,3.915969010970398
NCI-H2452,53392493,2.782389188766079,2.6682095211005485
NCI-H1568,445091,4.097432324473231,4.41274505446822
K-562,9926054,1.8612748023096723,1.4629247655096724
HCC1500,24978538,-1.6021545775061432,1.1027318616685824
COR-L95,25126798,4.203058281978897,3.6868291286461794
LS180,44819697,-0.9723932292423276,-0.7477801972745739
BICR 22,5281321,-1.7077192732848236,-0.8808611062649788
PaTu 8902,656346,4.145274855759625,1.3338343180427645
BFTC-909,42642645,1.561027146692027,0.9182621657662762
IGROV-1,49836020,5.658436828096057,3.18213640232068
Daudi,168313200,1.4988300519601074,2.824799749500491
MOLM-13,24779724,4.7751629548446894,3.891674078847682
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-3.620198222890618
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.9232409009384372
RKN,2828334,5.965623907482328,6.294436563577883
NCI-H2452,5280436,4.838161671645799,3.535532273626901
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,2.0582515638474206
BICR 22,637858,2.779101364791116,2.180343184256054
RERF-LC-MS,56963564,0.3267097404636779,0.8676281514404507
RCC10RGB,2949965,2.9970768068045577,2.8870994426278878
WM115,10074640,2.7921613557017473,2.8603595826186226
KU-19-19,25154868,3.204596310046931,4.511422590449083
BICR 22,49793307,-5.020228152199773,-2.2442987874863887
SU-DHL-1,5460769,-0.475427190707336,1.8851613023312757
NCI-H2452,9868037,3.199558399493599,3.355906466034268
SaOS-2,9823820,4.1201217228566565,3.551297236862988
SU-DHL-1,9444,2.825333870881758,3.891316817268722
HCC1500,53495165,1.6495193303321407,0.4108200008450501
RCC10RGB,9952709,4.37754893062567,3.1977976745500705
Granta-519,73707398,-0.348610297970246,0.26247192929467805
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.1962473228683044
MOLM-13,26596,-2.2068545341754295,-2.433696463454825
K-562,52912189,0.5484446218637569,0.7839106738329614
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-1.8533821907640158
IGROV-1,375860,0.7731558163124775,-0.20892438389637924
IA-LM,11964036,4.998383188027045,1.4417540257898276
MDST8,387447,-2.914953377887094,-3.8588564357938595
IA-LM,9915743,1.455667571666015,1.1780676746951033
LS180,6918328,-0.1069758097146191,-0.0729117291289413
PaTu 8988t,6610216,5.064895456595333,4.263546979452287
SU-DHL-1,104842,-6.410970225096146,-3.7546275567426988
P31/FUJ,56946209,-4.67609529352027,-4.91695303630416
SW948,6917907,-5.884345700630281,-5.118392228575062
BICR 22,53232,4.030024483575548,2.5138347276354174
PaTu 8902,568763,1.8312011651342244,0.5135095265938895
ALL-SIL,6505803,0.7073572306495796,-0.4693484129655318
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,1.6492125521566465
LS411N,10302451,4.220534629483678,2.735538862001879
RKN,11238147,3.9265768628415487,2.8266968730197988
PaTu 8902,135440466,3.176809791892748,2.0352378641356013
MOLM-13,119607,3.836878131829583,4.573225200640553
HEL,11612883,1.9962168488272864,1.7445217930583579
COR-L95,11485656,1.8696119642586884,2.1371830814031605
MDST8,675434,4.4652962141660595,4.841515749125023
IGROV-1,11507802,1.5049911819213722,1.3267942333311271
SK-HEP-1,2708,5.260013220141412,4.950414828761621
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.3613144969381294
SU-DHL-1,5738263,2.757121948334044,2.953344995708327
Granta-519,54626689,4.523537450364534,3.940344305920389
SW948,135421197,1.7477185084776832,1.7244918476487034
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.6514014297974648
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-0.629506578047151
BICR 22,4917,3.6655313291566327,3.0186445818230525
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.6643771237074
MOLP-8,16736978,0.6033273838828506,0.31632964262910424
SW948,11396600,3.556168564723583,3.6439783740162834
IGROV-1,2113511,5.982902824257526,5.6532613747635985
Panc 02.03,16725315,5.289216895099664,4.474087323966625
K-562,9549297,1.810271401171294,1.8893541587439486
SU-DHL-1,60700,-3.861884777487788,-1.3743977583002873
MDST8,89183176,5.515733421140453,4.559638872882195
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,3.5442126354983987
WM115,10113978,3.3670712397266698,2.9993750499705474
SW48,25154868,5.084018259884556,4.388992315044508
Granta-519,107985,-5.079154139769343,-4.255460619372482
IA-LM,15953870,4.160803294534019,3.4816541080850016
RKO,19582717,4.345992572306107,3.4222250354663335
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,3.1822008915097286
ALL-SIL,2742550,3.1857763586562577,2.9817075392777084
COR-L95,375860,0.21091681928276,-0.3200835609991449
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,-0.05745011799111958
COR-L95,702558,5.203109308170341,4.759713900814605
ALL-SIL,5329102,0.5818325089631969,1.3017253191966405
MDST8,9911463,4.372295154952754,3.9051442120272117
LS411N,44607531,1.9881484499388475,1.294076949719598
Daudi,68056272,2.8001037652797818,3.0174884567398634
MOLP-8,4521392,3.737637773211522,4.0174290537317585
MDST8,20959075,-2.855250986095604,-2.2526220645901156
IA-LM,400769,-0.2498086542393983,-0.47133162642928766
IA-LM,16722836,2.5380745713557893,1.5178661236909081
HCC15,445091,5.451686926059382,4.442030990742732
HCC15,11507802,1.1916077520331714,1.7932091576504623
MOLM-13,9903786,0.7109980532390177,1.4780980159613009
SW948,24901704,3.213341299668661,3.1952069169980337
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.727111453549593
SU-DHL-1,10427712,3.576020229714379,3.7005807305231566
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-2.9967834428642233
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,1.9682593890862976
Granta-519,51039095,1.7779321154646133,2.113445761743227
RERF-LC-MS,65628,5.693639897620667,4.300063782468262
SaOS-2,2828334,6.074749772556143,6.123660164350549
SW48,3815108,2.5063295630391806,2.6764864654241993
SK-CO-1,11626560,0.3943389380121196,1.5656115682071783
HEL,107985,-3.965696416470184,-3.8606918007006072
KU-19-19,60700,0.8700483452505813,-0.17619239662289726
Daudi,5280436,1.0789231424034973,2.579327420271016
MOLP-8,54613361,-0.8734170036218252,-0.21404369994691483
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-2.06118429151189
SK-CO-1,24978538,-0.5683899539074425,0.717868533689945
SU-DHL-1,54649381,3.644517842316546,3.751244733069378
SU-DHL-1,44493528,3.922242735424854,4.110870517157938
P31/FUJ,5282054,2.945149434876345,2.790530356475445
SK-OV-3,49850262,4.3958011115665006,3.6238814296214468
IA-LM,10184653,0.8510906912410041,1.5303344976574074
NCI-H1568,36314,4.092621701538515,-1.1486511976122713
BICR 22,46843906,2.889476079217857,3.036212638514875
SU-DHL-6,9444,3.111459322097769,3.716552237288135
ALL-SIL,10410894,2.969142576372873,2.4934854947714
ALL-SIL,9549297,0.2429486516660708,1.406118513973234
Daudi,46926350,-6.041265180126537,-4.730804571330853
RKO,1750826,1.760307875609834,-2.6619373998618623
PaTu 8988t,4477,0.4312443696129938,0.6374202924128622
Granta-519,5282054,2.5814189459390957,2.718544033388801
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.3251878485371993
IA-LM,16065773,2.795317455347302,2.478153324786119
RCC10RGB,156422,4.423389512885201,4.266639438834867
IGROV-1,11214940,1.360660548899077,1.8783909318610017
Panc 02.03,16720766,4.473005389666903,0.8691808458199926
Granta-519,3081361,1.7559432073327723,2.0936895016020696
MOLP-8,52947716,-7.872176911001468,-2.0031694475835082
KU-19-19,5281321,2.871465791170073,-0.9516839849154092
IGROV-1,5282054,3.614574021382022,3.8015553390617565
MDST8,4261,1.8348924416255383,1.891831453951346
MOLP-8,100016,7.090961588333011,5.0580845460616395
Granta-519,168313200,2.290121636997186,2.6724951812084483
HCC1500,462382,0.0787876699821948,0.5550495014636112
IGROV-1,10113978,2.874171865860951,3.1459484489768514
IGROV-1,BRD-K55473186,4.387806234483854,4.2084651217787155
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.8434617226162935
P31/FUJ,10410894,5.368264014178215,2.7708077805525044
BFTC-909,3025986,-2.0399601309440336,-0.4967473225561271
MOLP-8,24771867,-5.187641849515016,0.016183872208207578
BICR 31,11214940,4.966543096658616,2.0410292325251818
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.3870369297681149
UACC-812,9936388,-5.022392750910281,-1.8864002312744212
ALL-SIL,24772860,-3.38763553354356,-2.7827536478039763
MOLP-8,11626560,-0.689912231097504,0.8957445742200905
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,2.173180293451461
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,2.105163473858477
SW948,262093,3.1804911198162036,2.505253066158642
SW948,216239,1.8650010893863176,2.0799312783094193
SW948,11364421,-5.809742751249139,-2.8450125704787705
HEL,10302451,3.814274659252608,2.2758056242704283
K-562,46398810,1.812730009869126,2.1256922842992214
Daudi,216239,1.5780166370194677,1.835064587476503
LS411N,10231331,0.2083934704449227,1.6505513169763752
MOLP-8,46926350,-5.986975596425451,-4.532798942750563
SK-HEP-1,11964036,3.325100881793091,1.5075579964845098
Granta-519,11485656,1.6660529916447626,1.4353776386893602
K-562,2871966,0.96376622724181,-0.151625141192517
P31/FUJ,54454,2.7341923640247123,2.251957580651864
SW48,54613361,-1.8010952783890095,0.2672144932536352
NCI-H2452,46843906,4.012061875028764,3.230439635441593
HEL,135875424,2.9448279330391927,3.3105306869762217
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.463186793244879
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.068004944215193
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,2.895903323588642
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,-0.8023061743511746
HCC1500,54678924,1.846277418486191,2.02290644562263
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,0.7483329621887853
MOLP-8,9927531,5.438833274000949,4.1526455991377595
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.2523949721687573
HCC15,9952709,3.084010703088348,3.087743742883002
K-562,3503,1.244026999465694,1.8692683024980672
SaOS-2,3689413,0.0712794264513353,-0.5434555702327745
MDST8,10427712,3.921886084986449,4.4629451781778515
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,2.831967863089178
SU-DHL-1,1716436,3.093009546519781,2.590199586823451
PaTu 8902,25105715,3.5553172149604375,3.3620694295451505
HuP-T3,24771867,4.228511460696379,2.854727359396658
RKN,31703,-0.7196573309741882,-1.0832844305544744
MDST8,60700,1.1908209554887386,0.07717294006348291
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.323497062850107
HEL,54454,2.1583735480761437,2.6085080399903813
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.640811678860744
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,0.8330249641392219
SU-DHL-1,135875424,2.8587183873170847,3.5515498401752517
SU-DHL-1,36462,-1.6063137198477124,0.5049972951531843
MOLM-13,73707386,2.881964792667641,2.4091399027381963
P31/FUJ,3854666,0.6136756098719494,0.5433421685339764
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,0.0036921539303371186
MOLM-13,159324,-0.2587959593058327,0.4619505526917035
SW948,19582717,2.742329976582949,3.69822627370599
SK-CO-1,444795,5.109688629113172,4.408303678580949
Daudi,400769,-1.3686052359334673,-1.62620518269791
SK-HEP-1,10296883,4.4971190241998835,3.982716697617253
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-0.7562449581701813
LS180,17759555,2.746757712453425,3.415946186397081
MOLM-13,156414,-0.1970532812518614,0.35505376658361876
ALL-SIL,72376,-2.2514410459425043,-3.4821705327847092
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.3853153032812076
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.6128215615572598
HCC1500,51039095,2.9997605815390935,2.893786286724409
WM115,44185566,3.0030021210520794,2.448461356466412
COR-L105,4705,0.5312031062005766,3.1769196000084294
Granta-519,8515,3.731909716775835,3.2495662037427397
ALL-SIL,11234052,3.5011978223530926,2.894210818010084
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.3430547236837903
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.400878524489736
Granta-519,613753,3.0344429390603493,2.7137446156321805
HuP-T3,5329102,2.4996480668272527,2.2023931635300076
SU-DHL-1,2828334,5.462697908299577,5.994109910224342
SK-OV-3,51039095,2.3576173335626147,2.9426082931329476
UACC-812,5470400,-2.2578344499942418,-0.5977565171643967
HCC15,9935249,4.091947122155354,3.3521138674367608
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,1.0297878873739028
SW1271,322968,3.7653444240208263,3.7667123350807996
COR-L105,54678924,1.4327429630461548,2.2252596906028352
Panc 02.03,31703,0.91391851070637,-0.638860216876302
NCI-H1568,5329102,1.5348278867114138,2.206033154600396
Granta-519,9887053,0.035640336798207,2.1167583984293774
IA-LM,6610216,4.173583896241699,4.3542468241709695
NCI-H1568,119182,-0.8732650634834633,-0.7223497901841368
IGROV-1,159324,2.8766947154825044,2.8303092799019094
NCI-H1568,5566,2.911706555521376,3.0834490358818125
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,-0.2918523887829665
NCI-H2452,10385095,2.425738192808243,1.353422323459508
HuP-T3,16065773,2.155269900494742,2.401742449228364
SW948,448949,1.5714288146717783,1.8608235922780083
NCI-H2452,107985,-2.625758680845612,-3.2641512302630282
RCC10RGB,1750826,-3.277944046627699,-1.3682102599971018
Granta-519,16736978,1.0160166250823044,0.3376543026093233
HEL,104842,-4.135712202151618,-3.8393595375321734
MOLP-8,71466445,1.892906464336944,2.496076428552903
MDST8,262093,2.389063867163299,2.6839778687621516
COR-L95,4259181,0.8580425806970188,0.3082839914811582
Daudi,45279963,2.6753649589319854,3.0482639579866007
IGROV-1,656346,1.6285470744333117,1.002454279141527
SK-HEP-1,10427712,4.527720982072863,4.428510571252008
SaOS-2,11647372,0.6261520317366223,1.156679130977901
COR-L105,53495165,0.9627099148057476,0.9078674307040263
Granta-519,11404337,-2.8078628280004048,-1.2263931018809862
SW1573,25154868,3.281093993360062,4.771300501785809
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,2.1111617269698
BICR 31,3503,3.4488620791118993,2.370640330506543
SK-CO-1,3062316,0.5910144260309655,1.4988208713964004
RKN,6917907,-6.438038185084336,-4.633728773784734
LS411N,23635314,4.011909681168236,-1.5309314398042193
WM115,11234052,4.1182935305671435,4.241197396916564
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-3.3234848452461585
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.13275980981392874
RERF-LC-MS,11485656,1.5190166417661397,2.491328429512872
PaTu 8988t,46224516,2.924922546378164,2.751527972109131
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,-0.49641016364650825
SK-CO-1,5287620,-2.837552470898679,-2.036056430554786
PaTu 8988t,24772860,-1.5593380796956875,-1.8340713671161388
PaTu 8988t,6184667,3.5063575702163345,3.26518518626129
BICR 22,36462,0.4717839486114671,1.9381474019037095
RKN,16722836,2.340122812915413,1.6042184489184192
Panc 02.03,54618164,4.482290203520866,4.260080903116963
BFTC-909,2841722,4.3094465275997536,4.370767198051601
COR-L105,2746,3.1035280268076217,3.2402551591020807
IGROV-1,9929138,6.483056540257463,5.713428114818895
HCC1500,2708,5.151987441269929,5.149720469409959
MOLM-13,11238147,1.4582306649534449,1.824353349573604
RERF-LC-MS,11364421,-3.8493036468537265,-1.8442394686433052
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,6.366229610256356
RERF-LC-MS,16736978,2.30801467798398,1.7953837897963003
LS180,44241473,4.435457667187811,4.719100434745112
SW48,16722836,0.2197322523934369,1.2865399531555652
NCI-H2452,9444,3.5242093703527697,4.297175093778297
SU-DHL-1,5284616,2.4488241799592143,0.3312247341253365
K-562,54454,3.689215856042272,2.5331270791788456
HEL,2945648,2.719646445320408,2.1940358098849315
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.889744357849263
HuP-T3,9936388,0.6940852338085793,-0.6727479413496854
LCLC-97TM1,10427712,4.124790087544491,4.382050696570363
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.604946567078972
SW1271,135398738,5.657599080768866,4.309465893590822
RKN,216468,4.351451769225332,3.3315634945007484
SW1271,46224516,1.263100640010589,2.5833822933894273
SK-OV-3,60750,-4.210978436614257,-2.090442722025442
SU-DHL-1,11455910,0.1271925880707346,0.5344596415977637
Granta-519,25161177,3.429453868131532,3.3576836357680575
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.3687539891955192
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,3.0349544262862995
UACC-812,16065773,1.9582746458630844,2.272701005119535
MOLP-8,2858523,3.112163707938977,2.858152717880072
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,1.140149568639538
IGROV-1,6505803,-0.2382223795960626,-0.3234428518340662
HEL,24772860,-2.0205510075596425,-2.782880548102051
HCC15,4917,3.2753021602409267,3.1553448628835317
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,-0.11355809949849548
P31/FUJ,6184667,2.9500590386465393,2.7711158621159537
MOLP-8,46843906,0.174682801852784,1.8112520949619568
NCI-H2452,54618305,4.302077073898344,4.422165241887109
BICR 22,8515,4.348804794701894,3.759704625406614
COR-L105,24821094,-1.121187296223131,3.2561018320160615
HCC1500,4788,5.676843976237076,5.568561698071281
SK-HEP-1,2746,4.04921422913523,3.351963774260305
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.590379739245325
COR-L95,46199207,3.11604668311128,3.0395210783224407
MOLM-13,1641662,2.418131669664625,2.8735145845216645
WM115,135984461,4.094268409164816,3.760057637362499
LS411N,10127622,0.4126946340819594,3.547478267265544
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,4.029391528029509
ALL-SIL,11364421,-5.245070547120315,-4.649533061196536
NCI-H1568,44607531,1.2688225542701184,1.526188852824112
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.8529130923322645
SW948,104842,-0.6555530305877334,-2.76620579270904
SK-CO-1,46907787,4.316773762169295,1.799850774921251
HuP-T3,104842,-2.1883971380944054,-2.4811366228919485
IGROV-1,11178236,-2.8618715106425725,-3.625490883182926
HCC1500,71751553,4.671922723370954,4.588659626877879
SW1271,54618771,-0.1319273231055389,1.1867721559825746
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,3.2093705552142717
IGROV-1,654092,-1.340387623873854,-0.0810077324444633
HCC1500,44819697,2.691999336982048,-0.6485847150170208
HEL,44137675,4.224171499328968,3.0417272075264763
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-2.8656905534851154
COR-L95,5328940,2.113977806947162,1.6136463522260454
SK-OV-3,3825829,4.139200001280225,4.069787394151462
Panc 02.03,216468,3.8655539989600176,3.7998222272858584
SW948,25195348,3.534636067330416,3.091976805659497
MOLM-13,9444,3.2439366633039426,3.5690530476828917
NCI-H1568,24821094,1.7576462865100984,3.134303822162479
MOLP-8,1566236,0.7132031003128095,1.5573651133856254
HuP-T3,11455910,1.0919804440303738,1.2131103949609625
MDST8,44185566,3.0590843033834116,2.5139893787146566
NCI-H2452,216345,4.1608899350266615,4.1343835297127365
SaOS-2,23635314,-2.530968731721941,-2.0571334908392505
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,1.3564245196370177
LS180,168312962,-1.039638615515642,1.7779259290652956
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,1.904720369550969
BICR 22,322968,4.6496227244818416,4.005480813387735
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,3.30150382866423
RKO,6918837,-1.4612228483082623,-3.5319897320016516
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,2.3879167767894045
SW48,613753,3.5910736246612323,3.0080856527939157
IGROV-1,44507138,2.359177395411688,2.6474908072100125
WM115,52947716,-6.8465929822900815,0.7996011995751112
RKN,73707398,1.136221501718042,1.2582628764889732
HCC1500,4477,0.2789780560390432,0.6536595072116677
Granta-519,11719255,2.4006867045586953,2.5716720921885945
HCC1500,6918736,0.2919336581768246,-1.0977137073669383
IGROV-1,4477,1.1767656777594142,0.74503935650936
IA-LM,11609586,4.073174168632335,2.6958857258877327
NCI-H2452,11404337,-0.3859535574072682,-0.19221998562811643
Daudi,136227924,1.3476403322374937,2.442911015906195
SK-OV-3,387447,-3.0618968905277164,-3.9140049341864316
MOLM-13,3854666,0.5101644656521153,0.7024915568438723
RKN,46843906,3.906010302389018,3.1971137006156694
ALL-SIL,1641662,2.105441320822025,2.781716809367264
MOLP-8,46199207,3.622115707782432,2.720612317390774
HEL,17755052,2.5427584711612554,0.7511953996537195
MOLP-8,9915743,0.5160575940701332,0.10164315588415498
NCI-H2452,135398516,0.2354885350790482,2.470684151762913
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,1.131771558372419
SW1573,9911463,3.734935340044018,3.925079564438589
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,1.2352336763314877
IGROV-1,23725625,5.712368491237602,4.819147751632328
IGROV-1,54143018,0.8385018685685798,0.5277005245682688
WM115,135875424,2.968517855352779,3.6319864868167513
SW948,16659841,2.968981271202921,3.4324100130645263
SW48,25183872,-1.521332471338628,-0.4876619944210563
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,0.4601426171153761
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.5649613505744784
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,1.9685548436644393
WM115,5284616,2.9108529677003565,2.024219340527425
SW948,4705,1.720002028261835,2.94499193843762
HCC1500,71680916,4.362866442203444,4.452157940399789
PaTu 8902,17755052,3.1533076581920936,1.8774779668147517
COR-L95,11427553,2.745819698220539,2.345247966241715
MOLP-8,11707110,-0.9708482925672104,-0.5263821820426267
HCC15,5351362,1.1207822529279785,1.633241981735851
SaOS-2,11234052,4.364959006359101,4.205027701956279
SK-OV-3,6918837,-1.7709381590236568,-2.51451961990671
RKN,10113978,4.430129932581481,3.1030248591435123
Panc 02.03,5566,2.8367562997211815,3.081879255808002
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.8515188556088085
Granta-519,4096211,0.4087245803445845,1.3315772491789142
SK-HEP-1,72193861,3.0367238048594603,1.956904909330979
SW948,9933475,1.7222383900333498,1.8610038015230381
SW48,9936388,-6.68623848822316,-2.294696618293122
NCI-H1568,11222830,1.5738139714037271,1.6053114822937158
IGROV-1,24856436,0.4840146383282276,0.5557111971157287
SW1271,25105715,2.9104912505007143,3.3720057672987895
IA-LM,11238147,3.064975348903814,2.778139382835712
PaTu 8988t,23635314,0.3317794086663004,-1.2641035551275919
Granta-519,3136844,3.153984140395424,3.4366853232843706
COR-L105,24951314,2.139685821030411,1.595758258943708
IGROV-1,135398744,6.402844237905131,6.279602239746169
LCLC-97TM1,156414,1.5907536031970133,1.2838542111358737
BICR 22,46926350,-6.042960620867506,-2.992502116883536
Granta-519,387447,-5.4996124066637435,-4.960320877506869
BFTC-909,51039095,2.7594177275421403,2.927800100418261
Panc 02.03,5746,2.615751109567445,1.2994772318455978
SW948,71466380,3.8629020707603914,4.306498348321949
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-0.11889350102528264
COR-L105,24856436,1.5602990639828938,0.6785529624103568
K-562,327653,3.3038748071855175,2.739461122828329
Daudi,16725315,3.035985748437892,3.3368711810444385
LCLC-97TM1,6917907,-8.098980466082804,-5.423246678916049
NCI-H2452,4261,1.8682088943565944,2.032998611102596
SU-DHL-6,241158,1.5794519300851928,2.7837543419412776
IGROV-1,9840324,5.720969888694302,5.558474647592273
COR-L95,10074640,3.0551355702246292,2.9010570071215005
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,-0.32042845234407985
BICR 31,5460769,3.9433617709959696,3.0311101697269773
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.715274313399675
ALL-SIL,171352865,4.1926931777749346,2.3956349974174542
PaTu 8988t,5351362,2.286773409161727,1.7006064514887984
COR-L105,54618164,4.149947168538197,4.18178969107687
K-562,168312962,1.3008721680360658,0.8121983596904818
NCI-H2452,3634881,3.1517111283550854,3.5475823547585787
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.7041397136188874
LS411N,2858523,3.1062955336512603,2.916433903397693
NCI-H1568,65628,3.926137474064237,4.320212478539337
SW1573,25126798,4.147065453172024,3.849072284083757
SU-DHL-1,9868037,1.568771805047012,2.7473596990541767
HCC15,46174525,4.292402667650191,4.090020020305117
HCC15,54626689,4.436341034968849,4.753615875831139
K-562,241158,3.183928650435804,2.832107097710969
HEL,400769,-1.0010167847558078,-1.77411532657589
MOLP-8,24180125,2.8280981087253605,2.639458784662647
LCLC-97TM1,6918837,-2.241539398034031,-3.0008587312362174
SW948,52947716,2.6983492764143984,-1.4747249162198515
HuP-T3,11609586,3.0975126346448056,2.9748364926484565
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,3.172030748908512
K-562,9911830,-1.954559593888618,1.7284888192378367
Panc 02.03,54454,5.027619058009229,2.6608083226842614
Daudi,9967941,1.9498714635628245,2.891679566561375
SK-CO-1,46224516,2.9108482414820833,2.4334312934167097
IGROV-1,56963564,1.8260986108097368,0.40264567613736907
PaTu 8902,119607,6.110313748168657,5.335409679753889
SK-OV-3,1750826,-0.3132155362058529,-1.3066023817636434
NCI-H1568,11507802,1.223292685938289,1.8213853725923463
SU-DHL-1,6918736,-2.1290482192432396,-2.2481294295247314
MOLM-13,6252,-1.803091878000868,-1.464537315487946
HuP-T3,16659841,4.694527425679891,4.028836563163058
COR-L105,135440466,2.282908830244017,2.3944957456169615
COR-L105,36462,5.237060103367249,2.4846532783517046
LS180,16038120,0.768362963165676,0.832935525195495
COR-L95,11719255,2.8113582651389684,3.025900654287856
K-562,71466380,4.109476883218819,3.7786424257681084
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,1.0939656372331779
LCLC-97TM1,65064,4.239331302053654,4.918043093579046
ALL-SIL,11626560,-1.2475078800938888,0.22753995071058636
IGROV-1,9903786,1.7387584479757865,2.961895593063502
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.314639402940059
UACC-812,3025944,3.7003704595595894,4.1016081515019485
HCC15,52912189,2.9796194932949875,1.9184392764589808
SK-CO-1,24951314,2.193758155281627,1.291645289295569
IGROV-1,208908,2.822483792004996,2.1050416699331125
BICR 31,2945648,3.0787524499283023,2.9111710539145554
WM115,11485656,3.738489726762909,2.5130725318465834
IGROV-1,126941,-2.246216453812328,-2.5557702043974597
KU-19-19,135411,0.3258457054887789,0.8260719271373368
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-1.1312939418869694
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,0.33544716945702613
MOLP-8,25105715,3.7016775455761968,3.207614165992103
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.1573435434800563
NCI-H1568,25126798,3.633705991567496,3.84966053447704
LCLC-97TM1,3689413,0.1289764847745495,-0.25004477031776134
SW48,5311,0.4861581581750583,1.349475629517925
LS180,409805,6.164182483443964,4.950450301991285
ALL-SIL,17759555,3.7861470032844418,3.2838119350086736
K-562,7326481,2.6072018104551824,2.5650644742308852
SK-CO-1,8515,5.207883928071115,3.719114375713765
NCI-H1568,439501,-2.6831567396736022,-1.7146585219872825
BICR 31,3634881,3.594506321194918,3.41223744768598
KU-19-19,656346,4.826208082880011,1.0654084693559633
SW1271,10410894,3.9794007270318903,3.3177168102215644
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,-0.30845412990683047
SK-HEP-1,16722836,2.576451725849178,1.7429045037126687
RERF-LC-MS,10113978,3.210216765519601,3.141697589464718
LS180,54454,2.0147485365690945,2.619516619947691
NCI-H1568,9866186,-0.23967308205821,0.9824262268615266
IGROV-1,10302451,0.4135234554742116,2.9477168757168237
PaTu 8988t,9935249,3.4642640806067897,3.335765287934563
HuP-T3,65064,5.168937665689206,5.19286343257841
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,1.9507398353846772
LCLC-97TM1,44543605,5.020704141539917,4.186076012374199
KU-19-19,3062316,3.300727237006398,1.5966963442951876
IA-LM,54143018,6.360653223606267,0.7091323166058362
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,1.8672400754727527
PaTu 8988t,11497983,4.771256524847766,4.144202456020593
IA-LM,7326481,3.2597510497719964,3.0958162774811933
MOLP-8,57519531,1.794840771759573,2.082127561174169
Panc 02.03,387447,-4.21908064053878,-4.180640713277643
Panc 02.03,9866186,1.4364847380387245,0.8487935669835833
BFTC-909,56946209,-2.8280109825858943,-3.895213680956094
K-562,46843906,1.6079735978006011,1.9754732018723635
IGROV-1,3038522,3.6829378423722416,2.889399378055911
COR-L95,9933475,1.8209744616881691,1.9104324939919801
NCI-H1568,54613361,-1.9115789745186575,0.5102137484986528
PaTu 8988t,11178236,-5.843883599227575,-3.6297607791236124
IGROV-1,24856436,0.4840146383282276,0.5557111971157287
HEL,5746,-1.0378501544368317,-0.4043397490956175
LS180,216345,2.343571728213523,3.7142157645040004
MOLM-13,11234052,1.8885372726820036,3.054972659583108
IGROV-1,656346,1.6285470744333117,1.002454279141527
IGROV-1,613753,3.483244781428779,3.3005313932332045
RERF-LC-MS,44632017,0.7768655843829712,1.1126692997232817
LCLC-97TM1,10113978,4.598206277837053,3.123043780700616
LS180,136227924,2.415770069388299,2.976990168604877
Granta-519,5978,-7.678617575463935,-3.313610826537779
MOLM-13,2828334,5.861258184508348,5.696621148425818
ALL-SIL,3815108,1.81429533281988,1.858059850831352
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.222235621819018
LS180,10385095,1.937933801431244,1.184419851755953
SW1271,7326481,3.1173859417421985,2.9754246952096737
COR-L105,176870,-0.2151307909405896,3.463128964719944
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,4.078620436962899
HEL,6918878,-0.4197772532459504,0.48646956678153025
RCC10RGB,44589607,3.0966280095343777,3.348619795432937
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.5847237870119779
SW48,89183176,5.513741245898386,3.788113067530561
KU-19-19,168312962,-2.211081322704064,2.2418462371180072
LCLC-97TM1,11656518,-4.424964199082896,1.7727271078879108
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.751748821057509
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,3.603640887814897
WM115,6918328,0.4200257259119496,0.19860594174795718
RKO,44491742,4.905526099010324,4.036473195520746
SU-DHL-1,5280436,3.4353188558540895,2.8543195021624577
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.744497692100671
P31/FUJ,702558,3.294053878414949,4.132025596710175
MDST8,322968,3.292336134337166,3.9054618578849856
MOLP-8,66577038,2.4807994544381997,2.642142226930318
NCI-H2452,216239,2.289885444542123,2.3995304332718614
LS411N,24951314,1.1768436480242177,0.8668088400691017
HCC15,5291,3.948819619575577,3.9302538733616865
RERF-LC-MS,11152667,0.0782441689403026,-0.16942060379349377
NCI-H1568,285033,-1.965656578387781,-1.9949903463476915
K-562,119607,4.708269214175102,4.77420807120243
MOLM-13,6918328,-1.6668605659600593,-1.763124349558653
HuP-T3,51039095,3.318948357155543,2.8965922926725387
COR-L105,3025944,3.915005293474353,4.343689436822523
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.4861417250815494
NCI-H2452,42642645,0.8357005775142816,0.9965505558782604
PaTu 8988t,67156097,0.822255948885768,-0.42129464210027584
P31/FUJ,44507138,1.0120664141515707,0.9484342828516393
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,0.9175670449340942
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,0.40412590937136633
HCC15,10074640,3.1199478074334106,3.273581552991171
IGROV-1,53392493,2.352084848618059,2.5506020443416753
SK-HEP-1,135398516,1.8011759760648425,2.313692894899758
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,2.1592510447785314
IGROV-1,1242560,3.902441161940491,3.586070697937061
IGROV-1,24901704,3.0789156375765936,3.3206369378704554
RERF-LC-MS,23635314,-3.639251677232653,-1.4910769362394842
KU-19-19,56946209,-3.434845070293707,-3.6264207214722446
SK-CO-1,11427553,2.3636745936222177,2.937660968117393
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,2.2949025374114242
Panc 02.03,6852167,4.143336119644561,2.949600450781302
NCI-H1568,26596,-1.690126811671561,-1.0426845069241535
ALL-SIL,100016,4.099229681419155,5.192062259120365
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-0.8305626775417676
BICR 22,219104,4.618531153522784,3.888741637517979
HuP-T3,4378219,2.0668857590794767,2.9302326772218317
IGROV-1,11647372,-0.6595372928368528,0.941963313128303
BICR 31,46843906,2.802485697538939,3.1940138768770656
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,1.7602025511114427
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,2.070715178641457
PaTu 8902,65064,4.553320484088526,5.103920891704493
NCI-H1568,10410894,1.924104691976128,3.541115927929651
SU-DHL-1,72376,-3.386078956410557,-2.8070443313686235
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.71186627581385
NCI-H1568,16659841,3.88074746768202,4.039483446475148
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,1.6033807209582698
LS411N,54618164,4.167426775220608,3.917187095488891
MOLP-8,5287969,-2.4943575090146903,-1.9284734810034345
Granta-519,24856436,-2.399051702227432,-1.103470351992113
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.7144045935088812
BICR 22,3689413,1.1307119933583345,-0.30044720484451715
SW948,11494412,0.3616963479580831,1.458462177265127
RCC10RGB,3552672,3.073432883089278,2.9607301192545843
LCLC-97TM1,72376,-4.375427192181232,-2.0289686049834184
SW948,11234052,4.776317924055416,4.089726149386148
P31/FUJ,89928392,-0.2575535361410093,0.5390885151723503
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.7529501182747524
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,2.0857029706256736
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.8204627979191017
NCI-H2452,2742550,5.209305166760603,4.142232472975225
SW48,9884685,-1.5395746259931604,0.4246571718510051
SU-DHL-1,16722836,1.4294085247204618,1.4385392824084462
MOLP-8,11640390,2.6566405323234057,2.047708141682682
RKN,5113032,5.131058822839954,5.015264226275851
Panc 02.03,5311,2.7910052639268415,1.6029975502544676
HuP-T3,36462,3.380707637397105,2.254317453598307
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.5548830640832477
K-562,6852167,3.2696177089982807,1.9152019434572152
KU-19-19,16725315,4.810213458660102,4.3164138615253185
Daudi,44819697,-3.048561633253287,-1.546577198171489
NCI-H2452,73707398,1.4673083704761625,1.241718885279757
SU-DHL-1,6438330,0.8462618394668467,1.440203492904743
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,3.113879662768068
IGROV-1,400769,-0.5589612210030486,-0.6897832473664086
PaTu 8988t,6918736,-0.015847459349983,-1.6686313410521563
NCI-H2452,12003241,-1.7557808561862691,-1.0836377193977378
SW48,89928392,0.7467993581529679,1.7917308477018727
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,3.945508269571818
NCI-H2452,71466380,5.164331301376758,4.584377953241212
Panc 02.03,4917,3.7856869354758342,3.253153319366049
SW48,25062766,1.0755009410821956,2.0244349337273078
IGROV-1,4259181,0.1937358171291443,0.2344295659738771
BICR 31,46926350,-4.294934659479777,-3.6489693141335255
Granta-519,72199292,2.8103945289975623,0.38127802705904457
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.1769785658724485
MOLM-13,11222830,0.9845802392597008,0.536741007156571
SK-HEP-1,676352,1.798347685811885,2.1772142855892644
SK-CO-1,36314,-5.371942323616045,-0.7167195083405411
P31/FUJ,71466380,4.574945433624961,3.5773989287257986
PaTu 8988t,11427553,3.005069211450264,2.820197345855361
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.7755680608775544
NCI-H1568,151289,0.8908355813530987,1.1362477106176283
SW48,216345,1.323366684487305,3.651916783388619
SK-HEP-1,44819697,-0.1381867301228731,-0.4990590941009211
BFTC-909,24951314,2.3445794180209565,1.5029608255794684
SK-CO-1,107985,-2.728069079888901,-3.4302200710423176
BICR 22,168313016,4.910867780923905,4.831381733809066
SW48,3025986,-2.1875732043663048,-0.8601390130886629
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-3.077171593128741
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,2.599084048558649
HCC15,446155,0.1844871361320988,2.846298142896682
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.670784268477127
BFTC-909,56963564,-0.1720168824982637,0.5464408780113005
MOLP-8,151289,0.9447515089929442,0.601667731120978
HEL,11609586,2.7821230127549663,1.7276341807806017
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,3.0967819391895386
SW948,46174525,3.747184504681747,3.9519656930437193
HCC15,11964036,0.8100768326008368,1.328827689730653
SK-OV-3,53232,3.610813443380856,2.7111234927129884
NCI-H2452,9884685,3.2183676658345868,0.5626594077663591
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.5189178002835905
K-562,44241473,4.342180714885996,4.505106142797996
HCC1500,65628,4.452955395596753,4.355703990326868
MOLM-13,24771867,-2.755307399303063,-0.6081914025693688
RERF-LC-MS,168312962,0.3496483928324376,2.4774452541390284
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,2.8994124366295138
NCI-H1568,44589607,2.521775448277625,2.9760540817203394
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.249745437105476
Granta-519,5280436,1.7342596657129103,2.9063070799672484
NCI-H1568,72199292,0.3941551729128716,1.4539418688285246
SK-CO-1,439501,-2.410857533331093,-1.6515753715936452
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,0.6595574979430421
PaTu 8902,3038522,3.855914834510199,3.1246282954013593
SU-DHL-1,159324,0.2044468524757833,1.9668581540873276
BFTC-909,46398810,2.674147192871529,2.721098014360584
LCLC-97TM1,148198,-1.8422045751990368,-3.05328517392867
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,1.073296434582717
LS180,5351362,1.0497784443121565,1.5076915606509746
NCI-H1568,5311281,2.6261557759532974,2.6362459812684187
SW1271,44589607,3.6432775089048888,2.8273575326229063
RKO,54143018,-0.3751060369564643,0.5481877577371724
COR-L105,44607530,0.5885750535327339,1.8381736380879965
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-1.1441126291541823
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,1.2017991520557973
SW948,387447,-4.931777613053621,-4.493652152370641
BICR 31,168313016,4.3680397842259095,4.914454544024342
LS411N,36314,3.823716751686664,-0.9478945509245436
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,0.8762243335008318
MDST8,67291369,1.5579520311273356,2.9635891284199634
RERF-LC-MS,3062316,3.070306969339253,1.7014090395110364
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-1.5936877382476782
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-1.202116483358182
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,1.0257452403622764
MOLP-8,11964036,0.2292639686830329,0.5431981093984124
RKN,66577038,3.4891743358782104,3.0228272545644272
PaTu 8988t,5978,-2.779195325360685,-0.6544392426488413
RKO,8515,4.32265921632429,3.5170454382755336
SU-DHL-1,46907787,0.92481130470373,0.8940389431931461
COR-L95,216468,4.837628080392179,2.101965998944053
SW948,462382,0.505941174695894,0.8268446514128853
NCI-H1568,448949,1.6827994040181535,2.1583436743251387
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,2.012103765619733
NCI-H2452,10184653,1.4868368660739673,1.709401577373304
NCI-H2452,1285940,4.318373702463549,3.616700710812866
SW48,52912189,0.0060801339095902,1.9017810278110656
RERF-LC-MS,46926350,-4.177207395055215,-3.303533991152087
P31/FUJ,5978,-3.805650321394954,-3.2764509661740053
Daudi,4917,1.6956741153412938,2.73824009677486
LS411N,44507138,1.8249335905604152,2.3439929002739444
RERF-LC-MS,10231331,0.9954911948227504,2.578637807553428
HCC15,4261,-0.2961876318733478,1.8360571585799517
P31/FUJ,16722836,0.3472605187822769,0.8282856269989479
MOLP-8,45279963,3.839697844480557,3.257370638405565
NCI-H2452,446155,1.665772886963468,2.539905689426702
NCI-H2452,11609586,3.752552997604344,2.9366812371565403
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,1.1273581683329754
IA-LM,9933475,1.89794527933904,2.0065543275759885
MOLP-8,4477,0.6768027916096236,0.6629102369467205
IGROV-1,42642645,0.3750175292659389,0.8951668088073391
IGROV-1,6852167,1.5305143027352028,2.724939136727143
Daudi,5287969,-2.32062356362434,-2.337046242959684
WM115,44607530,1.3586937130527126,2.026110939779767
SU-DHL-6,5291,3.0098231219330422,3.0375055642689217
IA-LM,53392493,3.818463276064527,2.586774575230147
MOLP-8,5328940,1.3442597724286955,1.1892574922104695
NCI-H1568,11626560,1.7284579168385834,1.6848484888823916
NCI-H1568,9967941,2.084939505363619,3.8579001597336116
BICR 31,24856436,1.9770307243044476,0.7930109712363173
LS411N,6918289,4.168112514533401,1.6472775266941335
SK-CO-1,49766530,2.416603727276247,-0.1914339058091092
LS180,15547703,3.0095925001469577,2.867053015056929
SK-CO-1,24771867,2.6665073598645086,2.7701777768839144
MOLP-8,17755052,-0.3093261728985458,1.364702145107651
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.1402405246348373
NCI-H2452,6610216,4.12804282735119,4.31003008655707
RERF-LC-MS,16065773,2.958049600168222,2.6135824271031605
SaOS-2,6610216,4.351676798413151,4.400042331772983
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,1.8931106837843696
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,4.227151400788967
NCI-H1568,3854666,0.7326561551321923,2.0149747915006473
SU-DHL-1,11404337,-0.9851913382580488,-1.1746138811791285
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,4.9215119403733745
K-562,2746,2.4328857060914797,1.9019091967542667
Daudi,16038120,0.2901991168563289,0.4186760766616369
MOLM-13,71466380,3.777949844495899,3.6401557765819206
Panc 02.03,11955716,-1.8470517927785437,-1.2552385548696523
LCLC-97TM1,2858523,3.382646598163124,3.0323567210804456
SK-HEP-1,11234052,4.66363668535284,4.418497549632628
HCC1500,322968,2.559368987278369,3.36270135798323
COR-L95,24772860,-0.7858558168975444,-1.6848096531189753
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,2.239362311924023
SW1271,89928392,3.428275427880058,1.6145860254086628
RCC10RGB,24821094,3.8097926200280225,3.274751830492438
HEL,24753719,3.7144242054355985,3.719628478735929
K-562,445091,4.14956176193418,4.1746175793480385
HEL,136227924,2.725456875957553,2.49227050679047
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.7911063007221366
LCLC-97TM1,159324,3.194316902825419,2.4482208214434706
RERF-LC-MS,57519531,1.5399611647939,2.612925554603348
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.13526078289659318
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.7582618082768255
HCC1500,51037431,2.242858518427135,3.330919097143008
ALL-SIL,12003241,-5.746631994241774,-2.3028428586553273
P31/FUJ,44819697,-1.8374306821299025,-1.3356128398424014
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.310250352121845
MDST8,107970,2.8941750874079744,2.356346374377365
SK-OV-3,3503,3.0304882575129497,2.3707798783841265
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,3.629662203223512
HCC1500,9927531,5.051014893697188,4.820508234974496
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,3.226059376462408
HCC15,5328940,2.162982624771584,1.6396879109040636
Panc 02.03,11626927,4.481877662185247,3.784174530825961
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-2.0644698713291714
SU-DHL-6,2749,-0.5951367082815587,0.9212926418201793
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.2520463672477913
MDST8,135398516,1.8788362071916904,2.5913935942729465
MOLM-13,5328940,0.1532905912336842,0.8802702307346287
WM115,4477,-0.2872762876800434,0.7574427968783355
ALL-SIL,5746,-1.6673474530311534,-0.7099355312875243
PaTu 8902,25150857,2.644837375624729,2.596951877811142
MDST8,219104,3.7181204954875864,3.963158832510822
Daudi,11228183,2.4864875823277557,0.7182253391702864
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.233665562370068
Daudi,984333,-2.2486456844128333,-0.30771088039466105
Granta-519,12003241,-2.1147517064841925,-1.8943634440930237
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,3.7803637620530868
SW48,387447,-4.885505238560258,-3.741600081650859
COR-L105,36314,4.185071185075879,-0.33638953877529537
HuP-T3,4705,2.7233440783632608,3.3652694810069557
Panc 02.03,54678924,2.4878586568917536,2.1250599506127417
SW1573,16065773,3.287625611468905,2.284752612757396
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.7571959849989174
COR-L95,10385095,1.3959867651371194,1.068078286586523
P31/FUJ,2945648,2.3869646223252365,2.219956663864021
PaTu 8902,55283,3.4956890773009097,2.507573920855528
COR-L105,89183176,5.033590250009003,4.696217584602919
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,-0.05452712583933949
HCC1500,445091,4.393350110080019,4.349797704183362
SK-CO-1,11175137,2.477148698701912,2.5823385256077604
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,1.0064628575627175
BFTC-909,54618771,2.8225313881877545,1.1363561740872048
HCC1500,73707398,0.9868057798362108,1.1975462990426318
WM115,135398516,0.1940094116062491,2.212656558229368
SW948,11977753,-4.015233583581633,-1.3435593388245872
KU-19-19,446155,2.785852834205258,2.7536975831753927
BFTC-909,3854666,1.1654585644167257,1.8995949040414386
ALL-SIL,327653,2.0915878780614623,2.3233603742654223
RERF-LC-MS,2749,2.1448012118135176,2.2572937950415515
SK-CO-1,3503,2.662166466999906,2.2445829728076974
IA-LM,60700,0.8821511316384938,-0.09224998712535067
Panc 02.03,10302451,3.706546166543765,3.037467218850815
SaOS-2,45279963,3.893370234288743,3.717682740203999
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,3.0306296230688248
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-2.0175482419475697
K-562,11626560,-0.7477726232652755,1.0884574950865618
PaTu 8902,252682,7.782026892174048,6.493668946318771
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.7725639721145694
HCC1500,9887053,4.8738692747205175,3.798820367058883
IGROV-1,11717001,4.394306548697183,4.158609090348653
NCI-H2452,9911463,3.657985193851277,3.9198513837643842
HuP-T3,11707110,2.782188957571083,0.3366442469320874
COR-L105,5287620,-2.2558017577268665,-1.7808419043124157
K-562,9907093,4.115761716505682,3.6765449147576637
SW1573,53245473,3.5468633352222287,2.9155666558813738
COR-L95,100016,6.620829555802918,6.035094429227778
Granta-519,11178236,-5.517610268531398,-3.7548568067909436
IA-LM,3503,2.293282991199797,2.21098360530887
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,0.06273708434531212
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.465261454797478
MOLM-13,23635314,-2.1464398793300408,-2.328872779957605
WM115,45100481,5.666571363096329,4.634044343687245
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-3.10579703707456
COR-L105,5351362,1.5942690709113274,1.5966994744776846
IGROV-1,6610216,4.310938387105607,4.322452817271722
SK-CO-1,4521392,4.292734672993078,4.286059023462233
RERF-LC-MS,53232,1.207294902086358,2.497108107328483
NCI-H2452,16038120,1.767482091574877,1.056526363812643
LS180,107985,-4.080313435814333,-3.722995481908876
SU-DHL-1,24785538,0.8988368126388477,0.549431437236863
IGROV-1,11977753,-2.2284230058029433,-1.0437608059316792
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.4674994869707136
SW48,24964624,1.8073600797801577,2.2571448957326843
RKO,9911830,2.9376280530386123,1.9339575271870066
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,1.2357216142041356
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.9383246961969072
HEL,5287620,-1.51108604946339,-2.234301073658277
MDST8,11964036,-0.5107320494490124,1.6171609898364816
HCC1500,10385095,0.8648832931247582,1.2426257999872328
SW48,702558,4.851481027043998,4.937662340017099
BICR 22,15547703,3.054989624104991,3.091972948482223
LCLC-97TM1,375860,-0.9613247940016756,-0.06765343134134034
BICR 22,5566,3.0896765386345244,2.85450267292212
SW948,36462,2.9711779559511604,1.2190511387069163
SaOS-2,135411,0.7043200334589346,0.8429257748518819
SW1271,24889392,3.729104653817525,3.98774930876031
K-562,4917,1.7461656699737091,2.6823127492692436
MOLM-13,11964036,-0.3903680086882432,0.21995193028194093
SU-DHL-1,9907093,3.802209526559384,3.9741366516935432
MOLP-8,44507138,3.0437239609683515,1.4955433376912992
HCC15,441298,2.404091830829315,2.472022314213232
IGROV-1,246676,4.485924799339535,4.4593645210278146
IGROV-1,3136844,5.214591389089975,4.644571238491572
Daudi,119182,-1.0022442636317743,-2.7629546213261045
SK-CO-1,2742550,3.074063089907043,3.8599433014175535
COR-L95,5291,3.794551144961864,3.540283697198884
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,2.928312841788401
WM115,16219061,2.9198343751130036,3.4367038488292074
RERF-LC-MS,2871966,0.0193381278585586,0.8994315158345304
SW1271,44607531,2.0262821909932964,1.4731178143572745
NCI-H2452,53495165,2.6100799702143824,0.6814341450858993
SaOS-2,3825829,3.573326366415088,4.0324431835431
HEL,1242560,2.170830105823081,2.955975846403829
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,1.7664262422531931
MOLM-13,135423438,-5.2048777869707035,0.612435424382401
RKO,3815108,2.4813915623878264,2.468431260806689
SK-CO-1,57519531,1.3464743023672243,2.584859278586306
SU-DHL-1,2729026,1.1961155288156848,2.123962236677238
MOLP-8,57330099,4.408814311331857,4.142803847796932
SK-HEP-1,25262965,-1.9202339310426983,-1.158493396511608
HCC15,71466445,3.952377160133232,4.143631578243294
Daudi,49793307,-5.375388093698208,-3.877636459755597
RCC10RGB,52947716,3.397847809230189,-0.013847358987204399
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,1.8137955123276388
MOLM-13,10074640,2.6694741782411975,1.6571213026131153
HCC1500,16736978,0.2362509616809698,1.245830179064683
WM115,11228183,1.7654096487865938,2.4132153293993563
Granta-519,25150857,0.8022216450857215,1.7000658894394272
RERF-LC-MS,2858523,3.0171071482923826,3.1052233710741035
K-562,71466578,3.85538032532176,3.032110847387408
RKO,135875424,3.829354185480349,3.3156686663865025
HEL,4096211,2.9626104821001524,1.1136086684759783
LCLC-97TM1,67156097,-2.339870774569048,-0.9164309630320419
COR-L95,3503,2.5200783295079834,2.211352041113937
SW48,11609586,2.634017068041322,2.580213270998943
SU-DHL-1,375860,-0.8487932986720208,-0.47224146187931126
SU-DHL-1,5351362,0.9282229173955964,1.3287729184085533
SK-OV-3,6917907,1.1533351492785058,-4.8765640247169735
PaTu 8988t,65064,5.1728218990125,4.91617333362327
RKN,3503,2.6546301780010144,2.3898009889770098
IA-LM,23582824,0.7235929041173603,0.7275447472105472
IGROV-1,54143018,0.8385018685685798,0.5277005245682688
Daudi,11214940,1.5157277988308535,1.0810525916276539
SW948,4261,0.2066749270482282,1.3582954109872094
HuP-T3,15547703,4.355520728687953,3.123669106082413
NCI-H2452,24748573,1.1942514329138498,2.1740530264438913
IGROV-1,159324,2.8766947154825044,2.8303092799019094
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,-0.2276941293991857
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,0.39638779022344267
SU-DHL-1,3465537,3.713885766889003,1.955788195964104
NCI-H1568,60700,-0.8736945480852499,0.27274083151153716
P31/FUJ,3689413,-2.495432751898851,-1.3454449467460001
PaTu 8902,16722836,2.3982166809874768,1.8744698490476495
SW1271,452548,-0.0979853591066759,0.09165738816827218
HCC1500,9444,4.370086947523025,4.234413775634105
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-0.6013603485042979
MDST8,44137675,1.8173250203578384,3.6749143958545214
IGROV-1,5460769,1.6083174601829917,2.3052607097740268
SK-CO-1,10302451,2.4520332675877605,2.893080749361405
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.3156159637906714
SU-DHL-1,3384730,1.173741268518712,1.951769913892513
LS411N,11178236,-2.533537215148808,-2.9118015092015583
COR-L105,216239,2.81147830727615,2.420772535354656
MDST8,1750826,-3.2078848487443716,-1.524011940461116
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-0.49672702762186577
SW1573,3025986,2.659291536752942,-0.4540868273082942
SK-OV-3,73707398,1.4890038437616029,1.320514936579591
LCLC-97TM1,12003241,-0.8351557307101188,-0.9083423572465047
BFTC-909,1750826,-0.1726466566192349,-1.5493105409286405
WM115,44819697,0.4217395821242636,0.011827629244717346
Daudi,57330099,4.348234162675926,4.0480844609595
HCC15,6852167,3.485797740848402,2.8490828355598383
IGROV-1,23939,4.412541857664819,4.151528261924184
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,2.9139467799362446
MDST8,159324,4.143261975826356,3.0228258411338604
IGROV-1,9840324,5.720969888694302,5.558474647592273
LCLC-97TM1,36314,-6.600382606146434,-0.6497873774361517
UACC-812,11494412,1.976870257251046,1.6555255695776738
LS180,24785538,2.36344296814186,1.3850298232771063
SW1271,46398810,2.1181317502001864,2.5630621455738196
COR-L95,8515,4.297389552329342,3.693697252720629
HEL,67291369,-0.0398574366947598,1.2099634420995433
WM115,65064,5.519507799834776,4.824485010935365
K-562,11178236,-5.937287665657859,-3.553854471825902
MOLM-13,46398810,-0.3461491770759903,1.465273632861759
Daudi,49836020,3.49644839546437,2.564657400170581
SaOS-2,135659046,3.828911922642458,3.7946213802050663
MOLM-13,156422,2.6570896066322054,3.081389031578697
IGROV-1,11222830,1.5703285223102077,1.6423137331870301
MOLM-13,3062316,-0.5121609334560062,0.2258250420231332
RCC10RGB,24775005,3.7293513155953737,3.9093732732484083
Daudi,135411,0.411387979123234,-0.16461877372529163
HEL,6623618,1.8836955043929509,1.934643375003219
IGROV-1,5702613,4.420745339537274,3.1831876775102432
BICR 31,3025986,-1.7152493432112506,-0.513823603608884
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,0.8759716088118428
HuP-T3,46926350,-3.9956296104835447,-3.8617998123156756
SW948,11964036,0.9329377934210036,1.0566722387904794
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-1.8321682331991536
BICR 31,168313200,4.293337148285007,3.0669451228541824
LCLC-97TM1,613753,3.2994086878019693,3.135430238489674
NCI-H1568,2858523,2.9099207435493306,3.1145851004453537
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,2.2341405433481185
WM115,168312962,-0.8720769549309708,2.2885581041963534
COR-L105,3136844,4.323289843330604,4.5450898161498285
SaOS-2,24964624,2.194529135867758,2.6801187781418143
IGROV-1,322968,4.140599241163106,3.8211871453548945
SU-DHL-1,44259,0.9870469643742532,1.05034220613843
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,3.2104158922209565
Daudi,7326481,2.37278983949268,2.688315596683126
HCC1500,5284616,3.2143502285360395,1.2834696974452051
Granta-519,6918736,-3.0470654964091346,-2.2351163425464353
K-562,53232,2.317344808959498,2.9223117186311582
KU-19-19,6914657,-4.990300196809823,-3.793763111879715
Granta-519,72376,-3.0273971733074463,-3.3051692329285136
SW948,54678924,1.3690911042909353,2.0829103463217296
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,4.391986729383461
SU-DHL-1,2858523,2.096941494706986,2.8726023737841957
HCC15,11427553,0.4296382841284133,2.9277526666076725
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.0796614626188608
PaTu 8902,9444,4.223556509018044,4.201583524545415
Granta-519,10074640,3.4462174196318864,2.6146134322457204
NCI-H2452,11213558,2.927858740250081,2.101674968220714
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,3.177824693757795
SU-DHL-1,17755052,1.573040093702568,1.2797126485410566
HCC1500,44185566,2.7833515387265435,2.406269770234603
BFTC-909,107970,2.2861723254681774,2.415272916955206
WM115,46191454,1.770414974730312,1.655468954136883
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,3.2985857918436805
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,0.6299057543389239
SW48,984333,0.702746968378095,0.7037805779058027
MOLM-13,4378219,1.3750720877022855,1.9549285018132192
SK-CO-1,104842,-6.47047720162668,-2.503166183175864
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.4163557370617177
SU-DHL-1,753704,3.8222320630358344,4.625358468856294
NCI-H2452,11640390,3.686004280320225,3.762078323745289
IA-LM,44185566,3.1900951690600596,2.2801850299197715
SW948,24748573,3.0928652753553685,2.018569539287588
HCC15,16722836,0.9313515315756092,1.670418911505557
SK-CO-1,2858523,3.0692168261278345,3.0278740703966647
BICR 22,984333,1.5288435331300914,1.0696910614859492
WM115,46907787,1.8634039559333693,2.3797938287086775
K-562,135398516,2.1877631842117315,1.650993541108898
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.42222763378798644
SW1271,56649450,5.123918884487689,3.489858084850087
MOLM-13,73707438,4.222752629567675,3.7842680228618595
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,2.236863112262881
IGROV-1,9908783,5.873270433212515,4.984752061789001
COR-L105,100016,7.1590039780101895,6.428728821902093
MOLP-8,2733487,6.371854996101937,6.110470745779326
HuP-T3,40482356,5.071639396405957,3.0749455692281584
Daudi,10231331,6.134507235467236,1.0770261886642074
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.6968547453322942
ALL-SIL,135398738,2.8388897343309214,2.0997453891150584
Granta-519,15953870,3.078322892664931,2.719661173637719
SW1573,16722836,2.4665820842388606,1.8699024846188317
RKN,262093,2.5285063130840344,2.967092824122058
COR-L105,16736978,0.0668136597141226,1.9474701381386734
SU-DHL-1,3854666,0.5155348387571919,1.1322473901504932
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-3.566988986546437
HCC15,1242560,4.141842055686159,3.558122870317203
Daudi,227681,2.3413610492173533,2.8552561478231
BICR 22,9825149,1.9632507246672848,2.211074596317061
KU-19-19,57519531,2.7709295903751987,2.6947546588287286
HEL,675434,4.82305615478698,3.971809924732193
LCLC-97TM1,9927531,5.703886109604247,4.591954790618352
HCC1500,60700,0.3261825799377537,-0.039857064583806404
SK-HEP-1,3025986,-0.7748266135658505,-0.6072923954017062
LS180,5281321,-2.3743222213125703,-1.5777180872556535
RERF-LC-MS,11234052,4.094456859515875,4.388111580354497
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.4355070097216835
RERF-LC-MS,753704,5.128075002459309,5.139464782002085
ALL-SIL,71304818,1.8469641946240791,1.7188896650488923
LCLC-97TM1,2733526,4.142341185184233,3.827108713298136
SW1271,6918328,0.5991052607451842,0.02830552831484521
SW1271,24901704,3.681572165465946,3.3082044619683795
Granta-519,11656518,1.6452745070498538,0.49348031443102963
NCI-H2452,3025944,3.797054601848671,4.329311721457279
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,1.1303374854001271
RKN,24951314,1.3743916622304369,1.2989407645503492
SW1271,25126798,3.686543071113652,3.858227941204907
IGROV-1,6450551,2.579641476451469,2.7488953215962
IGROV-1,54454,2.453541831966438,2.7260297504660542
COR-L95,9936388,1.0197606854481494,-2.7575346600717983
Daudi,42611257,3.0497080994784307,2.528019351430665
BICR 22,54618771,-1.5156377594303725,0.8760405273355003
LCLC-97TM1,23939,4.339779460008714,4.181184808080588
NCI-H2452,46191454,2.4313233431346366,1.9381692300134987
COR-L105,42642645,1.1549939076973508,1.2602963878278468
MOLP-8,11609586,0.3617141221652126,1.9647840518342141
BICR 31,613753,3.1747241586791772,3.269988057720552
SU-DHL-1,5328940,1.3431964509037,1.342361907932552
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-1.7810356610473477
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.311278168093294
BFTC-909,11455910,1.958059547603208,0.8476723805005852
RERF-LC-MS,322968,4.758979615786181,4.115898323811002
KU-19-19,5351362,1.814646406429004,1.5092501568969525
MOLM-13,54649381,3.864277780400009,3.4986577764740847
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,1.784271660582776
NCI-H2452,72199292,1.1345413256627164,1.4176893601961127
MOLP-8,676352,1.5936675202889017,1.8793246330823865
HCC1500,676352,1.5631676801704226,2.071092817011068
COR-L95,51037431,4.395819234826154,3.077546748324888
Daudi,5328940,0.4604914818199462,1.056280182880158
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,-0.1516743224177604
IA-LM,168313200,3.804941602819176,2.9623083983735654
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.104777391878341
RKO,119182,-2.4803685643523,-1.689677656295682
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.4219387856382477
PaTu 8988t,25227462,0.2940996568558364,0.20115351036332446
SU-DHL-1,9929138,3.6810672504095385,5.467391947240214
SU-DHL-1,12003241,0.0778318253848937,-1.688943667883089
RKN,15547703,3.1395613683678287,3.1887074366993344
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,2.4992885646762826
MOLP-8,375860,-0.9263291950812266,-0.6706907388328041
PaTu 8988t,11234052,5.58672838892775,4.386642108656873
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.7199314910726249
SK-CO-1,126941,-2.257482818819106,-2.228142732734301
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.6112507177081552
LS180,3038522,3.8311766422201727,3.0032558051844362
SW948,1566236,2.0550116218076235,2.168776072588579
Granta-519,89928392,0.2978525114312038,0.2776201905791113
MOLP-8,19582717,2.2376953494036624,3.2290361091369335
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,1.0488246486843793
K-562,2874250,4.395305106833161,4.529986918154557
SU-DHL-1,11234052,1.0073590907004168,3.1022592762075614
BICR 22,73707398,1.4183060149157571,1.5089862436638648
COR-L95,46926350,-4.41571269577794,-4.643005268342712
Daudi,25154868,2.925803317483448,3.8568099060573626
HEL,16725315,4.4825385691379145,3.5065641967825583
IGROV-1,67291369,1.8066430555976296,2.289182331347584
PaTu 8988t,11404337,-0.5897258437911538,-0.44820779386777787
SK-CO-1,9911463,3.850014047184169,3.8319126767819864
LS411N,89928392,2.6081309937571655,1.3440789413078533
SW948,374536,1.478775672326772,1.9253887158253256
Daudi,3543504,2.1992036346279997,3.6854667255270757
NCI-H2452,5746,2.2152642195731818,1.324428567764247
K-562,451668,2.928523807666895,-1.1056777866973713
RERF-LC-MS,71680916,4.2559060280924665,4.640902129149338
BFTC-909,5311281,3.2468587214362175,2.368999830034793
HCC15,54649381,3.779002151510325,3.907520927727498
SaOS-2,6252,5.899001284083339,0.42978278515570184
SK-CO-1,2828334,6.603893313093487,6.177485594983094
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,3.9930172340304955
RKN,56946209,-4.407104587623599,-3.8504786964133775
P31/FUJ,54618164,3.783909273991047,3.597529450112282
P31/FUJ,46943432,0.8368365469264624,1.081065987808742
SU-DHL-1,24180719,4.350105317542874,3.2248149636764083
SK-CO-1,10113978,3.831664495659769,3.027532579237427
Granta-519,16659841,3.0104726191973756,2.99199757884784
HCC15,5329102,1.9423862085433257,2.2026300245349564
RKO,9903786,4.184024439899693,2.5252668596850327
Daudi,76446078,6.274042769130843,2.975207323252527
SU-DHL-1,5113032,6.615586057729586,4.898235735565344
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,2.9400171431071307
IA-LM,219104,4.299166533144503,3.673327930384003
P31/FUJ,5329102,0.6917422477571054,1.554876472353948
PaTu 8988t,5278396,4.086122365965545,3.7592432341854565
LCLC-97TM1,8515,3.105500626842055,3.8468440253621368
ALL-SIL,36314,-6.574209880787115,-2.8260483963422383
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,-0.46609203838170826
SU-DHL-1,252682,6.908372017357921,6.185420315649375
MOLM-13,24753719,4.086009941734247,3.5457481124305676
LS411N,119607,5.818355117504778,5.071901972977637
MOLM-13,66577038,2.3893764671204853,2.5341471698777807
HCC1500,25183872,-1.4621663438631347,-0.5711677968203874
KU-19-19,6917907,-4.52253618895935,-4.862474147991321
MOLM-13,11396600,-0.7885098330267027,2.7015382322766417
SW1271,25195348,2.4923805554625407,3.2189583959273875
NCI-H2452,15983966,-3.826639310361129,-0.8909620589283146
BICR 22,6184667,3.547514920621151,3.1228584748552417
IGROV-1,11396600,3.99372654279783,3.7382466468386273
PaTu 8902,24748573,3.607230896648149,2.3805140243398553
MDST8,54613361,0.3905773320508885,0.8262207924190232
SW948,136227924,2.9576701343794145,2.671026068632736
HEL,135411,-2.1892340188273836,-0.2026533842845809
RKN,322968,3.2277505791227776,3.9694833989744955
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.552971878649619
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,1.1732304259629476
COR-L105,444795,5.02091820523187,4.692655738862601
RERF-LC-MS,11175137,3.6286013190581503,2.703032295086432
RKN,54619267,4.894700718514424,4.0506214572450325
MDST8,54143018,0.2489025697900608,0.7577597666642242
LCLC-97TM1,4917,2.8423920861921803,3.125778409122412
Granta-519,60700,-4.015034522335836,-2.3101861303944253
MOLP-8,56649450,1.2499213171679169,2.883532419974195
RERF-LC-MS,11719255,3.775646564562419,3.519856058704383
BFTC-909,12001922,1.803559970478093,1.9022939818516846
MOLP-8,3384730,1.892166165987978,1.936235506036904
RKO,176870,5.862868084879783,3.1986912364441817
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.1613069169326982
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,1.1950046815475925
IGROV-1,24772860,-3.2892316801587835,-1.620644623931283
IA-LM,6450551,2.2909353415785403,2.347948912089318
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.6646985114464923
BFTC-909,6252,5.031852570794812,0.9647431134663619
BICR 31,9907093,4.585915925811977,4.237493324578178
MDST8,285033,-1.9150900594470792,-1.2156096479760654
MOLM-13,375860,-1.005106987112833,-0.6687215923056187
P31/FUJ,16725315,4.109597365862544,3.4911425945707326
IGROV-1,216345,3.498629789107092,3.7633839611102013
SW1271,208908,1.7498569635536685,2.124446425840729
COR-L95,11507802,0.9381723124038672,1.134645242794181
RERF-LC-MS,6918328,0.3946668064090056,0.31166829294862747
NCI-H1568,426756,4.294080241318686,4.726921717665524
K-562,67156097,-2.769244311294464,-1.8659555781454191
LS411N,2729026,2.9791300415919646,2.415257572255566
SK-HEP-1,2729026,3.094345392685322,2.8451447286852236
Panc 02.03,54618771,1.0884531427161812,1.2516490059174967
MDST8,5282054,3.0885738072945776,3.7876948599259714
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-1.0297679179479546
HEL,54143018,-0.2807045945993052,-0.3829706974935733
COR-L105,5278396,3.038896363429305,3.7086514840379197
SU-DHL-6,6450551,1.9173550036200224,1.347933583569536
LCLC-97TM1,1716436,2.9898763561132276,2.8200859949412576
K-562,54619267,3.679496217482672,3.6378247400208736
Granta-519,1641662,2.857235389717828,2.8226772731233307
PaTu 8902,219104,4.25826825351418,3.9565271125450967
NCI-H2452,24779724,6.409137734448782,4.707902802041851
RCC10RGB,2126,5.809199309072596,4.752351322344281
HuP-T3,24753719,4.122061219367772,4.331388584847067
RKN,44197249,3.9607888926275217,3.642690508925905
SU-DHL-1,44543605,4.013392575246718,3.7997817902341247
HEL,11455910,0.7002369428142345,0.327538671533594
SK-HEP-1,5281672,4.68841423543723,4.7788217366638746
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-1.3857088340522432
BICR 31,23582824,0.6119811525421108,1.0871418908821304
SW48,57330099,4.121753491452113,4.299205945592371
MOLP-8,3825829,4.0673932001437,3.418558286309355
Granta-519,5746,-3.467826904777232,-0.7193798145504282
K-562,46215462,1.6076592131491731,1.2473036386474654
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,-0.8854540989858054
MOLM-13,6852167,0.0474303723036755,1.3973624995601244
PaTu 8902,44819697,-0.6077719001286086,-0.28353005838124923
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,2.9712220682499293
HCC15,135875424,4.57405525423842,3.980914933756261
BFTC-909,6918736,-1.9066217610366931,-1.5401684225673824
MOLP-8,25195348,2.8158250690550215,2.6060810266023413
KU-19-19,11175137,2.6409229524549858,2.811104061020116
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,1.7394546871077659
SU-DHL-1,15983966,-4.109397573586815,-2.419978506961646
Granta-519,4705,3.4024179319436483,2.5728292971408346
SaOS-2,6450551,2.5324870379200113,2.4627838077382367
SU-DHL-1,6918837,-2.995399398295858,-4.1054677539513325
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,3.846710349821915
SW1573,159324,2.9705070550476274,3.0217082380424465
LS180,11625818,4.457813695022962,4.296238728956277
Granta-519,10296883,3.749738066673353,3.1050636878085403
Panc 02.03,285033,-1.023489563814438,-1.6481236740577807
SU-DHL-1,11175137,1.828860424721981,2.097402895003891
HEL,124202324,1.0355607531680788,1.1025461888681536
NCI-H1568,702558,5.469457182473135,5.102637738569865
IGROV-1,46191454,1.3777495915525844,1.6808407930597744
WM115,55283,3.7426713954425415,2.3819465763963756
SW948,7251185,1.827873481109932,2.261959306079923
MDST8,4521392,4.294685623216763,4.496575183021164
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.390606327975534
LS180,11455910,2.088798844266998,0.8911767099437872
NCI-H2452,151289,3.721937933525537,1.3891557083262893
LCLC-97TM1,11214940,1.4536772193180694,1.979679216819205
RKO,25062766,2.7314931301361476,1.912914901758581
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,0.5942670042147137
COR-L105,3385,6.244906352702261,4.275621569611254
IGROV-1,375860,0.7731558163124775,-0.20892438389637924
SU-DHL-1,9936388,0.846879508636978,-4.020367813014635
MOLP-8,11955716,-2.2423093620343666,-1.7907827052691159
IGROV-1,11455910,-0.2792640061206097,1.0139357818805728
HEL,216468,1.594172428774628,1.1765522575488057
K-562,216345,3.9110155346915088,3.5701238084415268
SK-HEP-1,6450551,3.663777137244395,2.968594410408485
Daudi,5460769,0.2326576177581661,1.699919094650343
BICR 22,1750826,0.8880077925102622,-1.0366007892934361
RERF-LC-MS,11238147,2.4729298726299147,2.9114742369294713
BFTC-909,54649381,4.487285574329416,3.853000922025647
RERF-LC-MS,9926054,1.8051014319834384,2.1154851376506594
IA-LM,1750826,-4.675530321169698,-1.87962382495703
BICR 22,46398810,2.733805979632988,2.5979677042871803
WM115,445643,3.76443753653658,4.042479866493544
LS411N,3689413,2.701640891749041,-0.4687089286760716
SW48,71304818,2.1411626536950323,2.3433816938360357
HuP-T3,5291,4.150853397708747,3.8782379329018797
SW48,9911463,3.374803590447597,3.7418365666955595
Daudi,16219061,1.2860438148144782,2.609942402565622
SaOS-2,9911830,2.995519789289086,2.3147263505893996
BFTC-909,5329102,1.9658448878596055,2.0091956184710282
NCI-H1568,53495165,-0.6133813456223128,0.5359164494485262
BICR 22,6918878,1.3704913724877863,3.184173519033771
SK-OV-3,4259181,0.9080230343390464,0.23062900129575042
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,3.1128902291013585
BFTC-909,445091,4.3207806819680625,4.497770004760141
WM115,2130404,3.451007656106494,3.3499406875955318
RCC10RGB,11152667,2.8531679730856268,-0.28319735669148727
HEL,5460769,3.63888115942649,1.9503613633902426
HEL,969516,2.4495484774391296,2.2276658222295573
MDST8,11152667,-1.6082048518025778,-0.07379027740355232
WM115,54596490,4.400808012137458,4.226944106920967
NCI-H2452,1716436,2.783046357832639,3.07553139265047
MOLM-13,4917,2.9272389210025955,2.498946478894896
ALL-SIL,119182,-4.503247338331098,-3.0352956259595927
MDST8,3552672,1.9687663546279843,2.849520405624025
HCC15,16720766,-0.3160262480808965,0.9235325250663838
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,1.951402015084775
MOLM-13,12003241,-3.578107028375036,-1.5834356808547765
SW948,24856436,-0.402936098482521,0.330330785911086
HCC1500,44202524,3.676243999694772,2.264525325143851
Daudi,4261,-0.6156785773872924,0.5815650916241698
MDST8,11507802,0.9258202338292296,2.11186796562852
BFTC-909,54626689,4.365294423210906,4.6034267737052685
NCI-H1568,16741245,4.262204040009308,4.192271780013827
HCC1500,25154868,1.8923567203600569,4.311281141005148
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,1.8791000955384072
COR-L105,3825829,4.424164708702568,4.1435488073724995
HEL,10074640,3.098757234686198,1.9322958629278812
RKO,44202524,1.4476976505001866,1.7149771710568251
SK-HEP-1,6852167,5.53454213252302,2.9287406331118744
